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A B S T R A C T
Background
Common mental health problems, such as depression and anxiety, are estimated to affect up to 15% of the UK population at any
one time, and health care systems worldwide need to implement interventions to reduce the impact and burden of these conditions.
Collaborative care is a complex intervention based on chronic disease management models that may be effective in the management of
these common mental health problems.
Objectives
To assess the effectiveness of collaborative care for patients with depression or anxiety.
Search methods
We searched the following databases to February 2012: The Cochrane Collaboration Depression, Anxiety and Neurosis Group (CC-
DAN) trials registers (CCDANCTR-References andCCDANCTR-Studies)which include relevant randomised controlled trials (RCTs)
from MEDLINE (1950 to present), EMBASE (1974 to present), PsycINFO (1967 to present) and the Cochrane Central Register
of Controlled Trials (CENTRAL, all years); the World Health Organization (WHO) trials portal (ICTRP); ClinicalTrials.gov; and
CINAHL (to November 2010 only). We screened the reference lists of reports of all included studies and published systematic reviews
for reports of additional studies.
Selection criteria
Randomised controlled trials (RCTs) of collaborative care for participants of all ages with depression or anxiety.
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Data collection and analysis
Two independent researchers extracted data using a standardised data extraction sheet. Two independent researchers made ’Risk of bias’
assessments using criteria from The Cochrane Collaboration. We combined continuous measures of outcome using standardised mean
differences (SMDs) with 95% confidence intervals (CIs). We combined dichotomous measures using risk ratios (RRs) with 95% CIs.
Sensitivity analyses tested the robustness of the results.
Main results
We included seventy-nine RCTs (including 90 relevant comparisons) involving 24,308 participants in the review. Studies varied in
terms of risk of bias.
The results of primary analyses demonstrated significantly greater improvement in depression outcomes for adults with depression
treated with the collaborative care model in the short-term (SMD -0.34, 95% CI -0.41 to -0.27; RR 1.32, 95% CI 1.22 to 1.43),
medium-term (SMD -0.28, 95% CI -0.41 to -0.15; RR 1.31, 95% CI 1.17 to 1.48), and long-term (SMD -0.35, 95% CI -0.46 to -
0.24; RR 1.29, 95% CI 1.18 to 1.41). However, these significant benefits were not demonstrated into the very long-term (RR 1.12,
95% CI 0.98 to 1.27).
The results also demonstrated significantly greater improvement in anxiety outcomes for adultswith anxiety treatedwith the collaborative
care model in the short-term (SMD -0.30, 95% CI -0.44 to -0.17; RR 1.50, 95% CI 1.21 to 1.87), medium-term (SMD -0.33, 95%
CI -0.47 to -0.19; RR 1.41, 95% CI 1.18 to 1.69), and long-term (SMD -0.20, 95% CI -0.34 to -0.06; RR 1.26, 95% CI 1.11 to
1.42). No comparisons examined the effects of the intervention on anxiety outcomes in the very long-term.
There was evidence of benefit in secondary outcomes including medication use, mental health quality of life, and patient satisfaction,
although there was less evidence of benefit in physical quality of life.
Authors’ conclusions
Collaborative care is associated with significant improvement in depression and anxiety outcomes compared with usual care, and
represents a useful addition to clinical pathways for adult patients with depression and anxiety.
P L A I N L A N G U A G E S U M M A R Y
Collaborative care for people with depression and anxiety
Many people suffer from depression and anxiety. These problems can make people feel sad, scared and even suicidal, and can affect
their work, their relationships and their quality of life. Depression and anxiety can occur because of personal, financial, social or health
problems.
‘Collaborative care’ is an innovative way of treating depression and anxiety. It involves a number of health professionals working with
a patient to help them overcome their problems. Collaborative care often involves a medical doctor, a case manager (with training in
depression and anxiety), and a mental health specialist such as a psychiatrist. The case manager has regular contact with the person
and organises care, together with the medical doctor and specialist. The case manager may offer help with medication, or access to a
‘talking therapy’ to help the patient get better.
Collaborative care has been tested with patients in a number of countries and health care systems, but it is not clear whether it should
be recommended for people with depression or anxiety.
In this review we found 79 randomised controlled trials (RCTs) (90 comparisons) including 24,308 patients worldwide, comparing
collaborative care with routine care or alternative treatments (such as consultation-liaison) for depression and anxiety. There were
problems with the methods in some of the studies. For example, the methods used to allocate patients to collaborative care or routine
care were not always free from bias, and many patients did not complete follow-up or provide information about their outcomes. Most
of the studies focused on depression and the evidence suggests that collaborative care is better than routine care in improving depression
for up to two years. A smaller number of studies examined the effect of collaborative care on anxiety and the evidence suggests that
collaborative care is also better than usual care in improving anxiety for up to two years. Collaborative care increases the number of
patients using medication in line with current guidance, and can improve mental health related quality of life. Patients with depression
and anxiety treated with collaborative care are also more satisfied with their treatment.
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B A C K G R O U N D
Description of the condition
Common mental health problems, such as depression and anxi-
ety, are highly prevalent with estimates of up to 15% of the UK
population affected at any one time (NICE 2011a). The preva-
lence of individual commonmental health disorders varies consid-
erably. The one-week prevalence rates from the Office of National
Statistics 2007 national survey were 4.4% for generalised anxiety
disorder, 3.0% for post-traumatic stress disorder (PTSD), 2.3%
for depression, 1.4% for phobias, 1.1% for obsessive compulsive
disorder (OCD), and 1.1% for panic disorder (McManus 2009).
Worldwide, depression affects about 154 million people, and an
estimated 5.8% of men and 9.5% of women will experience a de-
pressive episode in any given year (WHO 2001a).
Depression and anxiety are a major cause of disease burden and
disability (Ustun 2004) with depression projected to become one
of the three leading causes of burden of disease by 2030 (Mathers
2006). Symptoms of depression include: depressed mood; loss of
interest or pleasure in activities; insomnia or sleeping too much;
and fatigue or loss of energy. Symptoms of anxiety differ but can
include: excessive worry; feeling tense or restless; significant ten-
sion in muscles; and irritability (APA 2000). The impact of both
disorders on social and occupational functioning, physical health
and mortality is also substantial (Ormel 1999), and often anxi-
ety and depression present together, disabling the person further
(NICE 2011a). Depression also accounts for two-thirds of all sui-
cides (Sartorius 2001).
Depression and anxiety are often chronic in nature, characterised
by high rates of relapse and recurrence. Following their first episode
of depression, at least 50% of people will go on to have one or
more further episode(s), with the risk of relapse increasing to 70%
after the second episode, and as high as 90% after a third episode
(Kupfer 1991).
Description of the intervention
It is estimated that up to 90% of patients diagnosed with depres-
sion and anxiety are treated solely in primary care (NICE 2011a).
However, the management of these disorders is often suboptimal
(NHS 2002). The most common method of treatment for com-
mon mental health disorders in primary care is psychotropic med-
ication (NICE 2011a). There are problems with this approach, as
patients do not take the medication as prescribed for a variety of
reasons including fears of addiction, dependency and side effects
(Lingam 2002). Care for patients with chronic problems like de-
pression is often not proactive; patients do not receive ongoing
monitoring and care designed to reduce the burden of disorder
and the likelihood of recurrence and relapse (Buszewicz 2011).
It has been recognised that improving the treatment of common
mental health problems is a very complex task which requires
changes to the way care is provided, together with additional re-
sources to develop the appropriate systems to enable primary care
professionals to deliver high quality care (Gilbody 2003a; Katon
1997; Katon 2001). Four distinct models of quality improvement
in common mental health problems have been identified: training
primary care staff, consultation-liaison, replacement/referral, and
collaborative care (Bower 2005).
The collaborative care model is based on the principles of chronic
disease management applied to conditions such as diabetes. The
model can involve a large number of different interventions includ-
ing: screening, education of patients, changes in practice routines,
and developments in information technology (Wagner 1996).
Collaborative caremodels are exemplars of ’complex interventions’
which consist of a number of separate elements, where the particu-
lar elements that function as the ‘active ingredient’ can be difficult
to identify (Medical Research Council 2008).
The term ’collaborative care’ was first used to describe an interven-
tion which was delivered by a primary care provider and a psychi-
atrist (Katon 1995a). However, there have been significant devel-
opments in the model since that time, and thus clear specification
of the meaning of the term in line with current thinking is im-
portant. A widely accepted definition of collaborative care used in
a systematic review of complex system interventions requires that
four key criteria are met: a multi-professional approach to patient
care, structured management plan, scheduled patient follow-ups,
and enhanced inter-professional communication (Gunn 2006).
How the intervention might work
Research has suggested that a key aspect of effective collaborative
care is ’case management’ (Gilbody 2003a). Case management has
been described as a health worker taking responsibility for proac-
tively following up patients, assessing patient adherence to psy-
chological and pharmacological treatments, monitoring patient
progress, taking action when treatment is unsuccessful, and de-
livering psychological support (Von Korff 2001). Case managers
work closely with the primary care provider (who retains overall
clinical responsibility) and can receive regular supervision from a
mental health specialist (Gilbody 2003a; Katon 2001).
Why it is important to do this review
Collaborative care is a model of care for common mental health
problems which has generated worldwide interest in its effective-
ness and cost-effectiveness. Although a number of reviews of col-
laborative care have been published, significant uncertainties re-
main. Many trials are from the United States, and their generalis-
ability to other contexts and health care systems is unclear. Effec-
tiveness may vary by patient population; collaborative care was not
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recommended by the National Institute for Clinical Excellence
(NICE) for depression (NICE 2010) or anxiety (NICE 2011b),
but was recommended for depression in patients with chronic
disease (NICE 2009). The evidence base for collaborative care is
also rapidly developing. Mental health policy in the UK highlights
the importance of patient choice in treatments for mental health
problems, and collaborative care could provide another option for
services to complement other proven treatments. This review will
consolidate the developing body of evidence on collaborative care
and provide an up-to-date and rigorous assessment to inform pol-
icy and practice.
O B J E C T I V E S
This review aims to evaluate the effectiveness of collaborative care
for depression and anxiety.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all randomised controlled trials (RCTs), including
cluster-RCTs.
Types of participants
Participant characteristics: Trial participants were either male or
female patients of any age.
Diagnosis: Trial participants had a primary diagnosis of depression
(including: acute, chronic, persistent, remitted, subthreshold and
postnatal) or anxiety (including: generalised anxiety, panic, post-
traumatic stress disorder (PTSD), phobias, social anxiety, health
anxiety and obsessive compulsive disorder (OCD)). Diagnosis of
trial participants was according to one of the following: 1) diagno-
sis made by primary care provider; 2) ResearchDiagnostic Criteria
(RDC), Diagnostic and Statistical Manual (DSM) (APA 2000)
or International Classification of Diseases (ICD) (WHO 1992)
criteria; or 3) assessment through self-rated or clinician-rated vali-
dated instruments, e.g. Patient Health Questionnaire 9 (PHQ-9)
(Kroenke 2001), Beck Depression Inventory (BDI) (Beck 1987)
and/or Beck Anxiety Inventory (BAI) (Beck 1988). Some studies
included a mixed population, of which only a proportion were
depressed or anxious (e.g. where studies included a mix of patients
who were at-risk drinking, suicidal or depressed). These were in-
cluded only if themajority (>=50%)of participantswere depressed
and/or anxious, to ensure that the results of the study related to
our target group.
Comorbidity: Trial participants could also have long-term con-
ditions (i.e. asthma, diabetes, chronic obstructive pulmonary dis-
ease), as well as a common mental health problem.
Setting: Trial participants could be identified in a variety of health-
care settings (excluding in-patient/specialist mental health), but
the intervention had to be predominantly delivered in primary
care or community settings.
Types of interventions
Experimental intervention
This review has adopted four key collaborative care criteria (Gunn
2006). We regarded studies as collaborative care studies if they
fulfilled the following criteria.
1. A multi-professional approach to patient care. A primary
care provider (general practitioner, family physician, primary
care physician or a specialist providing undifferentiated medical
care) and at least one other health professional (e.g. nurse,
psychologist, psychiatrist, or pharmacist) or paraprofessional is
involved with patient care. For the purposes of the current
review, we characterised primary care as medical care involving
first contact and ongoing care to patients, regardless of the
patient’s age, gender or presenting problem (Boerma 1999;
WHO 2001b).
2. A structured management plan. Introduction of an
organised approach to patient care including access to evidence
based management information in the form of guidelines or
protocols. Management included either or both pharmacological
(e.g. antidepressant medication) and non-pharmacological
interventions (e.g. patient and provider education, counselling,
or cognitive behaviour therapy (CBT)).
3. Scheduled patient follow-ups. An organised approach to
patient follow-up defined as one or more scheduled telephone or
in-person follow-up appointments to provide specific
interventions, facilitate treatment adherence, or monitor
symptoms or adverse effects.
4. Enhanced inter-professional communication. Introduction
of mechanisms to facilitate communication between
professionals caring for the patient, including team meetings,
case conferences, individual consultation/supervision, shared
medical records, and patient-specific written or verbal feedback
between care-givers.
Comparator interventions
We included studies that compared collaborative care with ’usual
care’ (for example, routine primary care, waiting lists, or untreated
groups identified through screening) or collaborative care with
other interventions.
Based on analysis of studies identified in the review, we distin-
guished the following three types of usual care.
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1. Studies that provided no additional intervention in the
usual care group, including no notification of patient depression
status.
2. Studies that provided additional interventions in the usual
care group (such as education of primary care providers, or
notification of patient depression status), but where these aspects
of the intervention were applied to both arms, and potentially
cancelled out.
3. Studies that enhanced usual care by providing an
intervention that the collaborative care arm did not receive e.g.
where only primary care clinicians in the usual care arm received
training and educational materials on depression evaluation and
treatment (Asarnow 2005).
Based on analysis of studies identified in the review, we distin-
guished the following three types of ‘active comparisons’.
1. ‘Alternative interventions’ such as feedback alone,
consultation-liaison and enhanced referral, which were compared
with collaborative care.
2. ’Enhancements of collaborative care’ such as collaborative
care plus consultation-liaison, and collaborative care plus
psychotherapy, which were compared with collaborative care.
3. ‘Models of collaborative care interventions’ such as
collaborative care (medication) versus collaborative care
(psychotherapy), which were compared directly.
Types of outcome measures
Where relevant (i.e. for the effects of collaborative care on depres-
sion) we reported both continuous and dichotomous outcomes.
For dichotomous outcomes, studies generally reported either ‘re-
sponse’ outcomes (i.e. a≥ 50% reduction in symptom scores from
baseline) or ’remission’ (patients at each time point with scores un-
der a particular threshold). For consistency, we reported response
outcomes where possible.
Primary outcomes
Change indepressionor anxiety, asmeasured by observer or patient
self-report.
Secondary outcomes
• Medication for depression and/or anxiety. This was
reported as the proportion of patients using medication,
proportions meeting predefined levels of use, or proportions with
‘appropriate’ use according to guidelines or other measures. Such
data could be based on administrative data or patient self-report.
We pooled data relating to rates of use and adherence, and
administrative data and self-report.
We included the following outcomes only when a validated tool
was used.
• Social functioning, e.g. Social Adaptation Self-evaluation
Scale (SASS) (Bosc 1997).
• Quality of life, e.g. Short Form Health Survey (SF-36, SF-
12) (Ware 1993).
• Patient satisfaction, e.g. Client Satisfaction Questionnaire
(CSQ) (Attkinson 2003).
Timing of outcome assessment
We categorised outcomes as short-term (0 to 6 months), medium-
term (7 to 12 months), long-term (13 to 24 months), and very
long-term (25 months or more). We rounded down studies that
reported unconventional follow-up points (e.g. 27 weeks).
Search methods for identification of studies
CCDAN’s Specialised Register
The Cochrane Collaboration Depression, Anxiety and Neurosis
Group (CCDAN) maintain two clinical trials registers at their
editorial base in Bristol, UK; a references register and a studies-
based register. The CCDANCTR-References Register contains
over 29,500 reports of trials in depression, anxiety and neurosis.
Approximately 65% of these references have been tagged to indi-
vidual, coded trials. The coded trials are held in theCCDANCTR-
Studies Register and records are linked between the two registers
through the use of unique Study ID tags. Coding of trials is based
on the EU-Psi coding manual. Further details are available from
the CCDAN Trials Search Co-ordinator (TSC). Reports of trials
for inclusion in the registers are collated from routine (weekly)
generic searches ofMEDLINE (1950 to present), EMBASE (1974
to present), and PsycINFO (1967 to present); quarterly searches of
the Cochrane Central Register of Controlled Trials (CENTRAL);
and review specific searches of additional databases. Reports of tri-
als are also sourced from international trials registers c/o theWorld
Health Organization’s (WHO’s) trials portal (ICTRP) (http://
apps.who.int/trialsearch/), drug companies, the handsearching of
key journals, conference proceedings, and other (non-Cochrane)
systematic reviews and meta-analyses.
Details of CCDAN’s generic search strategies can be found on the
Group‘s website.
Electronic searches
We searched the CCDAN registers (to 9th February 2012) using
the following terms.
1. CCDANCTR-Studies
Condition = (depress* or dysthymi* or anxiety or anxious or panic
or *phobi* or obsessi* or compulsi* or post-traumatic) and
Intervention = (“care manag*” or “case manage*” or collaborat* or
”disease manag*“ or “enhanced care” or “managed care” or mul-
ticomponent or multi-component or multidisciplinary or multi-
disciplinary or stepped)
2. CCDANCTR-References
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TheCCDANCTR-References Register was searched using a more
sensitive set of terms to identify additional untagged/uncoded ref-
erences:
1. (depress* or dysthymi* or anxiety or anxious or *phobi* or
PTSD or post-trauma* or “post trauma*” or postrauma* or panic
or OCD or obsessi* or compulsi* or GAD) [ti, ab, kw]
2. ((collaborat* or coordinat* or co-ordinat* or shared or integrat*
or stepped or systematic) AND (care or healthcare or “health care”
or working or intervention* or service or model or effort* or man-
age*)) [free-text]
3. ((augment* or enhance*) AND (care* or healthcare or “health
care” or communicat*)) [free-text]
4. (“care manage*” or ”case manage*“ or “chronic care*” or “com-
plex intervention*” or “cooperative behav*” or “co-operative be-
hav*” or “joint working” or pathway or interprofessional or in-
ter-professional or interdisciplinary or inter-disciplinary or multi-
disciplin* or multi-disciplin* or multiprofession* or multi-profes-
sion* or transdisciplin* or trans-disciplin* or multifacet* or multi-
facet* or “complex intervention*” or “multiple intervention*” or
multi-intervention* or “organisational intervention*” or “organi-
zational intervention*” or “interpersonal relation*” or “ inter-per-
sonal relation*” or “interinstitutional relation*” or “inter-institu-
tional relation*” or “consultation liaison” or algorithm* or “treat-
ment guideline*” or “treatment protocol*” or “treatment delivery”
or “treatment model” or adherence or compliance or concordance
or “patient care team” or “patient care management” or “patient
care planning” or “case management” or “managed care program*”
or “delivery of healthcare” or “continuity of patient care” or “pro-
fessional-patient relations” or “interprofessional relations”) [free-
text]
5. (1 and (2 or 3 or 4))
3. CINAHL (1982 to 11th November 2010)
We conducted an additional search on CINAHL (Cumulative
Index to Nursing and Allied Health) (search strategy in Appendix
1).
4. International Trial Registers
We also carried out searches on the WHO trials portal (ICTRP)
and ClinicalTrials.gov to identify ongoing or unpublished studies
using the terms:
(”stepped care“ or ”collaborative care“ or interprofessional or in-
terdisciplinary or multidisciplinary). We imported and filtered re-
sults into Excel using terms for depression and anxiety.
Searching other resources
We checked the reference lists of reports of all included studies and
other systematic reviews for additional published, unpublished or
ongoing research.
Data collection and analysis
Selection of studies
Two review authors (JA and PB) independently scanned the iden-
tified studies and excluded studies according to the criteria above,
on the basis of titles and abstracts. We retrieved full copies of the
studies deemed eligible by one of the team (JA) for closer examina-
tion. If there was uncertainty or disagreement, we reached consen-
sus by discussion and consultationwith another review author (PB,
DR or SG). A log of all studies which initially appeared to meet
the inclusion criteria but which we later excluded on retrieval of
the full-text are detailed in the Characteristics of excluded studies
tables. We kept a record of the reasons for exclusion.
Data extraction and management
Content data were extracted by JA, DR, KL and LG and double-
extracted by research assistants/associates. Outcome data were ex-
tracted by PB and research assistants. A standardised data extrac-
tion form was used for the following characteristics.
1. The patient population (demographic and clinical
characteristics).
2. The nature of the intervention (e.g. types of interventions
used, contact between patient and professional, and amount of
collaboration between professionals).
3. Internal validity (assessment of risk of bias).
4. External validity (context of recruitment and methods of
recruitment).
We presented analyses using the following structure. In the anal-
ysis of primary outcomes we distinguished all collaborative care
interventions, separating studies by diagnosis (depression and anx-
iety) and age (adolescents and adults). Therefore analyses 1.1, 1.2
and 1.3 report outcomes for depression in adults, analyses 1.4, 1.5
and 1.6 report outcomes for anxiety in adults and analyses 2.1, 2.2
and 2.3 report outcomes for depression in adolescents. No studies
reported anxiety outcomes in adolescents.
We separately analysed primary outcomes reported as dichoto-
mous outcomes and as continuous outcomes. Each type of out-
come was reported at four time periods: 0 to 6 months, 7 to 12
months, 13 to 24 months, and 25+ months.
For the secondary outcome ofmedication use, we applied the same
analytical methods. The majority of studies reported medication
use using dichotomous outcomes; we excluded the minority re-
porting continuous outcomes.
For the secondary outcome of quality of life, we combined anal-
yses across collaborative care interventions for patients with de-
pression and anxiety. The majority of studies reported quality of
life using continuous outcomes; we excluded the minority report-
ing dichotomous outcomes. We split quality of life outcomes into
mental health quality of life (e.g. SF-36 emotional role, SF-mental
component score), and physical health quality of life (e.g. SF-36
physical functioning, SF-physical component score). We excluded
measures that did not report separate mental health and physical
health dimensions (e.g. EQ5D overall utility).
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For satisfaction outcomes, we combined analyses across collabora-
tive care intervention for patients with depression and anxiety. We
analysed satisfaction outcomes reported as dichotomous outcomes
and continuous outcomes separately. We only reported a single
satisfaction outcome point for each study, choosing the outcome
closest to six months as the likely best indicator of patient experi-
ence of the intervention, unaffected by memory or other bias.
As part of the protocol, we intended to report on social function
outcomes.However, a very wide variety of social function outcome
measures were reported, and there was a lack of clarity over their
definition, scope, and comparability. It was therefore not possible
to produce a rigorous synthesis in the time frame of the review.
We have extracted social function outcomes and may report on
these in a later update of the review when a suitable typology has
been developed to ensure consistency in analysis.
Assessment of risk of bias in included studies
For each included study, one review author (JA, PC, CD or DR)
and one research assistant/associate independently applied The
Cochrane Collaboration’s ’Risk of bias’ tool (Higgins 2011b). This
tool encourages consideration of:
1. selection bias due to inadequate generation of a randomised
sequence;
2. selection bias due to inadequate concealment of allocations
prior to assignment;
3. performance bias due to knowledge of the allocated
interventions by participants and personnel during the study
(blinding);
4. detection bias due to knowledge of the allocated
interventions by outcome assessors (blinding);
5. attrition bias due to amount, nature or handling of
incomplete outcome data;
6. reporting bias due to selective outcome reporting;
7. bias due to integrity of the intervention; and
8. bias due to other problems, such as:
• any potential source of bias related to the specific study
design used; or
• claims to have been fraudulent; or
• some other problem.
We used our comments to show how we assessed the risk of bias,
with judgements of either low risk of bias, unclear risk of bias,
or high risk of bias. If there was uncertainty or disagreement, we
reached consensus by discussion and consultation with another
review author (PC).
Measures of treatment effect
Studies in the review reported both dichotomous (e.g. recovered/
not recovered) and continuous outcomes (such as patient scores
on self-reported outcome scales). For dichotomous outcomes, we
calculated risk ratios (RRs) and 95% confidence intervals (CIs).
For continuous outcomes, as a range of different measures were
used, we calculated standardised mean differences (SMDs) and
95% CIs.
Unit of analysis issues
Cluster-randomised controlled trials
As collaborative care is an organisational intervention, cluster tri-
als are commonly used as a way of avoiding bias associated with
contamination. We identified studies using cluster randomisation
and we adjusted the precision of analyses based on these studies in
the meta-analysis using the ‘effective sample size’ method outlined
in the Cochrane Handbook for Systematic Reviews of Interventions
(section 16.3.4) (Higgins 2011a).We calculated the effective sam-
ple size of groups in each cluster trial on the basis of the original
sample size divided by the ‘design effect’. The design effect was
calculated by 1 + (M - 1) ICC, where M represents the average
cluster size and ICC is the intracluster correlation coefficient. We
assumed a common design effect across groups. For the base anal-
ysis we assumed an intra-class correlation of 0.02 (Adams 2004).
We examined the effect of adjustment for clustering in a sensitivity
analysis using intra-class correlations of 0.00 and 0.05 (Donner
2002).
Studies with multiple treatment groups
Where studies reported multiple collaborative care interventions
against a single control we extracted each collaborative care inter-
vention as a separate comparison and entered themwhere relevant
in themeta-analysis, dividing the control group sample size appro-
priately to avoid double-counting in the analysis. Where a study
reported a single collaborative care intervention against two differ-
ent types of controls (individual and cluster controls) we treated
this as two separate comparisons, dividing the intervention group
sample size to avoid double-counting in the analysis.
Dealing with missing data
We distinguished between two types of ‘loss’ of data: patients who
didnot complete their assigned collaborative care treatment (‘treat-
ment completion’) and patients who did not complete follow-up
for assessment of outcome (‘loss to follow-up’).
For ‘treatment completion’, we assessed whether the study used an
appropriate ’intention-to-treat’ analysis (including all patients in
the analysis irrespective of treatment completion) or ‘per proto-
col’ analysis (excluding patients who did not complete treatment
according to some defined criterion). We describe the approaches
used by individual studies in Characteristics of included studies.
To assess ’loss to follow-up’ in included studies, we also calculated
the proportion of randomised patients who were lost to follow-
up at the 0 to 6 month follow-up across arms, and within each
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arm, and also calculated the difference in the proportions between
collaborative care and usual care arms.
Data for the meta-analysis were missing for many outcomes, usu-
ally in terms ofmissing standard deviations (SDs) and sample sizes.
In a change from the study protocol, we did not contact all authors
to collect missing data as it was not possible to complete this task
in the time available for the review. We did contact two authors
for data in order to allow us to include their studies in the review
(McCusker 2008; Rost 2001a; Rost 2001b) as the data reported
in the published papers was not in the form required. We did not
impute missing data required for calculations of treatment effect
(e.g. missing SDs), but we did recalculate necessary parameters
frompublished data (e.g. calculating SDs frompublished standard
errors). When we update the review we will impute data for meta-
regression analysis to maximise the numbers of studies available
for the analysis.
Assessment of heterogeneity
We examined heterogeneity using the I² statistic, an estimate of the
percentage of total variation across studies that can be attributed
to heterogeneity rather than chance. This statistic is interpreted as
follows: 0% to 40% might not be important, 30% to 60% might
represent moderate levels of heterogeneity, 50% to 90% might
represent substantial levels of heterogeneity, and 75% to 100%
considerable heterogeneity (Deeks 2011). We calculated the 95%
confidence intervals around the I2 estimate using the Stata com-
mand heterogi. In the original protocol, we planned to use a ran-
dom-effects model where a moderate to high (50% or more) level
of statistical heterogeneity was found (Higgins 2003). However,
given the high levels of clinical and methodological heterogeneity
in terms of participants, interventions, comparisons and outcome
measures (see Characteristics of included studies), we used ran-
dom-effects models in all analyses.
Assessment of reporting biases
We examined funnel plots to test for asymmetry which can indi-
cate a number of issues including: selection bias (such as publi-
cation bias), poor methodological quality, and true heterogeneity
(Egger 1997).We also reported any instances of selective outcome
reporting in the ’Risk of bias’ assessment.
Data synthesis
We used a random-effects model for all meta-analyses.
Subgroup analysis and investigation of heterogeneity
From previous analyses we expected heterogeneity in terms of
treatment effects across different populations and types of inter-
ventions and we planned to examine these. Our primary analysis
was collaborative care versus usual primary care. Other planned
secondary analyses were to examine comparisons of different study
designs, participants and types of collaborative care. This would
include:
• types of participants
◦ country (United States, other)
◦ location of recruitment (primary care, community,
specialist, mixed); and location of delivery (primary care,
community, specialist, mixed)
◦ ethnicity (75% or more white, other)
◦ baseline severity (subthreshold, met criteria for major
depressive or anxiety disorder, mixed)
• the complexity of the intervention
◦ types of professionals (primary care provider and case
manager, or primary care provider, case manager and mental
health specialist)
◦ intervention intensity (measures of sessions, and
sessions multiplied by session length)
◦ intervention content (medication management alone,
psychological intervention alone, and combined).
We had planned to undertake a series of exploratory analyses us-
ing meta-regression, to examine the influence of these and other
study-level factors in predicting the magnitude and direction of
outcomes (Thompson 2002).We had planned to assess the signif-
icance of predictive factors (selected a priori and outlined above)
in explaining between-study heterogeneity, as measured by the I²
statistic, according to the method proposed in (Higgins 2004).
We did not undertake these further exploratory analyses due to
time constraints, but it is envisaged that we will include them in
the review update.
Sensitivity analysis
We conducted sensitivity analyses to assess the effects of excluding
certain types of studies: cluster trials; trials including patients on
the basis of comorbid physical conditions; studies considered at
high risk of bias based on concealment of allocation methods and
attrition (studies with > 20% loss to follow-up). We conducted
these sensitivity analyses only on depression outcomes (both con-
tinuous and dichotomous) at six months.
Following review, we also conducted a posthoc sensitivity analysis
on intervention length. Our analysis of outcomes was based on
time since randomisation (0 to 6 months, 7 to 12 months, 13
to 24 months, 25+ months), but some collaborative care inter-
ventions continue for periods of greater than six months, and it
is possible that the longer-term effects of collaborative care (i.e.
those in the 7- to 12-month period and beyond) do not reflect
any enduring effect of the intervention, but simply reflect those
interventions that are extended beyond the initial outcome period
(0 to 6 months). To assess this possibility, we coded studies as to
whether the intervention is completed in the 0- to 6-month out-
come point, or extended beyond that. In a sensitivity analysis, we
removed those studies where the intervention extended beyond six
months, to assess whether the effects found at the 7- to 12-month
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time point were significantly different when studies with longer-
term interventions were excluded.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies
Results of the search
After removal of duplicates, we identified 3473 references from
the searches. After assessing the titles and abstracts we checked
618 full-texts, and included 79 randomised controlled studies (90
individual comparisons) in the review (435 references; nine studies
had multiple comparisons) (see flow diagram in Figure 1).
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Figure 1. Study flow diagram.
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Included studies
We included 79 randomised controlled trials (RCTs) (90 compar-
isons) involving 24,308 participants in the review.
The ‘Characteristics of included studies’ table details the charac-
teristics of the studies, including study design, the characteristics
of participants, the characteristics of interventions and outcome
measures. These are summarised for the 90 comparisons below
(figures are rounded to nearest whole numbers, and so the overall
percentage does not always equal 100).
Design
All included comparisons were RCTs; 21 (23%) comparisons used
cluster randomisation, where the unit of randomisation was either
a primary care practice (n = 19) or a primary care provider (n = 2).
Setting
Sixty-eight comparisons (76%) were conducted in the US; 10
(11%) in the UK; five (6%) in other European countries (Ger-
many, The Netherlands); and seven (8%) from other countries
(Canada, Chile, India, Puerto Rico).
Sixty-nine comparisons (77%) recruited participants from pri-
mary care; eight (9%) from community settings; 11 (12%) from
specialist physical health settings; and two (2%) used a mixture of
primary/community/specialist settings.
Participants
Participant characteristics: Seventy-nine comparisons (88%) fo-
cused on adults aged 18 to 64 years; two (2%) on adolescents un-
der the age of 18; and nine (10%) on those 65 years or more. For
comparisons with available data (n = 70), 33 (47%) included a
sample of predominately white origin (classed as 75% or more of
the sample). Twenty-one comparisons (23%) included only those
who were taking medication for depression and/or anxiety at base-
line.
Diagnosis: Eighty-four comparisons (93%) included participants
with symptoms of depression or depression and anxiety; six (7%)
included only participants with anxiety disorders.
The diagnostic status of participants was identified in 45 compar-
isons (50%) using Research Diagnostic Criteria (RDC), Diagnos-
tic and Statistical Manual (DSM) (APA 2000) or International
Classification Disorder (ICD) (WHO 1992) criteria. In the re-
mainder, depression or anxiety status at point of entry was defined
by self-rated or clinician-rated validated instruments or by the pri-
mary care provider without the use of standardised measures or
criteria. In three comparisons (3%) participants did not have to
have symptoms of depression at baseline (Bartels 2004; Kroenke
2010;Williams 2007). As stated in the protocol, we included these
studies since at least 50% of participants had depression at base-
line, based on mean score of depression outcome measure or num-
bers provided.
Sixty-five comparisons (72%) includedparticipantswith both sub-
threshold and diagnosed major depressive or anxiety disorder; 23
(26%) included only those that met diagnostic criteria for major
depressive or anxiety disorder; and two (2%) included only sub-
threshold patients.
Sixteen comparisons (18%) had physical comorbidity as an in-
clusion criteria, such as, diabetes (Bogner 2010; Ell 2010; Katon
2004; Piette 2011), cancer (Dwight-Johnson 2005; Ell 2008;
Kroenke2010; Strong2008), epilepsy (Ciechanowski 2010), post-
stroke (Williams 2007), heart disease (Huffman 2011; Rollman
2009) or other/mix of conditions (Bogner 2008; Katon 2010;
Pyne 2011; Vera 2010).
Setting: In 82 comparisons (91%) the main healthcare provider
was based in primary care; in eight comparisons (9%) a specialist
provided general medical care.
Interventions
All comparisons had to meet the four criteria of collaborative care
stated in the protocol although there was considerable variability
in the exact nature of the intervention.
• A multi-professional approach to patient care: all
comparisons involved a primary care provider (generic medical
professional) and at least one other health professional (e.g.
psychiatrist, nurse, psychologist). In 78 comparisons (87%) the
intervention involved contributions from people with three
distinct roles (primary care provider, case manager, mental health
specialist); 12 (13%) involved two professional roles (primary
care provider and case manager, although in these comparisons
typically the case manager was a mental health specialist). In 50
comparisons (56%) the case manager was a mental health
practitioner; in 40 (44%) the case manager did not have a
professional background in mental health.
• A structured management plan: all comparisons included
an organised approach to patient care (e.g. evidence based
medication algorithm, manualised psychological interventions
such as behavioural activation or cognitive behaviour therapy
(CBT)). In 48 comparisons (53%) the intervention included
medication management and psychological therapy; 37 (41%)
included medication management only; and 5 (6%)
psychological therapy only.
• Scheduled patient follow-ups: all comparisons included an
organised approach to patient follow-up (e.g. scheduled
telephone or in-person follow-up appointments). In 49 (54%) of
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the comparisons the intervention lasted six months or less, in 31
(34%) comparisons the intervention lasted more than six
months, and it was unclear how long the intervention lasted in
10 (11%) comparisons.
• Enhanced inter-professional communication: all
comparisons introduced mechanisms to facilitate
communication between professionals (e.g. team meetings,
individual consultation/supervision, shared medical records, and
patient-specific written or verbal feedback between care-givers).
The duration of the intervention varied across studies and data
extraction was complex. Detailed data were not always reported,
and the intensity of collaborative care interventions is sometimes
contingent on short-termoutcomes rather thanbeing standardised
for all patients, and may be titrated over time so that an initial
high intensity intervention is replaced by low intensity monitoring
over the longer-term. We estimated that 32 comparisons (36%)
included an intervention of more than six months duration.
Wewill explore variability between studies inmeta-regression anal-
yses and include this in the updated review.
Comparison group
Thirty-four (38%) comparisons provided no additional interven-
tion in the usual care group. Fifty-two (58%) comparisons did
provide additional interventions in the usual care group (such as
education (guidelines or brief training session) for primary care
providers on the recognition and management of depression, or
notification of patient’s depression status) but these aspects of the
intervention were also applied in the intervention arm. One (1%)
comparison enhanced usual care by providing an intervention that
the collaborative care arm did not receive (Asarnow 2005). One
(1%) comparison did not describe usual care (Uebelacker 2011).
Excluded studies
Of the 3473 records screened, we excluded 2855 (82%) on title
and abstract. We retrieved 618 full-text articles and excluded 183
(30%) from the review. Of these, 27 did not meet study design
criteria (e.g. not RCTs), 97 did not meet intervention criteria (e.g.
the intervention was not focused on the depression or anxiety, only
included one professional, did not include enhanced communica-
tion or scheduled follow-ups), 18 did not meet diagnostic criteria
(e.g. less than 50% of participants were depressed or anxious at
baseline), and 41 were companion papers of the excluded ones.
The ‘Characteristics of excluded studies’ table lists those trials
which were potentially relevant (n = 37) but which did not meet
all the inclusion criteria for the review, together with the exact cri-
teria on which they were excluded. We excluded 24 because of the
type of intervention used, 11 because of the types of participants
included, and two because of study design.
Ongoing studies
Twenty studies are classified as ’ongoing’ (Characteristics of
ongoing studies). We contacted all lead authors of these studies,
and whilst some studies were complete, data were not published/
available in time to include in the review.
Studies waiting classification
Eight studies are awaiting classification because we either have
not been able to contact authors/are awaiting author response, the
study is completed and we are awaiting publication of results, or
translation was not possible within the time frame of the review
(Characteristics of studies awaiting classification).
Risk of bias in included studies
A graphical representation of the risk of bias in included studies is
presented in Figure 2.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Generation of random sequence
In sixty-three (70%) comparisons random sequence generation
was described adequately and we rated these as ‘low risk’ of bias.
In twenty-five (28%) comparisons the description of how the se-
quence was generated was either missing or there was insufficient
information available to make an assessment and we rated these as
‘unclear risk’ of bias. Two (2%) comparisons described methods
which were considered to be at ‘high risk’ of bias (Bartels 2004;
Roy-Byrne 2005).
Allocation
In forty (44%) comparisons there was adequate description of al-
location concealment and we rated these as ‘low risk’ of bias. In
forty-nine (54%) comparisons the description of allocation con-
cealment was either missing or there was insufficient information
available for assessment and we rated these as ‘unclear risk’ of bias.
One (1%) comparison described methods which were considered
to be at ‘high risk’ of bias (Gensichen 2009).
Blinding
Blinding of participants and personnel was not possible in any
case. We therefore rated all comparisons at ‘high risk’ of bias in
relation to this criterion.
Sixty-one (68%) comparisons described adequate blinding of
those completing outcome assessment and we rated these at ‘low
risk’ of bias. In twenty-two (24%) comparisons the description
of blinding of outcome assessment was either missing or there
was insufficient information available for assessment and we rated
these as ‘unclear risk’ of bias. Seven (8%) comparisons described
methods which we considered to be at ‘high risk’ of bias (Bartels
2004; Datto 2003; Gensichen 2009; Smit 2006a; Smit 2006b;
Smit 2006c; Wilkinson 1993).
Incomplete outcome data
In terms of the proportion of randomised patients whowere lost to
follow-up at the 0 to 6 month follow-up, for the 87 comparisons
where rates could be calculated, 26 (30%) had 10% or less loss
to follow-up, 38 (44%) had 11% to 20%, 14 (16%) had 21% to
30%, 6 (7%) had 31% to 40%, and 3 (3%) had 40% or more loss
to follow-up.
In terms of differences in the proportions between collaborative
care and usual care arms, seven (8%) comparisons had differences
of greater than 10% between trial arms.
Twenty-three (26%) comparisons did not have high rates of loss
to follow-up or imbalance and described adequate methods of
dealing with incomplete outcome data and we rated these as ‘low
risk’ of bias. In sixty-six (73%) comparisons the rates of loss to
follow-up or imbalance were high, the description of methods
for dealing with incomplete outcome data was missing, or there
was insufficient information available for assessment, and we rated
these as ‘unclear risk’ of bias. One (1%) comparison had high rates
of loss to follow-up and describedmethods of dealing withmissing
data which were considered to be at ‘high risk’ of bias (Uebelacker
2011).
Selective reporting
In twenty-five comparisons (28%) the authors had made proto-
cols available and reported on all expected outcomes, therefore we
rated these as ‘low risk’ of bias. Sixty-five comparisons (72%) did
not have a protocol available and/or insufficient information was
available to judge selective reporting, and we rated these as ‘unclear
risk’ of bias.
Other potential sources of bias
Using the three criteria to assess other potential sources of bias:
1) any potential source of bias related to the specific study design
used; 2) study claimed to have been fraudulent; or 3) some other
problem, we rated 81 comparisons (90%) as ’unclear risk’ of bias,
three (3%) as ’low risk’ of bias and six (7%) as ’high risk’ of bias.We
made the high risk of bias judgements based on analytical methods
used or cross-contamination, where case managers were specified
to provide care for patients in both usual care and collaborative
care groups.
Effects of interventions
1. Collaborative care versus usual care (adults)
1.1 and 1.2 Depression
Short-term: 0 to 6 months
Thirty comparisons (5984 participants) reported short-term con-
tinuous outcomes for depression for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (standard mean difference (SMD) -0.34, 95% CI -0.41 to -
0.27, I² = 34%) (Analysis 1.1).
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Forty-eight comparisons (11,250 participants) reported short-
term dichotomous outcomes for depression for collaborative care
versus usual care. Collaborative care was significantly more effec-
tive than usual care (risk ratio (RR) 1.32, 95% CI 1.22 to 1.43,
I² = 71%) (Analysis 1.2).
The funnel plots for the analyses of short-term continuous and
dichotomous outcomes are shown in Figure 3 and Figure 4. Nei-
ther showed marked evidence of asymmetry.
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Figure 3. Forest plot of comparison: 1 Collaborative care versus ’usual care’ (adults), outcome: 1.1
Improvement in depression symptoms.
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Figure 4. Forest plot of comparison: 1 Collaborative care versus ’usual care’ (adults), outcome: 1.2
Depression response.
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Medium-term: 7 to 12 months
Thirteen comparisons (4092 participants) reported medium-term
continuous outcomes for depression for collaborative care versus
usual care. Collaborative care was significantly more effective than
usual care (SMD-0.28, 95%CI -0.41 to -0.15, I² = 72%) (Analysis
1.1).
Twenty-nine comparisons (8001 participants) reported medium-
term dichotomous outcomes for depression for collaborative care
versus usual care. Collaborative care was significantly more effec-
tive than usual care (RR 1.31, 95% CI 1.17 to 1.48, I² = 83%)
(Analysis 1.2).
Long-term: 13 to 24 months
One comparison (1379 participants) reported long-term contin-
uous outcomes for depression for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (SMD -0.35, 95%CI -0.46 to -0.24, I² not applicable) (Anal-
ysis 1.1).
Six comparisons (2983 participants) reported long-term dichoto-
mous outcomes for depression for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (RR 1.29, 95% CI 1.18 to 1.41, I² = 0%) (Analysis 1.2).
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for depression for collaborative care versus usual care.
Five comparisons (943 participants) reported very long-term di-
chotomous outcomes for depression for collaborative care versus
usual care. There were no significant differences between the two
groups (RR 1.12, 95% CI 0.98 to 1.27, I² = 0%) (Analysis 1.2).
1.3 Antidepressant medication use
Short-term: 0 to 6 months
Forty-four comparison studies (10,117 participants) reported
short-term dichotomous outcomes for antidepressant medication
use. Collaborative care was significantly more effective than usual
care (RR 1.47, 95% CI 1.33 to 1.63, I² = 81%) (Analysis 1.3).
Medium-term: 7 to 12 months
Twenty-six comparisons (6486 participants) reported medium-
term dichotomous outcomes for antidepressant medication use.
Collaborative care was significantly more effective than usual care
(RR 1.43, 95% CI 1.26 to 1.61, I² = 78%) (Analysis 1.3).
Long-term: 13 to 24 months
Six comparisons (2963 participants) reported long-term dichoto-
mous outcomes for antidepressant medication use. Collaborative
care was significantly more effective than usual care (RR 1.22,
95% CI 1.03 to 1.45, I² = 54%) (Analysis 1.3).
Very long-term: 25 months or more
Three comparisons (232 participants) reported very long-term di-
chotomous outcomes for antidepressant medication use. There
were no significant differences between the two groups (RR 1.02,
95% CI 0.87 to 1.21, I² = 0%) (Analysis 1.3).
1.4 and 1.5 Anxiety
Short-term: 0 to 6 months
One comparison (876 participants) reported short-term continu-
ous outcomes for anxiety for collaborative care versus usual care.
Collaborative care was significantly more effective than usual care
(SMD -0.30, 95% CI -0.44 to -0.17, I² not applicable) (Analysis
1.4).
Four comparisons (1248 participants) reported short-term di-
chotomous outcomes for anxiety for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (RR 1.50, 95% CI 1.21 to 1.87, I² = 55%) (Analysis 1.5).
Medium-term: 7 to 12 months
One comparison (813 participants) reported medium- term con-
tinuous outcomes for anxiety for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (SMD -0.33, 95%CI -0.47 to -0.19, I² not applicable) (Anal-
ysis 1.4).
Five comparisons (1374 participants) reported medium- term di-
chotomous outcomes for anxiety for collaborative care versus usual
care. Collaborative care was significantly more effective than usual
care (RR 1.41, 95% CI 1.18 to 1.69, I² = 58%) (Analysis 1.5).
Long-term: 13 to 24 months
One comparison (804 participants) reported long-term continu-
ous outcomes for anxiety for collaborative care versus usual care.
Collaborative care was significantly more effective than usual care
(SMD -0.20, 95% CI -0.34 to -0.06, I² not applicable) (Analysis
1.4).
One comparison (804 participants) reported long-term dichoto-
mous outcomes for anxiety for collaborative care versus usual care.
Collaborative care was significantly more effective than usual care
(RR 1.26, 95% CI 1.11 to 1.42, I² not applicable) (Analysis 1.5).
Very long-term: 25 months or more
No comparisons reported very long-term continuous or dichoto-
mous outcomes for anxiety for collaborative care versus usual care.
1.6 Anxiety medication use
Short-term: 0 to 6 months
Three comparisons (1144 participants) reported short-term di-
chotomous outcomes for anxiety medication use. There were no
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significant differences between the two groups (RR 1.24, 95% CI
0.93 to 1.63, I² = 56%) (Analysis 1.6).
Medium-term: 7 to 12 months
Four comparisons (1225 participants) reported medium-term di-
chotomous outcomes for anxiety medication use. Collaborative
care was significantly more effective than usual care (RR 1.17,
95% CI 1.03 to 1.32, I² = 0%) (Analysis 1.6).
Long-term: 13 to 24 months
One comparison (804 participants) reported longer-termdichoto-
mous outcomes for anxiety medication use. There were no signif-
icant differences between the two groups (RR 1.09, 95% CI 0.92
to 1.30, I² not applicable) (Analysis 1.6).
Very long-term: 25 months or more
No comparisons reported very long-term dichotomous outcomes
for anxiety medication use.
1.7 Mental health quality of life
Short-term: 0 to 6 months
Fourteen comparisons (4954 participants) reported short-term
continuous outcomes for mental health quality of life. Collabo-
rative care was significantly more effective than usual care (SMD
0.26, 95% CI 0.13 to 0.38, I² = 76%) (Analysis 1.7).
Medium-term: 7 to 12 months
Eleven comparisons (3534 participants) reported medium-term
continuous outcomes for mental health quality of life. Collabo-
rative care was significantly more effective than usual care (SMD
0.20, 95% CI 0.09 to 0.31, I² = 58%) (Analysis 1.7).
Long-term: 13 to 24 months
Three comparisons (1278 participants) reported long-term con-
tinuous outcomes for mental health quality of life. Collaborative
care was significantly more effective than usual care (SMD 0.25,
95% CI 0.08 to 0.43, I² = 51%) (Analysis 1.7).
Very long-term: 25 months or more
Two comparisons (991 participants) reported very long-term con-
tinuous outcomes for mental health quality of life. There were no
significant differences between the two groups (SMD 0.10, 95%
CI -0.03 to 0.23, I² = 0%) (Analysis 1.7).
1.8 Physical health quality of life
Short-term: 0 to 6 months
Ten comparisons (2957 participants) reported short-term contin-
uous outcomes for physical health quality of life. There were no
significant differences between the two groups (SMD 0.06, 95%
CI -0.01 to 0.13, I² = 0%) (Analysis 1.8).
Medium-term: 7 to 12 months
Ten comparisons (4552 participants) reported medium-term con-
tinuous outcomes for physical health quality of life. There were no
significant differences between the two groups (SMD 0.07, 95%
CI -0.04 to 0.18, I² = 67%) (Analysis 1.8).
Long-term: 13 to 24 months
Four comparisons (2657 participants) reported long-term contin-
uous outcomes for physical health quality of life. Collaborative
care was significantly more effective than usual care (SMD 0.10,
95% CI 0.02 to 0.17, I² = 0%) (Analysis 1.8).
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for physical health quality of life.
1.9 and 1.10 Patient satisfaction
Ten comparisons (3333 participants) reported continuous out-
comes for patient satisfaction. Collaborative care was significantly
more effective than usual care (SMD 0.31, 95% CI 0.13 to 0.49,
I² = 82%) (Analysis 1.9).
Twenty-four comparisons (5500 participants) reported dichoto-
mous outcomes for patient satisfaction. Collaborative care was sig-
nificantly more effective than usual care (RR 1.27, 95% CI 1.18
to 1.38, I² = 75%) (Analysis 1.10).
2. Collaborative care versus usual care (adolescents)
2.1 and 2.2 Depression
Short-term: 0 to 6 months
Two comparisons (471 participants) reported short-term contin-
uous depression outcomes for collaborative care versus usual care
in adolescents. There were no significant differences between the
two groups (SMD -0.17, 95%CI -0.35 to 0.01, I² = 0%) (Analysis
2.1).
Two comparisons (460 participants) reported short-term dichoto-
mous outcomes for depression for collaborative care versus usual
care in adolescents. Collaborative care was significantly more ef-
fective than usual care (RR 0.73, 95% CI 0.56 to 0.96, I² = 0%)
(Analysis 2.2).
Medium-term: 7 to 12 months
One comparison (114 participants) reported medium-term con-
tinuous depression outcomes for collaborative care versus usual
care in adolescents. There were no significant differences between
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the two (SMD -0.32, 95% CI -0.69 to 0.05, I² not applicable)
(Analysis 2.1).
Two comparisons (441 participants) reported medium-term di-
chotomous outcomes for depression for collaborative care versus
usual care in adolescents. There were no significant differences be-
tween the two groups (RR 1.05, 95% CI 0.54 to 2.06, I² = 32%)
(Analysis 2.2).
Long-term: 13 to 24 months
No comparisons reported long-term continuous outcomes for de-
pression for collaborative care versus usual care in adolescents.
One comparison (322 participants) reported long-term dichoto-
mous outcomes for depression for collaborative care versus usual
care in adolescents. There were no significant differences between
the two groups (RR 0.75, 95% CI 0.51 to 1.11, I² not applicable)
(Analysis 2.2).
Very long-term: 25 months or more
No comparisons reported very long-term continuous or dichoto-
mous outcomes for depression for collaborative care versus usual
care in adolescents.
2.3 Antidepressant medication use
Short-term: 0 to 6 months
One comparison (335 participants) reported short-term dichoto-
mous outcomes for antidepressant medication use. There were no
significant differences between the two groups (RR 0.80, 95% CI
0.47 to 1.35, I² not applicable) (Analysis 2.3).
Medium-term: 7 to 12 months
One comparison (327 participants) reported medium-term di-
chotomous outcomes for antidepressant medication use. There
were no significant differences between the two groups (RR 0.80,
95% CI 0.47 to 1.39, I² not applicable) (Analysis 2.3).
Long-term: 13 to 24 months
One comparison (321 participants) reported longer-termdichoto-
mous outcomes for antidepressant medication use. There were no
significant differences between the two groups (RR 0.68, 95% CI
0.36 to 1.30, I² not applicable) (Analysis 2.3).
Very long-term: 25 months or more
No comparisons reported very long-term dichotomous outcomes
for antidepressant medication use.
2.4 Mental health quality of life
Short-term: 0 to 6 months
Two comparisons (471 participants) reported short-term contin-
uous outcomes for mental health quality of life. There were no
significant differences between the two groups (SMD 0.15, 95%
CI -0.03 to 0.33, I² = 0%) (Analysis 2.4).
Medium-term: 7 to 12 months
Two comparisons (441 participants) reported medium-term con-
tinuous outcomes for mental health quality of life. There were no
significant differences between the two groups (SMD 0.05, 95%
CI -0.24 to 0.33, I² = 47%) (Analysis 2.4).
Long-term: 13 to 24 months
One comparison (322 participants) reported medium-term con-
tinuous outcomes for mental health quality of life. There were no
significant differences between the two groups (SMD 0.09, 95%
CI -0.13 to 0.31, I² not applicable) (Analysis 2.4).
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for mental health quality of life.
2.5 Physical health quality of life
Short-term 0 to 6 months
One comparison (127 participants) reported short-term contin-
uous outcomes for physical health quality of life. There were no
significant differences between the two groups (SMD -0.25, 95%
CI -0.59 to 0.10, I² not applicable) (Analysis 2.5).
Medium-term: 7 to 12 months
Two comparisons (114 participants) reported medium-term con-
tinuous outcomes for physical health quality of life. There were no
significant differences between the two groups (SMD 0.12, 95%
CI -0.25 to 0.49, I² not applicable) (Analysis 2.5).
Long-term: 13 to 24 months
No comparisons reported long-term continuous outcomes for
physical health quality of life.
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for physical health quality of life.
2.6 Patient satisfaction
Two comparisons (471 participants) reported continuous out-
comes for patient satisfaction. There were no significant differ-
ences between the two groups (SMD 0.09, 95% CI -0.38 to 0.57,
I² = 82%) (Analysis 2.6).
No comparisons reported dichotomous outcomes for patient sat-
isfaction.
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3. Collaborative care versus feedback (adults)
3.1 Depression
Short-term: 0 to 6 months
No comparisons reported continuous outcomes for depression for
collaborative care versus feedback.
One comparison (396 participants) reported dichotomous out-
comes for depression for collaborative care versus feedback. Col-
laborative care was significantly more effective than feedback (RR
1.25, 95% C I 1.02 to 1.53, I² not applicable) (Analysis 3.1).
Medium-term: 7 to 12 months
No comparisons reported medium-term continuous outcomes for
depression for collaborative care versus feedback.
No comparisons reported medium-term dichotomous outcomes
for depression for collaborative care versus feedback.
Long-term: 13 to 24 months
No comparisons reported long-term continuous outcomes for de-
pression for collaborative care versus feedback.
No comparisons reported long-term dichotomous outcomes for
depression for collaborative care versus feedback.
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for depression for collaborative care versus feedback.
No comparisons reported very long-term dichotomous outcomes
for depression for collaborative care versus feedback.
4. Collaborative care versus consultation-liaison
(adults)
4.1 Depression
Short-term: 0 to 6 months
No comparisons reported continuous outcomes for depression for
collaborative care versus consultation-liaison.
One comparison (77 participants) reported short-term dichoto-
mous outcomes for depression for collaborative care versus consul-
tation-liaison. There were no significant differences between the
two groups (RR 1.30, 95% CI 0.43 to 3.89, I² not applicable)
(Analysis 4.1).
Medium-term: 7 to 12 months
One comparison (77 participants) reported medium-term di-
chotomous outcomes for depression for collaborative care versus
consultation-liaison.Therewere no significant differences between
the two groups (RR 1.14, 95% CI 0.40 to 3.22, I² not applicable)
(Analysis 4.1).
Long-term: 13 to 24 months
No comparisons reported long-term continuous or dichotomous
outcomes for depression for collaborative care versus consultation-
liaison.
Very long-term: 25 months or more
No comparisons reported very long-term continuous or dichoto-
mous outcomes for depression for collaborative care versus con-
sultation-liaison.
5. Collaborative care plus consultation-liaison versus
collaborative care (adults)
5.1 Depression
Short-term: 0 to 6 months
One comparison (128 participants) reported short-term dichoto-
mous outcomes for depression for collaborative care plus consulta-
tion-liaison versus collaborative care. Collaborative care plus con-
sultation-liaison was significantly more effective than usual care
(RR 1.27, 95% CI 1.00 to 1.62, I² not applicable) (Analysis 5.1).
Medium-term: 7 to 12 months
No comparisons reported medium-term dichotomous outcomes
for depression for collaborative care plus consultation-liaison ver-
sus collaborative care.
Long-term: 13 to 24 months
No comparisons reported long-term dichotomous outcomes for
depression for collaborative care plus consultation-liaison versus
collaborative care.
Very long-term: 25 months or more
One comparison (133 participants) reported very long-term di-
chotomous outcomes for depression for collaborative care plus
consultation-liaison versus collaborative care. There were no sig-
nificant differences between the two groups (RR 1.31, 95% CI
0.80 to 2.16, I² not applicable) (Analysis 5.1).
6. Collaborative care versus enhanced referral
(adults)
6.1 Depression
Short-term: 0 to 6 months
One comparison (1220 participants) reported continuous out-
comes for depression for collaborative care versus enhanced refer-
ral. There were no significant differences between the two groups
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(SMD 0.08, 95% CI -0.03 to 0.19, I² not applicable) (Analysis
6.1).
No studies reported dichotomous outcomes for depression for
collaborative care versus enhanced referral.
Medium-term: 7 to 12 months
No comparisons reported medium-term continuous outcomes for
depression for collaborative care versus enhanced referral.
Long-term: 13 to 24 months
No comparisons reported long-term continuous outcomes for de-
pression for collaborative care versus enhanced referral.
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for depression for collaborative care versus enhanced referral.
7. Collaborative care (psychotherapy) versus
collaborative care (medication) (adults)
7.1 Depression
Short-term: 0 to 6 months
No comparisons reported continuous outcomes for depression for
collaborative care (psychotherapy) versus collaborative care (med-
ication).
One comparison (521 participants) reported short-term dichoto-
mous outcomes for depression for collaborative care (psychother-
apy) versus collaborative care (medication). There were no signif-
icant differences between the two groups (RR 1.00, 95% CI 0.87
to 1.15, I² not applicable) (Analysis 7.1).
Medium-term: 7 to 12 months
No comparisons reported continuous outcomes for depression for
collaborative care (psychotherapy) versus collaborative-care (med-
ication).
One comparison (513 participants) reported medium-term di-
chotomous outcomes for depression for collaborative care (psy-
chotherapy) versus collaborative care (medication). There were no
significant differences between the two groups (RR 1.02, 95% CI
0.88 to 1.18, I² not applicable) (Analysis 7.1).
Long-term: 13 to 24 months
No comparisons reported continuous outcomes for depression for
collaborative care (psychotherapy) versus collaborative care (med-
ication).
One comparison (523 participants) reported long-term dichoto-
mous outcomes for depression for collaborative care (psychother-
apy) versus collaborative care (medication). There were no signif-
icant differences between the two groups (RR 1.02, 95% CI 0.88
to 1.17, I² not applicable) (Analysis 7.1).
Very long-term: 25 months or more
No comparisons reported continuous outcomes for depression for
collaborative care (psychotherapy) versus collaborative care (med-
ication).
One comparison (485 participants) reported very long-term di-
chotomous outcomes for depression for collaborative care (psy-
chotherapy) versus collaborative care (medication). There were no
significant differences between the two groups (RR 1.03, 95% CI
0.90 to 1.18, I² not applicable) (Analysis 7.1).
8. Collaborative care plus psychotherapy versus
collaborative care (adults)
8.1 and 8.2 Depression
Short-term: 0 to 6 months
One comparison (43 participants) reported continuous outcomes
for depression for collaborative care plus psychotherapy versus col-
laborative care. There were no significant differences between the
two groups (SMD -0.27, 95% CI -0.87 to 0.33, I² not applicable)
(Analysis 8.1).
Two comparisons (488 participants) reported short-term dichoto-
mous outcomes for depression for collaborative care plus psy-
chotherapy versus collaborative care. There were no significant
differences between the two groups (RR 1.14, 95% CI 0.97 to
1.33, I² = 0%) (Analysis 8.2).
Medium-term: 7 to 12 months
No comparisons reported medium-term continuous outcomes for
depression for collaborative care plus psychotherapy versus collab-
orative care.
One comparison (41 participants) reported medium-term di-
chotomous outcomes for depression for collaborative care plus
psychotherapy versus collaborative care. There were no significant
differences between the two groups (RR 1.17, 95% CI 0.79 to
1.75, I² not applicable) (Analysis 8.2).
Long-term: 13 to 24 months
No comparisons reported long-term continuous outcomes for de-
pression for collaborative care plus psychotherapy versus collabo-
rative care.
No comparisons reported long-term dichotomous outcomes for
depression for collaborative care plus psychotherapy versus collab-
orative care.
Very long-term: 25 months or more
No comparisons reported very long-term continuous outcomes
for depression for collaborative care plus psychotherapy versus
collaborative care.
One comparison (137 participants) reported very long-term di-
chotomous outcomes for depression for collaborative care plus
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psychotherapy versus collaborative care. There were no significant
differences between the two groups (RR 1.43, 95% CI 0.90 to
2.26, I² not applicable) (Analysis 8.2).
Sensitivity analyses
Themain analysis of the effects of collaborative care on continuous
depression outcomes at six months (SMD -0.34, 95% CI -0.41 to
-0.27) was notmarkedly changedwhen the intracluster correlation
coefficient (ICC) used to analyse cluster comparisons was 0.00
(SMD -0.33, 95% CI -0.39 to -0.26) or 0.05 (SMD -0.34, 95%
CI -0.41 to -0.26) (Analysis 1.1).
The main analysis of the effects of collaborative care on contin-
uous depression outcomes at six months (SMD -0.34, 95% CI -
0.41 to -0.27) was not markedly changed when sensitivity analy-
sis removed cluster comparisons (SMD -0.37, 95% CI -0.46 to -
0.28), comparisons with inclusion criteria of physical comorbidity
(SMD -0.29, 95% CI -0.37 to -0.21) or comparisons at unclear
or high risk of bias in terms of allocation concealment (SMD -
0.34, 95% CI -0.42 to -0.26) or loss to follow-up (SMD -0.33,
95% CI -0.40 to -0.26) (Analysis 1.1).
The effects of collaborative care on continuous depression out-
comes at 12months (SMD-0.28, 95%CI -0.41 to -0.15) changed
to SMD -0.19 (95% CI -0.30 to -0.08) when comparisons in-
cluding intervention beyond six months were removed.
The main analysis of the effects of collaborative care on dichoto-
mous depression outcomes at six months (RR 1.32, 95% CI 1.22
to 1.43) was not markedly changed when the estimates of the ICC
used to analyse cluster comparisons were 0.00 (RR 1.32, 95% CI
1.22 to 1.42) or 0.05 (RR 1.34, 95% CI 1.23 to 1.45) (Analysis
1.2).
The main analysis of the effects of collaborative care on dichoto-
mous depression outcomes at six months (RR 1.32, 95% CI 1.22
to 1.43) was not markedly changed when sensitivity analysis re-
moved cluster comparisons (RR 1.35, 95%CI 1.22 to 1.49), com-
parisons with inclusion criteria of physical comorbidity (RR 1.26,
95% CI 1.16 to 1.37) and comparisons at unclear or high risk of
bias in allocation concealment (RR 1.37, 95% CI 1.21 to 1.57) or
loss to follow-up (RR 1.36, 95% CI 1.24 to 1.49) (Analysis 1.2).
The effects of collaborative care at 12 months (RR 1.31, 95%
CI 1.17 to 1.48) changed to RR 1.19 (95% CI 1.06 to 1.34)
when comparisons including intervention beyond sixmonthswere
removed.
D I S C U S S I O N
Wehave summarised a large body of evidence from 79 randomised
controlled trials (RCTs) (90 comparisons) which predominantly
compare collaborative care with usual care, although there are a
small number of comparisons of types of collaborative care, or
comparisons of collaborative care and other active interventions.
This is the first Cochrane review of this body of evidence and our
main findings are outlined below.
Summary of main results
Collaborative care versus usual care (adults)
In terms of primary outcomes, collaborative care for patients with
depression is more effective than usual care in terms of depression
outcomes at around six months, 12 months, and 24 months, al-
though the effects were not significant after 24months. Collabora-
tive care for patients with anxiety is more effective than usual care
in terms of anxiety outcomes at around six months, 12 months
and 24 months.
In terms of secondary outcomes, collaborative care for patients
with depression increases rates of antidepressant use at around six
months, 12 months and 24 months, although the effects are not
significant beyond 24 months. Collaborative care for patients with
anxiety led to significantly higher rates of anxiety medication use
at 12 months.
Collaborative care is more effective than usual care in terms of
mental health quality of life at around six months, 12 months and
24 months. Collaborative care is more effective than usual care in
terms of physical health quality of life at around 24 months only.
Collaborative care is more effective than usual care in terms of
patient satisfaction post-intervention.
Other comparisons
Collaborative care was not significantly more effective than usual
care in adolescents with depression at around six months or 12
months whenmeasured using continuous outcomes, although the
intervention was significantly more effective than usual care at six
months when measured using dichotomous outcomes. Collabo-
rative care for adolescents with depression had no significant ef-
fects on antidepressant use. There were no significant differences
in mental or physical health quality of life or patient satisfaction.
There were a limited number of randomised comparisons of col-
laborative care versus other interventions. Collaborative care was
significantly more effective than feedback alone, but no more ef-
fective than consultation-liaison or enhanced referral. There was
limited evidence that adding consultation-liaison to collaborative
care was significantly more effective than collaborative care alone
at around six months only. There were no significant differences
between collaborative care and psychotherapy compared with col-
laborative care alone. There were no differences between collabo-
rative care based on a psychotherapy model, and collaborative care
based on a medication model.
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Overall completeness and applicability of
evidence
This review has included 79 RCTs (90 comparisons) of collabo-
rative care most of which focus on improving mental health out-
comes for adults with depression in primary care. This means that
collaborative care for anxiety and depression is one of the most
well evaluated interventions in mental health in primary care.
Types of study design
Most studies were individually randomised trials but a proportion
(21; 23%) used cluster randomisation. Cluster-RCTs are recom-
mended for testing systems-level interventions such as collabora-
tive care (Ukoumunne 1999), as patient randomised trials may be
vulnerable to contamination i.e. changes in the behaviour of pri-
mary care providers influenced by system-level changes such as ad-
vice frommental health specialists and routine screening and feed-
back of patients’ mental health status (Richards 2008a). However,
cluster-RCTs generally require larger patient samples and may be
vulnerable to other sources of bias (selective patient recruitment
after cluster randomisation; baseline imbalance due to the smaller
number of clusters recruited; loss of clusters; and incorrect analy-
sis). This review explored the inclusion of cluster-RCTs in sensi-
tivity analysis and there was no evidence that the main outcomes
were sensitive to the inclusion of such trials, or the estimates of the
level of clustering used to estimate outcomes in the meta-analysis.
Types of participants
Although themajority of the included studies have been conducted
in the US, more studies are being conducted worldwide, and the
positive outcomes reported in the US do seem to be replicated in
other countries in Europe (Chew-Graham 2007; Gensichen 2009;
Richards 2012) and wider contexts (Araya 2003; Patel 2010; Rojas
2007). However, given the more limited evidence base, the main
findings of the review need to be interpreted with more caution
when considering other settings.
Originally, collaborative care studies were conducted on patients
with depression. However, more recently the study of collabora-
tive care has diversified, recruiting participants with anxiety disor-
ders, and patients with diagnosed physical health conditions (e.g.
specialist centres treating people with lung cancer or diabetes).
Clinical diagnosis was not necessarily a prerequisite for inclusion
in the studies and therefore we included a wide range of symp-
toms and/or disorders (subthreshold, mild and major depression,
chronic, postnatal). Studies that use diagnostic criteria to screen
participants for eligibility are often prioritised over studies that use
self-report outcome measures or clinician judgement, particularly
as evidence based guidelines often exclude the latter from their
reviews of the literature (NICE 2010). Whilst positive outcomes
may be more likely when interventions are targeted to a specific
diagnostic group (Roth 1996), studies where interventions are of-
fered based on levels of symptoms rather than research diagnoses
may be more representative of routine practice.
Types of intervention
Collaborative care is a complex intervention which is difficult to
define precisely. This review based inclusion and exclusion crite-
ria on a published definition of collaborative care (Gunn 2006).
Whilst this was considered themost comprehensive and internally
consistent definition to date, there was still variation in what was
delivered as part of a collaborative care model in relation to all four
intervention criteria.
In terms of a multi-professional approach some studies included
just two health professionals (primary care provider and case man-
ager/and or mental health specialist), while others included a pri-
mary care provider, case manager and a mental health specialist.
There was variation in the amount of structure in themanagement
plan, where some studies were highly prescriptive (e.g. providing
a written manual for the primary care provider and/or the case
manager to follow) and others were less so (providing written treat-
ment guidelines and encouraging individualised treatment plans).
There was variation also in the intensity of the intervention in
each study in terms of number of follow-ups scheduled (ranging
from 1 to 20+); method of delivery (face-to-face, telephone or a
combination); and session duration. This variation in ‘key ingre-
dients’ of collaborative care complicates the interpretation of the
results.
We excluded studies from this review examining stepped caremod-
els where access to collaborative care was restricted and reserved
for a small proportion of participants meeting specific criteria, as
it would have been impossible to assess the added value of the col-
laborative care element. This may be an important consideration,
particularly in the UK where stepped care is the recommended
service model for depression and anxiety (NICE 2010).
Types of comparison
Most of the studies compared collaborative care with ‘usual care’.
A limitation of this review is that ’usual care’ is hard to define and
included studies did not clearly describe the key elements. Many
of the most traditional ‘usual care’ studies also included some lim-
ited level of intervention (distribution of treatment guidelines, in-
forming patients of depression status, training and education of
primary care practitioners). The evidence for these interventions
delivered in isolation is limited (Bower 2005) but such interven-
tions could result in a lower treatment effect.
Several studies have compared collaborative care with another ac-
tive treatment (such as consultation-liaison or enhanced referral)
but the numbers of available comparisons is low and confidence
in the conclusions about their relative value is limited.
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Quality of the evidence
Most of the 90 comparisons were included in analyses of depres-
sion outcomes, enabling estimates of the effects of collaborative
care in the short-term and medium-term with a high level of pre-
cision.
We found clinical and methodological heterogeneity in terms of
participants, interventions, comparisons and outcome measures.
In primary analyses, the value of the I² statistic for the continuous
measure of depression outcome at six months was 34%; ’moderate’
according to recommended criteria (Deeks 2011). For dichoto-
mous measures of depression outcome at six months it was 71%
indicating ’substantial’ heterogeneity according to recommended
criteria. Using the same criteria, ’considerable’ heterogeneity was
apparent in the analysis of antidepressant use at six months (I²
statistic = 81%). The 95% confidence intervals around the I2 esti-
mate, calculated using the Stata command heterogi, are presented
in Appendix 2. We used random-effects models in all analyses.
We did not identify any adverse outcomes. Trials in this area of
research rarely record adverse events.
Applying ’Risk of bias’ criteria to the studies has identifiedmethod-
ological limitations in the studies, although some of these (e.g.
blinding of participants and clinicians) reflect the reality of con-
ducting complex intervention trials in practice. Some studies rated
as ‘high risk’ of bias for ‘blinding of participants’ used self-reported
outcomes which may not be as vulnerable to bias as an unblinded
external observer. There was no evidence that removing studies at
high risk of bias (assessed in terms of allocation concealment) had
a large effect on the estimate of treatment effect in the main anal-
yses. Studies varied in whether they reported outcomes in terms
of continuous measures or dichotomous outcomes, and there is a
risk of bias if this represents selective reporting. However, this is
very difficult to judge without access to study protocols.
Potential biases in the review process
Since the published protocol, we have made several changes in
response to peer review, and as a result of internal discussions, on
the best way to synthesise data about a complex and multifaceted
intervention. These changes are documented in line with good
practice.
We did not contact all authors to collect missing data. Given the
size and complexity of the review thiswould have requiredmultiple
requests for data from many authors and study timelines did not
allow for this task.
There are a number of analyses that we had planned, but given the
size and complexity of the review we have been unable to complete
such analyses because of time constraints.
Wewere unable to conduct a rigorous and reliable analysis of social
function outcomes in the time frame of the review, as themeasures
reported were highly varied and their comparability difficult to
judge without extensive work on individual scales. We will add
these outcomes at a later date.
The protocol discussed several subgroup analyses and exploratory
meta-regression. We analysed outcomes separately for adolescents
and adults, and for interventions targeting patientswith depression
and anxiety. We did not conduct subgroup analyses for country,
location of recruitment, ethnicity, or aspects of the intervention,
or conduct the exploratory meta-regression. Exploration of the
impact of such factors will benefit from a multivariate approach
which can assess the relative importance of factors, rather than a
series of single subgroup analyses which may be confounded with
other important factors. Such a meta-regression analysis will re-
quire extensive imputation of missing outcome data, and trans-
lation of continuous and dichotomous outcomes into a common
format. These activities could not be completed in the time frame
of the review, but we will add these at a later date.
We did not extract data from studies that reported antidepressant
medication as a continuous outcome only, or from studies that
reported quality of life as a dichotomous outcome only, or as a
general quality of life measure only that combined physical and
mental health. In all cases this represented less than 5% of studies.
We extracted data on satisfaction at six months only. Although
it is possible that satisfaction could change over time, our judge-
ment was that satisfaction measures are fundamentally associated
with views of the treatment process, and thus measures close to
treatment receipt are much more likely to be accurate and uncon-
founded by memory issues.
We have included analyses of collaborative care plus enhancement
versus collaborative care. We accept that such studies provide an
assessment of the effects of the enhancement, not collaborative
care. However, we felt that such analyses were of relevance, as it is
an important clinical issue as to whether the effects of collaborative
care can be increased by adding other features to the basic model.
Our analysis split outcomes into four time periods based on time
since randomisation. The nature of collaborative care means that
interventions are sometimes provided over longer periods of time,
and thus it is possible that long-term effects of collaborative care
(i.e. those in the 12-month period and beyond) do not reflect any
enduring effect of the intervention, but simply reflect those in-
terventions that are extended beyond the initial outcome period
(0 to 6 months). We conducted a sensitivity analysis, removing
studies where the intervention extended beyond six months, to
assess whether the effects found at the 7- to 12-month time point
were significantly different when studies with longer-term inter-
ventions were excluded. In both outcomes, the effect of collab-
orative care at 7 to 12 months was reduced, which supports the
suggestion that long-term effects on outcome are more likely when
the intervention is also conducted over the longer-term. However,
the effects of collaborative care are still statistically significant at
both times points even with longer-term interventions removed,
and this issue needs further research.
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We did not contact all first authors or experts in the field to check
for additional studies to those found through our searches.
Agreements and disagreements with other
studies or reviews
A number of reviews have examined the effectiveness of collabo-
rative care, enhanced care, disease management and complex sys-
tem interventions (Badamgarav 2003; Bijl 2004;Gensichen 2009;
Gilbody 2006; Gunn 2006; Kates 2007; Neumeyer-Gromen
2004). These reviews have used a mixture of narrative and meta-
analyses to examine outcomes including: depression symptoms
and caseness, patient satisfaction, adherence to treatment and cost-
effectiveness.
These reviews mainly include RCTs. A previous review conducted
in 2006 included37RCTsof collaborative care (Gilbody 2006) us-
ing broader inclusion criteria for collaborative care (Katon 2001).
A recent review (Thota 2012) identified a further 32 studies be-
tween 2004 and 2009. The current review demonstrates the in-
crease in activity in the implementation and evaluation of collab-
orative care, although some of the differences in the numbers of
studies included in different reviews represent differences in exact
inclusion and exclusion criteria.
Like the current review, all of the published reviews concluded
collaborative care was effective in the short-term and medium-
term, and some reviews also considered longer-term outcomes,
reporting trends for significant effects up to five years (Gilbody
2006).
Less evidence has been reported for other outcomes such as quality
of life and patient satisfaction although some previous reviews
have reported potential positive outcomes for collaborative care
in terms of patient satisfaction (Badamgarav 2003; Neumeyer-
Gromen 2004; Thota 2012).
We did not identify any reviews that examined collaborative care
for adults with anxiety; across different age ranges (including ado-
lescents and older age) and compared with other active treatments
(such as consultation-liaison and enhanced referral).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review has demonstrated clear and robust evidence of effec-
tiveness for collaborative care in improving depression outcomes
in the short- and medium-term.
These findings have important implications for current clinical
guidelines for depression. The overall finding that collaborative
care is associated with improvements in depression is based on a
large and varied database and is highly likely to be rigorous. How-
ever, debate will continue over the magnitude of the benefits. The
standardised mean difference (SMD) demonstrated in the main
analyses, although significant, is modest by current convention
(Lipsey 1990), and less than some important comparison treat-
ments (such as cognitive behaviour therapy (CBT)) when evalu-
ated in contexts other than primary care (Churchill 2002; NICE
2010). Although there is a lack of consensus on ‘minimally clin-
ically important differences’ in mental health, a SMD of 0.5 has
been used previously as a criteria for adoption in the UK, and the
data in this review shows effects which are less than this, and some
benefits (such as those on physical health quality of life) are statis-
tically significant but potentially of limited clinical significance.
However, the benefits of collaborative care are similar to other
treatments (such as CBT and other psychological therapies) when
delivered in primary care settings (Cape 2010) and it is important
to note that the benefits, although modest, do seem to endure over
time, possibly reflecting the chronic disease management basis of
the collaborative care intervention.
Currently the National Institute for Clinical Excellence (NICE)
in the UK only recommends collaborative care at step 3 for people
with long-term physical conditions and depression (NICE 2009).
This current review did not find that excluding studies in patients
with long-term physical conditions made a substantive difference
to the findings of the review (main analysis SMD -0.34; sensitiv-
ity analysis excluding studies in patients with comorbidity SMD
-0.29). As noted previously, such simple comparisons are prob-
lematic, as there are many additional differences between studies
that could account for this variation, beyond the types of patients
recruited. For example, collaborative care is a complex interven-
tion and there is significant variation in the exact nature of the
intervention in the included studies, as well as differences in pa-
tient populations, contexts, comparisons, and design. Replication
of an earlier meta-regression including the new studies is required
(Bower 2006), accounting for the full range of studies and rele-
vant characteristics, and we will conduct this as an update to this
review.
Implications for research
The evidence for the effectiveness of collaborative care for depres-
sion in the short- and medium-term is robust. There is a need
for further research in collaborative care for anxiety, in patients
with depression and long-term physical health conditions, and
in different age groups (adolescents and older age). Comparisons
of collaborative care models with other interventions would also
be useful to better determine its optimal place in current clinical
pathways.
Exploration of the moderators and mediators of the effects of col-
laborative care (Kraemer 2002) might provide useful guidance on
how current models could enhance effectiveness through greater
focus on ‘active ingredients’ and better targeting of patient popu-
lations most likely to benefit.
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Improvements in the way research is reported are required. We
were unable to make accurate judgements about many risk of bias
issues, and we could not include large numbers of outcomes in the
analyses because key data were missing. Researchers should also be
encouraged to include more consistent data on the actual inter-
ventions included in collaborative care studies and report adverse
events.
A C K N OW L E D G E M E N T S
The reviewers would like to thank the editorial team of the
CochraneCollaborationDepression, Anxiety andNeurosisGroup
for its advice and support.
The review was supported by the National Institute for Health
Research (NIHR) Cochrane Review Incentive Scheme 2012.
The reviewers would also like to thank: Jasmine Knopp, Chris
Keyworth, Dr Charlotte Garrett, Dr Cassandra Kenning, Angee
Khara, JacquelineHill,Dr ChrisGibbons and SarahTully for their
support with the data extraction.
Thank you also to the study authorswhohave responded to queries
and requests for further information.
Peter Coventry (PC) is funded by the NIHR Collaboration for
Leadership in Applied Health Research and Care for Greater
Manchester. Peter Bower (PB) acknowledges the support of the
NIHR School for Primary Care Research. The views expressed in
this article are those of the authors and not necessarily those of the
NIHR.
R E F E R E N C E S
References to studies included in this review
Adler 2004 {published data only}
∗ Adler DA, Bungay KM, Wilson IB, Pei Y, Supran S,
Peckham E, et al.The impact of a pharmacist intervention
on 6-month outcomes in depressed primary care patients.
General Hospital Psychiatry 2004;26(3):199–209.
Bungay KM, Adler DA, Rogers WH, McCoy C, Kaszuba
M, Supran S, et al.Description of a clinical pharmacist
intervention administered to primary care patients with
depression. General Hospital Psychiatry 2004;26(3):210–8.
Araya 2003 {published data only}
Araya R, Flynn T, Rojas G, Fritsch R, Simon G. Cost-
effectiveness of a primary care treatment program for
depression in low-income women in Santiago, Chile.
American Journal of Psychiatry 2006;163(8):1379–87.
∗ Araya R, Rojas G, Fritsch R, Gaete J, Rojas M, Simon G,
et al.Treating depression in primary care in low-income
women in Santiago, Chile: a randomised controlled trial.
Lancet 2003;361(9362):995–1000.
Rojas G, Araya R, Simon G, Fritsch R, Gaete J. Treating
depression among low income women in primary care,
Santiago, Chile. 156th Annual Meeting of the American
Psychiatric Association; 2003 May 17-22; San Francisco
CA. 2003:NR109.
Asarnow 2005 {published data only}
Asarnow J, McKowen J, Jaycox L. Improving care for
depression: integrating evidence-based depression treatment
within primary care services. In: Essau C editor(s).
Treatments for Adolescent Depression: Theory and Practice.
Oxford: Oxford University Press, 2009:159–74.
∗ Asarnow JR, Jaycox LH, Duan N, LaBorde AP, Rea MM,
Murray P, et al.Effectiveness of a quality improvement
intervention for adolescent depression in primary care
clinics: a randomized controlled trial. JAMA 2005;293(3):
311–9.
Asarnow JR, Jaycox LH, Tang L, Duan N, LaBorde AP,
Zeledon LR, et al.Long-term benefits of short-term quality
improvement interventions for depressed youths in primary
care. American Journal of Psychiatry 2009;166(9):1002–10.
Bartels 2004 {published data only}
Arean PA, Ayalon L, Jin C, McCulloch CE, Linkins K,
Chen H, et al.Integrated specialty mental health care among
older minorities improves access but not outcomes: Results
of the PRISMe study. International Journal of Geriatric
Psychiatry 2008;23(10):1086–92.
Azar AR, Chopra MP, Cho LY, Coakley E, Rudolph JL.
Remission in major depression: results from a geriatric
primary care population. International Journal of Geriatric
Psychiatry 2011;26(1):48–55.
∗ Bartels SJ, Coakley EH, Zubritsky C, Ware JH, Miles
KM, Arean PA, et al.Improving access to geriatric mental
health services: A randomized trial comparing treatment
engagement with integrated versus enhanced referral care
for depression, anxiety, and at-risk alcohol use. American
Journal of Psychiatry 2004;161(8):1455–62.
Chen H, Coakley EH, Cheal K, Maxwell J, Costantino G,
Krahn DD, et al.Satisfaction with mental health services in
older primary care patients. American Journal of Geriatric
Psychiatry 2006;14(4):371–9.
Datto CJ, Thompson R, Knott K, Katz IR. Older adult
report of change in depressive symptoms as a treatment
decision tool. Journal of the American Geriatrics Society
2006;54(4):627–31.
Gallo JJ, Zubritsky C, Maxwell J, Nazar M, Bogner
HR, Quijano LM, et al.Primary care clinicians evaluate
integrated and referral models of behavioral health care for
older adults: results from a multisite effectiveness trial
27Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(PRISM-e). Annals of Family Medicine 2004;2(4):305–9.
Krahn DD, Bartels SJ, Coakley E, Oslin DW, Chen H,
McIntyre J, et al.PRISM-E: comparison of integrated
care and enhanced specialty referral models in depression
outcomes. Psychiatric Services 2006;57(7):946–53.
Levkoff SE, Chen H, Coakley E, Herr EC, Oslin DW, Katz
I, et al.Design and sample characteristics of the PRISM-E
multisite randomized trial to improve behavioral health care
for the elderly. Journal of Aging and Health 2004;16(1):
3–27.
Mavandadi S, Ten Have TR, Katz IR, Durai UN, Krahn
DD, Llorente MD, et al.Effect of depression treatment on
depressive symptoms in older adulthood: the moderating
role of pain. Journal of the American Geriatrics Society 2007;
55(2):202–11.
Wiley-Exley E, Domino ME, Maxwell J, Levkoff SE. Cost-
effectiveness of integrated care for elderly depressed patients
in the PRISM-E study. The Journal of Mental Health Policy
and Economics 2009;12(4):205–13.
Wittink MN, Oslin D, Knott KA, Coyne JC, Gallo JJ,
Zubritsky C. Personal characteristics and depression-related
attitudes of older adults and participation in stages of
implementation of a multi-site effectiveness trial (PRISM-
E). International Journal of Geriatric Psychiatry 2005;20(10):
927–37.
Zanjani F, Mavandadi S, TenHave T, Katz I, Durai NB,
Krahn D, et al.Longitudinal course of substance treatment
benefits in older male veteran at-risk drinkers. Journals of
Gerontology 2008;63(1):98–106.
Blanchard 1995 {published data only}
∗ Blanchard MR, Waterreus A, Mann AH. The effect of
primary care nurse intervention upon older people screened
as depressed. International Journal of Geriatric Psychiatry
1995;10(4):289–98.
Mann AH, Blanchard M, Waterreus A. Depression in older
people. Some criteria for effective treatment. Encephale
1993;19(Spec No 3):445–50.
Waterreus A, Blanchard M, Mann AH. Community
psychiatric nurses for the elderly: well tolerated, few side-
effects and effective in the treatment of depression. Journal
of Clinical Nursing 1994;3(5):299–306.
Bogner 2008 {published data only}
∗ Bogner HR, de Vries HF. Integration of depression and
hypertension treatment: a pilot, randomized controlled
trial. Annals of Family Medicine 2008;6(4):295–301.
Bogner 2010 {published data only}
∗ Bogner HR, de Vries HF. Integrating type 2 diabetes
mellitus and depression treatment among African
Americans: a randomized controlled pilot trial. Diabetes
Educator 2010;36(2):284–92.
Bruce 2004 {published data only}
Alexopoulos GS, Katz IR, Bruce ML, Heo M, Ten Have T,
Raue P, et al.Remission in depressed geriatric primary care
patients: a report from the PROSPECT study. American
Journal of Psychiatry 2005;162(4):718–24.
Alexopoulos GS, Reynolds CF III, Bruce ML, Katz IR,
Raue PJ, Mulsant BH, et al.Reducing suicidal ideation
and depression in older primary care patients: 24-month
outcomes of the PROSPECT study. American Journal of
Psychiatry 2009;166(8):845–8.
Bao Y, Alexopoulos GS, Casalino LP, Ten Have TR,
Donohue JM, Post EP, et al.Collaborative depression
care management and disparities in depression treatment
and outcomes. Archives of General Psychiatry 2011;68(6):
627–36.
Bao Y, Casalino LP, Ettner SL, Bruce ML, Solberg LI,
Unutzer J. Designing payment for collaborative care for
depression in primary care. Health Services Research 2011;
46(5):1436–51.
Bao Y, Post EP, Ten TR, Schackman BR, Bruce ML.
Achieving effective antidepressant pharmacotherapy in
primary care: the role of depression care management
in treating late-life depression. Journal of the American
Geriatrics Society 2009;57(5):895–900.
Bogner HR, Bruce ML, Reynolds CF 3rd, Mulsant BH,
Cary MS, Morales K, et al.The effects of memory, attention,
and executive dysfunction on outcomes of depression in
a primary care intervention trial: the PROSPECT study.
International Journal of Geriatric Psychiatry 2007;22(9):
922–9.
Bogner HR, Cary MS, Bruce ML, Reynolds CF III, Mulsant
B, Ten-Have T, et al.The role of medical comorbidity
in outcome of major depression in primary care: the
PROSPECT study. American Journal of Geriatric Psychiatry
2005;13(10):861–8.
Bogner HR, Lin JY,Morales KH. Patterns of early adherence
to the antidepressant citalopram among older primary
care patients: the prospect study. International Journal of
Psychiatry in Medicine 2006;36(1):103–19.
Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes,
depression, and death: a randomized controlled trial of a
depression treatment program for older adults based in
primary care (PROSPECT). Diabetes Care 2007;30(12):
3005–10.
Bruce ML, Pearson JL. Designing an intervention to prevent
suicide: PROSPECT (Prevention of suicide in primary
care elderly: Collaborative trial). Dialogues in Clinical
Neurosciences 1999;1(2):100–12.
∗ Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II,
Schulberg HC, Mulsant BH, et al.Reducing suicidal
ideation and depressive symptoms in depressed older
primary care patients: a randomized controlled trial. JAMA
2004;291(9):1081–91.
Byers AL, Bruce ML, Raue P. Suicidal ideation in non-
depressed elderly primary care patients: The PROSPECT
Study [abstract]. American Journal of Geriatric Psychiatry
2009;17:A86.
Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce
ML. The effect of a primary care practice-based depression
intervention on mortality in older adults: a randomized
trial. Annals of Internal Medicine 2007;146(10):689–98.
Joo JH, Morales KH, de Vries HF, Gallo JJ. Disparity in use
of psychotherapy offered in primary care between older
African-American and white adults: results from a practice-
28Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
based depression intervention trial. Journal of the American
Geriatrics Society 2010;58(1):154–60.
Lin JY, Ten Have TR, Bogner H, Elliott MR. Baseline
patient characteristics and mortality associated with
longitudinal intervention compliance. Statistics in Medicine
2007;26(28):5100–15.
Lyness JM, Heo M, Datto CJ, Ten Have TR, Katz IR,
Drayer R, et al.Outcomes of minor and subsyndromal
depression among elderly patients in primary care settings.
Annals of Internal Medicine 2006;144(7):496–504.
Reynolds CF, Alexopoulos GS, Katz I, Bruce M, Schulberg
HC, Tenhave T. Shifting the paradigm: Methodological and
ethical questions in geriatric depression treatment research
in the general medical sector. 39th Annual Meeting of the
American College of Neuropsychopharmacology; 2000 Dec
10-14; San Juan; Puerto Rico. 2000:65.
Reynolds CF 3rd, Degenholtz H, Parker LS, Schulberg
HC, Mulsant BH, Post E, et al.Treatment as usual (TAU)
control practices in the PROSPECT Study: managing the
interaction and tension between research design and ethics.
International Journal of Geriatric Psychiatry 2001;16(6):
602–8.
Schulberg HC, Post EP, Raue PJ, Ten Have T, Miller M,
Bruce ML. Treating late-life depression with interpersonal
psychotherapy in the primary care sector. International
Journal of Geriatric Psychiatry 2007;22(2):106–14.
Wallace ML, Dombrovski AY, Morse JQ, Houck PR, Frank
E, Alexopoulos GS, et al.Coping with health stresses and
remission from late-life depression in primary care: A two-
year prospective study. International Journal of Geriatric
Psychiatry 2012;27(2):178–86.
Williams JW Jr. Managed depression care reduces mortality
in older adults with major depression. Evidence-Based
Mental Health 2008;11(1):16.
Buszewicz 2010 {published data only}
∗ Buszewicz M, Griffin M, McMahon EM, Beecham J,
King M. Evaluation of a system of structured, pro-active
care for chronic depression in primary care: A randomised
controlled trial [ISRCTN36610074]. Evidence-Based
Mental Health 2010;10:ArtID 61.
Capoccia 2004 {published data only}
Boudreau DM, Capoccia KL, Sullivan SD, Blough DK,
Ellsworth AJ, Clark DL, et al.Collaborative care model
to improve outcomes in major depression. Annals of
Pharmacotherapy 2002;36(4):585–91.
∗ Capoccia KL, Boudreau DM, Blough DK, Ellsworth
AJ, Clark DR, Stevens NG, et al.Randomized trial of
pharmacist interventions to improve depression care and
outcomes in primary care. American Journal of Health-
System Pharmacy 2004;61(4):364–72.
Chaney 2011 {published data only}
Chan D. Depression and comorbid PTSD in veterans:
Evaluation of collaborative care programs and impact
on utilization and costs [thesis]. Dissertation Abstracts
International: Section B: The Sciences and Engineering 2008;
68(12B):7922.
Chan D, Cheadle AD, Reiber G, Untzer J, Chaney EF.
Health care utilization and its costs for depressed veterans
with and without comorbid PTSD symptoms. Psychiatric
Services 2009;60(12):1612–7.
∗ Chaney EF. Implementing collaborative care for depression
treatment in primary care: A cluster randomized evaluation
of a quality improvement practice redesign. Implementation
Science 2011;6:121. [DOI: 10.1186/1748-5908-6-121]
Chaney EF. Well-being among veterans enhancement
study (WAVES) [NCT00105820]. ClinicalTrials.gov
[www.clinicaltrials.gov] 2005.
Chew-Graham 2007 {published data only}
∗ Chew-Graham CA, Lovell K, Roberts C, Baldwin R,
Morley M, Burns A, et al.A randomised controlled trial
to test the feasibility of a collaborative care model for the
management of depression in older people. British Journal
of General Practice 2007;57(538):364–70.
Gilbody S. Depression in older adults: collaborative care
model seems effective. Evidence-Based Mental Health 2008;
11(2):44.
Ciechanowski 2004 {published data only}
∗ Ciechanowski P, Wagner E, Schmaling K, Schwartz S,
Williams B, Diehr P, et al.Community-integrated home-
based depression treatment in older adults: a randomized
controlled trial. JAMA 2004;291(13):1569–77.
Ciechanowski 2010 {published data only}
Chaytor N, Ciechanowski P, Miller J, Fraser R, Russo J,
Unutzer J, et al.Long-term outcomes from the PEARLS
randomized trial for the treatment of depression in patients
with epilepsy. Epilepsy and Behavior 2011;20(3):545–9.
∗ Ciechanowski P, Chaytor N, Miller J, Fraser R, Russo
J, Unutzer J, et al.PEARLS depression treatment for
individuals with epilepsy: A randomized controlled trial.
Epilepsy and Behavior 2010;19(3):225–31.
Clarke 2005 {published data only}
∗ Clarke G, DeBar L, Lynch F, Powell J, Gale J, O’Connor
E, et al.A randomized effectiveness trial of brief cognitive-
behavioral therapy for depressed adolescents receiving
antidepressant medication. Journal of the American Academy
of Child and Adolescent Psychiatry 2005;44(9):888–98.
Cole 2006 {published data only}
∗ Cole MG, McCusker J, Elie M, Dendukuri N, Latimer E,
Belzile E. Systematic detection and multidisciplinary care of
depression in older medical inpatients: a randomized trial.
Canadian Medical Association Journal 2006;174(1):38–44.
Datto 2003 {published data only}
∗ Datto CJ, Thompson R, Horowitz D, Disbot M, Oslin
DW. The pilot study of a telephone disease management
program for depression. General Hospital Psychiatry 2003;
25(3):169–77.
Dietrich 2004 {published data only}
Corson K, Gerrity MS, Dobscha SK. Screening for
depression and suicidality in a VA primary care setting: 2
items are better than 1 item. American Journal of Managed
Care 2004;10(11 Pt 2):839–45.
Dietrich AJ. Improving primary care for PTSD: Lessons
from the RESPECT-Depression Project. 158th Annual
29Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Meeting of the American Psychiatric Association; 2005 May
21-26; Atlanta, GA. 2005:No. 23B.
∗ Dietrich AJ, Oxman TE, Williams JW, Schulberg HC,
Bruce ML, Lee PW, et al.Re-engineering systems for the
treatment of depression in primary care: cluster randomised
controlled trial. BMJ 2004;329(7466):602.
Dietrich AJ, Oxman TE, Williams JW Jr, Kroenke K,
Schulberg HC, BruceM, et al.Going to scale: re-engineering
systems for primary care treatment of depression. Annals of
Family Medicine 2004;2(4):301–4.
Dobscha SK, Corson K, Gerrity M. Comorbid PTSD
and alcohol abuse in veterans with elevated depression
scores. 157th Annual Meeting of the American Psychiatric
Association; 2004 May 1-6; New York, NY. 2004:NR555.
Dobscha SK, Corson K, Solodky J, Gerrity MS. Use of
videoconferencing for depression research: enrollment,
retention, and patient satisfaction. Telemedicine Journal and
E-Health 2005;11(1):84–9.
Kroenke K, Shen J, Oxman TE, Williams JW Jr, Dietrich
AJ. Impact of pain on the outcomes of depression treatment:
results from the RESPECT trial. Pain 2008;134(1-2):
209–15.
Lee PW, Dietrich AJ, Oxman TE, Williams JW Jr, Barry
SL. Sustainable impact of a primary care depression
intervention. Journal of the American Board of Family
Medicine 2007;20(5):427–33.
Lee PW, Schulberg HC, Raue PJ, Kroenke K. Concordance
between the PHQ-9 and the HSCL-20 in depressed primary
care patients. Journal of Affective Disorders 2007;99(1-3):
139–45.
Nutting PA, Gallagher K, Riley K, White S, Dickinson WP,
Korsen N, et al.Care management for depression in primary
care practice: findings from the RESPECT-Depression trial.
Annals of Family Medicine 2008;6(1):30–7.
Nutting PA, Gallagher KM, Riley K, White S, Dietrich AJ,
Dickinson WP. Implementing a depression improvement
intervention in five health care organizations: Experience
from the RESPECT-Depression trial. Administration and
Policy in Mental Health 2007;34(2):127–37.
Oxman TE, Schulberg EC, Greenberg RL, Dietrich AJ,
Williams JW Jr, Nutting PA, et al.A fidelity measure for
integrated management of depression in primary care.
Medical Care 2006;44(11):1030–7.
Schulberg HC, Lee PW, Bruce ML, Raue PJ, Lefever JJ,
Williams JW Jr, et al.Suicidal ideation and risk levels among
primary care patients with uncomplicated depression.
Annals of Family Medicine 2005;3(6):523–8.
Dwight-Johnson 2005 {published data only}
∗ Dwight-Johnson M, Ell K, Lee PJ. Can collaborative care
address the needs of low-income Latinas with comorbid
depression and cancer? Results from a randomized pilot
study. Psychosomatics 2005;46(3):224–32.
Dwight-Johnson 2010 {published and unpublished data}
∗ Dwight-Johnson M, Lagomasino IT, Hay J, Zhang L,
Tang L, Green JM, et al.Effectiveness of collaborative care
in addressing depression treatment preferences among low-
income Latinos. Psychiatric Services 2010;61(11):1112–8.
Dwight-Johnson 2011 {published data only}
∗ Dwight-Johnson M, Aisenberg E, Golinelli D, Hong
S, O’Brien M, Ludman E. Telephone-based cognitive-
behavioral therapy for Latino patients living in rural areas:
A randomized pilot study. Psychiatric Services 2011;62(8):
936–42.
Ell 2007 {published data only}
∗ Ell K, Unutzer J, Aranda M, Gibbs NE, Lee PJ, Xie B.
Managing depression in home health care: a randomized
clinical trial. Home Health Care Services Quarterly 2007;26
(3):81–104.
Ell 2008 {published data only}
Ell K, Quon B, Quinn DI, Dwight-Johnson M, Wells A,
Lee PJ, et al.Improving treatment of depression among low-
income patients with cancer: the design of the ADAPt-C
study. General Hospital Psychiatry 2007;29(3):223–31.
Ell K, Xie B, Kapetanovic S, Quinn DI, Lee PJ, Wells A, et
al.One-year follow-up of collaborative depression care for
low-income, predominantly Hispanic patients with cancer.
Psychiatric Services 2011;62(2):162–70.
∗ Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M,
Lee PJ. Randomized controlled trial of collaborative care
management of depression among low-income patients with
cancer. Journal of Clinical Oncology 2008;26(27):4488–96.
Ell 2010 {published data only}
Ell K, Katon W, Cabassa LJ, Xie B, Lee PJ, Kapetanovic S,
et al.Depression and diabetes among low-income Hispanics:
design elements of a socioculturally adapted collaborative
care model randomized controlled trial. International
Journal of Psychiatry in Medicine 2009;39(2):113–32.
∗ Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman
J, et al.Collaborative care management of major depression
among low-income, predominantly Hispanic subjects with
diabetes: a randomized controlled trial. Diabetes Care 2010;
33(4):706–13.
Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman
J, et al.One-year postcollaborative depression care trial
outcomes among predominantly Hispanic diabetes safety
net patients. General Hospital Psychiatry 2011;33(5):
436–42.
Ell K, Lee PJ, Xie B. Depression care for low-income,
minority, safety net clinic populations with comorbid
illness. Research on Social Work Practice 2010;20(5):467–75.
Hay JW, Katon WJ, Ell K, Lee PJ, Guterman JJ. Cost
effectiveness analysis of collaborative care management
of major depression among low-income, predominantly
Hispanics with diabetes. Journal of Mental Health Policy
and Economics. Proceedings of the 10th Workshop on
Costs and Assessment in Psychiatry; 2011 Mar 25-27;
Venice, Italy. 2011; Vol. 14:S11.
Palinkas LA, Ell K, Hansen M, Cabassa L, Wells A.
Sustainability of collaborative care interventions in primary
care settings. Journal of Social Work 2011;11(1):99–117.
Finley 2003 {published data only}
∗ Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA,
et al.Impact of a collaborative care model on depression
30Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in a primary care setting: A randomized controlled trial.
Pharmacotherapy 2003;23(9):1175–85.
Fortney 2007 {published data only}
Deen TL, Fortney JC, Pyne JM. Relationship between
satisfaction, patient-centered care, adherence and outcomes
among patients in a collaborative care trial for depression.
Administration and Policy in Mental Health and Mental
Health Services Research 2011;38(5):345–55.
Edlund MJ, Fortney JC, Reaves CM, Pyne JM, Mittal D.
Beliefs about depression and depression treatment among
depressed veterans. Medical Care 2008;46(6):581–9.
Fortney JC, MacIejewski ML, Tripathi SP, Deen TL,
Pyne JM. A budget impact analysis of telemedicine-based
collaborative care for depression. Medical Care 2011;49(9):
872–80.
Fortney JC, Pyne JM, Edlund MJ, Mittal D. Relationship
between antidepressant medication possession and
treatment response. General Hospital Psychiatry 2010;32(4):
377–9.
Fortney JC, Pyne JM, Edlund MJ, Robinson DE, Mittal
D, Henderson KL. Design and implementation of the
telemedicine-enhanced antidepressant management study.
General Hospital Psychiatry 2006;28(1):18–26.
Fortney JC, Pyne JM, Edlund MJ, Stecker T, Mittal
D, Robinson DE, et al.Reasons for antidepressant non-
adherence among veterans treated in primary care clinics.
Journal of Clinical Psychiatry 2011;72(6):827–34.
∗ Fortney JC, Pyne JM, Edlund MJ, Williams DK,
Robinson DE, Mittal D, et al.A randomized trial of
telemedicine-based collaborative care for depression. Journal
of General Internal Medicine 2007;22(8):1086–93.
Fortney JC, Pyne JM, Steven CA, Williams JS, Hedrick RG,
Lunsford AK, et al.A web-based clinical decision support
system for depression care management. American Journal
of Managed Care 2010;16(11):849–54.
Mittal D, Fortney JC, Pyne JM, Edlund MJ, Wetherell
JL. Impact of comorbid anxiety disorders on health-
related quality of life among patients with major depressive
disorder. Psychiatric Services 2006;57(12):1731–7.
Mittal D, Fortney JC, Pyne JM, Wetherell JL. Predictors of
persistence of comorbid generalized anxiety disorder among
veterans with major depressive disorder. Journal of Clinical
Psychiatry 2011;72(11):1445–51.
Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund
MJ, Williams DK. Cost-effectiveness analysis of a rural
telemedicine collaborative care intervention for depression.
Archives of General Psychiatry 2010;67(8):812–21.
Fritsch 2007 {published data only}
∗ Fritsch R, Araya R, Solis J, Montt E, Pilowsky D, Rojas
G. [A randomized trial of pharmacotherapy with telephone
monitoring to improve treatment of depression in primary
care in Santiago, Chile] [Spanish]. Revista Medica de Chile
2007;135(5):587–95.
Gensichen 2009 {published data only}
Gensichen J, Guethlin C, Sarmand N, Sivakumaran D, Jager
C, Mergenthal K, et al.Patients’ perspectives on depression
case management in general practice - a qualitative study.
Patient Education and Counseling 2012;86(1):114–9.
Gensichen J, Guthlin C, Kleppel V, Jager C, Mergenthal
K, Gerlach FM, et al.Practice-based depression case
management in primary care: A qualitative study on family
doctors’ perspectives. Family Practice 2011;28(5):565–71.
Gensichen J, Jaeger C, Peitz M, Torge M, Guthlin C,
Mergenthal K, et al.Health care assistants in primary care
depression management: Role perception, burdening
factors, and disease conception. Annals of Family Medicine
2009;7(6):513–9.
Gensichen J, Petersen JJ, Karroum T, Rauck S, Ludman
E, Konig J, et al.Positive impact of a family practice-based
depression case management on patient’s self-management.
General Hospital Psychiatry 2011;33(1):23–8.
Gensichen J, Torge M, Peitz M, Wendt-Hermainski
H, Beyer M, Rosemann T, et al.Case management
for the treatment of patients with major depression
in general practices - rationale, design and conduct
of a cluster randomized controlled trial - PRoMPT
(Primary care Monitoring for depressive Patient’s Trial)
[ISRCTN66386086] - study protocol. BMC Public Health
2005;5:101. [DOI: 10.1186/1471-2458-5-101]
∗ Gensichen J, von Korff M, Peitz M, Muth C, Beyer M,
Guthlin C, et al.Case management for depression by health
care assistants in small primary care practices: a cluster
randomized trial. Annals of Internal Medicine 2009;151(6):
369–78.
Kendrick T. Healthcare assistant case management may
reduce depression symptoms in primary care patients with
major depression more than usual care. Evidence-Based
Medicine 2010;15(1):10–1.
Gjerdingen 2009 {published data only}
∗ Gjerdingen D, Crow S, McGovern P, Miner M, Center B.
Stepped care treatment of postpartum depression: impact
on treatment, health, and work outcomes. Journal of the
American Board of Family Medicine 2009;22(5):473–82.
Hedrick 2003 {published data only}
Goering P. Collaborative care speeds recovery from
depression. Evidence-Based Mental Health 2003;6(4):116.
Hedrick SC, Chaney EF. Effectiveness of team treatment
of depression in primary care [NCT00012766].
ClinicalTrials.gov [www.clinicaltrials.gov] 2001.
∗ Hedrick SC, Chaney EF, Felker B, Liu CF, Hasenberg
N, Heagerty P, et al.Effectiveness of collaborative care
depression treatment in veterans’ affairs primary care.
Journal of General Internal Medicine 2003;18(1):9–16.
Lin P, Campbell DG, Chaney EF, Liu CF, Heagerty P, Felker
BL, et al.The influence of patient preference on depression
treatment in primary care. Annals of Behavioral Medicine
2005;30(2):164–73.
Liu CF, Hedrick SC, Chaney EF, Heagerty P, Felker B,
Hasenberg N, et al.Cost-effectiveness of collaborative
care for depression in a primary care veteran population.
Psychiatric Services 2003;54(5):698–704.
Hilty 2007 {published data only}
∗ Hilty D, Marks S, Wegelin J, Callahan EJ, Nesbitt
31Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
TS. Randomized, controlled trial of disease management
modules, including telepsychiatric care, for depression in
rural primary care. Psychiatry 2007;4(2):58–65.
Huffman 2011 {published data only}
Celano CM, Mastromauro CA, Lenihan EC, Januzzi JL,
Rollman BL, Huffman JC. Association of baseline anxiety
with depression persistence at 6 months in patients with
acute cardiac illness. Psychosomatic Medicine 2012;74(1):
93–9.
Huffman JC, Celano C, Mastromauro CA, Januzzi JL.
Effects of baseline anxiety on depression persistence in
a study of hospitalized cardiac patients. Psychosomatic
Medicine. Proceedings from the 69th Annual Meeting of
the American Psychosomatic Society; 2011 Mar 9-12; San
Antonio, TX United States. 2011; Vol. 73, issue 3.
Huffman JC, Mastromauro CA, Sowden G, Fricchione
GL, Healy BC, Januzzi JL. Impact of a depression care
management program for hospitalized cardiac patients.
Circulation. Cardiovascular Quality and Outcomes 2011;4
(2):198–205.
∗ Huffman JC, Mastromauro CA, Sowden GL, Wittmann
C, Rodman R, Januzzi JL. A collaborative care depression
management program for cardiac inpatients: Depression
characteristics and in-hospital outcomes. Psychosomatics:
Journal of Consultation Liaison Psychiatry 2011;52(1):26–33.
Hunkeler 2000 {published data only}
Hunkeler EM, Hargreaves WA, Meresman J. Efficacy of
nurse tele-health care as an augmentation to ssri treatment
of depression in primary care. 153rd Annual Meeting of
the American Psychiatric Association; 2000 May 13-18;
Chicago (IL). 2000:NR448.
Hunkeler EM, Hargreaves WA, Meresman J. Efficacy of
nurse tele-health care as an augmentation to ssri treatment
of depression in primary care. 155th Annual Meeting of
the American Psychiatric Association; 2002 May 18-23rd;
Philadelphia (PA). 2000:NR448.
∗ Hunkeler EM, Meresman JF, Hargreaves WA, Fireman B,
Berman WH, Kirsch AJ, et al.Efficacy of nurse telehealth
care and peer support in augmenting treatment of depression
in primary care. Archives of Family Medicine 2000;9(8):
700–8.
Meresman J, Hunkeler E, Hargreaves W. The nurse telecare
project for treating depression: A progress report. 35th
International Meeting of the Society for Psychotherapy
Research; 2004 June 16-19; Rome. 2004:170.
Katon 1995a {published data only}
∗ Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush
T, et al.Collaborative management to achieve treatment
guidelines impact on depression in primary care. JAMA
1995;273(13):1026–31.
Katon 1995b {published data only}
Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush
T, et al.Collaborative management to achieve treatment
guidelines impact on depression in primary care. JAMA
1995;273(13):1026–31.
Katon 1996a {published data only}
∗ Katon W, Robinson P, Von Korff M, Lin E, Bush T,
Ludman E, et al.A multifaceted intervention to improve
treatment of depression in primary care. Archives of General
Psychiatry 1996;53(10):924–32.
Robinson P, Katon W, Von Korff M, Bush T, Simon G, Lin
E, et al.The education of depressed primary care patients:
what do patients think of interactive booklets and a video?.
Journal of Family Practice 1997;44(6):562–71.
Katon 1996b {published data only}
Katon W, Robinson P, Von Korff M, Lin E, Bush T,
Ludman E, et al.A multifaceted intervention to improve
treatment of depression in primary care. Archives of General
Psychiatry 1996;53(10):924–32.
Robinson P, Katon W, Von Korff M, Bush T, Simon G, Lin
E, et al.The education of depressed primary care patients:
what do patients think of interactive booklets and a video?.
Journal of Family Practice 1997;44(6):562–71.
Katon 1999 {published data only}
∗ Katon W, Von Korff M, Lin E, Simon G, Walker E,
Unutzer J, et al.Stepped collaborative care for primary
care patients with persistent symptoms of depression: a
randomized trial. Archives of General Psychiatry 1999;56
(12):1109–15.
Katon WJ, Russo JE, Von Korff M, Lin EH, Ludman E,
Ciechanowski PS. Long-term effects on medical costs of
improving depression outcomes in patients with depression
and diabetes. Diabetes Care 2008;31(6):1155–9.
Shaughnessy A. In patients who do not respond to
antidepressants or who are at risk for recurrence, is
collaborative care effective?. Evidence-Based Practice 2003;6
(2):9.
Simon GE, Katon WJ, VonKorff M, Unuetzer J, Lin
EH, Walker EA, et al.Cost-effectiveness of a collaborative
care program for primary care patients with persistent
depression. American Journal of Psychiatry 2001;158(10):
1638–44.
Unutzer J, Katon WJ, Russo J, Simon G, von Korff M,
Lin E, et al.Willingness to pay for depression treatment in
primary care. Psychiatric Services 2003;54(3):340–5.
Walker EA, Koton WJ, Russo J, Von Korff M, Lin E, Simon
G, et al.Predictors of outcome in a primary care depression
trial. Journal of General Internal Medicine 2000;15(12):
859–67.
Katon 2001 {published data only}
Bullock R. A depression relapse prevention programme
improved adherence to medication and depressive symptoms
but did not decrease relapses. Evidence-Based Mental Health
2001;4(4):113.
Gopinath S, Katon WJ, Russo JE, Ludman EJ. Clinical
factors associated with relapse in primary care patients
with chronic or recurrent depression. Journal of Affective
Disorders 2007;101(1-3):57–63.
∗ Katon W, Rutter C, Ludman E J, Von Korff M, Lin E,
Simon G, et al.A randomized trial of relapse prevention of
32Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
depression in primary care. Archives of General Psychiatry
2001;58(3):241–7.
Lin EH, Von Korff M, Ludman EJ, Rutter C, Bush TM,
Simon GE, et al.Enhancing adherence to prevent depression
relapse in primary care. General Hospital Psychiatry 2003;25
(5):303–10.
Ludman E, Katon W, Bush T, Rutter C, Lin E, Simon G, et
al.Behavioural factors associated with symptom outcomes
in a primary care-based depression prevention intervention
trial. Psychological Medicine 2003;33(6):1061–70.
Ludman E, Von Korff M, Katon W, Lin E, Simon G,
Walker E, et al.The design, implementation, and acceptance
of a primary care-based intervention to prevent depression
relapse. International Journal of Psychiatry in Medicine 2000;
30(3):229–45.
Simon GE, Von Korff M, Ludman EJ, Katon WJ, Rutter C,
Unutzer J, et al.Cost-effectiveness of a program to prevent
depression relapse in primary care. Medical Care 2002;40
(10):941–50.
Von Korff M, Katon W, Rutter C, Ludman E, Simon G,
Lin E, et al.Effect on disability outcomes of a depression
relapse prevention program. Psychosomatic Medicine 2003;
65(6):938–43.
Katon 2004 {published data only}
Ciechanowski PS, Russo JE, Katon WJ. The difficult
patient: A developmental perspective using an attachment
theoretical framework. 63rd Annual Meeting of the
American Psychosomatic Society; 2005 March 2-5;
Vancouver, Canada. 2005:A122.
Ciechanowski PS, Russo JE, Katon WJ, Von Korff M,
Simon GE, Lin EHB, et al.The association of patient
relationship style and outcomes in collaborative care
treatment for depression in patients with diabetes. Medical
Care 2006;44(3):283–91.
Davidson MB, Echeverry D. Collaborative care for
depression and chronic illnesses [comment]. New England
Journal of Medicine 2011;364(13):1278; author reply 1278-
9.
Gask L, Ludman E, Schaefer J. Qualitative study of an
intervention for depression among patients with diabetes:
how can we optimize patient-professional interaction?.
Chronic Illness 2006;2(3):231–42.
Glasgow RE, Price DW. Individualised treatment improves
depression in people with depression and diabetes. Evidence-
Based Mental Health 2005;8(2):40.
Katon W, Russo J, Von Korff M, Lin E, Simon G, Bush T,
et al.Long-term effects of a collaborative care intervention
in persistently depressed primary care patients. Journal of
General Internal Medicine 2002;17(10):741–8.
Katon W, Von Korff M, Lin E, Simon G, Ludman E, Bush
T, et al.Improving primary care treatment of depression
among patients with diabetes mellitus: the design of the
pathways study. General Hospital Psychiatry 2003;25(3):
158–68.
Katon WJ, Von Korff M, Lin E, Simon G, Ciechanowski
P, Ludman E, et al.The PATHWAYS study: A randomized
trial of collaborative care in patients with diabetes and
depression. 157th Annual Meeting of the American
Psychiatric Association; 2004 May 1-6; New York (NY).
2004:No. 9A.
∗ Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E,
Russo J, et al.The Pathways Study: a randomized trial of
collaborative care in patients with diabetes and depression.
Archives of General Psychiatry 2004;61(10):1042–9.
Kinder LS, Katon WJ, Ludman E, Russo J, Simon G,
Lin EH, et al.Improving depression care in patients with
diabetes and multiple complications. Journal of General
Internal Medicine 2006;21(10):1036–41.
Lin EH, Katon W, Rutter C, Simon GE, Ludman EJ, Von
Korff M, et al.Effects of enhanced depression treatment on
diabetes self-care. Annals of Family Medicine 2006;4(1):
46–53.
Lin EH, Katon W, Rutter C, Von Korff M, Ludman EJ,
Simon GE, et al.Effects of enhanced depression care on
diabetes self management: A randomized-controlled trial.
63rd Annual Meeting of the American Psychosomatic
Society; 2005 March 2-5; Vancouver, Canada. 2005:A23.
O’Malley PG. Collaborative care for depression in patients
with diabetes increased depression-free days and had
economic benefit. ACP Journal Club 2007;146(3):78.
Simon GE, Katon WJ, Lin EH, Rutter C, Manning
WG, Von Korff M, et al.Cost-effectiveness of systematic
depression treatment among people with diabetes mellitus.
Archives of General Psychiatry 2007;64(1):65–72.
Upchurch SL. A collaborative care intervention improved
depression outcomes, but not glycaemic control, in diabetes
and comorbid depression. Evidence-Based Nursing 2005;8
(3):81.
Katon 2010 {published data only}
Hung W. Collaborative care for patients with depression
improves chronic disease management: Commentary.
Journal of Clinical Outcomes Management 2011;18(4):
156–7.
Katon W, Lin EH, Von Korff M, Ciechanowski P, Ludman
E, Young B, et al.Integrating depression and chronic disease
care among patients with diabetes and/or coronary heart
disease: the design of the TEAMcare study. Contemporary
Clinical Trials 2010;31(4):312–22.
Katon W, Russo J, Lin EHB, Schmittdiel J, Ciechanowski
P, Ludman E, et al.Cost-effectiveness of a Multicondition
Collaborative Care Intervention: A Randomized Controlled
Trial. Archives of General Psychiatry 2012;69(5):506–514.
∗ Katon WJ, Lin EH, Von Korff M, Ciechanowski P,
Ludman EJ, Young B, et al.Collaborative care for patients
with depression and chronic illnesses. New England Journal
of Medicine 2010;363(27):2611–20.
Katon WJ, Lin EHB, Von Korff M. The authors reply:
”Collaborative care for depression and chronic illnesses“
[Reply to comment]. New England Journal of Medicine
2011;364(13):1278–9.
McGregor M, Lin EH, Katon WJ. TEAMcare: an
integrated multicondition collaborative care program for
chronic illnesses and depression. Journal of Ambulatory Care
33Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Management 2011;34(2):152–62.
Von Korff M, Katon WJ, Lin EHB, Ciechanowski P,
Peterson D, Ludman EJ, et al.Functional outcomes of
multi-condition collaborative care and successful ageing:
Results of randomised trial. BMJ 2011;343(7833):1083.
Katzelnick 2000 {published data only}
Katzelnick DJ, Simon GE, Pearson SD, Manning WG,
Helstad CP, Henk HJ. Randomized trial of a depression
management program in high utilizers of medical care.
151st Annual Meeting of the American Psychiatric
Association; 1998 May 30- Jun 4; Toronto, Ontario,
Canada. 1998.
∗ Katzelnick DJ, Simon GE, Pearson SD, Manning WG,
Helstad CP, Henk HJ, et al.Randomized trial of a depression
management program in high utilizers of medical care.
Archives of Family Medicine 2000;9(4):345–51.
Katzelnick DJ, Simon GE, Pearson SD, Manning WG,
Helstad CP, Henks HJ. Clinical outcomes care study. 152nd
Annual Meeting of the American Psychiatric Association;
1999 May 15-20; Washington (DC). 1999.
Peveler R. A depression management programme reduced
depression in frequent users of healthcare but did not reduce
healthcare visits. Evidence-Based Mental Health 2001;4(3):
78–9.
Simon GE, Manning WG, Katzelnick DJ, Pearson SD,
Henk HJ, Helstad CP. Cost-effectiveness of systematic
depression treatment for high utilizers of general medical
care. Archives of General Psychiatry 2001;58(2):181–7.
Kroenke 2010 {published data only}
Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The
association of depression and anxiety with health-related
quality of life in cancer patients with depression and/or
pain. Psycho-Oncology 2010;19(7):734–41.
Johns SA, Kroenke K, Theobald DE, Wu J, Tu W. Telecare
management of pain and depression in patients with
cancer: patient satisfaction and predictors of use. Journal of
Ambulatory Care Management 2011;34(2):126–39.
Kroenke K, Theobald D, Norton K, Sanders R, Schlundt S,
McCalley S, et al.The Indiana Cancer Pain and Depression
(INCPAD) trial Design of a telecare management
intervention for cancer-related symptoms and baseline
characteristics of study participants. General Hospital
Psychiatry 2009;31(3):240–53.
Kroenke K, Theobald D, Wu J, Loza JK, Carpenter JS,
Tu W. The association of depression and pain with health-
related quality of life, disability, and health care use in
cancer patients. Journal of Pain and Symptom Management
2010;40(3):327–41.
∗ Kroenke K, Theobald D, Wu J, Norton K, Morrison G,
Carpenter J, et al.Effect of telecare management on pain
and depression in patients with cancer. JAMA 2010;304(2):
163–71.
Landis 2007 {published data only}
∗ Landis SE, Gaynes BN, Morrissey JP, Vinson N, Ellis AR,
Domino ME. Generalist care managers for the treatment
of depressed medicaid patients in North Carolina: a pilot
study. BMC Family Practice 2007;8:7.
Lobello 2010 {published data only}
∗ Lobello K, Reddy S, Musgnung J, Pedersen R, Ninan
P. Patient outcomes with education, drug therapy, and
support: A study of venlafaxine ER-treated outpatients
with major depressive disorder. Psychopharmacology Bulletin
2010;43(2):28–44.
Ludman 2007a {published data only}
∗ Ludman EJ, Simon GE, Grothaus LC, Luce C, Markley
DK, Schaefer J. A pilot study of telephone care management
and structured disease self-management groups for chronic
depression. Psychiatric Services 2007;58(8):1065–72.
Ludman 2007b {published data only}
Ludman EJ, Simon GE, Grothaus LC, Luce C, Markley
DK, Schaefer J. A pilot study of telephone care management
and structured disease self-management groups for chronic
depression. Psychiatric Services 2007;58(8):1065–72.
Ludman 2007c {published data only}
Ludman EJ, Simon GE, Grothaus LC, Luce C, Markley
DK, Schaefer J. A pilot study of telephone care management
and structured disease self-management groups for chronic
depression. Psychiatric Services 2007;58(8):1065–72.
Mann 1998 {published data only}
∗ Mann AH, Blizard R, Murray J, Smith JA, Botega N,
MacDonald E, et al.An evaluation of practice nurses
working with general practitioners to treat people with
depression. British Journal of General Practice 1998;48(426):
875–9.
McCusker 2008 {published data only}
∗ McCusker J, Cole M, Yaffe M, Cappeliez P, Dawes M,
Sewitch M, et al.Project direct: Pilot study of a collaborative
intervention for depressed seniors. Canadian Journal of
Community Mental Health 2008;27(2):201–18.
McMahon 2007 {published data only}
∗ McMahon L, Foran KM, Forrest SD, Taylor ML, Ingram
G, Rajwal M, et al.Graduate mental health worker case
management of depression in UK primary care: a pilot
study. British Journal of General Practice 2007;57(544):
880–5.
Oslin 2003 {published data only}
Oslin D. Telephone disease management for depression
and at-risk drinking. International Psychogeriatrics.
Proceedings of the International Psychogeriatric Association
Eleventh International Congress; 2003 Aug 17-22, Chicago.
2003; Vol. 15.
∗ Oslin DW, Sayers S, Ross J, Kane V, Ten Have T,
Conigliaro J, et al.Disease management for depression and
at-risk drinking via telephone in an older population of
veterans. Psychosomatic Medicine 2003;65(6):931–7.
Patel 2010 {published data only}
Patel V, Weiss H, Mann A. Predictors of outcome in
patients with common mental disorders receiving a brief
psychological treatment: An exploratory analysis of a
randomized controlled trial from Goa, India. African
Journal of Psychiatry (South Africa) 2010;13(4):291–6.
∗ Patel V, Weiss HA, Chowdhary N, Naik S, Pednekar S,
Chatterjee S, et al.Effectiveness of an intervention led by lay
34Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
health counsellors for depressive and anxiety disorders in
primary care in Goa, India (MANAS): A cluster randomised
controlled trial. Lancet 2010;376(9758):2086–95.
Patel V, Weiss HA, Chowdhary N, Naik S, Pednekar S,
Chatterjee S, et al.Lay health worker led intervention for
depressive and anxiety disorders in India: impact on clinical
and disability outcomes over 12 months. British Journal of
Psychiatry 2011;199(6):459–66.
Patel VH, Kirkwood BR, Pednekar S, Araya R, King M,
Chisholm D, et al.Improving the outcomes of primary care
attenders with common mental disorders in developing
countries: A cluster randomized controlled trial of a
collaborative stepped care intervention in Goa, India. Trials
2008;9:4.
Piette 2011 {published data only}
Piette J, Duffy S, Torres T, Vogel M, Himle J, Richardson
C, et al.12-month outcomes from a randomized trial
of telephone cognitive behavioral therapy for depressed
patients with type 2 diabetes. Journal of General Internal
Medicine. Proceedings of the 33rd Annual Meeting of the
Society of General Internal Medicine; 2010 Apr 28-May 1,
Minneapolis (MN) 2010;25(Suppl 3):S205.
∗ Piette JD, Richardson C, Himle J, Duffy S, Torres T,
Vogel M, et al.A randomized trial of telephonic counseling
plus walking for depressed diabetes patients. Medical Care
2011;49(7):641–8.
Pyne 2011 {published data only}
Curran GM, Pyne J, Fortney JC, Gifford A, Asch SM,
Rimland D, et al.Development and implementation of
collaborative care for depression in HIV clinics. AIDS Care
- Psychological and Socio-Medical Aspects of AIDS/HIV 2011;
23(12):1626–36.
∗ Pyne JM, Fortney JC, Curran GM, Tripathi S, Atkinson
JH, Kilbourne AM, et al.Effectiveness of collaborative care
for depression in human immunodeficiency virus clinics.
Archives of Internal Medicine 2011;171(1):23–31.
Richards 2008a {published data only}
McMillan D, Gilbody S, Richards D. Defining successful
treatment outcome in depression using the PHQ-9: A
comparison of methods. Journal of Affective Disorders 2010;
127(1-3):122–9.
Richards D. Models of Stepped Care: evidence from the first
UK trials of collaborative care for depression and stepped
care for common mental health problems. 34th Annual
Conference of the British Association for Behavioural and
Cognitive Psychotherapies; 2006 July 19-21, Warwick.
2006:60.
Richards DA, Lovell K, Gilbody S, Gask L, Torgerson D,
Barkham M, et al.Collaborative care for depression in UK
primary care: A randomized controlled trial: Corrigendum.
Psychological Medicine 2009;39(4):701.
∗ Richards DA, Lovell K, Gilbody S, Gask L, Torgerson
D, Barkham M, et al.Collaborative care for depression in
UK primary care: a randomized controlled trial [Erratum
published in Psychological Medicine 2009;39(4):701].
Psychological Medicine 2008;38(2):279–87.
Simpson A, Richards D, Gask L, Hennessy S, Escott
D. Patients’ experiences of receiving collaborative care
for the treatment of depression in the UK: a qualitative
investigation. Mental Health in Family Medicine 2008;5(2):
95–104.
Richards 2008b {published data only}
McMillan D, Gilbody S, Richards D. Defining successful
treatment outcome in depression using the PHQ-9: A
comparison of methods. Journal of Affective Disorders 2010;
127(1-3):122–9.
Richards D. Models of Stepped Care: evidence from the first
UK trials of collaborative care for depression and stepped
care for common mental health problems. 34th Annual
Conference of the British Association for Behavioural and
Cognitive Psychotherapies; 2006 July 19 - 21, Warwick.
2006:60.
Richards DA, Lovell K, Gilbody S, Gask L, Torgerson D,
Barkham M, et al.Collaborative care for depression in UK
primary care: A randomized controlled trial: Corrigendum.
Psychological Medicine 2009;39(4):701.
∗ Richards DA, Lovell K, Gilbody S, Gask L, Torgerson
D, Barkham M, et al.Collaborative care for depression in
UK primary care: a randomized controlled trial [Erratum
published in Psychological Medicine 2009;39(4):701].
Psychological Medicine 2008;38(2):279–87.
Simpson A, Richards D, Gask L, Hennessy S, Escott
D. Patients’ experiences of receiving collaborative care
for the treatment of depression in the UK: a qualitative
investigation. Mental Health in Family Medicine 2008;5(2):
95–104.
Richards 2012 {published and unpublished data}
Richards DA. Multi-centre randomised controlled trial of
collaborative care for depression [CADET (CollAborative
DEpression Trial) [Is collaborative care more clinically
and cost effective than usual care in the management of
patients with moderate to severe depression in UK primary
care?] [ ISRCTN32829227]. Current Controlled Trials
[www.controlled-trials.com] 2009.
∗ Richards DA, Hughes-Morley A, Hayes RA, Araya R,
Barkham M, Bland JM, et al.Collaborative depression trial
(CADET): Multi-centre randomised controlled trial of
collaborative care for depression - Study protocol. BMC
Health Services Research 2009;16(9):188.
Rojas 2007 {published data only}
∗ Rojas G, Fritsch R, Solis J, Jadresic E, Castillo C,
Gonzalez M, et al.Treatment of postnatal depression in low-
income mothers in primary-care clinics in Santiago, Chile:
a randomised controlled trial. Lancet 2007;370(9599):
1629–37.
Zayas LH. Six-month multicomponent intervention
improves postnatal depression in low-income settings.
Evidence-Based Mental Health 2008;11(3):80.
Rollman 2005 {published data only}
Rollman B, Mazumdar S, Belnap B, Houck P, Lenze
E, Schulberg H. Main outcomes from the relax trial
of telephone delivered collaborative care for panic and
generalized anxiety disorder. Journal of General Internal
Medicine. Proceedings of the Annual Meeting of the
35Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Society of General Internal Medicine Minneapolis; 2010
April 28th-May 1st. 2010:S326.
∗ Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F,
Gardner W, et al.A randomized trial to improve the quality
of treatment for panic and generalized anxiety disorders in
primary care. Archives of General Psychiatry 2005;62(12):
1332–41.
Rollman BL, Belnap BH, Mazumdar S, Zhu F, Kroenke K,
Schulberg HC, et al.Symptomatic severity of prime-MD
diagnosed episodes of panic and generalized anxiety disorder
in primary care. Journal of General Internal Medicine 2005;
20(7):623–8.
Rollman BL, Herbeck Belnap B, Reynolds CF, Schulberg
HC, Shear MK. A contemporary protocol to assist primary
care physicians in the treatment of panic and generalized
anxiety disorders. General Hospital Psychiatry 2003;25(2):
74–82.
Shear K, Belnap BH, Mazumdar S, Houck P, Rollman BL.
Generalized anxiety disorder severity scale (GADSS): a
preliminary validation study. Depression and Anxiety 2006;
23(2):77–82.
Rollman 2009 {published data only}
Gallagher R. Telephone-delivered collaborative care for
post-CABG depression is more effective than usual care for
improving quality of life related to mental health. Evidence-
Based Nursing 2010;13(2):37.
Morone NE, Weiner DK, Belnap BH, Karp JF, Mazumdar
S, Houck PR, et al.The impact of pain and depression on
recovery after coronary artery bypass grafting. Psychosomatic
Medicine 2010;72(7):620–5.
Rollman BL, Belnap BH, LeMenager MS, Mazumdar
S, Houck PR, Counihan PJ, et al.Telephone-delivered
collaborative care for treating post-CABG depression:
a randomized controlled trial. JAMA 2009;302(19):
2095–103.
Rollman BL, Belnap BH, LeMenager MS, Mazumdar S,
Schulberg HC, Reynolds CF 3rd. The Bypassing the Blues
treatment protocol: stepped collaborative care for treating
post-CABG depression. Psychosomatic Medicine 2009;71
(2):217–30.
∗ Rollman BL, Herbeck Belnap B, LeMenager MS,
Mazumdar S, Houck PR, Counihan PJ, et al.Telephone-
delivered collaborative care for treating post-CABG
depression: a randomized controlled trial. JAMA 2009;302
(19):2095–103.
Schulberg HC, Belnap BH, Houck PR, Mazumdar S,
Reynolds CF III, Rollman BL. Treating post-CABG
depression with telephone-delivered collaborative care:
Does patient age affect treatment and outcome?. The
American Journal of Geriatric Psychiatry 2011;19(10):
871–80.
Sriwattanakomen R, Mazumdar S, Belnap B, Houck P,
Reynolds C, Rollman B. The effect of comorbid anxiety on
post-CABG depressed patients’ mental health related quality
of life. Journal of General Internal Medicine. Proceedings
of the 33rd Annual Meeting of the Society of General
Internal Medicine; 2010 Apr 28- May 1; Minneapolis
(MN). 2010:S401.
Tindle HA, Belnap BH, Hum B, Houck PR, Mazumdar
S, Scheier M, et al.Optimism, depression, and depression
remission after CABG surgery. Psychosomatic Medicine.
Proceedings of the 69th Annual Meeting of the American
Psychosomatic Society; 2011 Mar 9-12; San Antonio (TX).
2011; Vol. 73:A49.
Tully PJ. Randomised controlled trial: telephone-delivered
collaborative care for post-CABG depression is more
effective than usual care for improving mental-health-related
quality of life. Evidence-Based Medicine 2010;15(2):57–8.
Ross 2008 {published data only}
∗ Ross JT, TenHave T, Eakin AC, Difilippo S, Oslin DW. A
randomized controlled trial of a close monitoring program
for minor depression and distress. Journal of General Internal
Medicine 2008;23(9):1379–85.
Rost 2001a {published data only}
Adams SJ, Xu S, Dong F, Fortney J, Rost K. Differential
effectiveness of depression disease management for rural
and urban primary care patients. Journal of Rural Health
2006;22(4):343–50.
Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith
LS, Sherbourne CD, et al.Primary care patients’ involvement
in decision-making is associated with improvement in
depression. Medical Care 2006;44(5):398–405.
Dickinson LM, Rost K, Nutting PA, Elliott CE, Keeley
RD, Pincus H. RCT of a care manager intervention for
major depression in primary care: 2-Year costs for patients
with physical vs psychological complaints. Annals of Family
Medicine 2005;3(1):15–22.
Keeley RD, Smith JL, Nutting PA, Miriam Dickinson
L, Perry Dickinson W, Rost KM. Does a depression
intervention result in improved outcomes for patients
presenting with physical symptoms?. Journal of General
Internal Medicine 2004;19(6):615–23.
Lo Sasso AT, Rost K, Beck A. Modeling the impact of
enhanced depression treatment on workplace functioning
and costs: a cost-benefit approach. Medical Care 2006;44
(4):352–8.
Nutting PA, Dickinson LM, Rubenstein LV, Keeley RD,
Smith JL, Elliott CE. Improving detection of suicidal
ideation among depressed patients in primary care. Annals
of Family Medicine 2005;3(6):529–36.
Nutting PA, Rost K, Dickinson M, Werner JJ, Dickinson P,
Smith JL, et al.Barriers to initiating depression treatment in
primary care practice. Journal of General Internal Medicine
2002;17(2):103–11.
Pyne JM, Rost KM, Farahati F, Tripathi SP, Smith J,
Williams DK, et al.One size fits some: the impact of patient
treatment attitudes on the cost-effectiveness of a depression
primary-care intervention. Psychological Medicine 2005;35
(6):839–54.
Pyne JM, Rost KM, Zhang M, Williams DK, Smith J,
Fortney J. Cost-effectiveness of a primary care depression
intervention. Journal of General Internal Medicine 2003;18
(6):432–41.
Pyne JM, Smith J, Fortney J, Zhang M, Williams DK, Rost
36Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
K. Cost-effectiveness of a primary care intervention for
depressed females. Journal of Affective Disorders 2003;74(1):
23–32.
Rost K, Adams S, Xu S, Dong F. Rural-urban differences
in hospitalization rates of primary care patients with
depression. Psychiatric Services 2007;58(4):503–8.
Rost K, Nutting P, Smith J, Werner J, Duan N. Improving
depression outcomes in community primary care practice:
A randomized trial of the QuEST intervention. Journal of
General Internal Medicine 2001;16(3):143–9.
∗ Rost K, Nutting P, Smith JL, Elliott CE, Dickinson M.
Managing depression as a chronic disease: a randomised
trial of ongoing treatment in primary care. BMJ 2002;325
(7370):934.
Rost K, Nutting PA, Smith J, Werner JJ. Designing and
implementing a primary care intervention trial to improve
the quality and outcome of care for major depression.
General Hospital Psychiatry 2000;22(2):66–77.
Rost K, Pyne JM, Dickinson LM, LoSasso AT. Cost-
effectiveness of enhancing primary care depression
management on an ongoing basis. Annals of FamilyMedicine
2005;3(1):7–14.
Rost K, Smith JL, Dickinson M. The effect of improving
primary care depression management on employee
absenteeism and productivity. A randomized trial. Medical
Care 2004;42(12):1202–10.
Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne
CD, Meredith LS, et al.The Quality Improvement for
Depression collaboration: general analytic strategies for a
coordinated study of quality improvement in depression
care. General Hospital Psychiatry 2001;23(5):239–53.
Rost KM, Nutting P, Smith J, Werner J. Primary care
training improves depression outcomes. 153rd Annual
Meeting of the American Psychiatric Association; 2000 May
13-18, Chicago (IL). 2000:No.36E.
Smith JL, Rost KM, Nutting PA, Elliott CE. Resolving
disparities in antidepressant treatment and quality-of-life
outcomes between uninsured and insured primary care
patients with depression. Medical Care 2001;39(9):910–22.
Smith JL, Rost KM, Nutting PA, Elliott CE, Dickinson
LM. Impact of ongoing primary care intervention on long
term outcomes in uninsured and insured patients with
depression. Medical Care 2002;40(12):1210–22.
Smith JL, Rost KM, Nutting PA, Elliott CE, Duan N. A
primary care intervention for depression. Journal of Rural
Health 2000;16(4):313–23.
Xu S, Rost K, Dong F, Dickinson LM. Stakeholder benefit
from depression disease management: Differences by
rurality?. The Journal of Behavioral Health Services and
Research 2011;38(1):114–21.
Rost 2001b {published data only}
Adams SJ, Xu S, Dong F, Fortney J, Rost K. Differential
effectiveness of depression disease management for rural
and urban primary care patients. Journal of Rural Health
2006;22(4):343–50.
Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith
LS, Sherbourne CD, et al.Primary care patients’ involvement
in decision-making is associated with improvement in
depression. Medical Care 2006;44(5):398–405.
Dickinson LM, Rost K, Nutting PA, Elliott CE, Keeley
RD, Pincus H. RCT of a care manager intervention for
major depression in primary care: 2-Year costs for patients
with physical vs psychological complaints. Annals of Family
Medicine 2005;3(1):15–22.
Keeley RD, Smith JL, Nutting PA, Miriam Dickinson
L, Perry Dickinson W, Rost KM. Does a depression
intervention result in improved outcomes for patients
presenting with physical symptoms?. Journal of General
Internal Medicine 2004;19(6):615–23.
Lo Sasso AT, Rost K, Beck A. Modeling the impact of
enhanced depression treatment on workplace functioning
and costs: a cost-benefit approach. Medical Care 2006;44
(4):352–8.
Nutting PA, Dickinson LM, Rubenstein LV, Keeley RD,
Smith JL, Elliott CE. Improving detection of suicidal
ideation among depressed patients in primary care. Annals
of Family Medicine 2005;3(6):529–36.
Nutting PA, Rost K, Dickinson M, Werner JJ, Dickinson P,
Smith JL, et al.Barriers to initiating depression treatment in
primary care practice. Journal of General Internal Medicine
2002;17(2):103–11.
Pyne JM, Rost KM, Farahati F, Tripathi SP, Smith J,
Williams DK, et al.One size fits some: the impact of patient
treatment attitudes on the cost-effectiveness of a depression
primary-care intervention. Psychological Medicine 2005;35
(6):839–54.
Pyne JM, Rost KM, Zhang M, Williams DK, Smith J,
Fortney J. Cost-effectiveness of a primary care depression
intervention. Journal of General Internal Medicine 2003;18
(6):432–41.
Pyne JM, Smith J, Fortney J, Zhang M, Williams DK, Rost
K. Cost-effectiveness of a primary care intervention for
depressed females. Journal of Affective Disorders 2003;74(1):
23–32.
Rost K, Adams S, Xu S, Dong F. Rural-urban differences
in hospitalization rates of primary care patients with
depression. Psychiatric Services 2007;58(4):503–8.
Rost K, Nutting P, Smith J, Werner J, Duan N. Improving
depression outcomes in community primary care practice:
A randomized trial of the QuEST intervention. Journal of
General Internal Medicine 2001;16(3):143–9.
Rost K, Nutting P, Smith JL, Elliott CE, Dickinson M.
Managing depression as a chronic disease: a randomised
trial of ongoing treatment in primary care. BMJ 2002;325
(7370):934.
Rost K, Nutting PA, Smith J, Werner JJ. Designing and
implementing a primary care intervention trial to improve
the quality and outcome of care for major depression.
General Hospital Psychiatry 2000;22(2):66–77.
Rost K, Pyne JM, Dickinson LM, LoSasso AT. Cost-
effectiveness of enhancing primary care depression
management on an ongoing basis. Annals of FamilyMedicine
2005;3(1):7–14.
Rost K, Smith JL, Dickinson M. The effect of improving
37Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
primary care depression management on employee
absenteeism and productivity. A randomized trial. Medical
Care 2004;42(12):1202–10.
Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne
CD, Meredith LS, et al.The Quality Improvement for
Depression collaboration: general analytic strategies for a
coordinated study of quality improvement in depression
care. General Hospital Psychiatry 2001;23(5):239–53.
Rost KM, Nutting P, Smith J, Werner J. Primary care
training improves depression outcomes. 153rd Annual
Meeting of the American Psychiatric Association; 2000 May
13-18; Chicago (IL). 2000:No.36E.
Smith JL, Rost KM, Nutting PA, Elliott CE. Resolving
disparities in antidepressant treatment and quality-of-life
outcomes between uninsured and insured primary care
patients with depression. Medical Care 2001;39(9):910–22.
Smith JL, Rost KM, Nutting PA, Elliott CE, Dickinson
LM. Impact of ongoing primary care intervention on long
term outcomes in uninsured and insured patients with
depression. Medical Care 2002;40(12):1210–22.
Smith JL, Rost KM, Nutting PA, Elliott CE, Duan N. A
primary care intervention for depression. Journal of Rural
Health 2000;16(4):313–23.
Xu S, Rost K, Dong F, Dickinson LM. Stakeholder benefit
from depression disease management: Differences by
rurality?. The Journal of Behavioral Health Services and
Research 2011;38(1):114–21.
Roy-Byrne 2001 {published data only}
Katon WJ, Roy-Byrne P, Russo J, Cowley D. Cost-
effectiveness and cost offset of a collaborative care
intervention for primary care patients with panic disorder.
Archives of General Psychiatry 2002;59(12):1098–104.
Pieters G. Collaborative care led to greater recovery,
improvement, and adherence than usual care at 12 months
in panic disorder. Evidence-Based Mental Health 2002;5(2):
49.
Roy-Byrne P, Katon W, Cowley DS, Russo J. A randomized
effectiveness trial for panic disorder in primary care.
39th Annual Meeting of the American College of
Neuropsychopharmacology; 2000 Dec 10-14; San Juan;
Puerto Rico. 2000:311.
Roy-Byrne PP, Cowley DS, Russo J, Cohen E, Michelson
E, Katon WJ. Primary care panic: id by doctor versus
screening. 153rd Annual Meeting of the American
Psychiatric Association; 2000 May 13-18; Chicago (IL).
2000:NR599.
Roy-Byrne PP, Craske MG, Stein MB, Sullivan JG,
Bystritsky A, Katon WJ, et al.Cognitive-behavior therapy
and medication for primary care panic disorder: Sustained
superiority to usual care. 157th Annual Meeting of the
American Psychiatric Association; 2004 May 1-6; New York
(NY). 2004:No. 9B.
∗ Roy-Byrne PP, Katon W, Cowley DS, Russo J. A
randomized effectiveness trial of collaborative care for
patients with panic disorder in primary care. Archives of
General Psychiatry 2001;58(9):869–76.
Roy-Byrne PP, Katon W, Cowley DS, Russo JE, Cohen
E, Michelson E, et al.Panic disorder in primary care:
Biopsychosocial differences between recognized and
unrecognized patients. General Hospital Psychiatry 2000;22
(6):405–11.
Roy-Byrne PP, Russo J, Cowley DS, Katon WJ. Panic
disorder in public sector primary care: clinical characteristics
and illness severity compared with ”mainstream“ primary
care panic disorder. Depression and Anxiety 2003;17(2):
51–7.
Roy-Byrne PP, Russo J, Cowley DS, Katon WJ.
Unemployment and emergency room visits predict poor
treatment outcome in primary care panic disorder. Journal
of Clinical Psychiatry 2003;64(4):383–9.
Roy-Byrne PP, Russo J, Katon WJ. Improving care for panic
in primary care. 153rd Annual Meeting of the American
Psychiatric Association; 2000 May 13-18; Chicago (IL).
2000:No. 36D.
Roy-Byrne 2005 {published data only}
Arch JJ, Craske MG, Stein MB, Sherbourne CD, Roy-
Byrne PP. Correlates of alcohol use among anxious and
depressed primary care patients. General Hospital Psychiatry
2006;28(1):37–42.
Bricker JB, Russo J, Stein MB, Sherbourne C, Craske M,
Schraufnagel TJ, et al.Does occasional cannabis use impact
anxiety and depression treatment outcomes?: Results from a
randomized effectiveness trial. Depression and Anxiety 2007;
24(6):392–8.
Bystritsky A, Wagner AW, Russo JE, Stein MB, Sherbourne
CD, Craske MG, et al.Assessment of beliefs about
psychotropic medication and psychotherapy: development
of a measure for patients with anxiety disorders. General
Hospital Psychiatry 2005;27(5):313–8.
Chavira DA, Stein MB, Golinelli D, Sherbourne CD,
Craske MG, Sullivan G, et al.Predictors of clinical
improvement in a randomized effectiveness trial for primary
care patients with panic disorder. Journal of Nervous and
Mental Disease 2009;197(10):715–21.
Craske MG, Edlund MJ, Sullivan G, Roy-Byrne P,
Sherbourne C, Bystritsky A, et al.Perceived unmet need for
mental health treatment and barriers to care among patients
with panic disorder. Psychiatric Services 2005;56(8):988–94.
Craske MG, Golinelli D, Stein MB, Roy-Byrne P, Bystritsky
A, Sherbourne C. Does the addition of cognitive behavioral
therapy improve panic disorder treatment outcome
relative to medication alone in the primary-care setting?.
Psychological Medicine 2005;35(11):1645–54.
Craske MG, Roy-Byrne P, Stein MB, Sullivan G, Hazlett-
Stevens H, Bystritsky A, et al.CBT intensity and outcome
for panic disorder in a primary care setting. Behavior
Therapy 2006;37(2):112–9.
Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan
M-Y, et al.Incremental cost-effectiveness of a collaborative
care intervention for panic disorder. Psychological Medicine
2006;36(3):353–63.
Kumar S. Coordinated care consisting of cognitive
behavioural therapy plus medication improves panic
38Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
disorder. Evidence-Based Mental Health 2005;8(4):110.
Mukherjee S, Sullivan G, Perry D, Verdugo B, Means-
Christensen A, Schraufnagel T, et al.Adherence to treatment
among economically disadvantaged patients with panic
disorder. Psychiatric Services 2006;57(12):1745–50.
Roy-Byrne P, Sherbourne C, Miranda J, Stein M, Craske M,
Golinelli D, et al.Poverty and response to treatment among
panic disorder patients in primary care. American Journal of
Psychiatry 2006;163(8):1419–25.
Roy-Byrne P, Stein MB, Russo J, Craske M, Katon W,
Sullivan G, et al.Medical illness and response to treatment
in primary care panic disorder. General Hospital Psychiatry
2005;27(4):237–43.
∗ Roy-Byrne PP, Craske MG, Stein MB, Sullivan G,
Bystritsky A, Katon W, et al.A randomized effectiveness trial
of cognitive-behavioral therapy and medication for primary
care panic disorder. Archives of General Psychiatry 2005;62
(3):290–8.
Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB,
Katon W, Sullivan G, et al.Moving treatment research from
clinical trials to the real world. Psychiatric Services 2003;54
(3):327–32.
Wagner AW, Bystritsky A, Russo JE, Craske MG,
Sherbourne CD, Stein MB, et al.Beliefs about psychotropic
medication and psychotherapy among primary care patients
with anxiety disorders. Depression and Anxiety 2005;21(3):
99–105.
Roy-Byrne 2010 {published data only}
Craske MG, Stein MB, Sullivan G, Sherbourne C,
Bystritsky A, Rose RD, et al.Disorder-specific impact of
coordinated anxiety learning and management treatment
for anxiety disorders in primary care. Archives of General
Psychiatry 2011;68(4):378–88.
∗ Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund
MJ, Lang AJ, et al.Delivery of evidence-based treatment for
multiple anxiety disorders in primary care: A randomized
controlled trial. JAMA 2010;303(19):1921–8.
Roy-Byrne PP, Sherbourne CD, Stein MB, Sullivan G,
Edlund M, Craske MG, et al.Coordinated Anxiety Learning
and Management (CALM): Improving primary care anxiety
outcomes [Primary Care Intervention Strategy for Anxiety
Disorders] [NCT00347269]. www.clinicaltrials.gov/ct2/
show/NCT00347269 (Accessed 3 May 2012).
Stein MB, Roy Byrne PP, Craske MG, Campbell Sills
L, Lang AJ, Golinelli D, et al.Quality of and patient
satisfaction with primary health care for anxiety disorders.
Journal of Clinical Psychiatry 2011;72(7):970–6.
Sullivan G, Craske MG, Sherbourne C, Edlund MJ, Rose
RD, Golinelli D, et al.Design of the Coordinated Anxiety
Learning and Management (CALM) study: innovations in
collaborative care for anxiety disorders. General Hospital
Psychiatry 2007;29(5):379–87.
Rubenstein 2002 {published data only}
Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith
LS, Sherbourne CD, et al.Primary care patients’ involvement
in decision-making is associated with improvement in
depression. Medical Care 2006;44(5):398–405.
Nutting PA, Dickinson LM, Rubenstein LV, Keeley RD,
Smith JL, Elliott CE. Improving detection of suicidal
ideation among depressed patients in primary care. Annals
of Family Medicine 2005;3(6):529–36.
Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne
CD, Meredith LS, et al.The Quality Improvement for
Depression collaboration: general analytic strategies for a
coordinated study of quality improvement in depression
care. General Hospital Psychiatry 2001;23(5):239–53.
∗ Rubenstein LV, Parker LE, Meredith LS, Altschuler A,
dePillis E, Hernandez J, et al.Understanding team-based
quality improvement for depression in primary care. Health
Services Research 2002;37(4):1009–29.
Simon 2000a {published data only}
∗ Simon GE, VonKorff M, Rutter C,Wagner E. Randomised
trial of monitoring, feedback, and management of care by
telephone to improve treatment of depression in primary
care. BMJ 2000;320(7234):550–4.
Williams JW Jr. Feedback to physicians plus telephone care
management improved outcomes in primary care patients
with depression [comment]]. ACP Journal Club 2000;133
(2):73.
Simon 2000b {published data only}
Simon GE, VonKorff M, Rutter C, Wagner E. Randomised
trial of monitoring, feedback, and management of care by
telephone to improve treatment of depression in primary
care. BMJ 2000;320(7234):550–4.
Williams JW Jr. Feedback to physicians plus telephone care
management improved outcomes in primary care patients
with depression [comment]]. ACP Journal Club 2000;133
(2):73.
Simon 2004a {published data only}
Ludman EJ, Simon GE, Tutty S, Von Korff M. A
randomized trial of telephone psychotherapy and
pharmacotherapy for depression: continuation and
durability of effects. Journal of Consulting and Clinical
Psychology 2007;75(2):257–66.
Simon GE, Ludman EJ, Rutter C. Incremental benefit
and cost of telephone care management and telephone
psychotherapy for depression in primary care. Archives of
General Psychiatry 2009;66(10):1081–9.
∗ Simon GE, Ludman EJ, Tutty S, Operskalski B,
Von Korff M. Telephone psychotherapy and telephone
care management for primary care patients starting
antidepressant treatment: a randomized controlled trial.
JAMA 2004;292(8):935–42.
Tutty S, Ludman EJ, Simon G. Feasibility and acceptability
of a telephone psychotherapy program for depressed adults
treated in primary care. General Hospital Psychiatry 2005;27
(6):400–10.
Simon 2004b {published data only}
Ludman EJ, Simon GE, Tutty S, Von Korff M. A
randomized trial of telephone psychotherapy and
pharmacotherapy for depression: continuation and
39Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
durability of effects. Journal of Consulting and Clinical
Psychology 2007;75(2):257–66.
Simon GE, Ludman EJ, Rutter C. Incremental benefit
and cost of telephone care management and telephone
psychotherapy for depression in primary care. Archives of
General Psychiatry 2009;66(10):1081–9.
Simon GE, Ludman EJ, Tutty S, Operskalski B, Von
Korff M. Telephone psychotherapy and telephone
care management for primary care patients starting
antidepressant treatment: a randomized controlled trial.
JAMA 2004;292(8):935–42.
Tutty S, Ludman EJ, Simon G. Feasibility and acceptability
of a telephone psychotherapy program for depressed adults
treated in primary care. General Hospital Psychiatry 2005;27
(6):400–10.
Simon 2011 {published data only}
Simon GE. Pilot trial of depression care management
by electronic secure messaging [feasibility of depression
care management by E-Mail] [NCT00755235].
www.clinicaltrials.gov/ct2/show/NCT00755235 (Accessed
3 May 2012).
∗ Simon GE, Ralston JD, Savarino J, Pabiniak C, Wentzel
C, Operskalski BH. Randomized trial of depression follow-
up care by online messaging. Journal of General Internal
Medicine 2011;26(7):698–704.
Smit 2006a {published data only}
Conradi HJ, de Jonge P, Kluiter H, Smit A, van der Meer
K, Jenner JA, et al.Enhanced treatment for depression in
primary care: long-term outcomes of a psycho-educational
prevention program alone and enriched with psychiatric
consultation or cognitive behavioral therapy. Psychological
Medicine 2007;37(6):849–62.
de Jonge P, Conradi HJ, Kaptein KI, Bockting CL, Korf
J, Ormel J. Duration of subsequent episodes and periods
of recovery in recurrent major depression [INSTEL trial].
Journal of Affective Disorders 2010;125(1-3):141–5.
∗ Smit A, Kluiter H, Conradi HJ, van der Meer K, Tiemens
BG, Jenner JA, et al.Short-term effects of enhanced
treatment for depression in primary care: Results from a
randomized controlled trial. Psychological Medicine 2006;36
(1):15–26.
Smit A, Tiemens BG, Ormel J, Kluiter H, Jenner JA, van de
Meer K, et al.Enhanced treatment for depression in primary
care: First year results on compliance, self-efficacy, the
use of antidepressants and contacts with the primary care
physician. Primary Care and Community Psychiatry 2005;10
(2):39–49.
Stant AD, Ten Vergert EM, Kluiter H, Conradi HJ, Smit A,
Ormel J. Cost-effectiveness of a psychoeducational relapse
prevention program for depression in primary care. Journal
of Mental Health Policy and Economics 2009;12(4):195-217,
220.
Smit 2006b {published data only}
Conradi HJ, de Jonge P, Kluiter H, Smit A, van der Meer
K, Jenner JA, et al.Enhanced treatment for depression in
primary care: long-term outcomes of a psycho-educational
prevention program alone and enriched with psychiatric
consultation or cognitive behavioral therapy. Psychological
Medicine 2007;37(6):849–62.
de Jonge P, Conradi HJ, Kaptein KI, Bockting CL, Korf
J, Ormel J. Duration of subsequent episodes and periods
of recovery in recurrent major depression [INSTEL trial].
Journal of Affective Disorders 2010;125(1-3):141–5.
Smit A, Kluiter H, Conradi HJ, van der Meer K, Tiemens
BG, Jenner JA, et al.Short-term effects of enhanced
treatment for depression in primary care: Results from a
randomized controlled trial. Psychological Medicine 2006;36
(1):15–26.
Smit A, Tiemens BG, Ormel J, Kluiter H, Jenner JA, van de
Meer K, et al.Enhanced treatment for depression in primary
care: First year results on compliance, self-efficacy, the
use of antidepressants and contacts with the primary care
physician. Primary Care and Community Psychiatry 2005;10
(2):39–49.
Stant AD, Ten Vergert EM, Kluiter H, Conradi HJ, Smit A,
Ormel J. Cost-effectiveness of a psychoeducational relapse
prevention program for depression in primary care. Journal
of Mental Health Policy and Economics 2009;12(4):195-217,
220.
Smit 2006c {published data only}
Conradi HJ, de Jonge P, Kluiter H, Smit A, van der Meer
K, Jenner JA, et al.Enhanced treatment for depression in
primary care: long-term outcomes of a psycho-educational
prevention program alone and enriched with psychiatric
consultation or cognitive behavioral therapy. Psychological
Medicine 2007;37(6):849–62.
de Jonge P, Conradi HJ, Kaptein KI, Bockting CL, Korf
J, Ormel J. Duration of subsequent episodes and periods
of recovery in recurrent major depression [INSTEL trial].
Journal of Affective Disorders 2010;125(1-3):141–5.
Smit A, Kluiter H, Conradi HJ, van der Meer K, Tiemens
BG, Jenner JA, et al.Short-term effects of enhanced
treatment for depression in primary care: Results from a
randomized controlled trial. Psychological Medicine 2006;36
(1):15–26.
Smit A, Tiemens BG, Ormel J, Kluiter H, Jenner JA, van de
Meer K, et al.Enhanced treatment for depression in primary
care: First year results on compliance, self-efficacy, the
use of antidepressants and contacts with the primary care
physician. Primary Care and Community Psychiatry 2005;10
(2):39–49.
Stant AD, Ten Vergert EM, Kluiter H, Conradi HJ, Smit A,
Ormel J. Cost-effectiveness of a psychoeducational relapse
prevention program for depression in primary care. Journal
of Mental Health Policy and Economics 2009;12(4):195-217,
220.
Strong 2008 {published data only}
Forchuk C. A nurse-delivered intervention was effective for
depression in patients with cancer. Evidence-Based Nursing
2009;12(1):17.
∗ Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker
J, et al.Management of depression for people with cancer
(SMaRT oncology 1): a randomised trial [see comment].
40Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lancet 2008;372(9632):40–8.
van der Feltz-Cornelis CM. A nurse delivered management
programme for depression in people with cancer reduces
depressive symptoms compared with usual care. Evidence-
Based Mental Health 2009;12(1):9.
Walker J, Sharpe M. Depression Care for People with
Cancer: a collaborative care intervention. General Hospital
Psychiatry 2009;31(5):436–41.
Walker M, Walker L, Walker A, Bateman J, Braid F,
Hebblewhite C, et al.Preventing psychiatric morbidity
in people with cancer. Psycho-Oncology. Proceedings
of the 11th World Congress of Psycho-Oncology of the
International Psycho-Oncology Society, IPOS; 2009 Jun
21-24; Vienna, Austria. 2009; Vol. 18:S238.
Swindle 2003 {published data only}
∗ Swindle RW, Rao JK, Helmy A, Plue L, Zhou XH,
Eckert GJ, et al.Integrating clinical nurse specialists into
the treatment of primary care patients with depression.
International Journal of Psychiatry in Medicine 2003;33(1):
17–37.
Weinberger M. An integrated model of primary care in
mental health. http://www.clinicaltrials.gov/ct2/show/
NCT00013260 (Accessed 3 May 2012).
Uebelacker 2011 {published data only}
∗ Uebelacker LA, Marootian BA, Tigue P, Haggarty
R, Primack JM, Miller IW. Telephone depression care
management for Latino Medicaid health plan members: A
pilot randomized controlled trial. Journal of Nervous and
Mental Disease 2011;199(9):678–83.
Unutzer 2002 {published data only}
Apesoa Varano EC, Hinton L, Barker JC, Unutzer J.
Clinician approaches and strategies for engaging older men
in depression care. American Journal of Geriatric Psychiatry
2010;18(7):586–95.
Arean PA, Ayalon L, Hunkeler E, Lin EH, Tang L, Harpole
L, et al.Improving depression care for older, minority
patients in primary care. Medical Care 2005;43(4):381–90.
Arean PA, Gum AM, Tang L, Unutzer J. Service use and
outcomes among elderly persons with low incomes being
treated for depression. Psychiatric Services 2007;58(8):
1057–64.
Bao Y, Casalino LP, Ettner SL, Bruce ML, Solberg LI,
Unutzer J. Designing payment for collaborative care for
depression in primary care. Health Services Research 2011;
46(5):1436–51.
Blasinsky M, Goldman HH, Unutzer J. Project IMPACT:
a report on barriers and facilitators to sustainability.
Administration and Policy in Mental Health 2006;33(6):
718–29.
Buist-Bouwman M A. Collaborative care management
improves physical functioning in older people with
depression. Evidence-Based Mental Health 2005;8(4):106.
Chan D, Fan MY, Unutzer J. Long-term effectiveness of
collaborative depression care in older primary care patients
with and without PTSD symptoms. International Journal of
Geriatric Psychiatry 2011;26(7):758–64.
Conn DK. Collaborative care depression management for
older adults: level of comorbidity does not affect outcome.
Evidence-Based Mental Health 2005;8(4):105.
Fann JR, Fan MY, Unutzer J. Improving primary care for
older adults with cancer and depression. Journal of General
Internal Medicine 2009;24(Suppl 2):S417–24.
Gensichen J. IMPACT collaborative care improves
depression in elderly patients in primary care in the longer
term. Evidence-Based Mental Health 2006;9(3):76.
Gilbody S M. IMPACT collaborative care programme
reduces suicide ideation in depressed older adults. Evidence-
Based Mental Health 2007;10(2):51.
Goldstein KM, Harpole LH, Stechuchak KM, Coffman CJ,
Bosworth HB, Steffens DC, et al.Hormone therapy does
not affect depression severity in older women. American
Journal of Geriatric Psychiatry 2005;13(7):616–23.
Grypma L, Haverkamp R, Little S, Unutzer J. Taking an
evidence-based model of depression care from research to
practice: making lemonade out of depression. General
Hospital Psychiatry 2006;28(2):101–7.
Gum AM, Arean PA, Hunkeler E, Tang L, Katon W,
Hitchcock P, et al.Depression treatment preferences in older
primary care patients. Gerontologist 2006;46(1):14–22.
Hegel MT, Imming Jr, Cyr-Provost M, Noel PH, Arean
PA, Unutzer J. Role of behavioral health professionals in a
collaborative stepped care treatment model for depression
in primary care: Project IMPACT. Families, Systems and
Health 2002;20(3):265–77.
Hinton L, Zweifach M, Oishi S, Tang L, Unutzer J.
Gender disparities in the treatment of late-life depression:
Qualitative and quantitative findings from the IMPACT
trial. American Journal of Geriatric Psychiatry 2006;14(10):
884–92.
Hunkeler EM, Katon W, Tang L, Williams JWJ, Kroenke
K, Lin EH, et al.Long term outcomes from the IMPACT
randomised trial for depressed elderly patients in primary
care [comments in: Evid Based Ment Health. 2006 Aug;
9(3):76; PMID: 16868195 and BMJ. 2006 Feb 4;332
(7536):249-50; PMID: 16455698]. BMJ 2006;332(7536):
259–63.
Katon W, Unutzer J, Fan MY, Williams JWJ, Schoenbaum
M, Lin EH, et al.Cost-effectiveness and net benefit of
enhanced treatment of depression for older adults with
diabetes and depression. Diabetes Care 2006;29(2):265–70.
Katon WJ, Fan MY, Lin EH, Unutzer J. Depressive
symptom deterioration in a large primary care-based elderly
cohort. American Journal of Geriatric Psychiatry 2006;14(3):
246–54.
Lin EH, Katon W, Von Korff M, Tang L, Williams JW,
Jr, et al.Effect of improving depression care on pain and
functional outcomes among older adults with arthritis: a
randomized controlled trial. JAMA 2003;290(18):2428–9.
Lin EH, Tang L, Katon W, Hegel MT, Sullivan MD,
Unutzer J. Arthritis pain and disability: response to
collaborative depression care. General Hospital Psychiatry
41Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2006;28(6):482–6.
Lin EHB. Depression and Osteoarthritis. American Journal
of Medicine 2008;121(11 Suppl 2):S16–9.
Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke
K. Monitoring depression treatment outcomes with the
patient health questionnaire-9. Medical Care 2004;42(12):
1194–201.
Noel PH, Williams Jr JW, Unutzer J, Worcbel J, Lee S,
Cornell J, et al.Depression and comorbid illness in elderly
primary care patients: Impact on multiple domains of
health status and well-being. Annals of Family Medicine
2004;2(6):555–62.
Oxman TE. Collaborative care may improve depression
management in older adults. Evidence-Based Mental Health
2003;6(3):86.
Pigeon WR, Hegel M, Unutzer J, Fan MY, Sateia MJ,
Lyness JM, et al.Is insomnia a perpetuating factor for late-
life depression in the IMPACT cohort?. Sleep 2008;31(4):
481–8.
Price J. Collaborative care improves health outcomes in
older people with depression and arthritis. Evidence-Based
Mental Health 2004;7(2):45.
Simon G. Collaborative care for depression: is effective in
older people, as the IMPACT trial shows. BMJ 2006;332
(7536):249–50.
Slimmer L. A collaborative care management programme in
a primary care setting was effective for older adults with late
life depression. Evidence-Based Nursing 2003;6(3):91.
Steffens DC, Snowden M, Fan MY, Hendrie H, Katon WJ,
Unutzer J. Cognitive impairment and depression outcomes
in the IMPACT study. American Journal of Geriatric
Psychiatry 2006;14(5):401–9.
Tang L, Song J, Belin TR, Unutzer J. A comparison of
imputation methods in a longitudinal randomized clinical
trial. Statistics in Medicine 2005;24(14):2111–28.
Thielke SM, Fan MY, Sullivan M, Unutzer J. Pain limits the
effectiveness of collaborative care for depression. American
Journal of Geriatric Psychiatry 2007;15(8):699–707.
Thompson A, Fan MY, Unutzer J, Katon W. One extra
month of depression: The effects of caregiving on depression
outcomes in the IMPACT trial. International Journal of
Geriatric Psychiatry 2008;23(5):511–6.
Unutzer J. Improving depression care for older adults. 155th
Annual Meeting of the American Psychiatric Association;
2002 May 18-23; Philadelphia (PA). 2002:No. 45D.
Unutzer J, Choi Y, Cook I A, Oishi S. A Web-based data
management system to improve care for depression in a
multicenter clinical trial. Psychiatric Services 2002;53(6):
671.
Unutzer J, Ferrell B, Lin EH, Marmon T. Pharmacotherapy
of pain in depressed older adults. Journal of the American
Geriatrics Society 2004;52(11):1916–22.
∗ Unutzer J, Katon W, Callahan CM, Williams JW
Jr, Hunkeler E, Harpole L, et al.Collaborative care
management of late-life depression in the primary care
setting: a randomized controlled trial. JAMA 2002;288
(22):2836–45.
Unutzer J, Katon W, Callahan CM, Williams JW Jr,
Hunkeler E, Harpole L, et al.Depression treatment in a
sample of 1,801 depressed older adults in primary care.
JAMA 2002;288(22):2836–45.
Unutzer J, Katon W, Williams JW Jr, Callahan CM,
Harpole L, Hunkeler EM, et al.Improving primary care
for depression in late life: the design of a multicenter
randomized trial. Medical Care 2001;39(8):785–99.
Unutzer J, Katon WJ, Fan MY, Schoenbaum MC, Lin EH,
Della Penna RD, et al.Long-term cost effects of collaborative
care for late-life depression. American Journal of Managed
Care 2008;14(2):95–100.
Unutzer J, Powers D, Katon W, Langston C. From
establishing an evidence-based practice to implementation
in real-world settings: IMPACT as a case study. Psychiatric
Clinics of North America 2005;28(4):1079–92.
Unutzer J, Tang L, Oishi S, Katon W, Williams JWJ,
Hunkeler E, et al.Reducing suicidal ideation in depressed
older primary care patients. Journal of the American
Geriatrics Society 2006;54(10):1550–6.
van Leeuwen Williams E, Unutzer J, Lee S, Noel PH.
Collaborative depression care for the old-old: findings from
the IMPACT trial. American Journal of Geriatric Psychiatry
2009;17(12):1040–9.
Vannoy SD, Arean P, Untzer J. Advantages of using
estimated depression-free days for evaluating treatment
efficacy. Psychiatric Services 2010;61(2):160–3.
Vannoy SD, Duberstein P, Cukrowicz K, Lin E, Fan MY,
Unutzer J. The relationship between suicide ideation and
late-life depression. American Journal of Geriatric Psychiatry
2007;15(12):1024–33.
Voils C, Olsen M, Williams Jr J. Identifying depressed older
adults in primary care: A secondary analysis of a multisite
randomized controlled trial. Primary Care Companion to the
Journal of Clinical Psychiatry 2008;10(1):9–14.
Williams JW Jr, Katon W, Lin EHB, Noel PH, Worchel J,
Cornell J, et al.Improving patient care: The effectiveness of
depression care management on diabetes-related outcomes
in older patients. Annals of Internal Medicine 2004;140(12):
1015.
Vera 2010 {published data only}
Vera M, Juarbe D. Depression Treatment in General
Medical Settings. http://www.clinicaltrials.gov/ct2/show/
NCT00797901 (Accessed 3 May 2012).
∗ Vera M, Perez-Pedrogo C, Huertas SE, Reyes-Rabanillo
ML, Juarbe D, Huertas A, et al.Collaborative care for
depressed patients with chronic medical conditions: A
randomized trial in Puerto Rico. Psychiatric Services 2010;
61(2):144–50.
Vlasveld 2011 {published data only}
Vlasveld MC, Anema JR, Beekman AT, van Mechelen W,
Hoedeman R, van Marwijk HW, et al.Multidisciplinary
collaborative care for depressive disorder in the occupational
health setting: design of a randomised controlled trial and
cost-effectiveness study. BMC Health Services Research 2008;
42Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
8:99.
∗ VlasveldMC, van der Feltz-Cornelis CM, Ader HJ, Anema
JR, Hoedeman R, van Mechelen W, et al.Collaborative care
for major depressive disorder in an occupational healthcare
setting. British Journal of Psychiatry 2011 Nov 24 [Epub
ahead of print]. [DOI: 10.1192/bjp.bp.111.095687]
Waitzkin 2011 {published data only}
∗ Waitzkin H, Getrich C, Heying S, Rodriguez L, Parmar A,
Willging C, et al.Promotoras as mental health practitioners
in primary care: A multi-method study of an intervention
to address contextual sources of depression. Journal of
Community Health 2011;36(2):316–31.
Wells 2000a {published data only}
Callahan CM, Kroenke K, Counsell SR, Hendrie HC,
Perkins AJ, Katon W, et al.Treatment of depression improves
physical functioning in older adults. Journal of the American
Geriatrics Society 2005;53(3):367–73.
Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith
LS, Sherbourne CD, et al.Primary care patients’ involvement
in decision-making is associated with improvement in
depression. Medical Care 2006;44(5):398–405.
Dwight-Johnson M, Unutzer J, Sherbourne C, Tang
L, Wells KB. Can quality improvement programs for
depression in primary care address patient preferences for
treatment?. Medical Care 2001;39(9):934–44.
Fraser SA, Kroenke K, Callahan CM, Hui SL, Williams
JWJ, Unutzer J. Low yield of thyroid-stimulating hormone
testing in elderly patients with depression. General Hospital
Psychiatry 2004;26(4):302–9.
Halpern J, Johnson MD,Miranda J, Wells KB. The partners
in care approach to ethics outcomes in quality improvement
programs for depression. Psychiatric Services 2004;55(5):
532–9.
Harpole LH, Stechuchak KM, Saur CD, Steffens DC,
Unutzer J, Oddone E. Implementing a disease management
intervention for depression in primary care: a random work
sampling study. General Hospital Psychiatry 2003;25(4):
238–45.
Harpole LH, Williams Jr JW, Olsen MK, Stechuchak
KM, Oddone E, Callahan CM, et al.Improving depression
outcomes in older adults with comorbid medical illness.
General Hospital Psychiatry 2005;27(1):4–12.
Hegel MT, Unutzer J, Tang L, Arean PA, Katon W, Noel
PH, et al.Impact of comorbid panic and posttraumatic
stress disorder on outcomes of collaborative care for late-life
depression in primary care. American Journal of Geriatric
Psychiatry 2005;13(1):48–58.
Jaycox LH, Miranda J, Meredith LS, Duan N, Benjamin
B, Wells K. Impact of a primary care quality improvement
intervention on use of psychotherapy for depression. Mental
Health Services Research 2003;5(2):109–20.
Johnson MD,Meredith LS, Hickey SC,Wells KB. Influence
of patient preference and primary care clinician proclivity
for watchful waiting on receipt of depression treatment.
General Hospital Psychiatry 2006;28(5):379–86.
Katon WJ, Schoenbaum M, Fan MY, Callahan CM,
Williams JJ, Hunkeler E, et al.Cost-effectiveness of
improving primary care treatment of late-life depression.
Archives of General Psychiatry 2005;62(12):1313–20.
Klap R, Tang L, Schell T,Wells K, Sherbourne C, Miranda J,
et al.How quality improvement interventions for depression
affect stigma concerns over time: A nine-year follow-up
study. Psychiatric Services 2009;60(2):258–61.
Koike AK, Unutzer J, Wells KB. Improving the care for
depression in patients with comorbid medical illness.
American Journal of Psychiatry 2002;159(10):1738–45.
Levine S, Unutzer J, Yip JY, Hoffing M, Leung M, Fan M-
Y, et al.Physicians’ satisfaction with a collaborative disease
management program for late-life depression in primary
care. General Hospital Psychiatry 2005;27(6):383–91.
Masaquel A, Wells K, Ettner SL. How does the persistence
of depression influence the continuity and type of health
insurance and coverage limits on mental health therapy?.
Journal of Mental Health Policy and Economics 2007;10(3):
133–44.
Meredith LS, Cheng WJY, Hickey SC, Dwight-Johnson
M. Factors associated with primary care clinicians’ choice
of a watchful waiting approach to managing depression.
Psychiatric Services 2007;58(1):72–8.
Meredith LS, Jackson-Triche M, Duan N, Rubenstein LV,
Camp P, Wells KB. Quality improvement for depression
enhances long-term treatment knowledge for primary care
clinicians. Journal of General Internal Medicine. 2000;15
(12):868–77.
Meredith LS, Orlando M, Humphrey N, Camp P,
Sherbourne CD. Are better ratings of the patient-provider
relationship associated with higher quality care for
depression?. Medical Care 2001;39(4):349–60.
Miranda J, Duan N, Sherbourne C, Schoenbaum M,
Lagomasino I, Jackson-Triche M, et al.Improving care for
minorities: can quality improvement interventions improve
care and outcomes for depressed minorities? Results of a
randomized, controlled trial. Health Services Research 2003;
38(2):613–30.
Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells
K. Effects of primary care depression treatment on minority
patients’ clinical status and employment. Archives of General
Psychiatry 2004;61(8):827–34.
Oishi SM, Shoai R, Katon W, Callahan C, Unutzer J,
Arean P, et al.Impacting late life depression: Integrating
a depression intervention into primary care. Psychiatric
Quarterly 2003;74(1):75–89.
Roeloffs C, Sherbourne C, Unutzer J, Fink A, Tang L, Wells
KB. Stigma and depression among primary care patients.
General Hospital Psychiatry 2003;25(5):311–5.
Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne
CD, Meredith LS, et al.The Quality Improvement for
Depression collaboration: general analytic strategies for a
coordinated study of quality improvement in depression
care. General Hospital Psychiatry 2001;23(5):239–53.
Rubenstein LV, Jackson-Triche M, Unutzer J, Miranda
J, Minnium K, Pearson ML, et al.Evidence-based care
for depression in managed primary care practices. Health
43Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Affairs 1999;18(5):89–105.
Schoenbaum M, Belin T, Wells K. Improving primary care
depression treatment: the effect on patients’ employment.
Association for Health Services Research 1999;16:87.
Schoenbaum M, Miranda J, Sherbourne C, Duan N, Wells
K. Cost-effectiveness of interventions for depressed Latinos.
Journal of Mental Health Policy and Economics 2004;7(2):
69–76.
Schoenbaum M, Sherbourne C, Wells K. Gender patterns
in cost effectiveness of quality improvement for depression:
Results of a randomized, controlled trial. Journal of Affective
Disorders 2005;87(2-3):319–25.
Schoenbaum M, Unutzer J, McCaffrey D, Duan N,
Sherbourne C, Wells KB. The effects of primary care
depression treatment on patients’ clinical status and
employment. Health Services Research 2002;37(5):1145–58.
Schoenbaum M, Unutzer J, Sherbourne C, Duan N,
Rubenstein LV, Miranda J, et al.Cost-effectiveness of
practice-initiated quality improvement for depression:
results of a randomized controlled trial. JAMA 2001;286
(11):1325–30.
Sherbourne CD, Edelen MO, Zhou A, Bird C, Duan
N, Wells KB. How a therapy-based quality improvement
intervention for depression affected life events and
psychological well-being over time: a 9-year longitudinal
analysis. Medical Care 2008;46(1):78–84.
Sherbourne CD, Schoenbaum M, Wells KB, Croghan
TW. Characteristics, treatment patterns, and outcomes of
persistent depression despite treatment in primary care.
General Hospital Psychiatry 2004;26(2):106–14.
Sherbourne CD, Weiss R, Duan N, Bird C, Wells K. Do
the effects of quality improvement for depression differ for
men and women?. Quality of Life Research 2003;12(7):767.
Sherbourne CD, Weiss R, Duan N, Bird CE, Wells KB. Do
the effects of quality improvement for depression care differ
for men and women? Results of a group-level randomized
controlled trial. Medical Care 2004;42(12):1186–93.
Sherbourne CD, Wells KB, Duan N, Miranda J, Unutzer
J, Jaycox L, et al.Long-term effectiveness of disseminating
quality improvement for depression in primary care.
Archives of General Psychiatry 2001;58(7):696–703.
Sherbourne DC, Unutzer J, Schoenbaum M, Duan N,
Lenert LA, Sturm R, et al.Can utility-weighted health-
related quality-of-life estimates capture health effects of
quality improvement for depression?. Medical Care 2001;
39(11):1246–59.
Unutzer J. Collaborative care for late-life depression.
International Psychogeriatrics. Proceedings of the
International Psychogeriatric Association Eleventh
International Congress; 2003 Aug 17-22 2003; Chicago
(IL). 2003; Vol. 15.
Unutzer J. Collaborative care for late life depression in
primary care: a randomized controlled trial. Proceedings of
the 14th Annual Meeting of the American Association for
Geriatric Psychiatry; 2001 23-26 Feb; San Francisco (CA).
2001.
Unutzer J, Rubenstein L, Katon WJ, Tang L, Duan
N, Lagomasino IT, et al.Two-year effects of quality
improvement programs on medication management for
depression. Archives of General Psychiatry 2001;58(10):
935–42.
Velarde F, Lagomasino IT, Miranda J, Sherbourne C, Wells
KB. Impact of a depression intervention on US-born and
immigrant Latinos. Proceedings of the 158th Annual
Meeting of the American Psychiatric Association; 2005 May
21-26; Atlanta (GA). 2005:NR141.
Watkins KE, Paddock SM, Zhang L, Wells KB. Improving
care for depression in patients with comorbid substance
misuse. American Journal of Psychiatry 2006;163(1):
125–32.
Wells K, Sherbourne C, Duan N, Unutzer J, Miranda J,
Schoenbaum M, et al.Quality improvement for depression
in primary care: Do patients with subthreshold depression
benefit in the long run?. American Journal of Psychiatry
2005;162(6):1149–57.
Wells KB. The design of partners in care: Evaluating
the cost-effectiveness of improving care for depression in
primary care. Social Psychiatry and Psychiatric Epidemiology
1999;34(1):20–9.
Wells KB, Rubenstein LV, Unutzer J, Miranda J, Jackson M.
Improving treatment resources for primary care depressed
patients in managed care. Proceedings of the 151st Annual
Meeting of the American Psychiatric Association; 1998 May
30-June 4; Toronto Ontario. 1998.
Wells KB, Schoenbaum M, Duan N, Miranda J, Tang L,
Sherbourne C. Cost-effectiveness of quality improvement
programs for patients with subthreshold depression or
depressive disorder. Psychiatric Services 2007;58(10):
1269–78.
Wells KB, Sherbourne CD, Miranda J, Tang L, Benjamin
B, Duan N. The cumulative effects of quality improvement
for depression on outcome disparities over 9 years: results
from a randomized, controlled group-level trial. Medical
Care 2007;45(11):1052–9.
Wells KB, Sherbourne CD, Schoenbaum M, Rubenstein
LV, Duan N, Meredith L, et al.Improving quality of care,
outcomes and employment of depressed primary care
patients. Association for Health Services Research 1999;16:88.
Wells KB Sherbourne CD Schoenbaum N Duan N
Meredith LS Unutzer J Miranda J Carney M Rubenstein
LV. Impact of disseminating quality improvement programs
for depression in managed primary care: a randomized
controlled trial [erratum appears in JAMA 2000 Jun 28;283
(24):3204]. JAMA 2000;283(2):212–20.
Wells K Sherbourne C Schoenbaum M Ettner S Duan N
Miranda J, et al.Five-year impact of quality improvement for
depression: results of a group-level randomized controlled
trial. Archives of General Psychiatry 2004;61(4):378–86.
Williams JW Jr, Katon W, Lin EH, Noel PH, Worchel
J, Cornell J, et al.The effectiveness of depression care
management on diabetes-related outcomes in older patients.
Annals of Internal Medicine 2004;140(12):1015–24.
Wells 2000b {published data only}
Callahan CM, Kroenke K, Counsell SR, Hendrie HC,
44Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Perkins AJ, Katon W, et al.Treatment of depression improves
physical functioning in older adults. Journal of the American
Geriatrics Society 2005;53(3):367–73.
Clever SL, Ford DE, Rubenstein LV, Rost KM, Meredith
LS, Sherbourne CD, et al.Primary care patients’ involvement
in decision-making is associated with improvement in
depression. Medical Care 2006;44(5):398–405.
Dwight-Johnson M, Unutzer J, Sherbourne C, Tang
L, Wells KB. Can quality improvement programs for
depression in primary care address patient preferences for
treatment?. Medical Care 2001;39(9):934–44.
Fraser SA, Kroenke K, Callahan CM, Hui SL, Williams
JWJ, Unutzer J. Low yield of thyroid-stimulating hormone
testing in elderly patients with depression. General Hospital
Psychiatry 2004;26(4):302–9.
Halpern J, Johnson MD,Miranda J, Wells KB. The partners
in care approach to ethics outcomes in quality improvement
programs for depression. Psychiatric Services 2004;55(5):
532–9.
Harpole LH, Stechuchak KM, Saur CD, Steffens DC,
Unutzer J, Oddone E. Implementing a disease management
intervention for depression in primary care: a random work
sampling study. General Hospital Psychiatry 2003;25(4):
238–45.
Harpole LH, Williams Jr JW, Olsen MK, Stechuchak
KM, Oddone E, Callahan CM, et al.Improving depression
outcomes in older adults with comorbid medical illness.
General Hospital Psychiatry 2005;27(1):4–12.
Hegel MT, Unutzer J, Tang L, Arean PA, Katon W, Noel
PH, et al.Impact of comorbid panic and posttraumatic
stress disorder on outcomes of collaborative care for late-life
depression in primary care. American Journal of Geriatric
Psychiatry 2005;13(1):48–58.
Jaycox LH, Miranda J, Meredith LS, Duan N, Benjamin
B, Wells K. Impact of a primary care quality improvement
intervention on use of psychotherapy for depression. Mental
Health Services Research 2003;5(2):109–20.
Johnson MD,Meredith LS, Hickey SC,Wells KB. Influence
of patient preference and primary care clinician proclivity
for watchful waiting on receipt of depression treatment.
General Hospital Psychiatry 2006;28(5):379–86.
Katon WJ, Schoenbaum M, Fan MY, Callahan CM,
Williams JJ, Hunkeler E, et al.Cost-effectiveness of
improving primary care treatment of late-life depression.
Archives of General Psychiatry 2005;62(12):1313–20.
Klap R, Tang L, Schell T,Wells K, Sherbourne C, Miranda J,
et al.How quality improvement interventions for depression
affect stigma concerns over time: A nine-year follow-up
study. Psychiatric Services 2009;60(2):258–61.
Koike AK, Unutzer J, Wells KB. Improving the care for
depression in patients with comorbid medical illness.
American Journal of Psychiatry 2002;159(10):1738–45.
Levine S, Unutzer J, Yip JY, Hoffing M, Leung M, Fan M-
Y, et al.Physicians’ satisfaction with a collaborative disease
management program for late-life depression in primary
care. General Hospital Psychiatry 2005;27(6):383–91.
Masaquel A, Wells K, Ettner SL. How does the persistence
of depression influence the continuity and type of health
insurance and coverage limits on mental health therapy?.
Journal of Mental Health Policy and Economics 2007;10(3):
133–44.
Meredith LS, Cheng WJY, Hickey SC, Dwight-Johnson
M. Factors associated with primary care clinicians’ choice
of a watchful waiting approach to managing depression.
Psychiatric Services 2007;58(1):72–8.
Meredith LS, Jackson-Triche M, Duan N, Rubenstein LV,
Camp P, Wells KB. Quality improvement for depression
enhances long-term treatment knowledge for primary care
clinicians. Journal of General Internal Medicine 2000;15
(12):868–77.
Meredith LS, Orlando M, Humphrey N, Camp P,
Sherbourne CD. Are better ratings of the patient-provider
relationship associated with higher quality care for
depression?. Medical Care 2001;39(4):349–60.
Miranda J, Duan N, Sherbourne C, Schoenbaum M,
Lagomasino I, JacksonTriche M, et al.Improving care for
minorities: can quality improvement interventions improve
care and outcomes for depressed minorities? Results of a
randomized, controlled trial. Health Services Research 2003;
38(2):613–30.
Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells
K. Effects of primary care depression treatment on minority
patients’ clinical status and employment. Archives of General
Psychiatry 2004;61(8):827–34.
Oishi SM, Shoai R, Katon W, Callahan C, Unutzer J,
Arean P, et al.Impacting late life depression: Integrating
a depression intervention into primary care. Psychiatric
Quarterly 2003;74(1):75–89.
Roeloffs C, Sherbourne C, Unutzer J, Fink A, Tang L, Wells
KB. Stigma and depression among primary care patients.
General Hospital Psychiatry 2003;25(5):311–5.
Rost KM, Duan N, Rubenstein LV, Ford DE, Sherbourne
CD, Meredith LS, et al.The Quality Improvement for
Depression collaboration: general analytic strategies for a
coordinated study of quality improvement in depression
care. General Hospital Psychiatry 2001;23(5):239–53.
Rubenstein LV, Jackson-Triche M, Unutzer J, Miranda
J, Minnium K, Pearson ML, et al.Evidence-based care
for depression in managed primary care practices. Health
Affairs 1999;18(5):89–105.
Schoenbaum M, Belin T, Wells K. Improving primary care
depression treatment: the effect on patients’ employment.
Association for Health Services Research 1999;16:87.
Schoenbaum M, Miranda J, Sherbourne C, Duan N, Wells
K. Cost-effectiveness of interventions for depressed Latinos.
Journal of Mental Health Policy and Economics 2004;7(2):
69–76.
Schoenbaum M, Unutzer J, McCaffrey D, Duan N,
Sherbourne C, Wells KB. The effects of primary care
depression treatment on patients’ clinical status and
employment. Health Services Research 2002;37(5):1145–58.
Schoenbaum M, Unutzer J, Sherbourne C, Duan N,
Rubenstein LV, Miranda J, et al.Cost-effectiveness of
practice-initiated quality improvement for depression:
45Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
results of a randomized controlled trial. JAMA 2001;286
(11):1325–30.
Schoenbaum M Sherbourne C Wells K. Gender patterns
in cost effectiveness of quality improvement for depression:
Results of a randomized, controlled trial. Journal of Affective
Disorders 2005;87(2-3):319–25.
Sherbourne CD, Edelen MO, Zhou A, Bird C, Duan
N, Wells KB. How a therapy-based quality improvement
intervention for depression affected life events and
psychological well-being over time: a 9-year longitudinal
analysis. Medical Care 2008;46(1):78–84.
Sherbourne CD, Schoenbaum M, Wells KB, Croghan
TW. Characteristics, treatment patterns, and outcomes of
persistent depression despite treatment in primary care.
General Hospital Psychiatry 2004;26(2):106–14.
Sherbourne CD, Weiss R, Duan N, Bird C, Wells K. Do
the effects of quality improvement for depression differ for
men and women?. Quality of Life Research 2003;12(7):767.
Sherbourne CD, Weiss R, Duan N, Bird CE, Wells KB. Do
the effects of quality improvement for depression care differ
for men and women? Results of a group-level randomized
controlled trial. Medical Care 2004;42(12):1186–93.
Sherbourne CD, Wells KB, Duan N, Miranda J, Unutzer
J, Jaycox L, et al.Long-term effectiveness of disseminating
quality improvement for depression in primary care.
Archives of General Psychiatry 2001;58(7):696–703.
Sherbourne DC, Unutzer J, Schoenbaum M, Duan N,
Lenert LA, Sturm R, et al.Can utility-weighted health-
related quality-of-life estimates capture health effects of
quality improvement for depression?. Medical Care 2001;
39(11):1246–59.
Unutzer J. Collaborative care for late life depression in
primary care: a randomized controlled trial. Proceedings of
the 14th Annual Meeting of the American Association for
Geriatric Psychiatry; 2001 23-26 February; San Francisco
(CA). 2001.
Unutzer J. Collaborative care for late-life depression.
International Psychogeriatrics. Proceedings of the
International Psychogeriatric Association Eleventh
International Congress; 2003 Aug 17-22; Chicago (IL).
2003.
Unutzer J, Rubenstein L, Katon WJ, Tang L, Duan
N, Lagomasino IT, et al.Two-year effects of quality
improvement programs on medication management for
depression. Archives of General Psychiatry 2001;58(10):
935–42.
Velarde F, Lagomasino IT, Miranda J, Sherbourne C, Wells
KB. Impact of a depression intervention on US-born and
immigrant Latinos. Proceedings of the 158th Annual
Meeting of the American Psychiatric Association; 2005 May
21-26; Atlanta (GA). 2005.
Watkins KE, Paddock SM, Zhang L, Wells KB. Improving
care for depression in patients with comorbid substance
misuse. American Journal of Psychiatry 2006;163(1):
125–32.
Wells K, Sherbourne C, Duan N, Unutzer J, Miranda J,
Schoenbaum M, et al.Quality improvement for depression
in primary care: Do patients with subthreshold depression
benefit in the long run?. American Journal of Psychiatry
2005;162(6):1149–57.
Wells K, Sherbourne C, Schoenbaum M, Ettner S, Duan N,
Miranda J, et al.Five-year impact of quality improvement for
depression: results of a group-level randomized controlled
trial. Archives of General Psychiatry 2004;61(4):378–86.
Wells KB. The design of partners in care: Evaluating
the cost-effectiveness of improving care for depression in
primary care. Social Psychiatry and Psychiatric Epidemiology
1999;34(1):20–9.
Wells KB, Rubenstein LV, Unutzer J, Miranda J, Jackson M.
Improving treatment resources for primary care depressed
patients in managed care. Proceedings of the 151st Annual
Meeting of the American Psychiatric Association; 1998 May
30-June 4; Toronto (Ontario). 1998.
Wells KB, Schoenbaum M, Duan N, Miranda J, Tang L,
Sherbourne C. Cost-effectiveness of quality improvement
programs for patients with subthreshold depression or
depressive disorder. Psychiatric Services 2007;58(10):
1269–78.
Wells KB, Sherbourne CD, Miranda J, Tang L, Benjamin
B, Duan N. The cumulative effects of quality improvement
for depression on outcome disparities over 9 years: results
from a randomized, controlled group-level trial. Medical
Care 2007;45(11):1052–9.
Wells KB, Sherbourne CD, Schoenbaum M, Rubenstein
LV, Duan N, Meredith L, et al.Improving quality of care,
outcomes and employment of depressed primary care
patients. Association for Health Services Research 1999;16:88.
∗ Wells KB, Sherbourne CD, Schoenbaum N, Duan N,
Meredith LS, Unutzer J, et al.Impact of disseminating
quality improvement programs for depression in managed
primary care: a randomized controlled trial [erratum
appears in JAMA 2000 Jun 28;283(24):3204]. JAMA 2000;
283(2):212–20.
Williams JW Jr, Katon W, Lin EH, Noel PH, Worchel
J, Cornell J, et al.The effectiveness of depression care
management on diabetes-related outcomes in older patients.
Annals of Internal Medicine 2004;140(12):1015–24.
Wilkinson 1993 {published data only}
Wilkinson G. The role of the practice nurse in the
management of depression. International Review of
Psychiatry 1992;4(3-4):311–5.
∗ Wilkinson G, Allen P, Marshall E, Walker J, Browne
W, Mann AH. The role of the practice nurse in the
management of depression in general-practice: treatment
adherence to antidepressant medication. Psychological
Medicine 1993;23(1):229–37.
Williams 2007 {published data only}
∗ Williams LS, Kroenke K, Bakas T, Plue LD, Brizendine E,
Tu W, et al.Care management of poststroke depression: a
randomized, controlled trial. Stroke 2007;38(3):998–1003.
Yeung 2010 {published data only}
∗ Yeung A, Shyu I, Fisher L, Wu S, Yang H, Fava M.
Culturally sensitive collaborative treatment for depressed
46Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chinese Americans in primary care. American Journal of
Public Health 2010;100(12):2397–402.
Zatzick 2001 {published data only}
∗ Zatzick DF, Roy-Byrne P, Russo JE, Rivara FP, Koike A,
Jurkovich GJ, et al.Collaborative interventions for physically
injured trauma survivors: A pilot randomized effectiveness
trial. General Hospital Psychiatry 2001;23:114–23.
Zatzick 2004 {published data only}
∗ Zatzick D, Roy-Byrne P, Russo J, Rivara F, Droesch R,
Wagner A, et al.A randomized effectiveness trial of stepped
collaborative care for acutely injured trauma survivors.
Archives of General Psychiatry 2004;61(5):498–506.
Zatzick DF. Early PTSD and risk behavior intervention
after admission for acute surgical trauma. Proceedings of
the 158th Annual Meeting of the American Psychiatric
Association; 2005 May 21-26; Atlanta (GA). 2005:No.
23C.
References to studies excluded from this review
Akerblad 2003 {published and unpublished data}
Akerblad AC, Bengtsson F, Ekselius L, Von Knorring
L. Effects of an educational compliance enhancement
programme and therapeutic drug monitoring on treatment
adherence in depressed patients managed by general
practitioners. International Clinical Psychopharmacology
2003;18:347–54.
Al-Saffar 2005 {published data only}
Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect
of information leaflets and counselling on antidepressant
adherence: Open randomised controlled trial in a
psychiatric hospital in Kuwait. International Journal of
Pharmacy Practice 2005;13:123–31.
Bolton 2001 {published data only (unpublished sought but not used)}
Bolton PG, Fergusson KJ, Parker SM, Orman JD.
Randomised controlled trial of cognitive-behavioural
therapy and routine GP care for major depression. Medical
Journal of Australia 2001;175:118–9.
Braamse 2010 {published data only}
Braamse AM, van Meijel B, Visser O, van Oppen P,
Boenink AD, Eeltink C, et al.Distress and quality of life
after autologous stem cell transplantation: a randomized
clinical trial to evaluate the outcome of a web-based stepped
care intervention. BMC Cancer 2010;10:361.
Britian 1999 {published data only (unpublished sought but not used)}
Britian O. Integration of services for elderly people reduced
costs and use of health services [commentary on Bernabei
R, Landi F, Gambassi G, Sgadari A, Zuccala G, Mor V, et al.
Randomized trial of impact of model of integrated care and
case management for older people living in the community.
BMJ 1998;316(7141):1348-51]. Evidence-Based Nursing
1999;2:20.
Brook 2003 {published data only}
Brook O, van Hout H, Nieuwenhuyse H, Heerdink E.
Impact of coaching by community pharmacists on drug
attitude of depressive primary care patients and acceptability
to patients; a randomized controlled trial. European
Neuropsychopharmacology 2003;13:1–9.
Callahan 1994 {published data only}
Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL,
Tierney WM. Improving treatment of late-life depression
in primary care: A randomized clinical trial. Journal of the
American Geriatrics Society 1994;42(8):839–46.
Callahan 2006 {published data only}
Callahan CM, Boustani MA, Unverzagt FW, Austrom MG,
Damush TM, Perkins AJ, et al.Effectiveness of collaborative
care for older adults with Alzheimer disease in primary
care: a randomized controlled trial. JAMA 2006;295(18):
2148–57.
Cheok 2003 {published data only}
Cheok F, Schrader G, Banham D, Marker J, Hordacre
AL. Identification, course, and treatment of depression
after admission for a cardiac condition: rationale and
patient characteristics for the Identifying Depression As a
Comorbid Condition (IDACC) project. American Heart
Journal 2003;146(6):978–84.
Coleman 1999 {published data only}
Coleman EA, Grothaus LC, Sandhu N, Wagner EH.
Chronic care clinics: a randomized controlled trial of a new
model of primary care for frail older adults. Journal of the
American Geriatrics Society 1999;47(7):908–9.
Dobscha 2006 {published data only}
Dobscha SK, Corson K, Hickam DH, Perrin NA, Kraemer
DF, Gerrity MS. Depression decision support in primary
care: a cluster randomized trial. Annals of Internal Medicine
2006;145(7):477–87.
Dobscha 2008 {published data only}
Dobscha SK, Corson K, Leibowitz RQ, Sullivan MD,
Gerrity MS. Rationale, design, and baseline findings
from a randomized trial of collaborative care for chronic
musculoskeletal pain in primary care. Pain Medicine 2008;9
(8):1050–64.
Dobscha 2009 {published data only}
Dobscha SK, Corson K, Perrin NA, Hanson GC, Leibowitz
RQ, Doak MN, et al.Collaborative care for chronic pain in
primary care: a cluster randomized trial. JAMA 2009;301
(12):1242–52.
Dozeman 2007 {published data only}
Dozeman E, van Schaik DJ, Beekman AT, Stalman WA,
Bosmans JE, van Marwijk HW. Depression and anxiety,
an indicated prevention (DIP) protocol in homes for the
elderly: feasibility and (cost) effectiveness of a stepped care
programme. BMC Geriatrics 2007;7:6.
Gellis 2010 {published and unpublished data}
Gellis ZD, Bruce ML. Problem-solving therapy for
subthreshold depression in home healthcare patients with
cardiovascular disease. The American Journal of Geriatric
Psychiatry 2010;18:464–74.
Geron 2006 {published and unpublished data}
Geron SM, Keefe B. Moving evidence-based interventions
to populations: a case study using social workers in primary
47Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
care. Home Health Care Services Quarterly 2006;25(1-2):
95–113.
Hees 2010 {published data only}
Hees HL, Koeter MW, de Vries G, Ooteman W, Schene AH.
Effectiveness of adjuvant occupational therapy in employees
with depression: design of a randomized controlled trial.
BMC Public Health 2010;10:558.
Katon 1992 {published data only}
Katon W, Von Korff M, Lin E, Bush T, Russo J, Lipscomb
P, et al.A randomized trial of psychiatric consultation with
distressed high utilizers. General Hospital Psychiatry 1992;
14(2):86–98.
Kroenke 2009 {published data only}
Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S,
Sutherland J, et al.Optimized antidepressant therapy
and pain self-management in primary care patients with
depression and musculoskeletal pain: A randomized
controlled trial. JAMA 2009;301(20):2099–110.
Lyles 2003 {published data only}
Lyles JS, Hodges A, Collins C, Lein C, Given CW, Given B,
et al.Using nurse practitioners to implement an intervention
in primary care for high-utilizing patients with medically
unexplained symptoms. General Hospital Psychiatry 2003;
25(2):63–73.
Meglic 2010 {published data only}
Meglic M, Furlan M, Kuzmanic M, Kozel D, Baraga D,
Kuhar I, et al.Feasibility of an eHealth service to support
collaborative depression care: results of a pilot study. Journal
of Medical Internet Research 2010;12(5):e63.
Mudge 2011 {published data only}
Mudge AM, Denaro CP, Scott AC, Atherton JJ, Meyers DE,
Marwick TH, et al.Exercise training in recently hospitalized
heart failure patients enrolled in a disease management
programme: Design of the EJECTION-HF randomized
controlled trial. European Journal of Heart Failure 2011;13
(12):1370–5.
Oslin 2004 {published data only}
Oslin DW, Thompson R, Kallan MJ, TenHave T, Blow
FC, Bastani R, et al.Treatment effects from UPBEAT:
a randomized trial of care management for behavioral
health problems in hospitalized elderly patients. Journal of
Geriatric Psychiatry and Neurology 2004;17(2):99–106.
Peveler 1999 {published data only}
Peveler R, George C, Kinmonth AL, Campbell M,
Thompson C. Effect of antidepressant drug counselling
and information leaflets on adherence to drug treatment in
primary care: randomised controlled trial. BMJ 1999;319
(7210):612–5.
Pols 2008 {published and unpublished data}
Pols R, Battersby MW. Coordinated care in the management
of patients with unexplained physical symptoms: depression
is a key issue. Medical Journal of Australia 2008;188:S133-
S137.
Raue 2009 {published data only}
Raue PJ, Schulberg HC, Heo M, Klimstra S, Bruce ML.
Patients’ depression treatment preferences and initiation,
adherence, and outcome: A randomized primary care study.
Psychiatric Services 2009;60(3):337–43.
Rickles 2005 {published data only}
Rickles NM, Svarstad BL, Statz-Paynter JL, Taylor LV,
Kobak KA. Pharmacist telemonitoring of antidepressant
use: effects on pharmacist-patient collaboration. Journal of
the American Pharmacists Association 2005;45(3):344–53.
Riegel 2006 {published data only}
Riegel B, Carlson B, Glaser D, Romero T. Randomized
controlled trial of telephone case management in Hispanics
of Mexican origin with heart failure. Journal of Cardiac
Failure 2006;12(3):211–9.
Seekles 2009 {published data only}
Seekles W, van Straten A, Beekman A, van Marwijk H,
Cuijpers P. Stepped care for depression and anxiety: from
primary care to specialized mental health care: a randomised
controlled trial testing the effectiveness of a stepped care
program among primary care patients with mood or anxiety
disorders. BMC Health Services Research 2009;9:90.
Simon 2006 {published data only}
Simon GE, Ludman EJ, Operskalski BH. Randomized trial
of a telephone care management program for outpatients
starting antidepressant treatment. Psychiatric Services 2006;
57(10):1441–5.
Sirey 2010 {published data only}
Sirey JA, Bruce ML, Kales HC. Improving antidepressant
adherence and depression outcomes in primary care: The
Treatment Initiation and Participation (TIP) Program. The
American Journal of Geriatric Psychiatry 2010;18(6):554–62.
Stevens 2009 {published data only}
Stevens J, Klima J, Chisolm D, Kelleher K J. A trial of
telephone services to increase adolescent utilization of health
care for psychosocial problems. Journal of Adolescent Health
2009;45:564–70.
Van’t Veer-Tazelaar 2009 {published data only}
van’t Veer-Tazelaar PJ, van Marwijk HW, van Oppen P,
van Hout HP, van der Horst HE, Cuijpers P, et al.Stepped-
care prevention of anxiety and depression in late life: A
randomized controlled trial. Archives of General Psychiatry
2009;66(3):297–304.
van der Feltz-Cornelis 2006 {published data only}
van der Feltz-Cornelis CM, van Oppen P, Ader HJ, van
Dyck R. Randomised controlled trial of a collaborative care
model with psychiatric consultation for persistent medically
unexplained symptoms in general practice. Psychotherapy
and Psychosomatics 2006;75(5):282–9.
van der Feltz-Cornelis 2010 {published data only}
van der Feltz-Cornelis CM, Hoedeman R, de Jong FJ,
Meeuwissen JAC, Drewes HW, van der Laan NC, et
al.Faster return to work after psychiatric consultation for
sicklisted employees with common mental health disorders
compared to care as usual. A randomized clinical trial.
Neuropsychiatric Disease and Treatment 2010;6:375–85.
Wang 2007 {published data only}
Wang PS, Simon GE, Avorn J, Azocar F, Ludman EJ,
McCulloch J, et al.Telephone screening, outreach, and care
48Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
management for depressed workers and impact on clinical
and work productivity outcomes: a randomized controlled
trial. JAMA 2007;298(12):1401–11.
Whooley 2000 {published data only}
Whooley MA, Stone B, Soghikian K. Randomized trial of
case-finding for depression in elderly primary care patients.
Journal of General Internal Medicine 2000;15(5):293–300.
References to studies awaiting assessment
Aragones 2007 {published data only}
∗ Aragones E, Caballero A, Pinol JL, Lopez-Cortacans G,
Badia W, Hernandez JM, et al.Assessment of an enhanced
program for depression management in primary care: a
cluster randomized controlled trial. The INDI project
(Interventions for Depression Improvement). BMC Public
Health 2007;7:253.
Aragones E, Lopez-Cortacans G, Badia W, Hernandez
JM, Caballero A, Labad A. Improving the role of nursing
in the treatment of depression in primary care in Spain.
Perspectives in Psychiatric Care 2008;44(4):248–58.
Joubert 2006 {published data only}
∗ Joubert J, Reid C, Joubert L, Barton D, Ruth D, Jackson
D, et al.Risk factor management and depression post-stroke:
The value of an integrated model of care. Journal of Clinical
Neuroscience 2006;13(1):84–90.
Joubert 2008 {published data only}
∗ Joubert J, Joubert L, Reid C, Barton D, Cumming T,
Mitchell P, et al.The positive effect of integrated care on
depressive symptoms in stroke survivors. Cerebrovascular
Diseases 2008;26(2):199–205.
Mareev 2010 {published data only}
∗ Mareev V, Danielyan M, Yu B. Congestive heart failure:
A multidisciplinary non-pharmacological approach for
changing in re-hospitalisation and prognosis in patients with
concomitant anxiety and depression (CHANCE-AND).
Journal of Cardiac Failure. Proceedings of the 14th Annual
Scientific Meeting, Heart Failure Society of America; 2010
Sept 12-15; San Diego (CA). 2010; Vol. 16:913.
O’Connor 2001 {published data only}
∗ O’Connor A. Evaluation of GP based mood disorder
clinic: A randomised controlled trial of an innovative model
of treating depressed people in the community. National
Research Register 2001.
Walker 2009a {published data only}
∗ Walker J, Cassidy J, Sharpe M, SMaRT Oncology-2
Trialists. The second symptom Management Research Trial
in Oncology (SMaRT Oncology-2): A randomised trial to
determine the effectiveness and cost-effectiveness of adding
a complex intervention for major depressive disorder to
usual care for cancer patients. Trials 2009;10:18.
Walker J, Sharpe M. Depression care for people with cancer:
a collaborative care intervention. General Hospital Psychiatry
2009;31(5):436–41.
Walker 2009b {published data only}
∗ Walker J, Cassidy J, Sharpe M. The third symptom
management research trial in oncology (SMaRT Oncology-
3): A randomised trial to determine the efficacy of adding
a complex intervention for major depressive disorder
(depression care for people with lung cancer) to usual care,
compared to usual care alone in patients with lung cancer.
Trials 2009;10:92.
Walker M, Walker L, Walker A, Bateman J, Braid F,
Hebblewhite C, et al.Preventing psychiatric morbidity
in people with cancer. Psycho-Oncology. Proceedings
of the 11th World Congress of Psycho-Oncology of the
International Psycho-Oncology Society; 2009 June 21-25;
Vienna, Austria. 2009.
Wu 2010 {published data only}
∗ Wu HS, Xu Y, Xu YF, Zhu HX, Zhu LP, Xue JJ, et
al.Effectiveness of case management of chronic disease for
elderly depression in community [Chinese]. Chinese Mental
Health Journal 2010;24(4):245–9.
References to ongoing studies
Chen 2011 {published data only}
∗ Chen S, Conwell Y, Xu B, Chiu H, Tu X, Ma Y.
Depression care management for late-life depression in
China in primary care: protocol for a randomized controlled
trial. Trials 2011;12:121.
Chung 2010 {published data only}
Chung B. Community partners in care: a partnership to
improve depression care in Los Angeles. Proceedings of the
164th Annual General Meeting of the American Psychiatric
Association. 2011:333–4.
∗ Chung B, Jones L, Dixon EL, Miranda J, Wells K,
Community Partners in Care Steering Council. Using
a community partnered participatory research approach
to implement a randomized controlled trial: planning
community partners in care. Journal of Health Care for the
Poor and Underserved 2010;21(3):780–95.
Cooper 2010 {published data only}
∗ Cooper LA, Ford DE, Ghods BK, Roter DL, Primm AB,
Larson SM, et al.A cluster randomized trial of standard
quality improvement versus patient-centered interventions
to enhance depression care for African Americans in the
primary care setting: study protocol. Implementation Science
2010;5:18.
Freund 2011 {published data only}
∗ Freund T, Peters-Klimm F, Rochon J, Mahler C,
Gensichen J, Erler A, et al.Primary care practice-based care
management for chronically ill patients (PraCMan): Study
protocol for a cluster randomized controlled trial. Trials
2011;12:163.
Gitlin 2012 {published data only}
∗ Gitlin LN, Harris LF, McCoy M, Chernett NL, Jutkowitz
E, Pizzi LT, Beat the Blues Team. A community-integrated
home based depression intervention for older African
Americans: description of the Beat the Blues randomized
trial and intervention costs. BMC Geriatrics 2012;12:4.
Jutkowitz E, Pizzi LT, Gitlin L, Foley K, Chernett N, McCoy
M. Costs of a community support program for depression:
Results from the beat the blues (BTB) trial. Value in Health.
49Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Proceedings of the 13th Annual International Meeting
of the International Society for Pharmacoeconomics and
Outcomes Research, ISPOR; 2010 Nov 6-9; Prague Czech
Republic. 2010; Vol. 13, issue 7:A449.
Pizzi LT, Jutkowitz E, Gitlin L, Suh DC, Dennis M. Baseline
results from beat the blues. Value in Health. Proceedings of
the 16th Annual International Meeting of the International
Society for Pharmacoeconomics and Outcomes Research,
ISPOR; 2011 May 21-25; Baltimore (MD). 2011; Vol. 14:
A195.
Graven 2011 {published data only}
∗ Graven C, Brock K, Hill K, Ames D, Cotton S, Joubert L.
From rehabilitation to recovery: Protocol for a randomised
controlled trial evaluating a goal-based intervention to
reduce depression and facilitate participation post-stroke.
BMC Neurology 2011;11:73.
Horn 2007 {published data only}
∗ Horn EK, Van Benthem TB, Hakkaart-Van Roijen L,
Van Marwijk HWJ, Beekman ATF, Rutten FF, et al.Cost-
effectiveness of collaborative care for chronically ill patients
with comorbid depressive disorder in the general hospital
setting, a randomised controlled trial. BMC Health Services
Research 2007;7:28.
Ijff 2007 {published data only}
Hakkaart L, Van Steenbergen K, Schawo S, Huijbregts K,
De Jong S, Van Marwijk H, et al.The cost effectiveness
of collaborative care in depressed patients in the primary
care. Journal of Mental Health Policy and Economics.
Proceedings of the 10th Workshop on Costs and Assessment
in Psychiatry; 2011 Mar 25-27; Venice, Italy. 2011.
Huijbregts KML, De Jong FJ, Martens F, Adr HJ, Van
Marwijk HWJ, Beekman ATF, et al.Effectiveness of
collaborative care for depression in Dutch primary care.
Journal of Psychosomatic Research. Proceedings of the
13th Annual Meeting of the European Association for
Consultation-Liaison Psychiatry and Psychosomatics,
EACLPP and the 28th European Conference on
Psychosomatic Research, ECPR; 2010 Jun 30-Jul 3;
Innsbruck, Austria. 2010.
∗ Ijff MA, Huijbregts KM, van Marwijk HW, Beekman AT,
Hakkaart-van Roijen L, Rutten FF, et al.Cost-effectiveness
of collaborative care including PST and an antidepressant
treatment algorithm for the treatment of major depressive
disorder in primary care; a randomised clinical trial. BMC
Health Services Research 2007;7:34.
Mitchell 2011 {published data only}
∗ Mitchell N, Hewitt C, Adamson J, Parrott S, Torgerson
D, Ekers D, et al.A randomised evaluation of CollAborative
care and active surveillance for Screen-Positive EldeRs with
sub-threshold depression (CASPER): study protocol for a
randomized controlled trial. Trials 2012;12:225.
Morgan 2009 {published data only}
∗ Morgan M, Dunbar J, Reddy P, Coates M, Leahy R.
The trueblue study: Is practice nurse-led collaborative care
effective in the management of depression for patients with
heart disease or diabetes?. BMC Family Practice 2009;10:46.
Muntingh 2009 {published data only}
Goorden M, Muntingh A, Balkom AJ, Van Marwijk HW,
Spinhoven P, De Waal MW, et al.Cost effectiveness of a
collaborative care stepped intervention for anxiety disorders
in the primary care setting. Value in Health. Proceedings of
the ISPOR 14th Annual European Congress; 2011 Nov 5-
8; Madrid, Spain. 2011.
∗ Muntingh AD, van der Feltz-Cornelis CM, van Marwijk
HW, Spinhoven P, Assendelft WJ, de Waal MW, et
al.Collaborative stepped care for anxiety disorders in
primary care: Aims and design of a randomized controlled
trial. BMC Health Services Research 2009;9:159.
Musselman 2006 {published data only}
∗ Musselman B L. Depression-Diabetes mechanisms:
Urban African Americans. www.clinicaltrials.gov/ct2/show/
NCT00209170 (accessed 7 May 2012).
Pommer 2012 {published data only}
∗ Pommer AM, Pouwer F, Denollet J, Pop VJM. Managing
co-morbid depression and anxiety in primary care patients
with asthma and/or chronic obstructive pulmonary disease:
study protocol for a randomized controlled trial. Trials
2012;13:6.
Pouwer CH. Disease management of depression and
anxiety (DiMaCoDeA) in primary care patients with
diabetes mellitus, asthma and/or COPD [NTR2626].
www.trialregister.nl/trialreg/admin/rctview.asp?TC=2626
(accessed 3 May 2012).
Rollman 2004 {published data only}
∗ Rollman BL. The RELAX Trial: Reducing limitations
from anxiety in primary care [Telephone–based care
management program for individuals with anxiety
disorders]. www.clinicaltrials.gov/ct2/show/NCT00158327
(accessed 3 May 2012).
Steel 2011 {published data only}
∗ Steel J, Geller DA, Tsung A, Marsh JW, Dew MA, Spring
M, et al.Randomized controlled trial of a collaborative care
intervention to manage cancer-related symptoms: Lessons
learned. Clinical Trials 2011;8(3):298–310.
Stoop 2011 {published data only}
∗ Stoop CH, Spek VRM, Pop VJM, Pouwer F. Disease
management for co-morbid depression and anxiety in
diabetes mellitus: design of a randomised controlled trial in
primary care. BMC Family Practice 2011;12:139.
Trinh 2011 {published data only}
∗ Trinh NH, Bedoya CA, Chang TE, Flaherty K, Fava
M, Yeung A. A study of a culturally focused psychiatric
consultation service for Asian American and Latino
American primary care patients with depression. BMC
Psychiatry 2011;11:166.
Tylee 2011 {published data only}
Tylee A, Ashworth M, Barley E, Brown J, Chambers J,
Farmer A, et al.Up-beat UK: a programme of research
into the relationship between coronary heart disease and
depression in primary care patients. BMC Family Practice
2011;12:38.
50Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Yeung 2011 {published data only}
∗ Yeung A, Hails K, Chang T, Trinh NH, FavaM. A study of
the effectiveness of telepsychiatry-based culturally sensitive
collaborative treatment of depressed Chinese Americans.
BMC Psychiatry 2011;11:154.
Zatzick 2011 {published data only}
∗ Zatzick D, Rivara F, Jurkovich G, Russo J, Trusz SG,Wang
J, et al.Enhancing the population impact of collaborative
care interventions: Mixed method development and
implementation of stepped care targeting posttraumatic
stress disorder and related comorbidities after acute trauma.
General Hospital Psychiatry 2011;33(2):123–34.
Additional references
Adams 2004
Adams G, Gulliford MC, Ukoumunne OC, Eldridge S,
Chinn S, Campbell M. Patterns of intra-cluster correlation
from primary care research to inform study design and
analysis. Journal of Clinical Epidemiology 2004;57:784–793.
APA 2000
American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. Fourth Text Revision.
Washington DC: American Psychiatric Association, 2000.
Attkinson 2003
Attkinson C, Zwixk R. The client satisfaction questionnaire:
psychometric properties and correlations with service
utilisation and psychotherapy outcome. Evaluation and
Program Planning 2003;5:233–7.
Badamgarav 2003
Badamgarav E, Weingarten S, Henning J, Knight K,
Hasselblad V, Gano A, et al.Effectiveness of disease
management programs in depression: a systematic review.
American Journal of Psychiatry 2003;160:2080–90.
Beck 1987
Beck AT, Steer R. Beck Depression Inventory: Manual. San
Antonio, TX: Psychological Corporation, 1987.
Beck 1988
Beck AT, Epstein N, Brown G, Steer RA. An inventory for
measuring clinical anxiety: Psychometric properties. Journal
of Consulting and Clinical Psychology 1988;56:893–7.
Bijl 2004
Bijl D, van Marwijk W, de Haan M, van Tilburg
W, Beekman A. Effectiveness of disease management
programmes for recognition, diagnosis and treatment of
depression in primary care: a review. European Journal of
General Practice 2004;10:6–12.
Boerma 1999
Boerma W, Verhaak P. The general practitioner as the first
contacted health professional by patients with psychological
problems: a European study. Psychological Medicine 1999;
29:689–96.
Bosc 1997
Bosc M, Dubini A, Poin V. Development and validation of a
social functioning scale, the Social Adaption Self-evaluation
Scale. European Neuropsychopharmacology 1997;7 Suppl 1:
S57–S70.
Bower 2005
Bower P, Gilbody S. Managing common mental health
disorders in primary care: conceptual models and evidence
base. BMJ 2005;330:839–42.
Bower 2006
Bower P, Gilbody S, Richards D, Fletcher J, Sutton A.
Collaborative care for depression in primary care. Making
sense of a complex intervention: systematic review and meta
regression. British Journal of Psychiatry 2006;189:484–93.
Buszewicz 2011
Buszewicz M, Griffin M, Beecham J, Bonin E, Hutson M.
ProCEED Report of a Study of Proactive Care by Practice
Nurses for People with Depression and Anxiety. London:
MIND, 2011.
Cape 2010
Cape J, Whittington C, Buszewicz M, Wallace P,
Underwood L. Effectiveness of brief psychological therapies
for anxiety and depression in primary care: meta-analysis
and meta-regression. BMC Health Services Research 2010;8:
38.
Churchill 2002
Churchill R, Hunot V, Corney R, Knapp M, McGuire H,
Tylee A, et al.A systematic review of controlled trials of the
effectiveness and cost-effectiveness of brief psychological
treatments for depression. Health Technology Assessment
2002;5(35):1–173.
Deeks 2011
Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9:
Analysing data and undertaking meta-analyses. In: Higgins
JPT, Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March
2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Donner 2002
Donner A, Klar N. Issues in the meta-analysis of cluster
randomised trials. Statistics in Medicine 2002;21:2971–80.
Egger 1997
Egger M, Davey-Smith G, Schneider M, Minder C. Bias
in meta-analysis detected by a simple graphical test. BMJ
1997;315:629–35.
Gilbody 2003a
Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational
and organisational interventions to improve the
management of depression in primary care: a systematic
review. JAMA 2003;289:3145–51.
Gilbody 2006
Gilbody S, Bower P, Fletcher J, Richards D, Sutton A.
Collaborative care for depression: a systematic review and
cumulative meta-analysis. Archives of Internal Medicine
2006;166:2314–21.
Gunn 2006
Gunn J, Diggens J, Hegarty K, Blashki G. A systematic
review of complex system interventions designed to increase
51Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
recovery from depression in primary care. BMC Health
Services Research 2006;6:88.
Higgins 2003
Higgins JP, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ 2003;327
(7414):557–60.
Higgins 2004
Higgins JPT, Thompson SG. Controlling the risk of
spurious findings from meta-regression. Statistics in
Medicine 2004;23:1663–82.
Higgins 2011a
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
[updated March 2011]. The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Higgins 2011b
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter
8: Assessing risk of bias in included studies. In: Higgins
JPT, Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 [updated March
2011]. The Cochrane Collaboration, 2011. Available from
www.cochrane-handbook.org.
Kates 2007
Kates N, Mach M. Chronic disease management for
depression in primary care: a summary of the current
literature and implications for practice. Canadian Journal of
Psychiatry 2007;52(2):77–85.
Katon 1997
Katon W, Von Korff M, Lin E, Unutzer J, Simon G, Walker
E, et al.Population-based care of depression: Effective
disease management strategies to decrease prevalence.
General Hospital Psychiatry 1997;19(3):169–78.
Kraemer 2002
Kraemer H, Wilson G, Fairburn C, Agras W. Mediators
and moderators of treatment effects in randomized clinical
trials. Archives of General Psychiatry 2002;59:877–83.
Kroenke 2001
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9:
validity of a brief depression severity measure. Journal of
General Internal Medicine 2001;16:606–13.
Kupfer 1991
Kupfer DJ. Long-term treatment of depression. Journal of
Clinical Psychiatry 1991;52 Suppl 5:28–34.
Lingam 2002
Lingam R, Scott J. Treatment non-adherence in affective
disorders. Acta Psychiatrica Scandinavica 2002;105:164–72.
Lipsey 1990
Lipsey M. Design Sensitivity: Statistical Power for
Experimental Research. Newbury Park: Sage, 1990.
Mathers 2006
Mathers CD, Loncar D. Projections of global mortality and
burden of disease from 2002 to 2030. PLoS Medicine 2006;
3(11):e442.
McManus 2009
McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins
R. Adult Psychiatric Morbidity in England, 2007: results of a
household survey. Leeds: The Information Centre for Health
and Social Care, 2009.
Medical Research Council 2008
Medical Research Council (UK). Developing and evaluating




Neumeyer-Gromen A, Lampert T, Stark K, Kallisschnigg G.
Disease management programs for depression: a systematic
review and meta-analysis of randomized controlled trials.
Medical Care 2004;42(12):1211–21.
NHS 2002
NHS Centre for Reviews and Dissemination. Improving
the recognition and management of depression in primary
care. Effective Health Care Bulletin YR:2002 Vol. 7:1–11.
NICE 2009
National Institute for Clinical Excellence (NICE).
Depression in Adults with a Chronic Physical Health Problem:
Treatment and Management - NICE guidance (Clinical
guidelines CG91). London: NICE, 2009.
NICE 2010
National Institute for Clinical Excellence (NICE). NICE
Guidance on the Treatment and Management of Depression in
Adults - NICE guidance (Clinical guidelines CG90). London:
NICE, 2010.
NICE 2011a
National Institute for Clinical Excellence (NICE). Common
Mental Health Disorders: Identification and Pathways to Care
- NICE guidance (Clinical guidelines CG123). London:
NICE, 2011.
NICE 2011b
National Institute for Clinical Excellence (NICE). NICE
Guidance on Generalised Anxiety Disorder and Panic disorder
(with or without agoraphobia) in Adults - NICE guidance
(Clinical guidelines CG113). London: NICE, 2011.
Ormel 1999
Ormel J, Von Korff M, Oldehinkel T. Onset of disability
in depressed and non-depressed primary care patients.
Psychological Medicine 1999;29:847–53.
Roth 1996
Roth A, Fonagy P.What Works for Whom? A Critical Review
of Psychotherapy Research. London: Guildford, 1996.
Sartorius 2001
Sartorius N. The economic and social burden of depression.
Journal of Clinical Psychiatry 2001;62 (Suppl 15):8–11.
Thompson 2002
Thompson SG, Higgins JP. How should meta-regression
analyses be undertaken and interpreted?. Statistics in
Medicine 2002;21:1559–73.
52Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Thota 2012
Thota A, Sipe T, Byard G, Zometa C, Hahn R, McKnight-
Eily L, et al.Collaborative care to improve the management
of depressive disorders: A community guide systematic
review and meta-analysis. American Journal of Preventive
Medicine 2012;42:525.
Ukoumunne 1999
Ukoumunne O, Gulliford M, Chinn S, Sterne J, Burney P.
Methods for evaluating area-wide and organisation-based
interventions in health and health care: a systematic review.
Health Technology Assessment 1999;3(5):iii–92.
Ustun 2004
Ustun T, Ayuso-Mateos J, Chatterji S, Mathers C, Murray
C. Global burden of depressive disorders in the year 2000.
British Journal of Psychiatry 2005;184:386–92.
Von Korff 2001
Von Korff M, Goldberg D. Improving outcomes in
depression: the whole process of care needs to be enhanced.
BMJ 2001;323(7319):948–9.
Wagner 1996
Wagner E, Austin B, Von Korff M. Organizing care for
patients with chronic illness. Milbank Quarterly 1996; Vol.
74:11–43.
Ware 1993
Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health
Survey: Manual and 1993 Interpretation Guide. Boston,
MA: New England Medical Center, Health Institute, 1993.
WHO 1992
World Health Organization. The ICD-10 Classification of
Mental and Behavioural Disorders. Geneva: WHO, 1992.
WHO 2001a
World Health Organization. Mental and Neurological
Disorder - Factsheet 265. Geneva: WHO, 2001.
WHO 2001b
World Health Organization. ATLAS - Mental Health
Resources in the World 2001. Geneva: WHO, 2001.
References to other published versions of this review
Archer 2007
Archer J, Bower P, Gilbody S, Lovell K, Richards D, Gask L,
et al.Collaborative care for depression and anxiety problems.
Cochrane Database of Systematic Reviews 2007, Issue 2.
[DOI: 10.1002/14651858.CD006525]
∗ Indicates the major publication for the study
53Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adler 2004
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Met DSM-IV criteria for MDD and/or dysthymia. Established DSM-IV
criteria using PC-SAD© self-administered
Inclusion criteria: Received care fromaPCP, 18 years or older, able to read andunderstand
English, no acute life threatening condition with a terminal prognosis of 6 months, not
pregnant/not given birth within the past 6 months
Exclusion criteria: Current alcoholism (defined as more than one positive response on
the CAGE, plus one item assessing current usage), bipolar disorder, and/or psychotic
disorders




Sample size (randomised): Total participants 533, intervention 268, control 265
Interventions Treatment: Pharmacist intervention
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: PCP, pharmacist (CM), psychiatrist
(MH specialist)
2) a structured management plan: The pharmacist intervention protocol was based on
AHCPR guidelines and emphasised: 1) obtaining medication history, 2) assessing side
effects or drug interactions, 3)monitoringdrug efficacy and toxicity, 4) educatingpatients
about depression and ADs, 5) encouraging patients to start and maintain AD therapy,
and 6) facilitating communication with PCP
3) scheduled patient follow-ups: Medication = nine times over 18 months (2, 4, 6, 8, 12
weeks, and 6, 9, 12, and 18 months)
4) enhanced inter-professional communication: CM facilitated communication with a
patient’s PCP, MH specialist provided clinical supervision as needed
Control: Treatment as usual enhanced as PCPs received results of depression screen
indicating a DSM-IV diagnosis of major depressive disorder and/or dysthymia
Outcomes Depression (mBDI): 3, 6, 12, 18 months
Medication use: 3, 6 months
Quality of Life (mental and physical health): 6 months
Notes AD: antidepressant; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; MDD: major depressive disorder; MH: mental health; PCP: primary
care provider; AHCPR: Agency for Health Care Policy and Research; PC-Sad: Primary
Care Screener for Affective Disorders; mBDI: modified Beck Depression Inventory
Risk of bias
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Adler 2004 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised coin-flip
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (mBDI) was:
overall 149/533 (28%), 75/268 (28%) in-
tervention and 74/265 (28%) control. Rea-
sons for loss to follow-up not provided at
6 months. Intention-to-treat analysis re-
ported, conducted an extensive analysis of
the potential bias introduced by missing
data using available data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Araya 2003
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: CurrentDSM-IVmajor depression. A score of 5 ormore on the general health
questionnaire (GHQ-12) at 2 screenings, mini international neuropsychiatric interview
(MINI) to ascertain a DSM-IV diagnosis
Inclusion criteria: Low-income, female, primary care patients aged 18 to 70 years
Exclusion criteria: Current psychotic symptoms, serious suicidal risk, history ofmania, or
current alcohol abuse, psychiatric consultation or admission to hospital in the 3 months
before the interview




55Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Araya 2003 (Continued)
Sample size (randomised): Total participants 240, intervention 120, control 120
Interventions Treatment: Stepped care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: PCP, nurse or social worker group
leaders (CM), psychiatrist (MH specialist)
2) a structured management plan: Step 1: those scoring 19 or less on HRSD received
psychoeducational group and those scoring > 19 received psychoeducational group plus
assessment for ADs. Step 2: after 6 week reassessment those scoring 12 or less received
two booster sessions at weeks 9 and 12 and those scoring > 12 were referred for PCP
reassessment to initiate ADs or adjust ADs. Psychoeducation topics included a manual
with information on symptoms and causes of depression, treatment options, scheduling
positive activities, problem-solving techniques, and basic cognitive and relapse-preven-
tion techniques. PCPs delivered a brief structured pharmacotherapy protocol using a
standard medication algorithm to ensure adequate dose and duration of treatment (flu-
oxetine, amitriptyline, or imipramine). Group leaders monitored medication adherence
and attendance at follow-up visits for patients receiving pharmacotherapy
3) scheduled patient follow-ups: The CM psychoeducational intervention group con-
sisted of sevenweekly sessions and two booster sessions at weeks 9 and 12. CMmonitored
AD adherence and attendance at follow-up visits for patients receiving pharmacotherapy
4) enhanced inter-professional communication: CM co-ordinated further management
with PCPs if needed and usually communicated with doctors through alert notes and
arranging appointments for patients, MH specialist provided clinical supervision
Control: Treatment as usual plus prior to the start of the study PCPs in the control group
received guidelines on how to treat depression in primary care
Outcomes Depression (HRSD): 3, 6 months
Medication use: 6 months
Quality of Life (mental and physical health): 3, 6 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; HRSD:
Hamilton Rating Scale for Depression; MH: mental health; PCP: primary care provider;
SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random numbers in
blocks of 20
Allocation concealment (selection bias) Low risk Standard block size. Sealed numbered en-
velopes opened by an individual not in-
volved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HDRS < 50%)
was: overall 29/240 (12%), 16/120 (13%)
intervention and 13/120 (11%) control.
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Araya 2003 (Continued)
Reasons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Asarnow 2005
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Either of 2 criteria: (1) endorsed “stem items” for major depression or dys-
thymia from the 12-month Composite International Diagnostic Interview (CIDI-12
[Core version 2.1]) modified slightly to conform to diagnostic criteria for adolescents,
1 week or more of past month depressive symptoms, and a total CES-D score of 16 or
greater (range of possible scores, 0-60); or (2) a CES-D score of 24 or greater
Inclusion criteria: Aged 13 to 21 years and presenting at clinic for primary care visit
Exclusion criteria: Having previously completed screening, not English-speaking, clini-
cian not in the study, and sibling already in the study




Sample size (randomised): Total participants 418, intervention 211, control 207
Interventions Treatment: Quality improvement intervention
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: PCP, psychotherapists withMHnursing
or nursing backgrounds (CM), study team (MH specialist)
2) a structured management plan: (1) expert leader teams at each site adapted and im-
plemented the intervention; (2) CMs supported PCPs with patient evaluation, educa-
tion, medication and psychosocial treatment, and linkage with specialty MH services;
(3) trained CMs delivered manualised CBT; and (4) patient and clinician choice of
treatments (CBT, medication, combined CBT and medication, care manager follow-
up, or referral). The CBT manual included a session introducing the treatment model,
three 4-session modules emphasising different CBT components (activities/social skills,
cognition, and communication/problem solving), and a final session emphasising relapse
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Asarnow 2005 (Continued)
prevention. The Texas Medication Algorithms for MDD guided medication treatment
and emphasised SSRI’s as the first-stage medication choice
3) scheduled patient follow-ups: 1 x 45 session with CM and 1 x 15 minute with PCP
then a) medication or medication and psychotherapy (follow-up visits and/or telephone
calls by CM and/or PCP) b) psychotherapy (CBT initiated and PCP and/or CM follow-
up arranged) c) no treatment (CM follow-up). CBT = 14 weekly sessions, CMs followed
up with patients during the 6-month intervention period
4) enhanced inter-professional communication: CMs supported PCPs with patient eval-
uation, education, medication and psychosocial treatment, and linkage with specialty
mental health service. Regular consultation from study team to support fidelity to the
treatment model and provide case-specific training in CBT and patient outreach/en-
gagement strategies
Control: Treatment as usual enhanced by providing PCPs with training and educational
materials (manuals, pocket cards) on depression evaluation and treatment
Outcomes Depression (CES-D): 6, 12, 18 months
Medication use: 6, 12 and 18 months
Quality of Life (physical and mental health): 6, 12, 18 months
Satisfaction: 6, 12, 18 months
Notes CBT: cognitive behaviour therapy; CES-D: Centre for Epidemiological Studies Depres-
sion; CIDI: Composite International Diagnostic Interview; CM: case manager; MDD:
major depressive disorder; MH: mental health; PCP: primary care provider; SSRI: se-
lective serotonin reuptake inhibitor
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment after a time
delay (median, 21 days)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (CES-D) was:
overall 74/418 (18%), 41/211 (19%) in-
tervention and 33/207 (16%) control. Rea-
sons for loss to follow-up provided, with
similar reasons for missing data across
groups. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
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Asarnow 2005 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Bartels 2004
Methods Study design: Randomised controlled trial
Participants Setting: Speciality settings and primary care
Diagnosis: Significant psychological distress on the General Health Questionnaire, a
positive response to suicidal ideation questions modified from the PRIME-MD, or at-
risk alcohol consumptionbased on quantity/frequency criteria ofmore than sevendrinks/
week or more than two binge episodes in the past 3months consisting of more than three
drinks on a single occasion. Assessed by using the Mini-International Neuropsychiatric
Interview, CES-D scale, Beck Anxiety Inventory, an alcohol quantity/frequency scale,
and a detailed medication review
Inclusion criteria: Met criteria for target conditions (depression, anxiety, and at-risk
drinking) assessed by using the Mini International Neuropsychiatric Interview, CES-
D scale, Beck Anxiety Inventory, an alcohol quantity/frequency scale, and a detailed
medication review
Exclusion criteria: Patients who had received mental health/substance abuse treatment
in the preceding 3 months and patients with severe cognitive impairment (≥ 16 on the
Brief Orientation Memory Concentration Test). Primary care providers were given the
opportunity to withdraw patients with positive screens for medical reasons; patients with
a positive assessment on theMini InternationalNeuropsychiatric Interview for psychosis,
mania, or hypomania, patients with incomplete data




Sample size (randomised): Total participants 2022, intervention 999, control 1023
Interventions Intervention: Integrated care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: PCP, social workers, psychologists,
psychiatric nurses, psychiatrists, and counsellors (CM)
2) a structured management plan: Integrated models included: 1) mental health and
substance abuse services co-located in the primary care setting (including counselling,
case management, psychotherapy, and pharmacological treatment); 2) services provided
by licensed mental health/substance abuse providers (including social workers, psychol-
ogists, psychiatric nurses, psychiatrists, and counsellors); 3) verbal or written communi-
cation between the MH specialist and PCP; and 4) an appointment within 2 to 4 weeks
following the PCP visit. Specific clinical interventions were not required. Patients with
at-risk drinking were offered a manualised Brief Alcohol Intervention
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Bartels 2004 (Continued)
3) scheduled patient follow-ups: Alcohol = 3 counselling sessions, depression = the
intervention varied across sites
4) enhanced inter-professional communication: Verbal or written communication about
the clinical evaluation and treatment plan between theCMs andPCP. PCPswere required
to remain involved in the patients’ care and document their role in the medical record,
and communicate with the CMs. PCPs were notified in the event that a patient failed
to attend the initial clinical visit
Control: Enhanced referralmodel which providedmental health/substance abuse services
in a specialty setting that was physically separate and designated as a mental health/
substance abuse clinic. Theminimumcriteria for the enhanced referral model included 1)
referral within 2-4 weeks of the PCP appointment; 2) comply with model requirements,
including time to first appointment and coordinated follow-up contacts if the patient
failed tomake the first scheduled visit; 3) assistance with transportation; and 4) assistance
in meeting the costs of treatment
Outcomes Depression (CES-D): 3, 6 months
Quality of Life (mental and mental health): 3, 6 months
Satisfaction: 3 months
Notes CES-D:Centre for Epidemiological StudiesDepression;CM: casemanager;MH:mental
health; PCP: primary care provider; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Computer generated blocks, the computer
system malfunctioned for 2 weeks and 44
patients did not conform to randomisation
procedure. Some patients assigned using
social security number (even or odd)
Allocation concealment (selection bias) Low risk Researchers telephoned an independent
person to receive patient allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (CES-D) was:
overall 311/1531 (20%), 159/758 (21%)
intervention and 152/773 (20%) control.
Reasons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
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Bartels 2004 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
Blanchard 1995
Methods Study design: Randomised controlled trial
Participants Setting: Community and primary care
Diagnosis: Depression measured by short-CARE. Short-CARE contains a diagnostic
depression scale (DPDS) which identifies subjects who are likely to be suffering from
pervasive depression, a level of depression warranting clinical interventions
Inclusion criteria: Older adults
Exclusion criteria: Not stated




Sample size (randomised): Total participants 96, intervention 47, control 49
Interventions Intervention: Community nurse management
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: General practitioner (PCP), community
psychiatric nurse (CM), old age psychiatry team (MH specialist)
2) a structured management plan: Initial assessment by psychiatrist and information
then presented toMH specialist team and individually-tailored care plans developed and
implemented by CM. Interventions were negotiated with the patient and their PCP. In-
terventions included: medication trial and review, increasing social network, counselling
when specific interpersonal/bereavement problems were identified, behaviour therapy
and review of physical health
3) scheduled patient follow-ups: 12 weekly face-to-face sessions
4) enhanced inter-professional communication: CM worked in close liaison with PCP
who remained clinically responsible. Interventions were negotiated with the PCP. The
CM was in regular contact with the MH specialist and could use them at any time in a
consultative capacity
Control: Initial assessment with psychiatrist and case then presented to MH specialist
(old age psychiatry team) and an individual management plan was developed which was
shared with the PCP after the intervention period. PCPs were made aware of severity of
depressive symptoms of patients
Outcomes Depression (short CARE): 3 months
Medication use: 3 months
Notes CM: case manager; MH: mental health; PCP: primary care provider
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Blanchard 1995 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Short CARE
DPDS) was: overall 14/96 (15%), 4/47
(9%) intervention and 10/49 (20%) con-
trol. Reasons for loss to follow-upprovided,
with similar reasons for missing data across
groups. Intention-to-treat analysis not re-
ported, no description ofmethods forman-
aging missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Bogner 2008
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: A diagnosis of depression or a prescription for an antidepressant medication
within the past year
Inclusion criteria: Aged 50 years and older, a systolic blood pressure of 140 mm Hg or
greater or diastolic blood pressure of 90 mm Hg or greater for non-diabetic patients, or
a systolic blood pressure of 130 mm Hg or greater or a diastolic blood pressure of 80
mm Hg or greater for patients with diabetes on at least 2 visits in the previous year, or a
prescription for an antihypertensive medication within the past year
Exclusion criteria: Cognitive impairment, unable to communicate in English, residing
in a care facility that provides medications on a schedule, unable to use Medication Event
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Bogner 2008 (Continued)
Monitoring System (MEMS) caps (AARDEX, Zug, Switzerland), which are microelec-
tronic monitoring devices
Age: Mean 58.6 (SD 6.8) years
Gender: 77% female
Ethnicity: 83% African American
Country: Unitd States
Sample size (randomised): Total participants 64, intervention 32, control 32
Interventions Intervention: Integrated care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Family physician (PCP), research co-
ordinator (CM), academic PCP (MH specialist)
2) a structured management plan: Intervention focused on depression and hypertension
and aimed to promote patients’ adherence to antihypertensive and AD treatment. CM
collaborated with physicians to help patients understand and recognise depression in the
context of hypertension, offered patients guideline-based treatment recommendations,
monitored treatment adherence and clinical status, assessed for side-effects and assistance
in their management, and provided appropriate follow-up or referral. Individualised
programme congruent with patients’ social and cultural context
3) scheduled patient follow-ups: 3 face-to-face, 2 phone contacts in 4-week period
4) enhanced inter-professional communication: CM acted as liaison between the PCP
and patient to help patients recognise depression in the context of hypertension. CM
received weekly supervision from MH specialist
Control: Treatment as usual
Outcomes Depression (CES-D): 2, 4, 6, 12 weeks
Medication use: 2, 4, 6 weeks
Notes AD: antidepressant; CES-D: Centre for Epidemiological Studies Depression; CM: case
manager; MH: mental health; PCP: primary care provider; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (CES-D) was:
overall 0/64 (0%), 0/32 (0%) intervention
and 0/32 (0%) control
Intention-to-treat analysis not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
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Bogner 2008 (Continued)
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Bogner 2010
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary Care
Diagnosis: A diagnosis of depression or a prescription for an antidepressant within the
past year
Inclusion criteria: Diabetics aged 50 and older, an A1C > 7 at their last primary care office
visit or a prescription for an oral hypoglycaemic agent within the past year, older African
Americans prescribed pharmacotherapy for type 2 diabetes mellitus and depression from
physicians at a large primary care practice
Exclusion criteria: Not stated
Age: Mean 60 years
Gender: 85% female
Ethnicity: 100% African American
Country: United States
Sample size (randomised): Total participants 58, intervention 29, control 29
Interventions Intervention: Integrated care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Family physician (PCP), research co-
ordinator (CM), academic PCP (MH specialist)
2) a structured management plan: Intervention focused on depression in the context
of type 2 diabetes mellitus and aimed to promote patients’ adherence to an oral hypo-
glycaemic agent and AD. CM collaborated with PCP to help participants understand
and recognise depression in the context of type 2 diabetes mellitus, offered guideline-
based treatment recommendations, monitored adherence and clinical status, assessment
for the presence of side effects and assistance in their management, and provided appro-
priate follow-up or referral. Individualised programme congruent with patients’ social
and cultural context
3) scheduled patient follow-ups: 3 face-to-face, 2 phone contacts in 4-week period
4) enhanced inter-professional communication: CM acted as liaison between PCP and
the elderly depressed patient with type 2 diabetes mellitus in promoting adherence to
medication. CM received weekly supervision from specialist
Control: Treatment as usual
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Outcomes Depression (CES-D): 12 weeks
Medication use: 2, 4, 6, 12 weeks
Notes AD: antidepressant; CES-D: Centre for Epidemiological Studies Depression; CM: case
manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (CES-D) was:
overall 0/58 (0%), 0/29 (0%) intervention
and 0/29 (0%) control. Intention-to-treat
analysis not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Bruce 2004
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: All patients with a CES-D score higher than 20 as well as a 5% random sample
of patients with lower scores. Patients scoring 20 or lower and not selected randomly were
recruited if they responded positively to supplemental questions about prior depressive
episodes or treatment
Inclusion criteria: Age 60 years or older, ability to give informed consent, Mini-Mental
State Examination (MMSE) score of 18 or higher, and ability to communicate in English
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Exclusion criteria: Not stated




Sample size (randomised): Total clusters 20, intervention 10, control 10; Total partici-
pants 598, intervention 320, control 278
Interventions Intervention: Primary care intervention
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: PCP, social workers, nurses, and psy-
chologists (CM), psychiatrist (MH specialist)
2) a structured management plan: The Prevention of Suicide in Primary Care Elderly:
Collaborative Trial (PROSPECT) intervention had two major components (1) PCP
worked with a clinical algorithm for treating geriatric depression in a primary care setting
which recommended a first-line trial of a SSRI (citalopram), (2)When a patient declined
medication therapy, the PCP could recommend IPT from the CM. CMs monitored
depressive symptoms, medication adverse effects, and treatment adherence
3) scheduled patient follow-ups: CM interacted with patients at scheduled intervals or
when clinically necessary
4) enhanced inter-professional communication: Practice based CMs collaborated reg-
ularly with PCPs and received weekly supervision from MH specialist and additional
monthly IPT supervision
Usual care: Treatment as usual enhanced by educating PCPs about the treatment guide-
lines and notifying them when a patient met criteria for depression diagnosis
Outcomes Depression (BDI-II): 3, 6, 12, 18, 24 months
Medication use: 24 months
Quality of Life (mental and physical health): 24 months
Notes BDI: Beck Depression Inventory; CES-D: Centre for Epidemiological Studies Depres-
sion; CM: case manager; IPT: interpersonal psychotherapy treatment; MH: mental
health; PCP: primary care provider; SSRI: selective serotonin reuptake inhibitor
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin-toss
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HRSD) was:
overall 122/598 (20%), 72/320 (23%) in-
tervention and 50/278 (18%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
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Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Buszewicz 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Two or more documented episodes of depression within the previous three
years, evidence of recurrent and/or chronic depression (measured with the Composite
International Diagnostic Interview), a score of 14 indicating mild depression on the
BDI-II
Inclusion criteria: Men and women aged 18 and over, sufficient English to be able to
complete self-report questionnaires
Exclusion criteria: Current psychotic symptoms, impaired cognitive function, incapaci-
tating alcohol or drug dependence
Age: Mean 48.4 years
Gender: 75% female
Ethnicity: 90% white British
Country: United Kingdom
Sample size (randomised): Total participants 558, intervention 282, control 276
Interventions Intervention: Proactive care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General Practitioner (PCP), practice
nurse (CM), study team of General Practitioner with Special Interest in MH and psy-
chologist (MH specialist)
2) a structured management plan: Baseline assessment including current treatment and
side-effects, potential treatments (medication, psychological therapies or social interven-
tions) and an educational booklet about depression and its treatment. Social factors were
explored (for example social isolation, low physical activity, unemployment, finance,
housing) and appropriate advice given or referrals to other agencies made. A collabora-
tive individualised plan was formulated and reviewed during follow-ups, together with
clinical review and progress towards goals. Plan also included relapse prevention
3) scheduled patient follow-ups: 10 appointments over a two-year period at baseline,
after one month, then two months later and every three months for the remainder of
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the 24 month period. Reviews could be over telephone
4) enhanced inter-professional communication: If practice based CMs were concerned
they discuss patient with the GP. CMs had regular telephone contact (every three to four
months) with the MH specialist
Control: Treatment as usual and it was stipulated that the participants should not see the
practice nurse for any MH intervention, although they might see the nurse for physical
health problems
Outcomes Depression (BDI-II): 3, 6, 12, 18 and 24 months
Antidepressant use: 24 months
Social: 24 months
Quality of Life: 24 months
Other: Primary care and mental health utilisation, informal care, costs
Notes BDI: BeckDepression Inventory; CM: case manager; MH:mental health; PCP: primary
care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Independent computer service
Allocation concealment (selection bias) Low risk Central independent allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDI-II) was:
overall 190/558 (34%), 81/282 (29%) in-
tervention and 109/276 (39%) control.
Reasons for loss to follow-up not provided.
Used intention-to-treat analysis, multiple
imputation used to manage missing data
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
68Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Capoccia 2004
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: A new episode of depression and started on an antidepressant medication.
Depression assessed using the Primary Care Evaluation of Mental Disorders (PRIME-
MD)
Inclusion criteria: Diagnosedwith a new episode of depression (PRIME-MD) and started
on an antidepressant medication
Exclusion criteria: Age of < 18 years, terminal illness, psychosis, recent (within the past 3
months) alcohol (AUDIT score of > 8) or substance abuse, two or more suicide attempts,
pregnancy or nursing, limited command of the English language, and unwillingness to
use the University of Washington Family Medical Centre as a source of care for the next
12 months




Sample size (randomised): Total participants 74, intervention 41, control 33
Interventions Intervention: Enhanced care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: PCP, pharmacist (CM), study psychia-
trist (MH specialist)
2) a structured management plan: CMs addressed depressive symptoms and medication-
related concerns. The initial contacts focused on support and education, as well as
medication dosage adjustment and the management of adverse effects including change
or discontinuation of ADs, and provision of additional pharmacotherapy for insomnia
or sexual dysfunction, as needed. Appointments with mental health providers were also
facilitated
3) scheduled patient follow-ups: 13 contacts during 12 month period.Weekly telephone
calls for the first four weeks, followed by phone contact every two weeks through week
12. During months 4-12, the subjects received a telephone call every other month
4) enhanced inter-professional communication: PCPs were informed of medication
changes made by CM and shared computerised medical records used. On a bi-monthly
basis, the CM and MH specialist reviewed individual cases. Patients were referred to
PCP and/or psychiatrist if suicidal ideation detected (also to psychiatrist if no symptom
improvement)
Control: Treatment as usual enhanced as case managers assessed patients and patients
encouraged to use available resources
Outcomes Depression (HSCL-20): 3, 6, 9, 12 months
Medication use: 3, 6, 9, 12 months
Satisfaction: 3, 6, 9, 12 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Sympton Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 >
50%)was: overall 4/74 (5%), 2/41 (5%) in-
tervention and 2/33 (6%) control. Reasons
for loss to follow-up not provided. Used in-
tention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias High risk Case managers had some contact with pa-
tients in the control group
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Chaney 2011
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Probable major depression based on a PHQ-9 score of 10 or above. Patients
with subthreshold depression (an initial PHQ-9 between five and nine) who also had a)
a prior history of depression, or b) dysthymia were also eligible
Inclusion criteria: At least one primary care appointment in the preceding 12 months
in a participating practice, and having one pending appointment scheduled within the
three months post-selection
Exclusion criteria: Conditions that required urgent care (acute suicidality, psychosis),
inability to communicate over the telephone, or prior naturalistic referral by the patient’s
PCP to the CM
Age: Mean 64.2 years
Gender: 4% female
Ethnicity: 87% white
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Country: United States
Sample size (randomised): Total clusters 10, intervention 7, control 3; Total participants
761, intervention 386, control 375
Interventions Intervention: Translating Initiatives for Depression into Effective Solutions (TIDES)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinician (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: PCPs were educated and CMs conducted a telephone
assessment and sent the patient education materials. For each patient’s treatment plan
(i.e. watchful waiting, medication, or referral to CBT/mental health specialist), the CM
provided follow-up, assessed symptom severity, medication adherence and side-effects,
as well as relapse prevention
3) scheduled patient follow-ups: Watchful waiting = 1 call at 3 months, Medication = 5
telephone calls at 1 or 2 weeks, 1, 2, 3 and 6 months, CBT/MH referral = 2 telephone
calls at 1 or 2 weeks and 6 months
4) enhanced inter-professional communication: CM communicates assessment to PCP
who initiates referral or medication. CM completes follow-ups in collaboration with
PCP and MH specialist. CM has weekly supervision with MH specialist
Control: Treatment as usual
Outcomes Depression (PHQ-9): 7 months
Medication use: 7 months
Quality of Life (mental and physical health): 7 months
Satisfaction: 7 months
Notes CBT: cognitive behaviour therapist; CM: case manager; MH: mental health; PCP: pri-
mary care provider; PHQ-9: Patient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 215/761 (28%), 98/386 (25%) in-
tervention and 117/375 (31%) control.
Reasons for loss to follow-up given, simi-
lar reasons for missing data across groups.
Used intention-to-treat analysis, methods
for handling missing data not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
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Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Chew-Graham 2007
Methods Study design: Randomised controlled trial
Participants Setting: Primary Care
Diagnosis: Clinically identified as depressed. Score of 5 or more on the Geriatric De-
pression Scale (GDS) and 24 or more on the Mini-Mental State Exam (MMSE)
Inclusion criteria: Over the age of 60
Exclusion criteria: Not stated




Sample size (randomised): Total participants 105, intervention 53, control 52
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: GP (PCP), community psychiatric nurse
(CM), old age psychiatrist (MH specialist)
2) a structured management plan: The complex intervention included education about
depression, advice about antidepressant medication, a manualised facilitated self-help
intervention (SHADE), and sign-posting to other services, particularly voluntary agen-
cies
3) scheduled patient follow-ups: The intervention lasted for 12 weeks and consisted of six
face-to-face sessions in each patient’s home and five sessions delivered via the telephone
4) enhanced inter-professional communication: CM liaised closely with PCPs and had
regular access to advice fromMH specialist according to a defined protocol. The protocol
did not define how often the CM liaised with the PCP (by post, email, telephone, or
face-to-face) but the CM sent a written report to the PCP at assessment, 4, 8 and 12
weeks. In between, the CM liaised with the PCP in-person if changes in medication were
required or if there were concerns about concordance or risk. CM reviewed patients’
progress with MH specialist every 4 weeks or sooner if CM had concerns
Control: Treatment as usual enhanced as all practices were supplied with hand delivered
guidelines which outlined diagnostic criteria, suggestions of appropriate investigations,
and the primary care management of depression in older people
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Outcomes Depression (HSCL-20): 4 months
Notes CM: case manager; GP: general practitioner; HSCL: Hopkins Sympton Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depressionoutcome (Proportionwith
5+ symptoms on SCID) was: overall 17/
105(16%), 8/53(15%) intervention and
9/52(17%) control. Reasons for loss to
follow-up provided, with similar reasons
across groups.Used intention-to-treat anal-
ysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Ciechanowski 2004
Methods Study design: Randomised controlled trial
Participants Setting: Community
Diagnosis: DSM-IV minor depression or dysthymia diagnostic criteria. 2-item Primary
Care Evaluation ofMental Disorders (PRIME-MD) depression screening tool and Struc-
tured Clinical Interview for DSM-IV (SCID) as a second-level screen
Inclusion criteria: Aged 60 years or older receiving services from senior service agencies
73Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ciechanowski 2004 (Continued)
or living in senior public housing
Exclusion criteria: No depression, major depression, bipolar disorder, psychosis, sub-
stance abuse, cognitive impairment
Age: Mean 73 (SD 8.5) years
Gender: 79% female
Ethnicity: 42% ethnic minority
Country: United States
Sample size (randomised): Total participants 138, intervention 72, control 66
Interventions Intervention: Programme to Encourage Active, Rewarding Lives for Seniors (PEARLS)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physicians (PCPs), social
workers (CM), study psychiatrist (MH specialist)
2) a structured management plan: PST sessions were modified to provide greater em-
phasis on social and physical activation. The goal of physical activation was to assist
patients in developing a regular physical activity programme consistent with national
recommendations for moderate activity of at least 30 minutes’ duration at least 5 days
per week. Physical activation began during the third or fourth PST session, allowing
patients to develop familiarity with problem-solving skills. The goal of social activation
was to increase patients’ interactions outside the home by using a resource list under the
guidance of the CM. Each session included selecting and engaging in pleasant activities,
using a suggestion list if necessary
3) scheduled patient follow-ups: Eight 50-minute in-home sessions over 19 weeks, in
weeks 1, 2, 3, 5, 7, 11, 15, and 19. After 19 weeks, monthly brief telephone contact to
assess clinical progress and use of PST
4) enhanced inter-professional communication: CM and MH specialist met weekly or
biweekly to review patients. MH specialist contacted PCP for patients lacking progress
to recommend initiating or adjusting ADs and to assess potential medical and substance
abuse aetiologies for depression. The MH specialist occasionally clarified details by con-
tacting PCPs
Control: Treatment as usual enhancedby letters sent toPCPs and social workers reporting
depression diagnosis with recommendations to continue treatment as usual
Outcomes Depression (HSCL-20): 6, 12 months
Medication use: 6, 12 months
Quality of Life (mental and physical health): 12 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; HSCL:
Hopkins Sympton Checklist; MH: mental health; PCP: primary care provider; SD:
standard deviation; PST: problem solving therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation using a 50:50 ran-
domisation allocation ratio in blocks of 10
(changed to 60:40 after 11 blocks)
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Allocation concealment (selection bias) Unclear risk Standard block size. An individual not in-
volved in patient recruitment created en-
velopes containing concealed assignment
codes assigned sequentially by a research as-
sociate
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL response
≥ 50 decrease) was: overall 6/138 (4%), 3/
72 (4%) intervention and 3/66 (5%) con-
trol. Reasons for loss to follow-upprovided,
with similar reasons across groups. Used in-
tention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Ciechanowski 2010
Methods Study design: Randomised controlled trial
Participants Setting: Specialist setting
Diagnosis: Clinically significant depression based on a score ≥ 10 on the PHQ-9
Inclusion criteria: English reading and speaking, 18 years or older, had an ICD-9 epilepsy
diagnosis, and had attended the UW Regional Epilepsy Centre or neurology clinics
within 2 years of recruitment
Exclusion criteria: Pregnancy or nursing, bipolar or psychotic disorder, current psychiatric
treatment, substance abuse based on the CAGE questionnaire, cognitive impairment
Age: Mean 43.9 (SD 11) years
Gender: 53% female
Ethnicity: 8% ethnic minority
Country: United States
Sample size (randomised): Total participants 80, intervention 40, control 40
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Interventions Intervention: Programme to Encourage Active, Rewarding Lives for Seniors (PEARLS)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Neurologist (PCPs), social workers
(CM), study psychiatrist (MH specialist)
2) a structured management plan: PST sessions were modified to provide greater empha-
sis on social and physical activation. The goal of physical activation was to assist patients
in developing a regular physical activity programme consistent with national recommen-
dations for mild to moderate activity of 30 minutes 5 days per week that would provide
benefits but not increase risk for inducing seizures. Physical activation began during
the third or fourth PST session, allowing patients to develop familiarity with problem-
solving skills. The goal of social activation was to increase patients’ interactions outside
the home by using a resource list under the guidance of the CM. Each session included
selecting and engaging in pleasant activities, using a suggestion list if necessary
3) scheduled patient follow-ups: Eight 50-minute in-home sessions over 19 weeks, in
weeks 1, 2, 3, 5, 7, 11, 15, and 19. After 19 weeks, monthly brief telephone contact to
assess clinical progress and use of PST
4) enhanced inter-professional communication: CM and MH specialist met weekly or
biweekly to review patients. MH specialist contacted PCP for patients lacking progress
to recommend initiating or adjusting ADs and to assess potential medical and substance
abuse aetiologies for depression. The MH specialist occasionally clarified details by con-
tacting PCPs
Control: Treatment as usual enhancedby letters sent toPCPs and social workers reporting
depression diagnosis with recommendations to continue treatment as usual
Outcomes Depression (HSCL-20): 6, 12, 18 months
Medication use: 12 months
Quality of Life (mental and physical health): 6, 12, 18 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; HSCL:
Hopkins Sympton Checklist; MH: mental health; PCP: primary care provider; PHQ-
9: Patient Health Questionnaire-9; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks using 50:50
allocation ratio
Allocation concealment (selection bias) Low risk An individual not involved in the interven-
tion generated randomisation sequence,
enrolled and allocated patients
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL20) was:
overall 15/80 (19%), 8/40 (20%) interven-
tion and 7/40 (18%) control. Reasons for
loss to follow-up provided, with similar rea-
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sons across groups. Used intention-to-treat
analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Clarke 2005
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: At least one recent dispense of an SSRI antidepressant medication prescribed
by a paediatric PCP. Current, research-ascertained DSM episode of major depression
Inclusion criteria: Adolescents 12 to 18 years old
Exclusion criteria: Chart indication of schizophrenia or significant developmental/in-
tellectual disability. Extreme suicidal risk that resulted in hospitalisation
Age: Mean 15.3 years
Gender: 78% female
Ethnicity: 14% ethnic minority
Country: United States
Sample size (randomised): Total participants 152, intervention 77, control 75
Interventions Treatment: Brief CBT plus treatment as usual SSRIs
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Paediatric primary care provider (PCP)
, psychologist/CBT (CM), psychologist (MH specialist)
2) a structured management plan: All patients were being treated with an SSRI at enrol-
ment. In addition those in the treatment group received brief CBT based on adult and
adolescent depression programmes. Acute phase: After initial decision making session
(session 1), CBT began with a choice of either four sessions of cognitive restructuring
or four sessions of behavioural activation. A workbook was provided. After completion
of the first module (sessions 2-5) progress was evaluated and if appropriate the second
module commenced (if recovered the youth entered maintenance phase). The second
module (sessions 6-9) consisted of the skills training approach not delivered in the first
module. The acute phase also aimed to maximise SSRI medication adherence by review-
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ing compliance, reported benefits/side effects, and risk of discontinuation. Limited psy-
choeducation about the benefits of SSRI medication and the importance of adherence
was provided
Maintenance phase: CM made brief telephone calls after completing acute sessions
3) scheduled patient follow-ups: Acute phase: 6-9 sessions of CBT delivered by CM;
maintenance phase: CMs made brief telephone calls to patients 1, 2, 3, 5, 7, and 9
months after completing acute sessions. Also option to request as many as six additional,
in-person sessions during the year long continuation phase
4) enhanced inter-professional communication: On-going communication with PCP
was part of protocol. CMs received weekly supervision from study psychologists
Control: Treatment as usual enhanced as all patients were being treated with an SSRI at
enrolment
Outcomes Depression (CES-D): 6, 12, 26, 52 weeks
Medication use: 12 weeks
Quality of Life (mental and physical health): 6, 12, 26, 52 weeks
Satisfaction: 6, 12, 26, 52 weeks
Notes CM: case manager; CBT: cognitive behaviour therapy; CES-D: Centre for Epidemiolog-
ical Studies Depression; DSM: Diagnostic and Statistical Manual; MH: mental health;
PCP: primary care provider; SSRI: selective serotonin reuptake inhibitor
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation. Insufficient informa-
tion available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (CES-D) was:
overall 25/152(16%), 12/77(16%) inter-
vention and 13/75(17%) control. Reasons
for loss to follow-up not provided. Used in-
tention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Cole 2006
Methods Study design: Randomised controlled trial
Participants Setting: Specialist setting and primary care
Diagnosis: Major depression (as defined by DSM-IV criteria) assessed using the Diag-
nostic Interview Schedule
Inclusion criteria: All patients aged 65 years and over admitted from the emergency
department to medical services and scored 4 or less on the Short Portable Mental Status
Questionnaire (indicating at most mild cognitive impairment)
Exclusion criteria: Admitted to the intensive care unit or cardiac monitoring unit for
more than 48 hours, had an imminently terminal illness, did not speak or understand





Sample size (randomised): Total participants 157, intervention 78, control 79
Interventions Treatment: Systematic detection and multidisciplinary care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Family physician (PCP), research nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: (1) assessment and treatment by MH specialist in
the hospital’s geriatric service; (2) follow-up by the CM; and (3) follow-up by the pa-
tient’s PCP. Treatment involved supportive psychotherapy and drug therapy with an AD,
prescribed according to clinical practice guidelines. Contacts involved monitoring con-
dition, providing supportive psychotherapy, ensuring maximum compliance with their
treatment and liaising with the family, MH specialist and PCP
3) scheduled patient follow-ups: Pre-discharge: at leastweekly. Post-discharge:CMvisited
or telephoned weekly for 24 weeks
4) enhanced inter-professional communication: CM liaised with PCP andMH specialist
and updatedMH specialist when patient followed up by PCP. Regular meetings between
CM andMH specialist to assure consistency in diagnosis and management of depression
Control: Treatment as usual enhanced as patients were advised of depression diagnosis
and advised to inform PCP
Outcomes Depression (HAM-D): 6 months
Medication use: 6 months
Quality of Life (mental and physical health): 6 months
Notes AD: antidepressant; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; HAM-D: Hamilton Depression Rating Scale; MH: mental health; PCP:
primary care provider
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Cole 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation (size varied ran-
domly) using 1:1 allocation ratio
Allocation concealment (selection bias) Low risk An individual not involved in patient re-
cruitment prepared sealed envelopes allo-
cated in order
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (≥ 50% decrease
inHAMD) was: overall 93/157 (59%), 45/
78 (58%) intervention and 48/79 (61%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons for missing data
across groups. Intention-to-treat analysis
reported based on the assumption data is
missing at random
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Datto 2003
Methods Study design: Pilot cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Significant depressive symptoms (Community Epidemiologic Survey of De-
pression, CES-D, score at least 16)
Inclusion criteria: Significant depressive symptoms (as above)
Exclusion criteria: Significant suicidal risk, ongoing substance abuse problems, current
psychotic symptoms, or evidence for bipolar affective disorder
Age: Mean 47.6 (SD 16.7) years
Gender: 61% female
Ethnicity: 80% white
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Datto 2003 (Continued)
Country: United States
Sample size (randomised): Total clusters 35, intervention 17, control 18; Total partici-
pants 61, intervention 30, control 31
Interventions Treatment: Telephone disease management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physicians (PCP), nurse
with MH experience (CM), psychiatrist (MH specialist)
2) a structured management plan: Baseline assessment and then telephone assessments
(structured but not scripted) to assess symptoms and gaining information on treatment
recommendations and assessing adherence. Prompted by computer generation the CM
discussed topics such as depression as a treatable medical illness, treatment options (in-
cluding psychotherapy and medications), coping skills for stress, risk factors for depres-
sion, suicide prevention strategies, and reinforcing follow-up with the PCP. Educational
materials on these topics were also sent to the patient. Treatment recommendations made
by the CM were general and often referred the PCP back to a particular stage of the
depression treatment algorithm, modelled after the AHRQ depression guidelines
3) scheduled patient follow-ups: Following baseline telephone assessment follow up was
attempted every 3 weeks during 16 week treatment period
4) enhanced inter-professional communication: After each assessment the resultswere fed
back to the PCP using summary letters, including the scores of the depression measures
and a clinical interpretation of them. All PCPs had contact with the MH specialist as
needed. CM had weekly supervision with MH specialist to facilitate treatment planning
and follow-up
Control: Treatment as usual enhanced as included patient evaluation and diagnosis,
patient education, provider education andpractice guidelines, final outcome andprovider
feedback
Outcomes Depression (CES-D): 16 weeks
Notes CES-D: Community Epidemiologic Survey of Depression; CM: case manager; MH:
mental health; PCP: primary care provider; AHRQ: Agency for Healthcare Research and
Quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (CESD) was:
overall 11/61 (18%), 5/30 (17%) interven-
tion and 6/31 (19%) control. Reasons for
loss to follow-up not provided. Intention-
to-treat analysis not reported
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Datto 2003 (Continued)
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
Dietrich 2004
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Meeting criteria for Diagnostic and Statistical Manual of Mental Disorders
fourth edition for major depressive disorder and dysthymia. Diagnosis determined using
a structured interview.The severity of depressionwas assessedwith theHopkins symptom
checklist-20, with a score of 0.5 or more required for enrolment
Inclusion criteria: 18 years or older and starting or changing treatment for depression.
Participants had to have a telephone and speak English
Exclusion criteria: Being unobtainable for an evaluation interview within 14 days of their
index primary care visit, pregnant, suicidal thoughts, schizophrenia, bipolar disorder,
post-traumatic stress disorder, or a substance misuse disorder
Age: Mean 42 years
Gender: 80% female
Ethnicity: 17% ethnic minority
Country: United States
Sample size (randomised): Total clusters 60, intervention 32, control 28; Total partici-
pants 405, intervention 224, control 181
Interventions Intervention: Quality improvement programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinicians (PCP), primary
care or mental health nurses (CM), psychiatrist (MH specialist)
2) a structured management plan: A systematic approach to the assessment and man-
agement of depression by PCPs which involved CMs assisting patients in overcoming
barriers to adherence to themanagement plan and supporting self-management practices
such as exercise or engaging in social activities
3) scheduled patient follow-ups: One week after initial visit and monthly thereafter until
remission
4) enhanced inter-professional communication: PCPs received faxed report about pa-
tient progress and care management actions after each call. MH specialists provided
suggestions for clinical management to PCPs either via CM faxes or by telephone. PCPs
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Dietrich 2004 (Continued)
can also request advice from MH specialist at specified times in the week
Control: Treatment as usual enhanced as clinicians took part in a 45-60 minute pro-
gramme on diagnosis of depression and assessment of suicidal thoughts
Outcomes Depression (HSCL-20): 3, 6 months
Medication use: 3, 6 months
Satisfaction: 3, 6 months
Notes CM: case manager; HSCL: Hopkins Sympton Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin-toss
Allocation concealment (selection bias) Unclear risk Central randomisation of clinic, those re-
cruiting patients may have been aware of
allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20) was:
overall 80/405 (20%), 45/224 (20%) in-
tervention and 35/181 (19%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Dwight-Johnson 2005
Methods Study design: Pilot randomised controlled trial
Participants Setting: Specialist
Diagnosis: Met study criteria for major depression or dysthymia or had persistent de-
pressive symptoms at both baseline and 1 month later
Inclusion criteria: Low-income, Latina women at least 3 months past initial diagnosis
(to avoid recruiting women with adjustment disorder) with carcinoma of the cervix or
breast cancer (stage I-IV) receiving care in the outpatient breast and gynaecology clinics
Exclusion criteria: In palliative care, suicidal, history of bipolar or psychotic disorder
, evidence of gross cognitive impairment, currently abusing drugs or alcohol, currently
receiving psychotherapy, or unable to speak Spanish or English




Sample size (randomised): Total participants 55, intervention 28, control 27
Interventions Treatment: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Oncologist (PCP), social worker (CM)
, psychiatrist (MH specialist)
2) a structured management plan: an initial assessment and education session linking the
importance of depression treatment to cancer treatment adherence, overall health, and
well-being. Patients were educated about ADs and manualised problem solving therapy
(PST) and allowed to choose either. ADs included: a meeting of the patient, the PCP, and
the CM to initiate ADs (according to modified treatment guidelines). PCPs provided
medication follow-up for patients during regularly scheduled clinic visits, which the CM
attendedwhen possible. TheCMused pre-printed forms to assess side effects, medication
adherence, and depressive symptom severity; they then provided feedback to the PCP and
the MH specialist. Patients who did not experience at least 50% reduction in depressive
symptoms were scheduled for an in-person evaluation by the MH specialist to identify
potential causes for persistent depressive symptoms and make treatment adjustments
3) scheduled patient follow-ups: PST = initial meeting then 8 weekly follow-ups, medi-
cation = regular scheduled visits with PCP which CM attended when possible and CM
contacted patients at least every two weeks either face-to-face or by telephone
4) enhanced inter-professional communication: Joint CM and PCP meeting to initiate
ADs, joint notes kept in medical record, same day telephone consultation available from
MH specialist, CM provided feedback on AD follow-ups to PCP and MH specialist,
biweekly supervision for CM by MH specialist, consultation with MH specialist for
those not progressing fed back to PCP and CM
Control: Treatment as usual enhanced as patients were informed of their depression
diagnosis and usual mental health resources available to them. The study recruiters
suggested that they talk with their doctor or the clinic social worker and placed a note
in the patient’s medical record indicating the presence of depressive symptoms
Outcomes Depression (Depression symptoms): 4, 8 months
Quality of Life (mental and physical health): 4, 8 months
Notes AD: antidepressant; CM: case manager; MH: mental health; PCP: primary care provider
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Dwight-Johnson 2005 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Sealed envelope
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on
primary depression outcome (depression
symptom improvement≥ 50%) was: over-
all 2/55 (4%), 1/28 (4%) intervention and
1/27 (4%) control. Reasons for loss to fol-
low-up not provided Used intention-to-
treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Dwight-Johnson 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Probable major depressive disorder or dysthymia, which was determined by
using the Primary care evaluation ofMental Disorders (PRIME-MD) and Patient Health
Questionnaire-9 (PHQ-9)
Inclusion criteria: Low income Latino patients aged 18 or older and able to speak English
or Spanish
Exclusion criteria: Probable bipolar disorder, cognitive impairment, lifetime psychotic
symptoms or disorder, or suicidal ideation
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Dwight-Johnson 2010 (Continued)
Sample size (randomised): Total participants 339, intervention 173, control 166
Interventions Treatment: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), social
worker (CM), psychiatrist (MH specialist)
2) a structured management plan: CMs educated patients about depression and its treat-
ment, elicited treatment preferences, and provided active outreach and systematic as-
sessment. Depending on patients’ treatment preferences, the CM provided short-term
manualised CBT, supported AD medication treatment, or both. Supported AD treat-
ment involved encouraging adherence, assessing side effects and treatment response, and
sharing this information with primary care providers. CBT was provided at no cost, and
prescriptions were filled at low or no cost
3) scheduled patient follow-ups: CBT = once a week for 12 weeks, medication = about
every 2 weeks initially and then at least monthly after that
4) enhanced inter-professional communication: CMs shared AD follow-up detail with
PCPs. MH specialist conducted weekly supervision by phone and with both CMs at
same time
Control: Treatment as usual enhanced as patients received a letter to take to PCP stating
that they had screened positive for depression, an educational pamphlet, and a list of
local mental health resources
Outcomes Depression (PHQ-9): 4 months
Medication use: 4 months
Notes AD: antidepressant; CBT: cognitive behaviour therapy; CM: case manager; MH: mental
health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was
unclear. Reasons for loss to follow-up not
provided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
86Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dwight-Johnson 2010 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Dwight-Johnson 2011
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: Probable major depressive disorder assessed using the PHQ-9. Criteria were
the reporting of a minimum of five of the nine symptoms assessed and a cut-off score of
10
Inclusion criteria: Rural areas, self-identified as Latino, spoke English or Spanish
Exclusion criteria: Bipolar disorder, cognitive impairment, current or lifetime psychotic
symptoms or disorder, current substance abuse, acute suicidal ideation




Sample size (randomised): Total participants 101, intervention 50, control 51
Interventions Treatment: Telephone CBT
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), social
workers (CM), social workers, psychiatrist, and psychologist/psychiatrist (MH specialist)
2) a structured management plan: Initial structured assessment of clinical history, moti-
vation for treatment, and use of strategies to enhance patients’ motivation to engage in
treatment (this session could be face-to-face). Each session focused on a chapter from a
patient workbook that had been translated into the Spanish language and made cultur-
ally relevant. The sessions emphasised behavioural activation and strategies for identify-
ing, interrupting, and distancing oneself from negative thoughts. Each session included
structured assessment of depressive symptoms, review of the previous session, debriefing
of homework assignment, introduction of new material, description of the new home-
work assignment, and a motivational assessment and enhancement exercise focused on
the homework assignment. If indicated, CMs made brief supportive telephone contacts
between sessions and could refer the patient for case management services for depression
care needs, such as assistance in making appointments with clinic providers and referrals
to community services. The CM did not take an active role in management of ADs but
could discuss medication as a treatment option and ask about medication adherence all
questions related to medication were referred back to PCP
3) scheduled patient follow-ups: CBT = 8 telephone sessions.
4) enhanced inter-professional communication: CMs liaised with PCPs when required
in relation to medication. Suicide safety plans when necessary were communicated to
PCP. CMs had weekly supervision with a team of MH specialists
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Dwight-Johnson 2011 (Continued)
Control: Treatment as usual enhanced as patients were encouraged to talk with their PCP
about depression treatment and PCPs received a letter informing them of their patient’s
depression status and study enrolment
Outcomes Depression (HSCL and PHQ-9): 6 weeks, 3, 6 months
Satisfaction: 6 weeks, 3, 6 months
Notes AD: antidepressant; CBT: cognitive behaviour therapy; CM: casemanager;HSCL:Hop-
kins Sympton Checklist; MH: mental health; PCP: primary care provider; PHQ-9: Pa-
tient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Stratified permuted-block randomisation
Allocation concealment (selection bias) Low risk Allocation revealed by telephone
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 24/101 (24%), 8/50 (16%) inter-
vention and 16/51 (31%) control. Reasons
for loss to follow-up not provided. Inten-
tion-to-treat analysis reported based on the
assumption data is missing at random
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Ell 2007
Methods Study design: Randomised controlled trial
Participants Setting: Community
Diagnosis: Screened positive for clinically significant depression
Inclusion criteria: Home care, 65 and older
Exclusion criteria: significant cognitive impairment, participation in another depression
study




Sample size (randomised): Total participants 311, intervention 155, control 156
Interventions Treatment: Stepped care decision support
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), existing
staff - nurses, social workers, psychiatric nurses, a telephone case manager and a psychol-
ogist (CM), existing staff - psychiatrist, nurses, social workers (MH specialist)
2) a structured management plan: A stepped care algorithm (based on IMPACT) in
which patients were offered a choice of PST or ADs prescribed by PCP, or combined
treatment if indicated. Step 1 (8-10 weeks) choice of AD or PST. Patients with full
response go to maintenance treatment. Step 2 (4-8 weeks): if AD in step 1 and partial
response give different AD type or augment AD, if no response PST. If PST in step 1 and
partial response add AD or different AD type, if no response give AD. CMs monitored
medication and delivered structured PST
3) scheduled patient follow-ups: PST = 6-12 sessions, medication = as per stepped care
algorithm
4) enhanced inter-professional communication: CM communicated with PCP about
medication or if a patient did not improve. Usual supervisory staff had the responsibility
of monitoring and supportive supervision
Control: Treatment as usual was enhanced by routine depression screening and staff
training in depression care management for older adults. Patients PCP informed if a
patient screened positive for probable major or minor depression
Outcomes Depression (PHQ-9): 4, 8, 12 months
Medication use: during study period
Quality of Life (mental and physical health): 4, 8, 12 months
Notes AD: antidepressant; CM: casemanager;MH:mental health; PCP: primary care provider;
PHQ-9: Patient Health Questionnaire-9; PST: problem solving therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depressionoutcome (PHQ-950%re-
duction) was: overall 113/311 (36%), 58/
156 (37%) intervention and 55/155 (35%)
control. Reasons for loss to follow-up not
provided across groups. Intention-to-treat
analysis reported using observed data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Ell 2008
Methods Study design: Randomised controlled trial
Participants Setting: Specialist
Diagnosis: One of the two cardinal depression symptoms more than half of the days
to nearly every day plus a PHQ-9 depression scale score of greater than or equal to 10
indicating major depression and/or two questions from the Structured Clinical Inter-
view for Diagnostic and Statistical Manual of Mental Disorders, 4th Edition indicating
dysthymia
Inclusion criteria: Low income, greater than or equal to 90 days after cancer diagnosis
and receiving acute or follow-up care in oncology clinics, 18 years or older
Exclusion criteria: Acute suicidal ideation, advanced cancer or other condition that lim-
ited remaining life expectancy to less than 6 months, a score of 8 or greater on the
Alcohol Use Disorders Identification Test alcohol assessment, recently used lithium/an-
tipsychotic medication, a self-reported adaptation of the Karnofsky Performance Status
Scale score of 2 or less on an 11-point scale representing severe functional impairment
in cancer patients and inability to speak English or Spanish




Sample size (randomised): Total participants 472, intervention 242, control 230
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Ell 2008 (Continued)
Interventions Treatment: Alleviating Depression Among Patients with Cancer (ADAPt-C)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Oncologist (PCP), social workers (CM)
, psychiatrist (MH specialist)
2) a structured management plan: A stepped care algorithm (based on IMPACT) in
which patients were randomised to AD or PST or combined. The algorithm included
CMs who provided psychotherapy and community services navigation (with assistance
from patient navigators) through a personalised treatment plan that included patient AD
or PST preferences, stepped care management and protocol for PST and CM telephone
maintenance/relapse prevention
3) scheduled patient follow-ups: PST= 6-12 weekly sessions, ADs = had as required
appointments with psychiatrist. In maintenance CM telephoned patients monthly for
up to 12 months post-treatment initiation
4) enhanced inter-professional communication: The CM communicates with the PCP
as needed and interacts via written notes or verbally. PCP provides maintenance pre-
scriptions in consultation with MH specialist. MH specialist provides weekly telephone
supervision to review the CMs caseload
Control: Treatment as usual enhanced by patient/family depression and cancer educa-
tional pamphlets and a listing of centre/community financial, social services, transporta-
tion, and childcare resources. The treating PCP was informed of patients depression
status
Outcomes Depression (PHQ-9): 6, 12, 18, 24 months
Medication use: 12, 18, 24 months
Quality of Life (mental and physical health): 6, 12, 18, 24 months
Satisfaction: 18, 24 months
Notes AD: antidepressant; CM: casemanager;MH:mental health; PCP: primary care provider;
PHQ-9: Patient Health Questionnaire-9; PST: problem solving therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Patients chose one of five sealed envelopes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9, 50%
reduction) was: overall 154/472 (33%),
76/242 (31%) intervention and 78/230
(34%) control. Reasons for loss to follow-
up provided, similar reasons for missing
data across groups. Intention-to-treat anal-
ysis reported using available data and they
also conducted analyses using multiple im-
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putation methods
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Ell 2010
Methods Study design: Randomised controlled trial
Participants Setting: Community and primary care
Diagnosis: One of two cardinal depression symptoms more than half the days to nearly
every day and scored greater than or equal to 10 on the PHQ-9, indicating a high
likelihood of clinically significant depression
Inclusion criteria: Low income and predominantly Hispanic, patients with diabetes, aged
greater than or equal to 18 years
Exclusion criteria: Acute suicidal ideation, a score of greater than or equal to 8 on the Al-
cohol Use Disorders Identification Test alcohol assessment, recent lithium/antipsychotic
medication use, and inability to speak English or Spanish




Sample size (randomised): Total participants 387, intervention 193, control 194
Interventions Treatment: Multifaceted Diabetes and Depression Programme (MDDP)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), social
workers (CM), psychiatrist (MH specialist)
2) a structured management plan: CM conducted assessment and implemented stepped-
care algorithm including 1) culturally adapted PST designed to enhance diabetes and
depression self-management and coping with socioeconomic stress provided byCM and/
or ADs prescribed by PCP; 2) CM monthly telephone follow-up symptom monitoring,
treatmentmaintenance, and relapse prevention; and 3) care and service systemnavigation
by the CM and an assistant patient navigator. The algorithm included the following:
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Ell 2010 (Continued)
Step 1 (weeks 1-8): based on patient preference PST or AD, Step 2 (weeks 9 -12):
patients with partial/non-response receive a different AD or the addition of AD or PST,
Step 3: patients with full response move to monthly maintenance/relapse prevention
telephone monitoring involving monitoring depressive symptoms, provide BA support
for engaging in pleasant activities and motivational support for ongoing use of PST skills
and medication adherence, and invites to attend an open-ended PST support group.
Nonresponsive patients were considered for additional PST, augmentation of low-dose
Trazodone for insomnia, and referral to specialty mental health care
3) scheduled patient follow-ups: Acute treatment: bimonthly PST and AD monitoring
over 4 months = 8-12 sessions plus booster sessions if indicated. Follow-up monthly
telephone calls by CM for up to 12 months. A PST open-ended patient support group
available up to 12 months post-treatment
4) enhanced inter-professional communication: MH specialist was available to CM
and PCP via pager and provided weekly telephone CM supervision. MH specialist
recommendations were communicated by the CM to the PCP and, if requested, the
MH specialist provided PCP medication telephone consultation
Control: Treatment as usual enhanced as patients were given patient and family-focused
depression educational pamphlets and a community, financial, social services, transporta-
tion, and child care resource list. PCPs were informed of patient depression diagnoses
Outcomes Depression (HSCL and PHQ-9): 6, 12, 18, 24 months
Medication use: 6, 12, 18, 18-24 months
Quality of Life (mental and physical health): 6, 12, 18, 24 months
Satisfaction: 24 months
Notes CM: case manager; HSCL: Hopkins Sympton Checklist; MH: mental health; PCP:
primary care provider; PHQ-9: Patient Health Questionnaire-9; PST: problem solving
therapy
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 10
Allocation concealment (selection bias) Low risk Standard block size. Patients chose one of
five sealed envelopes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 50%
reduction) was: overall 85/387 (22%), 42/
193 (22%) intervention and 43/194 (22%)
control. Reasons for loss to follow-up pro-
vided, similar reasons for missing data
across groups. Intention-to-treat analysis
reported using available data and also con-
ducted analyses using multiple imputation
methods
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Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Finley 2003
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depressive symptoms and just commenced antidepressant therapy to treat
this
Inclusion criteria: Not stated
Exclusion criteria: Evidence that subjects had received an antidepressant during the pre-
ceding 6 months; concurrent psychiatric or psychological treatment; current symptoms
of mania or bipolar disorder; psychotic symptoms; eminent suicidality; and active sub-
stance abuse or dependence. If psychiatric treatment was indicated at baseline or any time
during the investigation, subjects were referred to the HMO’s psychiatry department for
care (or were permitted to self-refer) and subsequently were excluded from further study
participation




Sample size (randomised): Total participants 125, intervention 75, control 50
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) amulti-professional approach topatient care: Primary care provider (PCP), pharmacist
(CM), psychiatrist (MH specialist)
2) a structured management plan: Assessment of severity of psychopathology, potential
stressors and other predisposing factors and patient education was provided. Information
on depression and the role of ADs was presented (including potential therapeutic effects/
adverse effects). Patients were advised of other treatment options and resources available.
CMs were permitted to titrate ADs consistent with clinical practice guidelines. CMs
could also prescribe ancillary drugs but if a change in AD drugs was indicated, approval
from the PCP was required. As patients improved CMs identified neglected activities
and encouraged patients to resume them. Patients were advised to contact the clinic if
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they were considering the discontinuation of antidepressants at any time in the future
3) scheduled patient follow-ups: Assessment plus 5 telephone calls at key junctures in
recovery process and 2 clinic visits at 6 and 24 weeks
4) enhanced inter-professional communication: All contactswere recorded in themedical
record in the form of a detailed progress note. CM discussed with PCP by phone or
messaging system any need for change to ADs. At the end of treatment a comprehensive
summary of the treatment course and patient disposition was entered into records.
Weekly case conferences with CMs and MH specialist clarified diagnostic issues and
more clearly delineate treatment plans. MH specialists were also available for off-site
telephone consultation on an as-needed basis for more pertinent issues
Control: Treatment as usual including brief information on the AD, therapeutic end
points, and side effects in a manner consistent with patient education routinely delivered
by the pharmacy.The referringPCPwas notified of assignment and subsequent treatment
and follow-up were left to the provider’s discretion
Outcomes Depression (BIDS): 6 months
Medication use: 114 days, 231 days, 3, 6, months
Satisfaction: 6 months
Notes AD: antidepressant; CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Low risk Sealed envelope
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Percentage with
50% reduction) was: overall 47/125 (38%)
, 21/75 (28%) intervention and 26/50
(52%) control. Reasons for loss to follow-
up not reported Intention-to-treat analy-
sis reported, no description of methods to
manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Fortney 2007
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Screened positive for depression, defined as a PHQ-9 score ≥ 12
Inclusion criteria: Veterans
Exclusion criteria: Diagnosis of schizophrenia, current suicidal ideation, recent bereave-
ment, pregnancy, a court-appointed guardian, substance dependence, bipolar disorder,
cognitive impairment, or receiving specialty mental health treatment




Sample size (randomised): Total clusters 7, intervention 3, control 4; Total participants
395, intervention 177, control 218
Interventions Intervention: Stepped care Telemedicine Enhanced Antidepressant Management
(TEAM)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), nurse
supported by pharmacist (CM), psychiatrist (MH specialist)
2) a structured management plan: stepped-care model including: Step (1) choice of ei-
ther watchful waiting or AD. CM encounters were conducted via telephone and were
scripted and administered using software package. During the initial care management
encounter, patients were: (1) clinically assessed; (2) educated and activated; and 3) as-
sessed for treatment barriers. Follow-up encounters monitored symptoms, medication
adherence, and side-effects. Step (2) If the patient did not respond to the initial AD,
the pharmacist conducted a medication history and provided pharmacotherapy recom-
mendations to PCPs via an electronic progress note. The pharmacist also provided non-
scripted medication management over the phone to patients experiencing severe side-
effects or problems with non-adherence. Step (3) If the patient did not respond to 2
AD trials, the protocol was to recommend a telepsychiatry consultation followed by
additional treatment recommendations to the PCP
3) scheduled patient follow-ups: Acute = Telephone calls scheduled every 2 weeksWatch-
ful waiting or continuation = every 4 weeks
4) enhanced inter-professional communication: All feedback was provided to PCPs us-
ing the electronic medical record. Progress notes reporting failed trials requested an elec-
tronic co-signature from the PCP. CM had weekly supervision with MH specialist and
pharmacist. Telepsychiatry consultation was followed by additional treatment recom-
mendations to the PCP
Control: Treatment as usual enhanced as provider education (via interactive video and
website) and patient education (via mail and website) were provided. Depression screen-
ing results were entered into the electronic medical record
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Outcomes Depression (HSCL-20): 6, 12 months
Medication use: 6, 12 months
Quality of Life (mental and physical health): 6, 12 months
Satisfaction: 6, 12 months
Notes CM: case manager; HSCL: Hopkins Sympton Checklist; MH: mental health; PCP:
primary care provider: PHQ-9: Patient Health Questionnaire; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on
primary depression outcome (Response
HSCL-20 50% improvement) was: overall
35/395 (9%), 17/177 (10%) intervention
and 18/218 (8%) control. Reasons for loss
to follow-up provided, with similar reasons
across groups.Used intention-to-treat anal-
ysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Major depression
Inclusion criteria: Adult women age 18-70 with major depression, without treatment in
last 3 months and at least one child between 6 and 16 living with her
Exclusion criteria: Alcohol or drug abuse, previous bipolar, current or past psychotic
symptoms, mental or physical disability which impedes their ability to participate in
activities and evaluations of the study, pregnancy and high risk of suicide




Sample size (randomised): Total Participants 345, intervention 175, control 170
Interventions Intervention: Pharmacological intervention
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), non-
professional (CM), psychiatrist (MH specialist)
2) a structured management plan: A medication adherence programme via telephone
where the CM used a protocol to provide education about medication, monitor adher-
ence and side effects and reinforce attendance to PCP
3) scheduled patient follow-ups: 6 telephone calls at 2, 4, 6, 8, 10, 12 weeks
4) enhanced inter-professional communication: Psychiatrist and PCPhadmonthlymeet-
ings to discuss cases
Control: Treatment as usual enhanced by consultation with PCP, pharmacotherapy,
individual or group psychotherapy with psychologists at clinics, referral to psychiatrist
Outcomes Depression (HRSD): 3, 6 months
Medication use: 3, 6 months
Quality of Life (mental and physical health): 3, 6 months
Notes CM: case manager; HRSD: Hamilton Rating Scale for Depression; MH: mental health;
PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Centrally allocated
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HRSD) was:
overall 71/345 (21%), 32/175 (18%) in-
tervention and 39/170 (23%) control. Rea-
sons for loss to follow-up not reported. In-
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tention-to-treat analysis reported, no de-
scription of methods to manage missing
data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Gensichen 2009
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosis of major depression with indication for any antidepressive treat-
ment. Diagnosis of major depression was based on a score of more than 9 points and a
categorical diagnosis in the PHQ-9, and was confirmed by the family physician by using
the checklists in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),
and International Classification of Diseases (ICD-10)
Inclusion criteria: Age 18 to80 years, access to a private telephone, ability to give informed
consent, and ability to communicate in German
Exclusion criteria: Confirmed pregnancy, severe alcohol or illicit drug consumption, or
acute suicidal ideation assessed by the family physician




Sample size (randomised): Total clusters 74, intervention 35, control 39; Total partici-
pants 626, intervention 310, control 316
Interventions Intervention: Case management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Family physician (PCP), healthcare
assistant (CM)
2) a structured management plan: CMs monitored depression symptoms and adherence
to medication using a protocol. Having been trained in behavioural activation CMs
encouraged patients to follow self-management activities, such as medication adherence
and activation for pleasant or social activities
3) scheduled patient follow-ups: 19 telephone contacts twice weekly for first month then
monthly for 11 months
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4) enhanced inter-professional communication: CMs provided PCP with information
on patient’s in a structured report
Control: Treatment as usual enhanced as PCPs received training on evidence-based
depression treatment guidelines
Outcomes Depression (PHQ-9): 6,12 months
Medication use: 12 months
Quality of Life (mental and physical health): 12 months
Satisfaction: 12 months
Notes CM: case manager; MH: mental health; PCP: primary care provider; PHQ-9:Patient
Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) High risk Central randomisation of clinic. Those re-
cruiting patients were aware of allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 71/626(11%), 43/310 (14%) inter-
vention and 28/316 (9%) control. Reasons
for loss to follow-up provided, with similar
reasons across groups. Used intention-to-
treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
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Gjerdingen 2009
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: Women who became positive on Structured Clinical Interview for the Diag-
nostic and Statistical Manual of Mental Disorders (SCID) at 0 to 6 months postpartum.
Participants were also given the opportunity to self-diagnose depression through a 9-
month survey question with a yes/no answer: “Since your baby was born, have you been
depressed or diagnosed with depression?”
Inclusion criteria: Being a mother of a 0- to 1-month-old infant who was registered at
one of the participating clinics, being English literate, and being greater than or equal
to 12 years old
Exclusion criteria: Not stated




Sample size (randomised): Total participants 39, intervention 19, control 20
Interventions Intervention: Stepped collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary physician (PCP), nurse with
MH experience (CM), psychiatrist (MH specialist)
2) a structured management plan: The stepped care intervention included (1) referral to
the PCP for initial treatment (AD and/or psychotherapy referral); (2) regular telephone
follow-up with a CM; (3) decision support for PCPs (e.g. advice regarding specific
ADs, additional treatment, or mental health referral); (4) consultation or referral to MH
specialist for complex cases (e.g., psychiatrists conducted psychiatric evaluations and
adjusted medications and therapists provided psychotherapy using CBT, interpersonal
psychotherapy (IPT), or other therapies depending on patient need); and (5) patient
educationprovided through the PCP,CM, and amailed postpartumdepressionbrochure.
Telephone calls addressed depressive symptoms,mental health visits, treatment adherence
and side effects, social support, suicidal ideation/plans, and lifestyle issues
3) scheduled patient follow-ups: 18 calls, conducted every two weeks until symptom
remission for up to 9 months
4) enhanced inter-professional communication: The content of each call was docu-
mented on a form and a copy was faxed to the PCP. If a participant’s symptoms were
not resolving as expected, this was specifically communicated
Control: Treatment as usual enhanced as patients were informed of their depression
diagnosis and referred to their PCP. The PCPs of some control patients were also PCPs
of patients in the intervention arm
Outcomes Depression (PHQ-9): 1, 9 months
Medication use: 9 months
Quality of Life (mental and physical health): 1, 2, 9 months
Satisfaction: 9 months
Notes AD: antidepressant; CBT: cognitive behaviour therapy; CM: case manager; MH: mental
health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire-9
101Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gjerdingen 2009 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 10
Allocation concealment (selection bias) Unclear risk Standard block size. Insufficient informa-
tion available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 5/39 (13%), 3/19 (16%) interven-
tion and 2/20 (10%) control. Reasons for
loss to follow-up not provided. Intention
to treat not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Hedrick 2003
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Current major depressive episode, dysthymia, or both. Assessed using Pri-
mary care evaluation of Mental Disorders (PRIME-MD) and additional questions from
the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
Disorders (SCID)
Inclusion criteria: Veterans
Exclusion criteria: Recent visit to mental health specialty clinic or who had scheduled a
future appointment, requiring treatment for substance abuse or PTSD prior to initiating
depression treatment, acute suicidality, psychosis or other condition requiring immediate
treatment
Age: Mean 57.2 years
Gender: 5% female
Ethnicity: 80% caucasian
102Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hedrick 2003 (Continued)
Country: United States
Sample size (randomised): Total clusters 4, intervention 2, control 2; Total participants
354, intervention 168, control 186
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), social
worker (CM), psychiatrist (MH specialist)
2) a structured management plan: The team (CM, MH specialist, psychologist and
psychologist technician) met weekly to develop treatment plans and conduct 6 and
12 week progress evaluations for each patient. Using Veteran Affairs Major Depression
Guidelines treatment options were: AD medication; add an adjunctive medication; a
CBT group; schedule with the psychologist or psychiatrist; or refer to MH speciality
care. Options were selected beginning with the least resource- intensive option based on
previous treatments and patient preference. Patients were stepped up if non-response at
6 or 12 weeks. A videotape and workbook were mailed to each patient. CMs telephoned
patients on a regular schedule to encourage adherence, address treatment barriers, and
assess response
3) scheduled patient follow-ups: Acute = 3 to 5 telephone calls, maintenance = 3 to 5
calls, plus for those also receiving CBT = 6 sessions
4) enhanced inter-professional communication:The team liaisedwith PCP remedication
prescribing and treatment plans using electronic progress notes and if not acted upon
the team contacted the PCP directly. The MH specialist contacted PCPs where there
was question about treatment recommendations
Control: Consultation-liaison (CL) in which the PCP was responsible for initiating and
coordinating the patient’s care, with consultation from or referral to a psychiatrist if
necessary. PCPs were notified of the patient’s diagnosis and were able to refer patients
to the psychiatrist, psychologist, and/or social workers, based in the organisation. The
CL mental health providers provided treatment directly during individual visits with
patients who were deemed manageable in the primary care setting
Outcomes Depression (HSCL): 3, 9 months
Medication use: 3, 6, 9, 12 months
Quality of Life (mental and physical health): 3, 9 months
Satisfaction: 3, 9 months
Notes AD: antidepressant; CBT: cognitive behaviour therapy; CM: casemanager;HSCL:Hop-
kins Sympton Checklist; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL≥ 50%)
was: overall 26/354 (7%), 12/168 (7%) in-
tervention and 14/186 (8%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Hilty 2007
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Major depression assessed using a structured diagnostic interview (i.e. mood
and psychotic sections of the Structured Clinical Interview for DSM-IV [SCID-I, re-
search version] and self-report measures - Beck Depression Inventory (BDI-13), Symp-
tom Checklist-90 Revised (HSCL-90-R), Medical Outcomes Study Short Form 36 (SF-
36)
Inclusion criteria: Rural primary care. Subjects were English-speaking men and women,
between ages of 18 and 80 years, who were willing to take an antidepressant medication
Exclusion criteria: Bipolar, schizoaffective, and schizophrenic disorders, no primary di-
agnosis of major depression, suicidal intention or plans. Patients with dementia, preg-
nancy, terminal illness, and plans to move in the next 12 months were not enrolled




Sample size (randomised): Total participants 93, intervention 52, control 41
Interventions Intervention: Intensive Disease Management Module
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), study
nurse or investigator (CM), psychiatrist (MH specialist)
2) a structuredmanagement plan: Patients received a handout and a video on the biology
of depression and how ADs work and had 5 scheduled PCP visits in 16 weeks. CM
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telephoned patients to assess adherence and side effects of medication, with referral to
the PCP or MH specialist if needed and proactive follow-up for missed appointments.
Five telepsychiatric consultations were offered in 18 weeks
3) scheduled patient follow-ups: CM telephone calls at 2 and 4 weeks
4) enhanced inter-professional communication: PCP and the telepsychiatrist discussed
cases by telephone or via televideo after each telepsychiatric consultation. The MH
specialist trained the PCP to administer care in accordance to national guidelines. PCP
contacted the MH specialist by telephone regarding questions. For urgent issues the
study coordinator notified the MH specialist, CM and PCP
Control: Disease Management Module and some patients received a one-off telepsychi-
atry visit as per pre-trial standard
Outcomes Depression (BDI-13): 3, 6, 12 months
Quality of Life (mental and physical health): 3, 6, 12 months
Satisfaction: 3, 6, 12 months
Notes BDI: Beck Depression Inventory; CM: case manager; DSM-IV: Diagnostic and Statis-
tical Manual fourth edition; HSCL: Hopkins Sympton Checklist; MH: mental health;
PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random table of numbers
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDI) was un-
clear. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
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Methods Study design: Randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: Clinical depression defined as a PHQ-9 score greater than or equal to 10,
with 5 or more symptoms (including either depressed mood or anhedonia) present more
than half the days for at least the preceding 2 weeks
Inclusion criteria: Hospitalised cardiac patients. Eligible patients were admitted to 1 of
3 inpatient cardiac units at an urban academic medical centre for acute cardiac disease,
defined as admission for myocardial infarction, unstable angina, decompensated heart
failure, or arrhythmia
Exclusion criteria: Bipolar disorder, psychotic symptoms, active substance abuse, active
suicidal ideation, unable to speak English or unable to provide informed consent due to
cognitive problems or the severity of their current medical illness




Sample size (randomised): Total participants 175, intervention 90, control 85
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary medical physician including
cardiologist (PCP), social worker (CM), psychiatrist (MH specialist)
2) a structured management plan: In hospital interventions: CM provided written and
verbal education about depression and its impact on cardiac disease, helped the patient to
schedule pleasurable activities after discharge, and described treatment options (pharma-
cotherapy or psychotherapy referral). CM then consulted withMH specialist, who devel-
oped individualised depression treatment recommendations based on previous/current
treatment and preference including SSRI and/or referral for therapy. CM worked to co-
ordinate these recommendations with inpatient and outpatient medical care providers.
Post-discharge interventions: Post-discharge interventions lasted 12 weeks. For patients
with clinical depression at any follow-up, a multi-component intervention (similar to the
in-hospital intervention) was undertaken. CMdiscussed the case with theMH specialist,
written treatment recommendations were generated (e.g., increase AD, therapy referral)
. These were discussed with the patient and the PCP (and faxed to the PCP), and the
CM worked to coordinate implementation
3) scheduled patient follow-ups: Inpatient = unclear, post-discharge = 3 telephone calls
in 12 weeks
4) enhanced inter-professional communication: Treatment recommendations discussed
with and faxed to PCP. CM and MH specialists held weekly team meetings
Control: Treatment as usual enhanced as CM informed the inpatient treatment team of
the patient’s depression and recommended that the patient receive treatment. If patients
met criteria for clinical depression at follow-up, the PCP was informed via written com-
munication that the patient had ongoing depression and would benefit from treatment
Outcomes Depression (PHQ-9): 6, 12 months
Medication use: 6 weeks
Quality of Life (mental and physical health): 6 weeks, 3, 6 months
Satisfaction: 6 months
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Notes CM: case manager; MH: mental health; PCP: primary care provider; PHQ-9: Patient
Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number generator
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9 50%
decrease) was: overall 37/175 (21%), 19/
90 (21%) intervention and 18/85 (21%)
control. Reasons for loss to follow-up not
reported by group. Intention-to-treat anal-
ysis reported using random-effects regres-
sion models to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Hunkeler 2000
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed by PCP as having major depressive disorder or dysthymia and
given a prescription for a selective serotonin reuptake inhibitor (SSRI) antidepressant
Inclusion criteria: Major depressive disorder or dythymia as diagnosed by PCP
Exclusion criteria: Had received a previous antidepressant drug prescription within the
past 6 months, had an inadequate command of the English language, reported current
problems with substance abuse, showed current suicide risk, or reported thoughts of
violence, required referral to other treatment, currently receiving an anti-depressant drug
or psychotherapy or refusing prescribed SSRI
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Sample size (randomised): Total participants 302, intervention 179, control 123
Interventions Intervention: Nurse telehealthcare (with or without peer support)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse
(CM), psychologist (MH specialist)
2) a structured management plan: During telephone calls CM inquired about medi-
cation, managed minor side effects, and emphasised the importance of taking medica-
tion regularly. CMs also offered emotional support and helped patients identify active
and pleasurable activities reviewing activities of the previous week and developing an
action plan with the patient. Peer support was provided by trained volunteer health
plan members who had experienced a successfully treated episode of major depression
or dysthymia. Peers contacted patients by telephone or visited them at least once and
continued support over 6 months
3) scheduled patient follow-ups: 12 to 14 telephone calls in 16 weeks, 1 to 2 per week
for first 2 weeks, 1 per week in weeks 3 to 8 and then fortnightly up to week 16
4) enhanced inter-professional communication: CMs gave regular feedback on the
progress of each patient to the patient’s PCP.CMs receivedweekly telephone andmonthly
visits for supervision from MH specialist
Control: Treatment as usual enhanced as PCPs received training on assessment and
treatment of depression
Outcomes Depression (BDI): 6 weeks, 6 months
Medication use: 6 weeks, 6 months
Quality of Life (mental and physical health): 6 weeks, 6 months
Satisfaction: 6 weeks, 6 months
Notes BDI: BeckDepression Inventory; CM: case manager; MH:mental health; PCP: primary
care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDI 50% im-
provement) was: overall 47/302 (16%), 29/
179 (16%) intervention and 18/123(15%)
control. Reasons for loss to follow-up not
provided by group. Intention to treat not
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reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Katon 1995a
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed by the primary care physician as meeting criteria for definite or
probable major depression and who had agreed to antidepressant therapy. A 20-item
Symptom Checklist (HSCL) depression screening score of 0.75 or greater
Inclusion criteria: Aged between 18 and 80 years and willingness to take antidepressant
medication
Exclusion criteria: Current alcohol abuse, current psychotic symptoms, serious suicidal
ideation or plan, dementia, pregnancy, terminal illness, limited command of English;
and plan to disenroll from the insurance plan within the next 12 months




Sample size (randomised: Minor depression): Total participants 126, intervention 59,
control 67
Interventions Intervention: Multifaceted intervention programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), psychi-
atrist (CM/MH specialist)
2) a structured management plan: Patients received a brief booklet on the biology of
depression, themechanism of action of ADs, a second booklet on simple CBT techniques
and a videotape covering similarmaterial. Patientswere asked towrite downany questions
in preparation for their initial meeting. The CM educated the patient about depression
and ADs and side-effects and also reviewed stressful life events. Changes in ADs could be
initiated by PCP or CM after verbal consultation. CM monitored automatic pharmacy
data to assess adherence
3) scheduled patient follow-ups: 2-4 visits over 4 to 6weeks interspersedwith 2 scheduled
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visits with PCP 7-10 days apart
4) enhanced inter-professional communication: CMs and PCPs held monthly case con-
ferences and case by case consultations. CMs helped PCPs choose alternative medication
for patients. Change in ADs could be initiated by the PCP or CM after verbal consulta-
tion. PCPs received a typed psychiatric consultation note within one week. CMs notified
PCPs when patients failed to refill AD prescriptions
Control: Treatment as usual
Outcomes Depression (HSCL): 4 months
Medication use: 1, 4 months
Satisfaction: 4 months
Notes CM: case manager; HSCL: Hopkins Sympton Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 13/126 (10%), 6/
59 (10%) intervention and 7/67 (10%)
control. Reasons for loss to follow-up not
provided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias High risk Reported analysis not by randomised group
but by participants with a) minor and b)
major depression
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed by the primary care physician as meeting criteria for definite or
probable major depression and who had agreed to antidepressant therapy. Symptom
Checklist (HSCL-20) depression screening score of 0.75 or greater
Inclusion criteria: Aged between 18 and 80 years and willingness to take antidepressant
medication
Exclusion criteria: Current alcohol abuse, current psychotic symptoms, serious suicidal
ideation or plan, dementia, pregnancy, terminal illness, limited command of English;
and plan to disenroll from the insurance plan within the next 12 months




Sample size (randomised: Major depression): Total participants 91, intervention 49,
control 42
Interventions Intervention: Multifaceted intervention programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), psychi-
atrist (CM/MH specialist)
2) a structured management plan: Patients received a brief booklet on the biology of
depression, themechanism of action of ADs, a second booklet on simple CBT techniques
and a videotape covering similarmaterial. Patientswere asked towrite downany questions
in preparation for their initial meeting. The CM educated the patient about depression
and ADs and side-effects and also reviewed stressful life events. Changes in ADs could be
initiated by PCP or CM after verbal consultation. CM monitored automatic pharmacy
data to assess adherence
3) scheduled patient follow-ups: 2-4 visits over 4 to 6weeks interspersedwith 2 scheduled
visits with PCP 7-10 days apart
4) enhanced inter-professional communication: CMs and PCPs held monthly case con-
ferences and case by case consultations. CMs helped PCPs choose alternative medication
for patients. Change in ADs could be initiated by the PCP or CM after verbal consulta-
tion. PCPs received a typed psychiatric consultation note within one week. CMs notified
PCPs when patients failed to refill AD prescriptions
Control: Treatment as usual
Outcomes Depression (HSCL): 4 months
Medication use: 1, 4 months
Satisfaction: 4 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 10/91 (11%), 5/49
(10%) intervention and 5/42 (12%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias High risk Reported analysis not by randomised group
but by participants with a) minor and b)
major depression
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Katon 1996a
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed by Primary Care Physician as meeting criteria for definite or
probable major depression and who scored 0.75 or greater on the 20-item depression
symptom checklist (HSCL-20). Stratified into moderate and severe depression groups
based on their HSCL-20 score (moderate, 0.75 to < 1.75, severe, 1.75 to 4.0)
Inclusion criteria: Aged 18 to 80 years, willingness to take antidepressant medication
Exclusion criteria: Current alcohol abuse, current psychotic symptoms, serious suicidal
ideation or plan, dementia, pregnancy, terminal illness, limited command of English and
plan to withdraw from the insurance plan within the next 12 months




Sample size (randomised: Minor depression): Total participants 88, intervention 46,
control 42
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Interventions Intervention: Multifaceted intervention programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), psychol-
ogist (CM), psychiatrist (MH specialist)
2) a structured management plan: Programme involved teaching cognitive behavioural
skills to manage depression and counselling to improve medication adherence. Sessions
1-4 involved education, skills training, and homework assignments or behavioural ex-
periments. Optional sessions (5 & 6) involved skills training, problem-solving, and re-
laxation training. A relapse prevention plan was also developed. Patients received a brief
booklet on the biology of depression, the mechanism of action of ADs, a second book-
let on simple CBT techniques and a videotape covering similar material. Non-response
patients could be referred to the MH specialist for direct visit
3) scheduled patient follow-ups: 4-6 contacts within 6 weeks and 4 telephone calls at 2,
4, 12 and 24 weeks
4) enhanced inter-professional communication: Case-by-case consultation occurred be-
tweenCMand PCP andCM’s provided PCPs with a handwritten consultation note after
each patient contact. A copy of the relapse prevention plan was put in the patient’s med-
ical notes. CM and MH specialist met weekly for supervision and CM recommended
medication changes (which had been made by the MH specialist) to the PCP
Control: Treatment as usual
Outcomes Depression (HSCL): 4 months
Medication use: 1, 4, 7 months
Satisfaction: 4 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 14/88 (16%), 7/46
(15%) intervention and 7/42 (17%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias High risk Reported analysis not by randomised group
but by participants with a) minor and b)
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major depression
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Katon 1996b
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed by PCP as meeting criteria for definite or probable major depres-
sion and who scored 0.75 or greater on the Symptom Checklist (HSCL-20). Stratified
into moderate and severe depression groups based on their HSCL-20 score (moderate,
0.75 to < 1.75, severe, 1.75 to 4.0)
Inclusion criteria: Aged 18 to 80 years, willingness to take antidepressant medication
Exclusion criteria: Current alcohol abuse, current psychotic symptoms, serious suicidal
ideation or plan, dementia, pregnancy, terminal illness, limited command of English and
plan to withdraw from the insurance plan within the next 12 months




Sample size (randomised: Major depression): Total participants 65, intervention 31,
control 34
Interventions Intervention: Multifaceted intervention programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), psychol-
ogist (CM), psychiatrist (MH specialist)
2) a structured management plan: Programme involved teaching cognitive behavioural
skills to manage depression and counselling to improve medication adherence. Sessions
1-4 involved education, skills training, and homework assignments or behavioural ex-
periments. Optional sessions (5 & 6) involved skills training, problem-solving, and re-
laxation training. A relapse prevention plan was also developed. Patients received a brief
booklet on the biology of depression, the mechanism of action of ADs, a second book-
let on simple CBT techniques and a videotape covering similar material. Non-response
patients could be referred to the MH specialist for direct visit
3) scheduled patient follow-ups: 4-6 contacts within 6 weeks and 4 telephone calls at 2,
4, 12 and 24 weeks
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4) enhanced inter-professional communication: Case-by-case consultation occurred be-
tweenCMand PCP andCM’s provided PCPs with a handwritten consultation note after
each patient contact. A copy of the relapse prevention plan was put in the patient’s med-
ical notes. CM and MH specialist met weekly for supervision and CM recommended
medication changes (which had been made by the MH specialist) to the PCP
Control: Treatment as usual
Outcomes Depression (HSCL): 4 months
Medication use: 1, 4, 7 months
Satisfaction: 4 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 10/65 (15%), 5/31
(16%) intervention and 5/34 (15%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias High risk Reported analysis not by randomised group
but by participants with a) minor and b)
major depression
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosis of depression or anxiety and patients at high risk for persistent
depression. The first-stage screen included the telephone Structured Clinical Interview
for DSM-III-R (SCID). Criteria for selection for the second-stage interview were having
4 or more residual major depressive symptoms, recurrent depression (2 or more prior
episodes), or dysthymia. Four or more major depressive symptoms on the SCID and a
score of 1.0 or greater on the 20 depression items of the Hopkins Symptom Checklist
(HSCL-20) or having fewer than 4 DSM-IV major depressive symptoms but with a
score of 1.5 or greater on the HSCL-20.16
Inclusion criteria: Patients between the ages of 18 and 80 years who received a new
antidepressant prescription (no prior prescriptions within the last 120 days) from a
primary care physician
Exclusion criteria: A screening score of 2 or more on the CAGE alcohol screening ques-
tionnaire, being pregnant or currently nursing, planning to pull out from the Group
Health Cooperative insurance plan within the next 12 months, currently seeing a psychi-
atrist, having limited command of English, and recently using lithium or antipsychotic
medication




Sample size (randomised): Total participants 228, intervention 114, control 114
Interventions Intervention: Stepped collaborative care
Contains the four elements of collaborative care:
1) amulti-professional approach topatient care: Primary care provider (PCP), psychiatrist
(CM/MH specialist)
2) a structured management plan: All patients were prescribed an AD 8-9 weeks before
initial intervention visit in which CM assessed clinical status and current medication
adherence and side effects. CM helped the patient and PCP alter AD medication and
monitored medication adherence by checking automated pharmacy data and alerted
the PCP if premature discontinuation occurred. CMs also referred patients with severe
psychosocial stressors for psychotherapy or support groups
3) scheduled patient follow-ups: 2 in 4 weeks with 2 additional if non-response with a
brief telephone call in between (2 calls in total)
4) enhanced inter-professional communication: CM informed PCP of non-adherence.
After final visit, the CM sent PCP a standardised note of the AD prescribed, recom-
mended duration of treatment, residual depressive symptoms and recommendations for
therapy
Control: Treatment as usual
Outcomes Depression (SCID): 3, 6 months
Medication use: 1, 3, 6 months
Quality of Life (mental and physical health): 1, 3, 6 months
Satisfaction: 3, 6 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Asymptomatic
by SCID) was: overall 36/228(16%), 18/
114(16%) intervention and 18/114(16%)
control. Reasons for loss to follow-up not
provided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Katon 2001
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosis of depression or anxiety and patients at high risk of relapse. The
first-stage screen included the depression section of the telephone Structured Clinical
Interview for DSM-III-R (SCID), Selection criteria for the second stage interview were
either having a high epidemiologic risk of relapse or 4 or more residual major depressive
symptoms. Fewer than 4 DSM-IV major depressive symptoms and a history of 3 or
more episodes of major depression or dysthymia or 4 residual depressive symptoms but
with a mean Symptom Checklist (HSCL-20) depression score of less than 1.0 and a
history of major depression/dysthymia
Inclusion criteria: Patients between the ages of 18 and 80 years from 1 of 4 primary care
clinics who received a new antidepressant prescription (no prior prescriptions within the
last 120 days) from a primary care physician
Exclusion criteria: Screening score of 2 or more on the CAGE alcohol screening ques-
tionnaire, being pregnant or currently nursing, planning to disenroll from insurance plan
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within the next 12 months, currently seeing a psychiatrist, having limited command of
English, and recently using lithium or antipsychotic medication




Sample size (randomised): Total participants 386, intervention 194, control 192
Interventions Intervention: Relapse prevention programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), psychol-
ogist, nurse, social worker (CM), psychiatrist (MH specialist)
2) a structured management plan: Patients were provided a book and videotape aimed
at increasing patient education and enhancing self-treatment of their depression. CM
assessed clinical status and biopsychosocial history. The intervention aimed to improve
long-term adherence to ADs, increase self-monitoring and relapse prevention strategies
such as early help seeking. Other goals were increasing pleasant activities, exercise, and
socializing, and identifying potential high-risk situations to promote problem-solving
ability, coping, and self-efficacy for managing depression. Follow-up telephone calls and
personalised mailings monitored progress and adherence to the plan
3) scheduled patient follow-ups: 2 visits and telephone calls at 1, 4 and 8.5 months after
session 2. Personalised mailings at 2, 6, 10 and 12 months
4) enhanced inter-professional communication: PCPs received intermittent verbal and
written consultation about patient progress and a copy of the relapse prevention plan.
CMs had weekly supervision with MH specialists
Control: Treatment as usual enhanced as PCPs were notified of group allocation
Outcomes Depression (HSCL): 3, 6, 9, 12 months
Medication use: 3, 6, 9, 12 months
Quality of Life (mental and physical health): 3, 6, 9, 12 months
Notes AD: antidepressant; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; HSCL: Hopkins SymptomChecklist;MH: mental health; PCP: primary
care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 8
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL) was:
overall 35/386 (9%), 13/194 (7%) inter-
vention and 22/192 (11%) control. Rea-
sons for loss to follow-up not provided.
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Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Katon 2004
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Although patients were not required to meet criteria for major depression,
they were required to have a score of 10 or greater on the PHQ-9 in the initial screening
and persistent symptoms, as evidenced by a Symptom Checklist (HSCL-90) depression
mean item score of higher than 1.1 at a second telephone screen 2 weeks later
Inclusion criteria: Diabetic patients, ambulatory, English speaking, had adequate hearing
to complete a telephone interview, and planned to continue to be enrolled in insurance
plan during the next year
Exclusion criteria: Currently in care with a psychiatrist, bipolar disorder or schizophre-
nia, use of antipsychotic or mood stabiliser medication, mental confusion on interview
suggesting significant dementia




Sample size (randomised): Total participants 329, intervention 164, control 165
Interventions Intervention: Stepped collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), nurse
(CM), psychologist/psychiatrist (MH specialist)
2) a structuredmanagement plan: Step 1: Initial choice of ADsor problem solving therapy
(PST). Step 2: If poor response after 10 to 12 weeks they could (1) switch to a different
AD; (2) switch to the alternative treatment (from PST to medication or vice versa); (3)
receive augmentation with PST or AD; or (4) receive a psychiatric consultation. Step 3:
For continued non-response a referral was made to specialty care. Once patients reached
a significant decrease in clinical symptoms CMs began continuation phase treatment,
which consisted of monthly scheduled telephone contacts
119Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Katon 2004 (Continued)
3) scheduled patient follow-ups: Acute phase: Assessment plus twice-a-month telephone
and in-person appointments. Continuation phase: monthly telephone calls or monthly
continuation groups
4) enhanced inter-professional communication: CMs interacted regularly (via written
notes and verbally) with PCP. CMs had supervision twice a month with a MH specialist
team to review new cases and patient progress. On alternate weeks, CMs reviewed cases
by telephone with the psychiatrist supervisor
Control: Treatment as usual andpatientswere advised to consultwith their PCP regarding
depression
Outcomes Depression (HSCL-90): 3, 6, 12, 24 months
Medication use: 3, 6, 9, 12, 24 months
Satisfaction: 6, 12 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk An individual not involved in patient re-
cruitment conducted allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-90 de-
pression ≥ 50% decrease) was: overall 37/
329 (11%), 21/164 (13%) intervention
and 16/149 (10%) control. Reasons for loss
to follow-up not provided. Used intention-
to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Katon 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Cut-off points of 3 or higher on the Patient Health Questionnaire 2 (PHQ-
2) and 10 or higher on the PHQ-9 used to identify patients who were eligible for the
trial
Inclusion criteria: Patients with diagnoses of diabetes, coronary heart disease, or both
coded according to the International Classification of Diseases (ICD9), or Current Pro-
cedural Terminology codes for coronary- artery interventions. These patients had one
or more measures of poor disease control within the previous 12 months, including:
blood pressure above 140/90 mmHg (based on two blood-pressure readings at separate
visits within 12 months), a low-density lipoprotein (LDL) cholesterol level above 130
mg per decilitre (>3.4 mmol per litre), or a glycated haemoglobin level of 8.5%or higher.
Patients who were ambulatory, spoke English, and planned to be enrolled in a health-
maintenance-organization (HMO) plan for 12 months
Exclusion criteria: Terminal illness, residence in a long-term care facility, severe hearing
loss, planned bariatric surgery within 3 months, pregnancy or breastfeeding, ongoing
psychiatric care, bipolar disorder or schizophrenia, use of an antipsychotic or mood-
stabiliser medication, and observed mental confusion suggesting dementia




Sample size (randomised): Total participants 214, intervention 106, control 108
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), nurse
(CM), psychologist/psychiatrist (MH specialist)
2) a structuredmanagement plan:CMsmotivated and coachedpatients to solve problems
and set goals for improved medication adherence and self-care (e.g. exercising and self-
monitoring of blood-pressure and glucose levels). Self-care materials, including a help
book, a video compact disk on depression care, a booklet and other materials on chronic
disease management, and self-monitoring devices (e.g., blood-pressure or blood-glucose
meters) were provided. Patients worked collaboratively with CMs and PCPs to establish
individualised clinical and self-care goals. CMs monitored the patient’s progress with
respect to management of depression, control of medical disease, and self-care activities.
Treatment protocols guided adjustments of commonly used medicines in patients who
did not achieve specific goals. CMs followed patients proactively to provide support for
medication adherence
3) scheduled patient follow-ups: Assessment plus telephone or in-person contact once
or twice a month until the patient achieved his or her treatment goals (treat-to-target)
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. After completion of recovery and a maintenance plan, patients were followed every
4 to 6 weeks by telephone calls from the CM to review adherence, lab test results and
depression score
4) enhanced inter-professional communication:CMcommunicated recommendedmed-
ication changes to PC. CMs received weekly supervision with MH specialist team to
review new cases and patient progress
Control: Treatment as usual enhanced as patients were advised to consult with their PCP
to receive care for depression, diabetes and/or CHD. With patient permission, PCPs
were notified about depression and poor medical disease control. All study laboratory
reports and results were entered into the electronic medical record
Outcomes Depression (HSCL-20): 6, 12 months
Medication use: 12 months
Quality of Life (mental and physical health): 6, 12 months
Satisfaction: 6, 12 months
Notes CHD: coronary heart disease; CM: case manager; HSCL: Hopkins Symptom Checklist;
MH: mental health; PCP: primary care provider; PHQ: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Permuted-blocks of 4, 6 or 8 (randomly
selected)
Allocation concealment (selection bias) Low risk Central allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20) was:
overall 21/214 (10%), 9/106 (8%) inter-
vention and 12/108 (11%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Current major depression or major depression in partial remission assessed
using a modified version of the Structured Clinical Interview for DSM-IV (SCID). Also
a score of 15 or more on the Hamilton Depression Rating Scale (HAM-D)
Inclusion criteria: Aged 25 to 63 years with continuous health plan enrolment for the
previous 2 years. High utilisers of health care defined as ambulatory visit counts above
the 85th percentile for both of the 2 previous years. Ambulatory office visits were defined
as primary care visits, medical specialty visits, and walk-in clinic visits
Exclusion criteria: Recent treatment for alcohol or other substance abuse; past treatment
for schizophrenia or bipolar disorder; life-threatening medical disorders (e.g., metastatic
malignant neoplasm), active treatment for depression (defined as current specialty men-
tal health treatment or minimal adequate trial of antidepressant medication), contraindi-
cations to taking an antidepressant, receiving treatment by a psychiatrist within the past
4 months, pregnancy, planned pregnancy within the next year, breastfeeding, positive
screen for alcohol abuse, and intent to disenroll from the Health Maintenance Organi-
sation




Sample size (randomised): Total clusters 163, intervention 82, control 81; Total partic-
ipants 407, intervention 218, control 189
Interventions Intervention: Depression management
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care physician (PCP), treatment
co-ordinator (CM), psychiatrist (MH specialist)
2) a structured management plan: Patient education using RHYTHMs which included
detail on nature of depression, use of ADs and adherence and a booklet and videotape.
Specific ADs were used and CMs reviewed patient prescription refills and office visits
to identify unplanned treatment discontinuation and monitored treatment adherence,
treatment response and medication adverse effects
3) scheduled patient follow-ups: Telephone calls at 2 and 10 weeks and if necessary at
18, 30, 42 weeks. Scheduled visits with PCP at weeks 1, 3, 6 and 10 weeks then every
10 weeks
4) enhanced inter-professional communication: CMs provided a written response to
PCPs or a call if progress was not as expected or patient discontinued treatment. PCPs
had periodic case reviews and as needed telephone consultation with the MH specialist
Control: Treatment as usual
Outcomes Depression (HAMD): 6 weeks, 3, 6, 12 months
Medication use: 6 months
Quality of Life (mental and physical health): 12 months
Notes AD: antidepressant; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; HAM-D: Hamilton Depression Rating Scale; MH: mental health; PCP:
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Sealed envelopes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HAMD) was:
overall 26/407(6%), 16/218(7%) inter-
vention and 10/189(5%) control. Reasons
for loss to follow-up not provided. Used in-
tention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Kroenke 2010
Methods Study design: Randomised controlled trial
Participants Setting: Specialist
Diagnosis: At least moderately severe depression, defined as a PHQ-9 score of 10 or
higher and endorsement of either depressed mood, anhedonia; or both
Inclusion criteria: Patients presenting for oncology clinic visits who screened positive for
either pain or depression. Pain had to be (1) definitely or possibly cancer related; (2) at
least moderately severe, (3) persistent despite trying at least 1 pain medicine
Exclusion criteria: Unable to speak English, moderately severe cognitive impairment,
schizophrenia or other psychosis, had a pending pain related disability claim, were preg-
nant, or were in hospice care
Age: Mean 58.9 years
Gender: 68% female
Ethnicity: 80% White
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Country: United States
Sample size (randomised): Total participants 405, intervention 202, control 203
Interventions Intervention: Care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Oncologist (PCP), nurse (CM), pain-
psychiatrist (MH specialist)
2) a structured management plan: CMs assessed symptom response and medication ad-
herence; provided pain and depression specific education; and made treatment adjust-
ments according to evidence based guidelines. Automated symptom monitoring was
also performed between sessions using interactive voice recorded telephone calls or web
based surveys. Participants who preferred not to take ADs were encouraged to consider
a referral for psychotherapy and speak to their oncologist re this
3) scheduled patient follow-ups: 4 in 12 weeks: at baseline, 1, 4 and 12 weeks plus
automated contact
4) enhanced inter-professional communication: Treatment recommendations were pro-
vided to PCP. CMhadweekly supervision withMH specialist who was available between
sessions
Control: Treatment as usual enhanced as patients were informed of their depressive and
pain symptoms, and their screening results were provided to PCP
Outcomes Depression (HSCL-20): 1, 3, 6, 12 months
Quality of Life (mental and physical health): 1, 3, 6, 12 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 4, 8 and
12 (randomly selected)
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20) was:
overall 182/405(45%), 92/202(46%) in-
tervention and 90/203(44%) control. Rea-
sons for loss to follow-up provided, with
similar reasons for missing data across
groups. Intention-to-treat analysis reported
with appropriate imputation methods to
manage missing data
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
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Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Landis 2007
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Significant depression determined by a score of 10 or more on the PHQ-9.
The primary care physician verified the presence of major depression by clinical exam
Inclusion criteria: Willing to begin or continue antidepressant medication
Exclusion criteria: Bipolar disorder, psychotic symptoms, active suicidal ideation requir-
ing psychiatric admission




Sample size (randomised): Total participants 45, intervention 22, control 23
Interventions Intervention: Care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), mental
health graduate (CM), psychiatrist (MH specialist)
2) a structured management plan: CMs provided patient education about depression
and instruction in self-management skills and goals and monitored adherence and side
effects
3) scheduled patient follow-ups: Acute: telephone or in-person every 2 weeks for up-to
12 weeks, maintenance: every 4 weeks until 6 months post-initial session
4) enhanced inter-professional communication: CMs coordinated with the PCP and
received bi-weekly telephone supervision from MH specialist
Control: Treatment as usual enhanced as PCP was informed of diagnosis
Outcomes Depression (PHQ-9): 3, 6 months
Medication use: 3, 6 months
Quality of Life (mental and physical health): 3, 6 months
Satisfaction: 3, 6 months
Notes CM: case manager; MH: mental health; PCP: primary care provider; PHQ-9: Patient
Health Questionnaire-9
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random assignment of 200 study numbers
pre-trial. Stratified by newly diagnosed and
already treated with AD medication
Allocation concealment (selection bias) Low risk Sealed envelope
Incomplete outcome data (attrition bias)
All outcomes
High risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 11/45 (24%), 5/22 (23%) interven-
tion and 6/23 (26%) control. Reasons for
loss to follow-up not provided. Intention-
to-treat analysis not reported, no descrip-
tion of methods to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Lobello 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Primary diagnosis ofmajor depressive disorder assessed using amodifiedMini-
International Neuropsychiatric Interview (MINI), and a diagnosis of major depressive
disorder, single or recurrent episode without psychotic features, was confirmed according
to Diagnostic and Statistical Manual of Mental Disorders(DSM-IV) criteria. Patients
were required to have a minimum Hamilton Rating Scale for Depression (HAM-D17)
score of 14
Inclusion criteria: Male and female outpatients aged 18 years or older. Sexually active
womenof child bearingpotential were required tousemedically acceptable contraception
Exclusion criteria: Current treatment with venlafaxine or previously failed venlafaxine
treatment at adequate dose and duration; significant risk of suicide based on clinical
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judgment; pregnancy or breastfeeding; introduction or change in cognitive behavioural
therapy, interpersonal therapy, or other psychotherapy within 3 months before randomi-
sation; and concomitant use of other psychopharmacologic drugs




Sample size (randomised): Total participants 537, intervention 268, control 269
Interventions Intervention: Venlafaxine ER plus Dialogues programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse
(CM)
2) a structured management plan: The Dialogues programme included a welcome kit
that included the first issue of the Dialogues Magazine, a Straight Talk booklet (on side
effects), and a tip sheet (points to discuss with PCP).Over a 4-month period, patients also
received a comprehensive resource guide, 2 additional issues of the Dialogues Magazine,
and 3 additional Straight Talk booklets (progress, managing stress, long-term therapy)
3) scheduled patient follow-ups: 3 planned periodic calls (weeks 1, 5 and 13) and access
to a 12-hour daily help line
4) enhanced inter-professional communication: After each telephone call a contact report
was sent to the PCP
Control: The venlafaxine ER group received venlafaxine ER as part of the standard
practice of care for the treatment of major depression
Outcomes Depression (HAM-D): 14, 45, 112, 135, 180 days
Medication use: 14, 45, 112, 135, 180 days
Quality of Life (mental and physical health): 14, 45, 112, 135, 180 days
Satisfaction: 14, 45, 112, 135, 180 days
Notes CM: case manager; HAM-D: Hamilton Depression Rating Scale; MH: mental health;
PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HAMD remis-
sion total score ≤ 7) was: overall 45/
537 (8%), 29/268 (11%) intervention and
16/269 (6%) control. Reasons for loss to
follow-up provided, with similar reasons
across groups.Used intention-to-treat anal-
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ysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Ludman 2007a
Methods Study design: Pilot randomised controlled trial
Participants Setting: Community, primary care
Diagnosis: Persistent symptoms of depression despite at least sixmonths of antidepressant
treatment prescribed in specialty care. Assessed by a score of 0.75 or above on a 20-
item depression scale extracted from the 90-item Hopkins Symptom Checklist (HSCL-
90). At least one major depressive episode in the past two years as diagnosed by a
structured interview and a history of either recurrent major depression (more than three
episodes in the past five years) or dysthymia. All patients met criteria for recurrent
major depression or dysthymia, but were heterogeneous with respect to current mood
state (dysthymia, chronic major depression, partial remission, relapse, or recurrence) and
current antidepressant treatment
Inclusion criteria: Aged 18 and older who had initiated antidepressant treatment at least
180 days previously, had a visit diagnosis of major depressive disorder at the time of
initial antidepressant prescription, and were continuously enrolled in insurance group
for at least the previous 180 days
Exclusion criteria: History of mania or hypomania, cognitive impairment, near-terminal
medical illness, intent to disenroll from insurance group within the next 12 months,
emergent clinical needs (for example, risk of harm to self or others), diagnosis of bipolar
disorder or psychotic disorder or prescription for a mood stabiliser or antipsychotic
medication in the past two years




Sample size (randomised): Total participants 52, intervention 26, control 26
Interventions Intervention: Telephone care management.
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care provider (PCP), counsellor
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(CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Using computer-assisted scripts, CMs provided ed-
ucation about medication adherence and management of side effects and incorporated
motivational enhancement strategies. CM also provided any needed outreach and care
coordination, including facilitation of follow-up care
3) scheduled patient follow-ups: CM=3 monthly telephone calls plus others if required.
Peer group=6 weekly sessions plus additional bimonthly group. Psychotherapy group=
10 weekly sessions plus 3 booster sessions
4) enhanced inter-professional communication: After each contact, CMs sent the PCP a
report of current symptoms, medication use, side effects, prior treatment, and algorithm-
based recommendations. In the case of moderate or severe symptoms CMs communi-
cated with the PCP by telephone within 24 hours
Control: Treatment as usual
Outcomes Depression (HSCL): 3, 6, 9, 12 months
Medication use: 12 months
Satisfaction: 6, 9, 12 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated block randomisation
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL depres-
sion) was: overall 7/52(13%), 5/26(19%)
intervention and 2/26(8%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis, no de-
scription of methods to manage missing
data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Ludman 2007b
Methods Study design: Pilot randomised controlled trial
Participants Setting: Community, primary care
Diagnosis: Persistent symptoms of depression despite at least sixmonths of antidepressant
treatment prescribed in specialty care. Assessed by a score of 0.75 or above on a 20-
item depression scale extracted from the 90-item Hopkins Symptom Checklist (HSCL-
90). At least one major depressive episode in the past two years as diagnosed by a
structured interview and a history of either recurrent major depression (more than three
episodes in the past five years) or dysthymia. All patients met criteria for recurrent
major depression or dysthymia, but were heterogeneous with respect to current mood
state (dysthymia, chronic major depression, partial remission, relapse, or recurrence) and
current antidepressant treatment
Inclusion criteria: Aged 18 and older who had initiated antidepressant treatment at least
180 days previously, had a visit diagnosis of major depressive disorder at the time of
initial antidepressant prescription, and were continuously enrolled in insurance group
for at least the previous 180 days
Exclusion criteria: History of mania or hypomania, cognitive impairment, near-terminal
medical illness, intent to disenroll from insurance group within the next 12 months,
emergent clinical needs (for example, risk of harm to self or others), diagnosis of bipolar
disorder or psychotic disorder or prescription for a mood stabiliser or antipsychotic
medication in the past two years




Sample size (randomised): Total participants 52, intervention 26, control 26
Interventions Intervention: Telephone care management plus a peer-led chronic-disease self-manage-
ment group programme
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care provider (PCP), counsellor
(CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Using computer-assisted scripts, CMs provided ed-
ucation about medication adherence and management of side effects and incorporated
motivational enhancement strategies. CM also provided any needed outreach and care
coordination, including facilitation of follow-up care
3) scheduled patient follow-ups: CM = 3 monthly telephone calls plus others if required.
Peer group=6 weekly sessions plus additional bimonthly group. Psychotherapy group=
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10 weekly sessions plus 3 booster sessions
4) enhanced inter-professional communication: After each contact, CMs sent the PCP a
report of current symptoms, medication use, side effects, prior treatment, and algorithm-
based recommendations. In the case of moderate or severe symptoms CMs communi-
cated with the PCP by telephone within 24 hours
Control: Treatment as usual
Outcomes Depression (HSCL): 3, 6, 9, 12 months
Medication use: 12 months
Satisfaction: 6, 9, 12 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated block randomisation
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL depres-
sion) was: overall 4/52 (8%), 2/26 (8%) in-
tervention and 2/26 (8%) control. Reasons
for loss to follow-up not provided. Used in-
tention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Pilot randomised controlled trial
Participants Setting: Community, primary care
Diagnosis: Persistent symptoms of depression despite at least sixmonths of antidepressant
treatment prescribed in specialty care. Assessed by a score of 0.75 or above on a 20-
item depression scale extracted from the 90-item Hopkins Symptom Checklist (HSCL-
90). At least one major depressive episode in the past two years as diagnosed by a
structured interview and a history of either recurrent major depression (more than three
episodes in the past five years) or dysthymia. All patients met criteria for recurrent
major depression or dysthymia, but were heterogeneous with respect to current mood
state (dysthymia, chronic major depression, partial remission, relapse, or recurrence) and
current antidepressant treatment
Inclusion criteria: Aged 18 and older who had initiated antidepressant treatment at least
180 days previously, had a visit diagnosis of major depressive disorder at the time of
initial antidepressant prescription, and were continuously enrolled in insurance plan for
at least the previous 180 days
Exclusion criteria: History of mania or hypomania, cognitive impairment, near-terminal
medical illness, intent to disenroll from insurance plan within the next 12 months,
emergent clinical needs (for example, risk of harm to self or others), diagnosis of bipolar
disorder or psychotic disorder or prescription for a mood stabiliser or antipsychotic
medication in the past two years




Sample size (randomised): Total participants 52, intervention 26, control 26
Interventions Intervention: Telephone care management plus a professionally led depression psy-
chotherapy group
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care provider (PCP), counsellor
(CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Using computer-assisted scripts, CMs provided ed-
ucation about medication adherence and management of side effects and incorporated
motivational enhancement strategies. CM also provided any needed outreach and care
coordination, including facilitation of follow-up care
3) scheduled patient follow-ups: CM = 3 monthly telephone calls plus others if required.
Peer group = 6 weekly sessions plus additional bimonthly group. Psychotherapy group
= 10 weekly sessions plus 3 booster sessions
4) enhanced inter-professional communication: After each contact, CMs sent the PCP a
report of current symptoms, medication use, side effects, prior treatment, and algorithm-
based recommendations. In the case of moderate or severe symptoms CMs communi-
cated with the PCP by telephone within 24 hours
Control: Treatment as usual
Outcomes Depression (HSCL): 3, 6, 9, 12 months
Medication use: 12 months
Satisfaction: 6, 9, 12 months
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Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated block randomisation
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL depres-
sion) was: overall 6/52 (12%), 4/26 (15%)
intervention and 2/26 (8%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Mann 1998
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: General Practitioners assessed as depressed. Severity defined after referral by
use of the Beck Depression Inventory (BDI) and Nurse Assessment Interview
Inclusion criteria: Patients aged 18-74 years, who had been depressed for at least four
weeks. Those currently receiving treatment from their GP for depression or presenting
with a new episode were included
Exclusion criteria: Suicidal ideation, those whose depression represented a phase in a
manic-depressive psychosis, and those currently receiving treatment for depression from
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specialist psychiatric services




Sample size (randomised): Total participants 419, intervention 271, control 148
Interventions Intervention: Nurse assisted follow-up care
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: General Practitioner (PCP), nurse (CM)
2) a structuredmanagement plan: CMs assessed patients using a depressionmeasurement
tool and reported result to PCP. CMs worked to a manual that covered: strategies to
improve compliance (theCM explained the rationale of treatment bymedication, helped
manage side-effects, and discussed dose changes with PCP), education of patients (leaflets
on depression were included in the manual for CMs to explore and explain depression
and, if necessary, provide to patients), initiation of social interventions (CMs made
contact with local support agencies that might help depressed patients) and CMs also
made contact with the local specialist psychiatric services
3) scheduled patient follow-ups: Regularly during first month with no specific regimen
thereafter
4) enhanced inter-professional communication: The CM discussed each patient with
the PCP, who decided upon treatment. CMs could discuss a patient with the PCP at
any time. Nurses received supervision from other nurses who had done similar work
previously
Control: Treatment as usual
Outcomes Depression (DSM-III depression): 4 months
Medication use: 4 months
Notes BDI: BeckDepression Inventory; CM: case manager; MH:mental health; PCP: primary
care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table
Allocation concealment (selection bias) Low risk Sealed envelope
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (DSM-III de-
pression) was: overall 34/419 (8%), 20/271
(7%) intervention and 14/148 (9%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
135Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mann 1998 (Continued)
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
McCusker 2008
Methods Study design: Pilot cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: A positive response to either of the PHQ-2 screening questions, followed by
a screen for major depression using a Structured Clinical Interview (SCID)
Inclusion criteria: Able to speak English or French well enough to be able to complete
study questionnaires, aged 60 or over, reside in an area easily accessible for the depression
care worker, with a maximum travel time of 45 minutes in each direction, see the
participating family physician as their principal primary care physician
Exclusion criteria: In active treatment with a Psychiatrist or Psychologist, bipolar, psy-
chosis, hearing impairment, and ability to provide consent (no or onlyminimal cognitive
impairment)




Sample size (randomised): Total participants 68, intervention 36, control 32
Interventions Intervention: Depression Care Practitioner
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Family physician (PCP), social worker/
psychologist (CM), psychiatrist (MH specialist)
2) a structured management plan: Patients were provided with an educational brochure
and a video prepared for the IMPACT study. CMs assessed and worked with each patient
and PCP to develop a treatment plan that could include pharmacotherapy using an
evidence-based medication algorithm and 4 sessions of problem solving therapy (PST).
During follow-up CMs monitored the patient’s progress
3) scheduled patient follow-ups: Assessment plus 4 weekly sessions (telephone or face-
to-face)
4) enhanced inter-professional communication: CMs sent the PCP a copy of the as-
sessment and all details of follow-up sessions. CMs had weekly supervision with MH
specialist. The MH specialist reviewed all medication recommendations proposed by
PCP, was available for rapid verbal consultations with physicians and CMs, and offered
an immediate consultation when needed
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Control: Treatment as usual enhanced as PCPs were informed of patients diagnosis
Outcomes Depression (HSCL): 2 months
Medication use: 2 months
Satisfaction: 2 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Physicians were randomised based on their
preference and size and type of practice, in
the patient randomised arm a prepared list
of random numbers in blocks of 4 were
used
Allocation concealment (selection bias) Unclear risk Standard block size. Allocation of patients
conducted by study coordinator
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL) was:
overall 2/34 (6%), 0/19 (0%) intervention
and 2/15 (13%) control. Reasons for loss
to follow-up provided and only observed
in control group. Intention-to-treat analy-
sis not reported, no description of methods
to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: International Classification of Diseases (ICD-10) diagnostic criteria for a de-
pressive illness, suffering from amoderate to severe episode (using theMini-International
Neuropsychiatric Interview), and scoring at least 14 on the Hamilton Depression Rating
Scale (HDRS17), indicating that they were not in remission
Inclusion criteria: Aged 18-65 years, currently prescribed an antidepressant and had been
on this for at least 8 weeks
Exclusion criteria: Secondary care mental health involvement, a recorded diagnosis of
personality disorder, an organic brain disorder, alcohol or drug dependency, pregnancy,
or learning disability




Sample size (randomised): Total participants 62, intervention 30, control 32
Interventions Intervention: Case management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General Practitioner (PCP), graduate
mental health worker (CM), psychiatrist (MH specialist)
2) a structured management plan: Patients were prescribed a recommended AD which
was monitored by the CM who recommended an
increase in dosage to the PCP, where appropriate and minimal supportive counselling
was provided throughout
3) scheduled patient follow-ups: 6 contacts in 16 weeks (face-to-face at weeks 1, 4 and
16 and telephone at weeks 2, 6 and 10)
4) enhanced inter-professional communication: CM recommended medication dose
changes at weeks 4 and 10 where appropriate. CMs received weekly supervision from
MH specialist, who was also available for telephone consultation when needed
Control: Treatment as usual enhanced as all patients received a prescription for an al-
ternative AD within a week of their baseline assessment and PCPs were instructed to
prescribe an AD of their choice, in line with NICE guidelines
Outcomes Depression (BDI): 3, 6 months
Medication use: 6 months
Satisfaction: 6 months
Notes AD: antidepressant; BDI: Beck Depression Inventory; CM: case manager; MH: mental
health; NICE: National Institute for Clinical Excellence; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
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Allocation concealment (selection bias) Low risk Central allocation by independent person
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDI) was: over-
all 26/62 (42%), 11/30 (37%) interven-
tion and 15/32 (47%) control. Reasons
for loss to follow-up not sufficiently pro-
vided. Intention-to-treat analysis reported,
with last-observation-carried-forward used
to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Oslin 2003
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Signs and symptoms of a depressive disorder (major depression, dysthymia,
or persistent minor depression). Major depression and dysthymia were determined using
Diagnostic Statistical Manual (DSM-IV) diagnostic criteria with inclusive strategies for
the evaluation of symptoms in patients with medical illness using the MINI psychiatric
interview. Persistent minor depression is defined as having DSM provisional criteria for
minor depression for a minimum of 4 weeks. The baseline assessment instruments
completed included theMini-InternationalNeuropsychiatric Interview (MINI)modules
for depression and anxiety disorders and a scripted version of the Hamilton Rating scale
for Depression (HDRS-24)
Inclusion criteria: 18 years or older, male or female, meet criteria for at-risk drinking as
defined by drinking more than 21 standard drinks per week (14 for women or those older
than age 65), or binge drinking (> 3 binges in 3 months), or positive CAGE responses
combined with any drinking
Exclusion criteria: Active suicidal ideation, regular use of illicit substances, current hallu-
cinations and delusions or a history of a primary psychotic disorder, a history of mania or
hypomania, and having a high potential for alcohol withdrawal symptoms as indicated
by a score more than 14 on the Alcohol Dependence Scale (ADS)
Age: Mean 61.6 years
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Sample size (randomised): Total clusters 37, intervention not stated, control not stated;
Total participants 97, intervention 46, control 51
Interventions Intervention: Telephone disease management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary physician (PCP), nurse (CM)
, psychiatrist (MH specialist)
2) a structured management plan: CMs developed a treatment plan, monitored out-
comes and adverse effects, assessed and encouraged adherence and offered support and
education. Contacts were manualised for both depression and at-risk drinking. Where
indicated patients were prescribed an AD following AHRQ treatment guidelines. Non-
response at 6 and 12 weeks resulted in re-evaluation of the treatment plan, to intensify or
enhance treatment. For those with at-risk drinking CMs monitored outcomes and used
motivational skills to review individual goals and the risks and benefits of drinking using
a workbook that was mailed to the patient after each visit. Non-response at 4 months
resulted in a recommendation for referral to the Addiction Recovery Unit being made
to the patient and PCP
3) scheduled patient follow-ups: Assessment followed by 7 telephone calls in 24 weeks
(1, 3, 6, 9, 12, 18 and 24 weeks)
4) enhanced inter-professional communication: CMs acted as physician extender giving
behavioural health, medication and referral recommendations to the PCP. CM had
weekly supervision with MH specialist who was also available for consultation
Control: Treatment as usual enhanced as PCPs were educated about existing treatment
guidelines, patients attending clinics were screened and PCPs were provided with written
diagnostic information for patients and encouraged to refer patients to the behavioural
health clinic
Outcomes Depression (Response to treatment - depression or alcohol): 4 months
Notes AD: antidepressant; CM: casemanager;MH:mental health; PCP: primary care provider;
AHRQ: Agency for Healthcare Research and Quality
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Response to
treatment - depression or alcohol) was:
overall 23/97(24%), 11/46(24%) inter-
vention and 12/51(24%) control. Reasons
140Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Oslin 2003 (Continued)
for loss to follow-up not provided across
groups. Intention-to-treat analysis not re-
ported, unclear methods to manage miss-
ing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Patel 2010
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Common mental disorder assessed using a score of over 5 on the General
Health Questionnaire (GHQ)
Inclusion criteria: Age >17 years, not requiring urgent medical attention, not already
screened in the previous 2 weeks; and not already receiving the intervention. Those
who fulfil the following criteria also invited to participate in the outcome evaluation of
the trial: resident in Goa for the subsequent 12 months; speak one of the three primary
study languages (Konkani, Marathi, English)
Exclusion criteria: Do not suffer from a serious impairment (hearing, speech, cognition)
which interferes with participation in an interview




Sample size (randomised): Total clusters 24, intervention 12, control 12; Total partici-
pants 2796, intervention 1360, control 1436
Interventions Intervention: Collaborative stepped care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Physician/General Practitioners (PCP)
, lay health counsellor (CM), psychiatrist (MH specialist)
2) a structured management plan: Step 1: Psychoeducation including strategies to alle-
viate symptoms, e.g. breathing exercises for anxiety and scheduling activities for depres-
sion. Step 2: Management of moderate or severe cases included ADs or interpersonal
psychotherapy (IPT) and adherence was encouraged and information provided on social/
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welfare organisations when needed. Step 3: Non-response patients offered AD and IPT
and adherence management. Step 4: Continue existing treatments and refer to clinical
specialist
3) scheduled patient follow-ups: IPT: minimum of 6 sessions, with an optimum of 8
and maximum of 12
4) enhanced inter-professional communication: CM collaborated closely with PCP and
MH specialist, PCP could request a patient consultation with the MH specialist if nec-
essary. MH specialists visited the practice once a month and were available for telephone
consultation
Control: Treatment as usual enhanced as PCP received screening results and were given
the treatment manual that provided information about commonly available drugs and
their side-effects and costs
Outcomes Depression (ICD-10 recovery): 2, 6, 12 months
Notes AD: antidepressant; CM: case manager; IPT: interpersonal psychotherapy treatment;
MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated cluster randomisation
Allocation concealment (selection bias) Unclear risk Clinics were centrally allocated by an indi-
vidual not involved in recruitment, those
involved in patient recruitment may have
been aware of clinic allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (ICD10 recov-
ery) was: overall 281/2242 (13%), 154/
1098 (14%) intervention and 127/1144
(11%) control. Reasons for loss to follow-
up provided, with similar reasons across
groups. Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Piette 2011
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression assessed by PHQ-9 score of greater than 11 and BDI score of over
14
Inclusion criteria: At least 21 years old, diagnosis of type 2 diabetes and using antihy-
perglycaemic medication
Exclusion criteria: Bipolar disorder or schizophrenia, or in active treatment for another
serious illness such as severe heart failure, severe chronic obstructive pulmonary disease,
or end-stage renal disease. Patients using antidepressant medication at the time of the
screening were excluded if they reported a change in the prior 30 days in either their
antidepressant medication or the physician prescribing their antidepressants, unable to
walk either 1 block or 10 minutes without rest, scored < 21 on the Short Orientation
Memory Concentration Test, or they reported drug or alcohol problems during the prior
3 months as measured by a modified version of the CAGE questionnaire




Sample size (randomised): Total participants 339, intervention 172, control 167
Interventions Intervention: Telephone CBT
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), MH/
primary care nurses (CM), CBT therapist (MH specialist)
2) a structured management plan: Telephone CBT focused on patients’ depressive symp-
toms, introduced a walking programme, and emphasised the links between depression,
physical activity, and diabetes outcomes. CMs and patients used a manual to guide ses-
sions and monitored each week’s CBT goals. CMs monitored patients’ depressive symp-
toms and their activity levels. Patient manuals were used to record homework exercises
and monitor progress. PCPs were informed of any: suicidal ideation, discontinuation of
ADs, persistent elevated depressive symptoms, need for a prescription refill. Additional
contacts to discuss patients other health problems were at the CMs discretion
3) scheduled patient follow-ups: Acute =12weekly telephoneCBTsessions,maintenance
= 9 monthly booster sessions
4) enhanced inter-professional communication: PCPs received written diagnosis detail
after assessment and every 3months thereafter. PCPs were alerted by fax and telephone in
the event of any: suicidal ideation, discontinuation of ADs, persistent elevated depressive
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symptoms, or need for a prescription refill. CMs received weekly group supervision from
the MH specialist
Control: Treatment as usual enhanced as patients received a self-help book on CBT
for depression, educational materials about depression and walking and diabetes, and a
list of local resources for depression. With permission PCPs were notified about their
depression scores
Outcomes Depression (BDI): 12 months
Medication use: 12 months
Quality of Life (mental and physical health): 12 months
Notes AD: antidepressant; BDI: Beck Depression Inventory; CM: case manager; MH: mental
health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table
Allocation concealment (selection bias) Low risk Sealed envelopes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDImean) was:
overall 48/339 (14%), 27/172 (16%) in-
tervention and 21/167 (13%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
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Methods Study design: Randomised controlled trial
Participants Setting: Specialist
Diagnosis: PHQ-9 depression score of 10 or higher
Inclusion criteria: Current treatment in the Veteran Affairs HIV clinic
Exclusion criteria: No access to a telephone, current acute suicidal ideation, significant
cognitive impairment and history of bipolar disorder or schizophrenia
Age: Mean 49.8 years
Gender: 3% female
Ethnicity: 63% African American
Country: United States
Sample size (randomised): Total participants 276 (249), intervention 138 (123), control
138 (126)
Interventions Intervention: Stepped care (HITIDES)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: HIV or mental health clinician (PCP),
nurse (CM), pharmacist/psychiatrist (MH specialist)
2) a structuredmanagement plan: CMs, usingwritten scripts, delivered education and ac-
tivation, assessment of treatment barriers and solutions, depression and substance abuse
monitoring, and instruction in self-management. The 5-step model included the fol-
lowing plus CMmonitoring: (1) watchful waiting, (2) counselling or guideline pharma-
cotherapy, (3) review by pharmacist, (4) combination pharmacotherapy and counselling,
and (5) referral to specialty mental health
3) scheduled patient follow-ups: depended on response. Acute = every 2 weeks (until
50% reduction in depression score), watchful waiting or continuation = every 4 weeks
(for 2months after maintaining remission or 6 months after maintaining a 50% decrease
in depression score)
4) enhanced inter-professional communication: CMs communicated with PCPs via elec-
tronic medical record progress notes. CMs communicated with MH specialist once a
week and as needed by telephone or in-person and made treatment recommendations
to PCPs
Control: Treatment as usual enhanced as all HIV health care providers received 1 hour of
HIV and depression training and were informed of depression scores. Specialty mental
health referral procedures were reviewed
Outcomes Depression (HSCL-20): 6, 12 months
Medication use: 6, 12 months
Quality of Life (mental and physical health): 6, 12 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
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Allocation concealment (selection bias) Unclear risk Envelopes labelled by patient number
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 re-
sponse 50% decrease) was: overall 50/276
(18%), 29/138 (21%) intervention and 21/
138 (15%) control. Reasons for loss to
follow-up provided, with similar reasons
across groups.Used intention-to-treat anal-
ysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Richards 2008a
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosed as depressed by a General Practitioner, confirmed by a score of ≥
5 on the depression section of the Standard Clinical Interview for DSM-IV (SCID)
Inclusion criteria: Patients aged over 18 with a newly identified episode of major depres-
sion, defined as a current episode of GP-initiated treatment of not more than 1 months
duration
Exclusion criteria: Postnatal, bereavement or physical causes for depression, active suicidal
plans and primary drug or alcohol dependence




Sample size (randomised): Total clusters 24, intervention 12, control 12; Total partici-
pants 76, intervention 41, control 35
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General practitioner (PCP), primary
care MH workers (CM), psychiatrist/psychological therapist (MH specialist)
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2) a structured management plan: Structured management plan of medication support
and behavioural activation
3) scheduled patient follow-ups: 10 in 3 months (initial face-to-face then weekly for 5
weeks, then fortnightly predominantly telephone calls)
4) enhanced inter-professional communication: Three levels of communication: Level
1: treatment plan entered into medical record and brief record after each contact where
patient was progressing/engaging satisfactorily, Level 2: CMs informed PCPs of changes
to treatment planby specific note, Level 3:CMs communicated in-personor by telephone
with PCP for urgent issues. CMs had weekly telephone supervision with MH specialists
Control: Treatment as usual
Outcomes Depression (PHQ-9): 3 months
Quality of Life (mental and physical health): 3 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; MH:
mental health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Clusters (PCP practice) were centrally al-
located by independent service. PCPs were
not informed of their allocated group
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 14/76 (18%), 6/41 (15%) interven-
tion and 8/35 (23%) control. Reasons for
loss to follow-up provided, with similar rea-
sons across groups. Used intention-to-treat
analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Low risk The study appears free of other sources of
bias
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Richards 2008b
Methods Study design: Randomised control trial (within cluster randomised trial)
Participants Setting: Primary care
Diagnosis: Diagnosed as depressed by a General Practitioner, confirmed by a score of ≥
5 on the depression section of the Standard Clinical Interview for DSM-IV (SCID)
Inclusion criteria: Patients aged over 18 with a newly identified episode of major depres-
sion, defined as a current episode of GP-initiated treatment of not more than 1 months
duration
Exclusion criteria: Postnatal, bereavement or physical causes for depression, active suicidal
plans and primary drug or alcohol dependence




Sample size (randomised): Total participants 79, intervention 41, control 38
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General practitioner (PCP), primary
care MH workers (CM), psychiatrist/psychological therapist (MH specialist)
2) a structured management plan: Structured management plan of medication support
and behavioural activation
3) scheduled patient follow-ups: 10 in 3 months (initial face-to-face then weekly for 5
weeks, then fortnightly predominantly telephone calls)
4) enhanced inter-professional communication: Three levels of communication: Level
1: treatment plan entered into medical record and brief record after each contact where
patient was progressing/engaging satisfactorily, Level 2: CMs informed PCPs of changes
to treatment planby specific note, Level 3:CMs communicated in-personor by telephone
with PCP for urgent issues. CMs had weekly telephone supervision with MH specialists
Control: Treatment as usual
Outcomes Depression (PHQ-9): 3 months
Quality of Life (mental and physical health): 3 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; MH:
mental health; PCP: primary care provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Within the treatment cluster group pa-
tients were centrally allocated by an inde-
pendent service
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 10/79 (13%), 6/41 (15%) interven-
tion and 4/38 (11%) control. Reasons for
loss to follow-up provided, with similar rea-
sons across groups. Used intention-to-treat
analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Low risk The study appears free of other sources of
bias
Implementation Integrity Unclear risk Implementation integrity not assessed
prior to outcome assessment, subsequent
analyses demonstrate good integrity/adher-
ence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Richards 2012
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression assessed using the Clinical Interview Schedule (CIS-R)
Inclusion criteria: 18 years and above and who are not currently receiving treatment for
depression from specialist mental health services. Also included patients suffering from
peri- or postnatal depression, with either co-morbid physical illness or co-morbid non-
psychotic functional disorders, such as anxiety. In line with the pragmatic nature of this
trial, we will reflect usual GP care and participants will be eligible to participate whether
they are in receipt of antidepressant medication or not
Exclusion Criteria: Patients whose risk of suicide is sufficiently acute to demand imme-
diate management by a specialist mental health crisis team. Patients with psychosis; both
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type I and type II bi-polar disorder, patients where the low mood is better explained by
the death of someone close to them and patients whose primary presenting problem is
alcohol or drug abuse. Patients who are currently receiving specialist treatment for their
depression will also be excluded




Sample size (randomised): Total clusters 51, intervention 24, control 27; Total partici-
pants 581, intervention 276, control 305
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General practitioner (PCP), primary
care MH workers (CM), psychiatrist/psychological therapist (MH specialist)
2) a structured management plan: Involved a structured management plan including ed-
ucation about depression, medication management, behavioural activation and relapse
prevention. CMs reinforce the information given by PCP and help problem solve any
difficulties with medication concordance. Behavioural activation focused on reducing
avoidance and increasing activity. Relapse prevention involved the development of indi-
vidualised recovery plans to identify symptoms and encourage reinstating pharmacolog-
ical and psychological depression management strategies
3) scheduled patient follow-ups: 6-12 telephone and face-to-face contacts in 14 weeks
(initial face-to-face then weekly for 5 weeks, then fortnightly predominantly telephone
calls)
4) enhanced inter-professional communication: CMs helped PCPs and patients prob-
lem solve any difficulties with medication. CMs receive weekly supervision from MH
specialists
Control: Treatment as usual
Outcomes Depression (PHQ-9): 4, 12 months
Quality of Life (mental and physical health): 4, 12 months
Satisfaction: 4, 12 months
Notes CM: case manager; GP: general practitioner; MH: mental health; PCP: primary care
provider; PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters randomised using a sequence gen-
erated by the trial statistician
Allocation concealment (selection bias) Low risk Allocation was conducted by central inde-
pendent service and research workers were
blind to cluster allocation and hence to pa-
tient allocation
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ-9) was:
overall 76/581 (13%), 46/276 (17%) in-
tervention and 30/305 (10%) control. Rea-
sons for loss to follow-up provided, with
similar reasons across groups. Intention to
treat not reported
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Low risk The study appears free of other sources of
bias
Implementation Integrity Unclear risk Implementation integrity not assessed
prior to outcome assessment, subsequent
analyses demonstrate good integrity/adher-
ence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Rojas 2007
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Mothers meeting criteria for major depression according to the Diagnostic
and Statistical Manual of mental disorders (DSM-IV) were eligible. Any depression de-
tected within 12 months after delivery assessed with the Edinburgh postnatal depression
scale (EPDS) scores of over 10 at 2 time points. Used the clinician-administered Mini
International Neuropsychiatry Interview (MINI) to ascertain clinical diagnoses
Inclusion criteria: Mothers at any stage during their first postnatal year from three clinics
in deprived urban areas. Includedmothers with an unrecognised and untreated postnatal
depression whose symptoms persisted at least for 2 weeks
Exclusion criteria: Women who had received any form of treatment for depression dur-
ing their current postnatal period, those who were pregnant, or those with psychotic
symptoms, serious suicidal risk, history of mania, or alcohol or drug abuse




Sample size (randomised): Total participants 230, intervention 114, control 116
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Interventions Intervention: Multi-component
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), non-
professional (CM), psychiatrist (MH specialist)
2) a structured management plan: The intervention included nurse psychoeducational
groups (problem solving and behavioural activation), CM structured pharmacotherapy
if needed, systematic monitoring of clinical progress and treatment compliance, further
training to doctors, and specialist supervision on a regular basis. CMs monitored atten-
dance and provided support and advice about AD use following a structured format
3) scheduled patient follow-ups: psychoeducation = 8weekly,medication = 8 in 6months
(weeks 2 and 4 then monthly)
4) enhanced inter-professional communication: Nurses had weekly supervision. PCPs
made pharmacotherapy decisions following training and had weekly supervision with
MH specialist
Control: Treatment as usual enhanced as PCPs were informed of the baseline assessment
Outcomes Depression (EPDS): 3, 6 months
Medication use: 3, 6 months
Quality of Life (mental and physical health): 3, 6 months
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Numbered sealed envelopes opened by an
individual not involved in patient recruit-
ment and registered centrally
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (EPDS) was:
overall 22/230 (10%), 8/114 (7%) inter-
vention and 14/116 (12%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Rollman 2005
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Anxiety symptoms assessed using the brief self-administered patient question-
naire portion of the PRIME-MD, Diagnostic and Statistical Manual (DSM-IV) criteria
for panic or generalised anxiety disorder assessed by PRIME-MD anxiety module. At
least moderate levels of anxiety severity as defined by a score of 14 or higher on the 14-
item structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)
Inclusion criteria: Aged 18 to 64, not receiving treatment from a mental health profes-
sional, no history of bipolar disorder; and no plans to leave the study practice within the
following year
Exclusion criteria: Dementia, psychotic illness, unstable medical condition, 2 or fewer
positive responses on the CAGE alcohol screening questionnaire, and language or other
communication barriers




Sample size (randomised): Total participants 191, intervention 116, control 75
Interventions Intervention: Telephone care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), non-
behavioural health specialist (CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: CM conducted telephone assessment, provided basic
psychoeducation about anxiety, and assessed treatment preferences. Patients chose any
combination of the following: (1) a self-management workbook with CM follow-up;
(2) a guideline-based trial of anxiolytic pharmacotherapy; or (3) referral to a community
mental health specialist. CMs telephoned patients to promote adherence and assess
clinical response
3) scheduled patient follow-ups: Acute = 8 telephone (at 1 week then every two weeks
for first 2-4 months), maintenance = 8 telephone calls (every 1-3 months for up to 12
months)
4) enhanced inter-professional communication: CMs informed PCPs of patient progress
and in consultation with MH specialists recommended specific medication and dose or
referral to PCP. CM received weekly supervision from MH specialists
Control: Treatment as usual enhanced as PCPs were informed of diagnosis by interactive
e-mail alert and an electronic letter. The messages encouraged the PCP to follow up
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patients to determine whether treatment was required. Patients were also informed of
diagnosis and provided with a disorder-specific brochure
Outcomes Anxiety (SIGH-A): 2, 4, 8, 12 months
Medication use: 12 months
Quality of Life (mental and physical health): 4, 12 months
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 25 or 30
Allocation concealment (selection bias) Low risk Opaque sequentially numbered sealed en-
velopes opened by an individual not in-
volved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on
primary anxiety outcome (SIGH-A) was:
overall 63/191 (33%), 38/116 (33%) in-
tervention and 25/75 (33%) control. Rea-
sons for loss to follow-up not provided
across groups. Intention-to-treat analysis
reported, used random regression models
to manage missing data
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
154Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rollman 2009
Methods Study design: Randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: PHQ-9 scores of 10 or greater confirmed the prior PHQ-2 screen results and
indicated at least a moderate level of depressive symptoms
Inclusion criteria: Post-CABG (Coronary Artery Bypass Graft) patients, mental compe-
tence to provide consent, have no current alcohol dependence or other substance abuse
disorder; not be in treatment with a mental health specialist, express actives suicidality,
or have a history of psychotic illness or bipolar disorder, be discharged home or to short-
term rehabilitation; and to speak English, have no communication barriers, and have
telephone access
Exclusion criteria: Not stated




Sample size (randomised): Total participants 302, intervention 150, control 152
Interventions Intervention: Telephone collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: CM conducted telephone assessment, provided basic
education about depression (its impact on cardiac disease, and various self-management
strategies) and assessed treatment preferences. Patients were supplied with written edu-
cational materials and offered a variety of treatment options: (1) initiation or adjustment
of AD; (2) referral to community mental health service; (3) a combination of the above;
or (4) watchful-waiting. CMs advised all patients to: (1) get sufficient rest; (2) engage in
appropriate exercise and other pleasurable activities; and (3) avoid tobacco, alcohol, and
unhealthy foods. CMs sent out a workbook that integrated both a psychotherapeutic and
pharmacologic approach to managing depression and worked with patients and PCPs
to promote adherence. For non-adherence or non-response after 6 weeks, combined
treatment was recommended. For continued non-response CMs recommended referral
to MH services and CMs monitored attendance and continued to telephone the patient
monthly to: (1) monitor mood; (2) relay clinical information to PCP andMH specialist;
and (3) promote adherence with follow-up appointments
3) scheduled patient follow-ups: Acute=4-8 telephone calls (fortnightly for 2-4 months)
, maintenance = 4-8 (every 1 to 2 months until end of 8 month)
4) enhanced inter-professional communication: CM reported back to the PCP clinical
progress, reasons for non-adherence and treatment recommendations via fax, telephone
or mail after each case review with MH specialist. CMs discussed AD prescriptions with
PCP. An end-of-intervention letter was sent to PCP describing current level of depressive
symptoms, care preferences, and final treatment recommendations. CMs had weekly
case review with MH specialist
Control: Treatment as usual enhanced as patients and PCPs were informed of diagnosis
Outcomes Depression (HRSD): 2, 4, 8 months
Medication use: 2, 4, 8 months
Quality of Life (mental and physical health): 2, 4, 8 months
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Notes CM: case manager; HRSD: Hamilton Rating Scale for Depression; MH: mental health;
PCP: primary care provider; PHQ-9: Patient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 4 using a
1:1 allocation ratio
Allocation concealment (selection bias) Low risk Prepared by an individual not involved in
patient recruitment and entered into com-
puter assisted programme and concealed
until after the patient was recruited
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (≥ 50% decline
in HRSD) was: overall 50/302 (17%), 24/
150 (16%) intervention and 26/152 (17%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons across groups.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Ross 2008
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: PHQ scores ranging from 0-16 without a diagnosis of major depression or
other severe axis 1 disorders. Minor depression (those with 2, 3, or 4 Diagnostic and
Statistical Manual depression criteria) and those with distress or depressive symptoms
not meeting minor depression criteria. Measured with the PHQ-9 for depression; the
MINI International Neuropsychiatric Interview modules for mania, psychosis, panic
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disorder, generalised anxiety disorder (GAD), PTSD, and alcohol abuse/dependence
Inclusion criteria: Clinical concern generated by the PCP and on the results of the
Behavioural Health Laboratory assessment. Subjects were eligible for inclusion if they
were referred by their PCP for a behavioural health concern and did not meet for any
exclusion criteria
Exclusion criteria: Current PTSD, panic disorder, alcohol dependence, suicidal ideation,
illicit drug use (past year), or if they had a history of or current bipolar or psychotic
disorder. Subjects were also excluded if they were being followed by a MH clinician
or if they were currently taking any antidepressants benzodiazepines, antipsychotics,
addiction medications, or mood stabilisers




Sample size (randomised): Total clusters unclear (54 practitioners but randomised by
clinic); Total participants 223, intervention 130, control 93
Interventions Intervention: Telephone close monitoring programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinician (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: Telephone contacts were manualised and included
recommending the PCP initiated ADs and CMs frequent monitoring of adverse effects,
adherence and depressive symptoms. CMs also provided support and education about
depressive disorders and for any other MH problems the CM formulated an appropriate
treatment plan which could include referral to specialty care or care management for
anxiety
3) scheduled patient follow-ups: 5 calls in 12 weeks (at weeks 2, 4, 6, 9, 12)
4) enhanced inter-professional communication: CMs recommended PCPs initiate ADs
and received supervision from MH specialist
Control: Treatment as usual enhanced as all subjects were assessed by the Behavioural
Health Laboratory and PCPs were given a report with suggestions for ongoing mon-
itoring of depressive symptoms and had the option to request referral of patients to a
mental health clinic. Patients received a letter following assessment that included self-
help advice for any significant depression symptoms and encouragement to discuss his
or her symptoms with PCP
Outcomes Depression (PHQ-9): 6 months
Medication use: 6 months
Quality of Life (mental and physical health): 6 months
Notes CM: case manager; GAD: generalised anxiety disorder; MH: mental health; PCP: pri-
mary care provider; PHQ-9: Patient Health Questionnaire: PTSD: post-traumatic stress
disorder
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depressionoutcome (PHQtotal)was:
overall 59/223 (26%), 36/130 (28%) inter-
vention and 23/93 (25%) control. Reasons
for loss to follow-up provided, with simi-
lar reasons for missing data across groups.
Intention-to-treat analysis reported, no de-
scription of methods to manage missing
data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Rost 2001a
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Patients screened first-stage positive for depression if they reported on Com-
posite InternationalDiagnostic Interview (CIDI) questions they had experienced 2weeks
ormore during the last year when they felt sad, empty, depressed, or lost interest in things
they normally enjoyed and reported 1 week or more of these symptoms during the past
month. Second stage screening: reporting 5 or more of 9 criteria for major depression in
the past 2 weeks on the Inventory to Diagnose Depression. Meeting DSM-III-R criteria
for major depression in the past two weeks. Depression severity measured by a modified
23 item Centre for Epidemiologic Studies depression scale (mCES-D)
Inclusion criteria: Age 18 or over, not pregnant, breastfeeding or less than 3 months
post-partum, sufficient literacy in English and cognitive function to complete surveys
requiring 6-month recall, no acute life threatening physical conditions; and access to a
telephone
Exclusion criteria: Depressive symptoms had begun after the loss of a loved one within
the last 2 months to exclude patients with bereavement. Patients were also excluded if
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they noted that they did not intend to receive ongoing care in the clinic during the
next year to target the intervention to patients who could participate in it over time.
Screening positive by self-report for lifetime mania, use of lithium, or current alcohol
dependence
Age: 42.6 (SD 13.1) years
Gender: 84% female
Ethnicity: 16% ethnic minority
Country: United States
Sample size (randomised): Total clusters 12, intervention 6 (4 urban and 2 rural), control
6 (4 urban and 2 rural); Total participants (Recently treated) 479, intervention 239,
control 240
Interventions Intervention:
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse
(CM), social worker/psychiatrist (MH specialist)
2) a structuredmanagement plan: CMs assessed patients, evaluated treatment preferences
(pharmacotherapy, psychotherapy, watchful waiting), and addressed barriers to care. A
checklist was then provided to the PCP who then saw the patient. CMs provided written
information on preferred treatment, the homework assignment they had agreed upon,
and the time/place of next CM contact. CMs used a similar protocol to guide subsequent
sessions. With PCP supervision, CMs provided medication samples to patients who
could not afford them
3) scheduled patient follow-ups: Face-to-face assessment followed by 5 weekly telephone
or face-to-face contacts with the option of extending the protocol for 2 additional weeks
4) enhanced inter-professional communication: CMs provided information from as-
sessment and follow-up to PCPs. PCPs were offered MH specialist consultation. CMs
received supervision from MH specialist (social worker)
Control: Treatment as usual
Outcomes Depression (mCESD): 6 months
Medication use: 6 months
Satisfaction: 6 months
Notes CIDI: Composite International Diagnostic Interview; CM: case manager; MH: mental
health; PCP: primary care provider; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters were randomised in blocks of 2,
with 1:1 allocation ratio, using coin-toss
Allocation concealment (selection bias) Unclear risk Clusters were identified by a number and
paired by the Principle Investigator based
on proportions
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (mCESD) was:
overall 26/268 (10%), 12/124 (10%) in-
tervention and 14/144 (10%) control. Rea-
sons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Rost 2001b
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Patients screened first-stage positive for depression if they reported on Com-
posite InternationalDiagnostic Interview (CIDI) questions they had experienced 2weeks
ormore during the last year when they felt sad, empty, depressed, or lost interest in things
they normally enjoyed and reported 1 week or more of these symptoms during the past
month. Second stage screening: reporting 5 or more of 9 criteria for major depression in
the past 2 weeks on the Inventory to Diagnose Depression. Meeting DSM-III-R criteria
for major depression in the past two weeks. Depression severity measured by a modified
23 item Centre for Epidemiologic Studies depression scale (mCES-D)
Inclusion criteria: Age 18 or over, not pregnant, breastfeeding or less than 3 months
post-partum, sufficient literacy in English and cognitive function to complete surveys
requiring 6-month recall, no acute life threatening physical conditions; and access to a
telephone
Exclusion criteria: Depressive symptoms had begun after the loss of a loved one within
the last 2 months to exclude patients with bereavement. Patients were also excluded if
they noted that they did not intend to receive ongoing care in the clinic during the
next year to target the intervention to patients who could participate in it over time.
Screening positive by self-report for lifetime mania, use of lithium, or current alcohol
dependence
Age: 42.6 (SD 13.1) years
Gender: 84% female
Ethnicity: 16% ethnic minority
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Country: United States
Sample size (randomised): Total clusters 12, intervention 6 (4 urban and 2 rural), control
6 (4 urban and 2 rural); Total participants (patients starting new treatment episode) 479,
intervention 239, control 240
Interventions Intervention:
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse
(CM), social worker/psychiatrist (MH specialist)
2) a structuredmanagement plan: CMs assessed patients, evaluated treatment preferences
(pharmacotherapy, psychotherapy, watchful waiting), and addressed barriers to care. A
checklist was then provided to the PCP who then saw the patient. CMs provided written
information on preferred treatment, the homework assignment they had agreed upon,
and the time/place of next CM contact. CMs used a similar protocol to guide subsequent
sessions. With PCP supervision, CMs provided medication samples to patients who
could not afford them
3) scheduled patient follow-ups: Face-to-face assessment followed by 5 weekly telephone
or face-to-face contacts with the option of extending the protocol for 2 additional weeks
4) enhanced inter-professional communication: CMs provided information from as-
sessment and follow-p to PCPs. PCPs were offered MH specialist consultation. CMs
received supervision from MH specialist (social worker)
Control: Treatment as usual
Outcomes Depression (mCESD): 6 months
Medication use: 6 months
Satisfaction: 6 months
Notes CIDI: Composite International Diagnostic Interview; CM: case manager; MH: mental
health; PCP: primary care provider; SD: standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters were randomised in blocks of 2,
with 1:1 allocation ratio, using coin-toss
Allocation concealment (selection bias) Unclear risk Clusters were identified by a number and
paired by the Principle Investigator based
on proportions
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (mCESD) was:
overall 22/211(10%), 18/115 (16%) inter-
vention and4/96 (4%) control. Reasons for
loss to follow-up not provided. Intention-
to-treat analysis reported, used random re-
gression analysis to manage missing data
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Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Roy-Byrne 2001
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Meeting Diagnostic and Statistical Manual (DSM-IV) criteria for Panic Dis-
order, with at least 1 panic attack in the past month. Assessment included portions of
the Composite International Diagnostic Interview (CIDI), modified for DSM-IV, the
PDSS, the Anxiety Sensitivity Inventory (ASI), the Fear Questionnaire; and the Centre
for Epidemiological Studies Depression Scale (CES-D)
Inclusion criteria: Between age 18 and 65, English-speaking and have a telephone to
participate in follow-up assessments
Exclusion criteria: Patients currently receiving psychiatric treatment and patients cur-
rently receiving or applying for disability benefits. Potentially life threatening co mor-
bidities (e.g., active suicidal ideation or terminal medical illness) or those that would
limit patient participation or adherence (psychosis, current substance abuse, dementia,
and pregnancy)




Sample size (randomised): Total participants 115, intervention 57, control 58
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), psychi-
atrist (CM/MH specialist)
2) a structured management plan: CMs assessed and prescribed SSRI (typically paroxe-
tine). Paroxetine was started at 10 mg daily, increased to 20 mg as tolerated in the second
week and, if no response was reported by the fourth week and the patient was able to
tolerate it, 40 mg. Patients also received an educational videotape about panic disorder
and an educational pamphlet about ADs and adverse effects. These points were sys-
tematically re-emphasised during follow-ups at which CMs addressed negative attitudes
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toward medication, ADs or diagnosis. Patients were encouraged to expose themselves,
as tolerated, to any feared and avoided situations
3) scheduled patient follow-ups: 2 face-to-face and 2 calls in 8 weeks then up to 5 calls
between 3 and 12 months. Selected patients also seen for up to 3 extra sessions
4) enhanced inter-professional communication: The PCP received a typed consultation
note after each CM contact
Control: Treatment as usual enhanced as PCPs were informed of diagnosis
Outcomes Anxiety (PDSS): 3, 6, 9, 12 months
Medication use: 3, 6, 9, 12 months
Satisfaction: 6, 12 months
Notes CIDI: Composite International Diagnostic Interview; CM: case manager; MH: mental
health; PCP: primary care provider; PDSS: Panic Disorder Severity Scale; SSRI: selective
serotonin reuptake inhibitor
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PDSS Panic)
was: overall 23/115 (20%), 12/57 (21%)
intervention and 11/58 (19%) control.
Reasons for loss to follow-up not provided.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
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Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Meeting Diagnostic and Statistical Manual (DSM-IV) criteria for panic dis-
order with at least 1 panic attack in the prior week. The Composite International Diag-
nostic Interview (CIDI) used to determine eligibility
Inclusion criteria: Between18 and70 years of age, English speaking, access to a telephone,
and willing to accept a combined treatment of anti-anxiety medication and CBT
Exclusion criteria: Potentially life threatening comorbidities (i.e. suicidal ideation, termi-
nal medical illness) or those expected to severely limit patient participation or adherence
(e.g., psychosis, current substance abuse, dementia, pregnancy). Patients receiving psy-
chiatric disability benefits or those already seeing a psychiatrist or cognitive-behavioural
therapist were excluded




Sample size (randomised): Total participants 232, intervention 119, control 113
Interventions Intervention: CBT
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care physician (PCP), graduates
(CM), psychiatrist (MH specialist)
2) a structured management plan: Patients received a video about panic disorder and
a workbook including education on medication, its management and synergies with
CBT. The medication algorithm involved dose titration of typically a Selective Serotonin
Reuptake Inhibitor (SSRI) for at least 6 weeks or adjunctive medications (e.g., benzo-
diazepines). CMs coordinated care and delivered CBT, which targeted panic symptoms
but also included modules to address depressive and social anxiety symptoms if required.
Follow-up calls monitored clinical status, reinforced medication use and CBT skills, and
make further medication recommendations if necessary
3) scheduled patient follow-ups: CBT = 6 sessions in 3 months (3 face-to-face and then
telephone if preferred) then 6 brief booster telephone calls at 6-12 week intervals
4) enhanced inter-professional communication: CMs relayed recommendations from
MH specialist to PCP. CMs communicated with PCPs using rapid systems of 2-way
communication (i.e. telephone, fax, and e-mail). CM received weekly supervision from
MH specialist
Control: Treatment as usual enhanced as PCPs were informed of diagnosis
Outcomes Anxiety (Composite measure of high end state functioning): 3, 6, 9, 12 months
Medication use: 3, 6, 9, 12 months
Quality of Life (mental and physical health): 3, 6, 9, 12 months
Notes CBT: cognitive behaviour therapy; CIDI: Composite International Diagnostic Inter-
view; CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
High risk Alternating assignment stratified by re-
ferred or screened
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on
primary outcome (composite measure of
high end state functioning -current MDD,
CESD, SF MCS) was: overall 56/232
(24%), 32/119 (27%) intervention and 24/
113 (21%) control. Reasons for loss to fol-
low-up provided, with similar reasons for
missing data across groups. Intention-to-
treat analysis reported, no description of
methods to manage missing data
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Roy-Byrne 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Meeting DSM-IV criteria for one or more of panic disorder, generalised
anxiety disorder, social anxiety disorder, or post-traumatic stress disorder based on the
Mini International Neuropsychiatric Interview and scoring at least 8 (moderate anxiety
symptoms on a scale ranging from0-20) on theOverall Anxiety Severity and Impairment
Scale (OASIS)
Inclusion criteria: 18-75 years
Exclusion criteria: Persons unlikely to benefit from the Coordinated Anxiety Learning
andManagement (i.e. unstable medical conditions, marked cognitive impairment, active
suicidal intent or plan, psychosis, bipolar I disorder, substance abuse of dependence
except for alcohol and marijuana abuse), receiving ongoing CBT or medication from a
psychiatrist, unable to speak English or Spanish
Age: Mean 43.5 (SD 13.4) years
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Sample size (randomised): Total participants 1004, intervention 503, control 501
Interventions Intervention: Stepped Co-ordinated Anxiety Learning and Management (CALM)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), social
workers, nurses, psychologists (CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Patient choice of CBT, medication or both during 10-
12 weeks. The computerised CBT programme included 5 generic modules (education,
self-monitoring, hierarchy development, breathing training, and relapse prevention) and
3modules (cognitive restructuring and exposure to internal and external stimuli) tailored
to each anxiety disorder and included psycho-educational materials and instructions for
skills practice and exposure. CMs entered data which then created a personalised work-
book and homework assignments. The medication algorithm emphasised selective sero-
tonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors
(SNRIs), dose optimisation, adverse effectmonitoring, followed by second and third step
combinations of 2 ADs or an AD and benzodiazepine for non-response. CMs provided
adherence monitoring, counselling to avoid alcohol and optimise sleep hygiene and be-
havioural activity. Non-responders could receive more of the same (stepping up) or the
alternative modality (stepping over) for up to 3 more steps of treatment. After treatment
completion, patients were entered into continued care and received monthly follow-up
telephone calls to reinforce CBT skills, medication adherence, or both. If symptoms re-
emerged within the first 9 months patients were referred back a step
3) scheduled patient follow-ups: computerisedCBT=6 to 8 weekly sessions in 3 months,
maintenance =monthly follow up calls
4) enhanced inter-professional communication: CMs relayed medication suggestions
from MH specialist to the PCP. CMs interacted regularly with the PCP both face-to-
face and via written communication. MH specialist provided PCPs with a medication
algorithmand as needed consultationby telephone or email. CMs hadweekly supervision
with MH specialist plus cross-site monthly conference supervision calls
Control: Treatment as usual
Outcomes Anxiety (BSI-12): 6, 12, 18 months
Medication use: 6, 12, 18 months
Quality of Life (mental and physical health): 6, 12, 18 months
Satisfaction: 6, 12, 18 months
Notes CBT: cognitive behaviour therapy; CM: case manager; DSM-IV: Diagnostic and Statis-
tical Manual fourth edition; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks
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Allocation concealment (selection bias) Low risk Block size was masked to all clinical site
study members
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary anxiety outcome (BSI-12 response)
was: overall 128/1004 (13%), 57/503
(11%) intervention and 71/501 (14%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons across groups.
Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Rubenstein 2002
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Major depression based on the Composite International Diagnostic Interview
(CIDI)
Inclusion criteria: Consecutive patients attending primary care appointments
Exclusion criteria: Not stated




Sample size (randomised): Total clusters 9, intervention 6, control 3; Total participants
567, intervention 369, control 198
Interventions Intervention: Evidence Based Quality Improvement depression care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinician (PCP), MH
nurse, psychologist, pharmacist (CM), psychiatrist (MH specialist)
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2) a structured management plan: Each area were given guidance, training and ma-
terials and then left to implement collaborative care which included: provider educa-
tion and decision support (training and feedback on performance), patient education
(classes and written materials), screening/detection (CMs screen for depression, com-
puter reminders, monitoring/enforcement), assessment (provider depression assessment
worksheet, provider assessment reminders), care management, collaboration with MH
specialists (improved referral process to MH speciality, MH specialist gives feedback to
PCP)
3) scheduled patient follow-ups: Patient education = 8 sessions
4) enhanced inter-professional communication: PCPs were sent computer reminders re
monitoring of care and received feedback from MH specialists
Control: Treatment as usual enhanced as PCPs were mailed copies of clinical practice
guidelines for depression
Outcomes Depression (Poor depression response - MDD, CESD, SF, MCS): 6, 12 months
Quality of Life (mental and physical health): 12 months
Satisfaction: 6 months
Notes CIDI: Composite International Diagnostic Interview; CM: case manager; MDD: major
depressive disorder; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Randomly assigned by an individual not
involved in patient recruitment
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (poor depres-
sion outcomes)was: overall 133/567 (23%)
, 87/369 (24%) intervention and 46/198
(23%) control. Reasons for loss to follow-
up not provided. Intention-to-treat analy-
sis not reported, no description of methods
to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Simon 2000a
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression. Based on antidepressant prescription and also used a 20 item
depression scale from the Hopkins symptom checklist
Inclusion criteria: Patients at participating clinics who had received new prescriptions
for antidepressants, with “new” defined as no antidepressant use in the previous 120 days
Exclusion criteria: Not been diagnosed with depression at any visit (nondepression indi-
cation for prescription); had been diagnosed with bipolar disorder or psychotic disorder
in the previous two years; had been diagnosed with alcohol or other substance misuse in
the previous 90 days; or had visited a psychiatrist in the previous 90 days




Sample size (randomised): Total participants 392, intervention 196, control 196
Interventions Intervention: Care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: CMs assessed current use of ADs, side effects, and
severity of depression. CMs supported PCPs by communicating urgent recommenda-
tions, assisting with arranging follow up visits, telephoning patients who had discon-
tinued treatment, and helping with referrals. Telephone contacts sometimes included
general support and encouragement but did not include any specific psychotherapeutic
content. CMs helped with medication management but were not expected to make pre-
scribing decisions but did recommend dosage changes or changes to different AD
3) scheduled patient follow-ups: 3 telephone calls at beginning, 8 and 16 weeks
4) enhanced inter-professional communication: After each telephone assessment PCPs
received a feedback report including computerised data, assessment data, and sophisti-
cated algorithm based recommendations. CMs received weekly supervision from MH
specialist
Control: Treatment as usual
Outcomes Depression (HSCL-20): 3, 6 months
Medication use: 6 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 50%
decrease) was: overall 20/392 (5%), 10/196
(5%) intervention and 10/196 (5%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Simon 2000b
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression. Based on antidepressant prescription and also used a 20 item
depression scale from the Hopkins symptom checklist
Inclusion criteria: Patients at participating clinics who had received new prescriptions
for antidepressants, with “new” defined as no antidepressant use in the previous 120 days
Exclusion criteria: Not been diagnosed with depression at any visit (nondepression indi-
cation for prescription); had been diagnosed with bipolar disorder or psychotic disorder
in the previous two years; had been diagnosed with alcohol or other substance misuse in
the previous 90 days; or had visited a psychiatrist in the previous 90 days




Sample size (randomised): Total participants 417, intervention 196, control 221
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Interventions Intervention: Care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: CMs assessed current use of ADs, side effects, and
severity of depression. CMs supported PCPs by communicating urgent recommenda-
tions, assisting with arranging follow up visits, telephoning patients who had discon-
tinued treatment, and helping with referrals. Telephone contacts sometimes included
general support and encouragement but did not include any specific psychotherapeutic
content. CMs helped with medication management but were not expected to make pre-
scribing decisions but did recommend dosage changes or changes to different AD
3) scheduled patient follow-ups: 3 telephone calls at beginning, 8 and 16 weeks
4) enhanced inter-professional communication: After each telephone assessment PCPs
received a feedback report including computerised data, assessment data, and sophisti-
cated algorithm based recommendations. CMs received weekly supervision from MH
specialist
Control: Feedback only. PCPs received a detailed report on each patient eight and 16
weeks after the initial prescription. These included computerised data (AD dosage and
repeat prescriptions, number of follow up visits, and arranged visits) and treatment
recommendations on the basis of a computerised algorithm
Outcomes Depression (HSCL-20): 3, 6 months
Medication use: 6 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 50%
decrease) was: overall 21/392 (5%), 10/196
(5%) intervention and 11/221 (5%) con-
trol. Reasons for loss to follow-up not pro-
vided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Simon 2004a
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression assessed by Hopkins Symptom Checklist Depression Scale
(HSCL) and Patient Health Questionnaire (PHQ). Those already in remission at the
baseline assessment (i.e. HSCL depression score < 0.5) were excluded
Inclusion criteria: Primary care patients beginning antidepressant treatment for depres-
sion
Exclusion criteria: Receiving psychotherapy, those already in remission when contacted,
diagnosis of bipolar or schizophrenia in the last 2 years, cognitive, language, or hearing
impairment severe enough to preclude participation




Sample size (randomised): Total participants 402, intervention 207, control 195
Interventions Intervention: Telephone care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
clinician (CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Using scripts and motivational enhancement tech-
niques each CM telephone call included a brief, structured assessment of depressive
symptoms, AD use, and adverse effects. CMs also provided crisis intervention and re-
ferral to mental health specialty care when necessary. Patients received a detailed self-
management workbook emphasising behavioural activation, identifying and challeng-
ing negative thoughts, and developing a long-term self-care plan. CMs recommended
reading the workbook but did not provide any specific counselling
3) scheduled patient follow-ups: 3 telephone contacts (weeks 4, 8 and 16) and 2 written
mailings (weeks 26 and 36)
4) enhanced inter-professional communication: CMs sent PCPs a structured report of
each contact including a summary of clinical progress and computer-generated rec-
ommendations regarding medication adjustment. If a change in treatment was recom-
mended, the CM contacted the PCP to facilitate patient-physician communication and
follow-up. CMs received weekly supervision from MH specialists
Control: Treatment as usual
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Outcomes Depression (HSCL): 6 weeks, 3, 6, 9, 12, 15, 18 months
Medication use: 6 months
Satisfaction: 3, 6 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Allocation conducted centrally by an indi-
vidual not involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 42/402 (10%), 23/
207 (11%) intervention and 19/195 (10%)
control. Reasons for loss to follow-up not
provided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Simon 2004b
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression assessed by Hopkins Symptom Checklist Depression Scale
(HSCL) and Patient Health Questionnaire (PHQ) Those already in remission at the
baseline assessment (i.e. HSCL depression score <0.5) were excluded
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Inclusion criteria: Primary care patients beginning antidepressant treatment for depres-
sion
Exclusion criteria: Receiving psychotherapy, those already in remission when contacted,
diagnosis of bipolar or schizophrenia in the last 2 years, cognitive, language, or hearing
impairment severe enough to preclude participation




Sample size (randomised): Total participants 393, intervention 198, control 195
Interventions Intervention: Telephone care management plus telephone psychotherapy
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
clinician (CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: Using scripts and motivational enhancement tech-
niques each CM telephone call included a brief, structured assessment of depressive
symptoms, AD use, and adverse effects. CMs also provided crisis intervention and re-
ferral to mental health specialty care when necessary. Patients received a detailed self-
management workbook emphasising behavioural activation, identifying and challeng-
ing negative thoughts, and developing a long-term self-care plan. CMs recommended
reading the workbook but did not provide any specific counselling. CBT sessions lasted
30 to 40 minutes and included: session 1 involved a detailed assessment and motiva-
tional enhancement exercises; sessions 2-4 focused on increasing pleasant and rewarding
activities; sessions 5-7 focused on identifying, challenging, and distancing from negative
thoughts; session 8 focused on creation of a personal self-care plan covering medication
use, self-monitoring, and self-management skills
3) scheduled patient follow-ups: 3 telephone contacts (weeks 4, 8 and 16) and 2 written
mailings (weeks 26 and 36) plus 8 session CBT with psychotherapist
4) enhanced inter-professional communication: CMs sent PCPs a structured report of
each contact including a summary of clinical progress and computer-generated rec-
ommendations regarding medication adjustment. If a change in treatment was recom-
mended, the CM contacted the PCP to facilitate patient-physician communication and
follow-up. CMs received weekly supervision from MH specialists
Control: Treatment as usual
Outcomes Depression (HSCL): 6 weeks, 3, 6, 9, 12, 15, 18 months
Medication use: 6, 12, 18 months
Satisfaction: 3, 6 months
Notes AD: antidepressant; CBT: cognitive behaviour therapy; CM: casemanager;HSCL:Hop-
kins Symptom Checklist; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
174Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Simon 2004b (Continued)
Allocation concealment (selection bias) Low risk Allocation conducted centrally by an indi-
vidual not involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL50% im-
provement) was: overall 45/393 (11%), 26/
198 (13%) intervention and 19/195 (10%)
control. Reasons for loss to follow-up not
provided. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Simon 2011
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: 20-item depression scale from the Hopkins Symptom Checklist (HSCL) was
used
Inclusion criteria: Age 18 or older, filled a new antidepressant prescription from a par-
ticipating primary care physician; did not fill any prescription for antidepressant medi-
cation in the prior 270 days; had a diagnosis of a depressive disorder associated with the
prescription; was registered to use online messaging
Exclusion criteria: Diagnosis of bipolar disorder or psychotic disorder or any prescription
for mood stabiliser or antipsychotic medication in the prior 2 years
Age: Mean 45.5 years
Gender: 72% female
Ethnicity: 16% ethnic minority
Country: United States
Sample size (randomised): Total participants 208, intervention 106, control 102
Interventions Intervention: Depression care management programme
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP),MHnurse
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(CM), psychiatrist (MH specialist)
2) a structured management plan: CMs began each contact with a message containing
a link to an online assessment (depression questionnaire, and questions regarding use of
ADs, side effects, and reasons for discontinuation). An algorithm generated a suggested
response which CMs could tailor. CMs facilitated follow-up visits, supported changes
in medication, or facilitated referral for specialty care. Each contact included this cycle:
outreachmessage fromCM,patient completionof online assessment, structured response
from CM, and follow-up communication with the patient and PCP as needed. Patients
were free to send additional messages or telephone the CM if needed. The CM was
expected to make outreach telephone calls in case of suicidal ideation or other urgent
clinical need
3) scheduled patient follow-ups: 4 on-line messaging contacts (baseline and weeks 2, 6
and 10)
4) enhanced inter-professional communication: CMs consulted with PCPs and commu-
nicated with PCPs using an electronic messaging system within the electronic medical
record. CMs had supervision with MH specialist (weekly for 3 months and monthly
thereafter)
Control: Treatment as usual
Outcomes Depression (HSCL): 4 months
Medication use: 6 months
Satisfaction: 4 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Computer generated
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL) was:
overall 11/208 (5%), 2/106 (2%) interven-
tion and 9/102 (9%) control. Reasons for
loss to follow-up not provided. Used inten-
tion-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Smit 2006a
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Current Diagnostic and Statistical Manual (DSM-IV) diagnosis of major
depressive disorder, according to the primary care physician and confirmed by an inde-
pendent structured psychiatric interview (Composite International Diagnostic Interview
version 2.0)
Inclusion criteria: Aged 18 - 70 years
Exclusion criteria: Patients suffering from a life threatening medical condition, a psy-
chotic disorder, dementia, alcohol addiction or drug abuse, women who were pregnant
or nursing, and patients already receiving mental health treatment elsewhere




Sample size (randomised: Depression Recurrance Programme): Total participants 184,
intervention 112, control 72
Interventions Intervention: Depression recurrence programme (DRP)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
nurse (CM), psychiatrist (MH specialist)
2) a structured management plan: Depression recurrence programme consisted of struc-
tured/standardised psychoeducational sessions including medication management, self-
care, relapse prevention and support. Patients received a book and videotape about de-
pression, treatment options, relapse prevention and self-management strategies. Face-to-
face contact provided overview of programme and collaboration between CM and PCP,
personal and medication history, stress reduction techniques, preparation of a recurrence
prevention plan, encouraging socialising and scheduling pleasant activities. Telephone
contacts included symptom monitoring and changes in recurrence prevention plan and/
or medication
3) scheduled patient follow-ups: 3 face-to-face (2-4 weekly) and 4 telephone contacts
(2.5 months after last face-to-face session then every 3 months for 3 years)
4) enhanced inter-professional communication: CMs sent written feedback to PCP after
each face-to-face contact and as needed. CMs also sent PCPs a copy of the recurrence
prevention plan and accompanying letter. CMs received regular supervision from MH
specialist
Control: Treatment as usual
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Outcomes Depression (DSM-IV recovered): 27 weeks
Medication use: 3, 6, 9, 12, 36 months
Quality of Life (mental and physical health): 36 months
Satisfaction: 3 months
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Centrally by telephone by an individual
not involved in patient recruitment, who
opened a sealed opaque envelope
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on
primary depression outcome (Recovered
DSM-IV) was: overall 26/184 (14%), 16/
112 (14%) intervention and 10/72 (14%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons across groups.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
Smit 2006b
Methods Study design: Randomised controlled trial
Participants Setting: Primary Care
Diagnosis: Current Diagnostic and Statistical Manual (DSM-IV) diagnosis of major
depressive disorder, according to the primary care physician and confirmed by an inde-
pendent structured psychiatric interview (Composite International Diagnostic Interview
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version 2.0)
Inclusion criteria: Aged 18 - 70 years
Exclusion criteria: Patients suffering from a life threatening medical condition, a psy-
chotic disorder, dementia, alcohol addiction or drug abuse, women who were pregnant
or nursing, and patients already receiving mental health treatment elsewhere




Sample size (randomised: Depression recurrence programme plus psychiatric consulta-
tion: Total participants 111, intervention 39, control 72
Interventions Intervention: Depression recurrence programme (DRP) plus psychiatric consultation
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
nurse (CM), psychiatrist (MH specialist)
2) a structured management plan: DRP consisted of structured/standardised psychoed-
ucational sessions including medication management, self-care, relapse prevention and
support. Patients received a book and videotape about depression, treatment options, re-
lapse prevention and self-management strategies. Face-to-face contact provided overview
of programme and collaboration between CM and PCP, personal and medication his-
tory, stress reduction techniques, preparation of a recurrence prevention plan, encourag-
ing socialising and scheduling pleasant activities. Telephone contacts included symptom
monitoring and changes in recurrence prevention plan and/or medication. Prior to DRP
a one 1-hour consultation with a psychiatrist was also offered who provided a report to
PCP and CM
3) scheduled patient follow-ups: 3 face-to-face (2-4 weekly) and 4 telephone contacts
(2.5 months after last face-to-face session then every 3 months for 3 years)
4) enhanced inter-professional communication: MH specialist sent PCP and CM report
following patient consultation. CMs sent written feedback to PCP after each face-to-
face contact and as needed. CMs also sent PCPs a copy of the recurrence prevention plan
and accompanying letter. CMs received regular supervision from MH specialist
Control: Treatment as usual
Outcomes Depression (DSM-IV recovered): 27 weeks
Medication use: 3, 6, 9, 12, 36 months




Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
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Allocation concealment (selection bias) Low risk Centrally by telephone by an individual
not involved in patient recruitment, who
opened a sealed opaque envelope
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on
primary depression outcome (Recovered
DSM-IV) was: overall 17/111 (15%), 7/
39 (18%) intervention and 10/72 (14%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons across groups.
Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
Smit 2006c
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Current Diagnostic and Statistical Manual (DSM-IV) diagnosis of major
depressive disorder, according to the primary care physician and confirmed by an inde-
pendent structured psychiatric interview (Composite International Diagnostic Interview
version 2.0)
Inclusion criteria: Aged 18 - 70 years
Exclusion criteria: Patients suffering from a life threatening medical condition, a psy-
chotic disorder, dementia, alcohol addiction or drug abuse, women who were pregnant
or nursing, and patients already receiving mental health treatment elsewhere




Sample size (randomised: Depression recurrence programme plus CBT): Total partici-
pants 116, intervention 44, control 72
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Interventions Intervention: Depression recurrence programme (DRP) plus CBT
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
nurse (CM), psychiatrist (MH specialist)
2) a structured management plan: Depression recurrence programme consisted of struc-
tured/standardised psychoeducational sessions including medication management, self-
care, relapse prevention and support. Patients received a book and videotape about de-
pression, treatment options, relapse prevention and self-management strategies. Face-to-
face contact provided overview of programme and collaboration between CM and PCP,
personal and medication history, stress reduction techniques, preparation of a recurrence
prevention plan, encouraging socialising and scheduling pleasant activities. Telephone
contacts included symptom monitoring and changes in recurrence prevention plan and/
or medication. CBT provided after DRP involved 1-hour sessions with a CBT therapist
3) scheduled patient follow-ups: 3 face-to-face (2-4 weekly) and 4 telephone contacts
(2.5 months after last face-to-face session then every 3 months for 3 years) plus 10-12
face-to-face CBT sessions (10-12 weekly)
4) enhanced inter-professional communication: CMs sent written feedback to PCP after
each face-to-face contact and as needed. CMs also sent PCPs a copy of the recurrence
prevention plan and accompanying letter. CMs received regular supervision from MH
specialist. At end of CBT the therapist informed CM of content and progress made
Control: Treatment as usual
Outcomes Depression (DSM-IV recovered): 27 weeks
Medication use: 3, 6, 9, 12, 36 months
Quality of Life (mental and physical health): 36 months
Satisfaction: 3 months
Notes CBT: cognitive behaviour therapy;CM: casemanager;MH:mental health; PCP: primary
care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Centrally by telephone by an individual
not involved in patient recruitment, who
opened a sealed opaque envelope
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on
primary depression outcome (Recovered
DSM-IV) was: overall 18/116 (16%), 8/
44 (18%) intervention and 10/72 (14%)
control. Reasons for loss to follow-up pro-
vided, with similar reasons across groups.
Used intention-to-treat analysis
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Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
Strong 2008
Methods Study design: Randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: Major depressive disorder. Patients with a score of 15 or more on the Hos-
pital Anxiety and Depression Scale interviewed using the major depression section of
the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV). A minimum severity of major depressive disorder, defined by a
score on the Symptom Checklist-20 (HSCL-20) depression scale of at least 1.75 (higher
than the 1.5 which is usually regarded as equivalent to major depressive disorder, to allow
for physical symptoms of cancer)
Inclusion criteria: A cancer prognosis of at least 6 months (to ensure that they could
complete the trial); major depressive disorder of at least a month’s duration that was not
associated with major changes in the patient’s cancer or its management (to ensure that
we did not include patients with transient adjustment disorders)
Exclusion criteria: Patients who were unlikely to be able to adhere to the intervention:
reasons included major communication difficulties such as severe deafness or dementia,
inability to attend the cancer centre, concurrent intensive anticancer treatment such as
frequent chemotherapy or radiotherapy, or another poorly controlled medical disorder
such as epilepsy that dominated their care. We also excluded those who were receiving,
or were judged to need, specialist psychiatric care (e.g., chronic major depressive disorder
of more than 2 years’ duration, severe substance or alcohol misuse, co morbid severe
psychiatric disorder such as psychosis, or risk of suicide)




Sample size (randomised): Total participants 200, intervention 101, control 99
Interventions Intervention: Depression Care for People with Cancer
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: General practitioner (PCP), nurse (CM)
, psychiatrist (MH specialist)
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2) a structured management plan: Using a detailed manual CMs delivered patient ed-
ucation about depression and its treatment, problem-solving treatment to teach coping
strategies and communication with each patient’s oncologist and PCP. If patients decided
to start or change AD the CMs encouraged them to contact PCP and then forwarded
details to the PCP
3) scheduled patient follow-ups: 10 in three months (mostly face-to-face) then 3 tele-
phone calls (monthly)
4) enhanced inter-professional communication: CMs communicated with PCPs and
oncologists via phone or fax in relation to patient information or recommendations from
MH specialist. CMs received weekly supervision from MH specialist
Control: Treatment as usual enhanced as PCPs and oncologists were informed of diag-
nosis and were given advice on choice of AD on request
Outcomes Depression (HSCL-20): 3, 6, 12 months
Medication use: 3, 6 months
Quality of Life (mental and physical health): 3, 6, 12 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Independent central service
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 ≥
50% decrease) was: overall 4/200 (2%), 4/
101 (4%) intervention and 0/99 (0%) con-
trol. Used intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Swindle 2003
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Major depression, dysthymia, or partially remitted major depression using
PRIME-MD structured diagnostic interview
Inclusion criteria: 2 or more general medicine clinic visits during the past year and plans
to receive ongoing medical care from insurance group, access to a telephone and provided
informed consent
Exclusion criteria: Incompetent for interview (e.g. active psychosis, dementia), residents
of a nursing home, actively suicidal, seen in a Veterans Affairs Medical Centres mental
health programme (made a visit during the previous 30 days and had a future appoint-
ment scheduled), active cocaine or opiate abuser, history of bipolar disorder, terminally
ill (death expected within 12 months)




Sample size (randomised): Total clusters 2, intervention 1, control 1; Total participants
268, intervention 134, control 134
Interventions Intervention: Integrated care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), MH
nurse specialist (CM), psychiatrist (MH specialist)
2) a structured management plan: CMs and patients developed individual treatment
plans including medication prescription (recommendation of initial 8 week course typ-
ically SSRI for those not currently on ADs), change in AD or dose (for those still symp-
tomatic on current medication), onward referral to CBT or specialist care (for those with
non-response to current medication);and liaison with PCP. CMs monitored progress
including depressive symptoms, review side effects, encourage treatment compliance,
schedule further visits to themselves or PCPs to modify medication and/or refer to men-
tal health specialists
3) scheduled patient follow-ups: 4 contacts at baseline, 2 weeks, one month and two
months (face-to-face or telephone)
4) enhanced inter-professional communication: CMs communicated the treatment plan
to PCPs who discussed and amended as appropriate and discussions between CM and
PCPpreceded any furthermodifications. CMrecordsweremaintained inmedical record.
CMs attended monthly meetings and MH specialists were available for CMs when
required
Control: Treatment as usual enhanced as PCPs received training in current treatment
strategies for depression and how to use brief diagnostic interview. Patient’s diagnosis
was placed in medical record
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Outcomes Depression (BDI): 3, 12 months
Medication use: 12 months
Satisfaction: 3, 12 months
Notes AD: antidepressant; BDI: Beck Depression Inventory; CM: case manager; MH: mental
health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin-toss
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (BDI) was: over-
all 22/268 (8%), 9/134 (7%) intervention
and 13/134 (10%) control. Reasons for loss
to follow-up not provided by group. Used
intention-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Uebelacker 2011
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: Meeting Diagnostic and Statistical Manual (DSM-IV) criteria for major de-
pression, minor depression, or dysthymia in the past year, or current elevated depressive
symptoms (Quick Inventory of Depression Symptoms [QIDS] score). Assessed using
Structured Clinical Interview for DSM-IV (SCID) and QIDS to determine whether the
participant met all eligibility criteria. If they did, the research staff administered the Cen-
tre for Epidemiological Studies Depression (CES-D) and World Health Organization
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Disability Assessment Schedule II (WHO-DAS)
Inclusion criteria: Membership in the Medicaid HealthMaintenance Organisation; self-
identified as Latino; having recently filled a prescription for an antidepressant medication
for depression, prescribed by a primary care provider; not currently receiving services
from a behavioural health specialist
Exclusion criteria: Not stated




Sample size (randomised): Total participants 38, intervention 19, control 19
Interventions Intervention: Telephone depression care management (DepressionHealth Enhancement
for Latino Patients: D-HELP)
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: Primary care physician (PCP), graduates
(CM), social worker/psychiatrist (MH specialist)
2) a structured management plan: CMs supported treatment provided by PCPs by use
of telephone calls consisting of a) assessment of depression symptoms, b) assessment
of medication use/adherence, c) discussion of next follow-up appointment with PCP,
and d) setting of depression treatment goals. DCMs assessed barriers toward meeting
depression treatment goals and assisted with problem-solving to decrease barriers
3) scheduled patient follow-ups: 8 telephone calls (weekly for 4 weeks then fortnightly
for 8 weeks)
4) enhanced inter-professional communication: CMs provided written feedback to PCPs
for a minimum of once per month and more often if required. CMs received weekly
supervision from MH specialist
Control: Treatment as usual
Outcomes Depression (QIDS): 6, 12 weeks
Medication use: 3, 6 months
Quality of Life (mental and physical health): 6, 12 weeks
Satisfaction: 6, 12 weeks
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information available to assess
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
High risk Short-term loss to follow-up based on pri-
mary depression outcome (QIDS) was:
overall 15/38 (39%), 7/19 (37%) interven-
tion and 8/19 (42%) control. Reasons for
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loss to follow-up not provided. Intention-
to-treat analysis not reported, no descrip-
tion of methods to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Unutzer 2002
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Current major depression or dysthymic disorder according to the Structured
Clinical Interview for DSM (SCID)
Inclusion criteria: Age 60 years or older, plans to use one of the participating clinics as
the main source of general medical care in the coming year, English speaking
Exclusion criteria: Current drinking problems, history of bipolar disorder or
Psychosis, ongoing treatment with a psychiatrist, severe cognitive impairment, acute risk
for suicide and needing immediate care, lack of transportation or access to a telephone
Age: Mean 71.2 (SD 7.5) years
Gender: 65% female
Ethnicity: 23% ethnic minority
Country: United States
Sample size (randomised): Total participants 1801, intervention 906, control 895
Interventions Intervention: Improving Mood-Promoting Access to Collaborative Treatment (IM-
PACT)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), nurse/
psychologist (CM), academic PCP/psychiatrist (MH specialist)
2) a structured management plan: CM educates using a brochure and a videotape at-
tempting to form a therapeutic alliance and encouraging patient to become an active
participant in depression care. CMs discuss treatment preferences (including ADs and
psychotherapy), offers follow-up for 1-year period and coordinates depression care with
patient’s PCP. CMs track clinical progress and monitor treatment side-effects at each
contact or delivers problem solving therapy (PST). A 3-step treatment algorithm was
developed allowing treatment team to establish a treatment plan for each patient’s need
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over time. Step 1: Start AD or PST. Non-response becomes step 2: alternative AD or
from AD to PST, or vice versa. Non-response at step 2 is discussed and considered for
psychiatric consultation and step 3: combination of treatments. Relapse prevention plans
were developed when recovery achieved
3) scheduled patient follow-ups: PST=6-8 sessions. Acute phase CM contact=weekly
or biweekly (telephone or face-to-face). Once symptoms in remission, follow-up about
once per month
4) enhanced inter-professional communication: CM coordinates depression care with
patient’s PCP and receives weekly supervision fromMH specialist who also sees patients
if necessary
Control: Treatment as usual enhanced as patients were informed of their diagnosis and
encouraged to follow-up with PCP
Outcomes Depression (HSCL-20): 3, 6, 12, 18, 24 months
Medication use: 3, 6, 12, 18, 24 months
Quality of Life (mental and physical health): 3, 6, 12, 18, 24 months
Satisfaction: 3, 6, 12, 18, 24 months
Notes AD: antidepressant; CM: case manager; HSCL: Hopkins Symptom Checklist; MH:
mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Low risk Centrally prepared numbered sealed en-
velopes, used sequentially
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL-20 de-
pression) was: overall 231/1801 (13%),
105/906 (12%) intervention and 126/895
(14%) control. Reasons for loss to follow-
up provided, with similar reasons across
groups. Used intention-to-treat analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Vera 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: PHQ-9 and the depression scale of the Hopkins SymptomChecklist (HSCL)
used. Meeting DSM-IV criteria for major depression based on their PHQ-9 score and a
mean item score higher than 1.0 on the HSCL-20
Inclusion criteria: Aged 18 or older, willing to provide informed consent, and had any of
the following health conditions diabetes, hypothyroidism, asthma, hypertension, chronic
bronchitis, arthritis, heart disease, high cholesterol, or stroke. Spanish speaking and to
have stated an intention to use the clinic as their main source of care in the next six-
month period
Exclusion criteria: Serious suicidal risk or terminal illness, a history of bipolar or psychotic
disorder or drug or alcohol abuse. Those receiving mental health treatment or applying
for disability benefits




Sample size (randomised): Total participants 179, intervention 89, control 90
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care physician (PCP), coun-
sellor/psychologist (CM), psychiatrist (MH specialist)
2) a structured management plan: CMs provided patient education and offered ADs (Se-
lective Serotonin Reuptake Inhibitor typically sertraline) or CBT (13 sessions with psy-
chologist). CMs participated in the coordination of treatment initiation and monitored
treatment adherence, side effects, and clinical response. CMs facilitated communication
between the patient, PCP and MH specialist. In the medication treatment option, CMs
provided follow-up based on depression severity. The MH specialist was responsible for
prescribing and the CM forwarded recommendations to PCP. In CBT CMs provided
mental health specialists with a progress report. Non-response resulted in a switch of
modality or combined treatment
3) scheduled patient follow-ups: At least fortnightly initially and then monthly for up
to six months (telephone or face-to-face). Additional contacts scheduled as needed
4) enhanced inter-professional communication: CMs facilitated communication be-
tween the patient, PCP andMHspecialist. In themedication treatment, CMs hadweekly
case conference with MH specialist and forwarded treatment recommendations to the
PCP
Control: Treatment as usual enhanced as patients were informed of their diagnosis and
themental health resources available. The CM encouraged patients to discuss depression
treatment options with their PCP. A note was placed in the patient’s medical record to
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notify PCPs
Outcomes Depression (HSCL): 6 months
Medication use: 6 months
Notes CM: case manager; HSCL: Hopkins Symptom Checklist; MH: mental health; PCP:
primary care provider; PHQ-9: Patient Health Questionnaire-9
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 20
Allocation concealment (selection bias) Low risk Centrally prepared and opened numbered
opaque envelopes
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (HSCL) was:
overall 12/179 (7%), 6/89 (7%) interven-
tion and 6/90 (7%) control. Reasons for
loss to follow-up not provided. Used inten-
tion-to-treat analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Vlasveld 2011
Methods Study design: Randomised controlled trial
Participants Setting: Community
Diagnosis: Major depressive disorder assessed using the PHQ-9. Workers who reached
the cut-off score of 10 were contacted for the administration of a diagnostic interview.
Those who met the Diagnostic and Statistical Manual (DSM-IV) criteria for major
depressive disorder according to the mini - International Neuropsychiatric Interview
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(MINI) were included
Inclusion criteria: Workers on the sick list for between 4 and 12 weeks who give informed
consent
Exclusion criteria: Patients who are suicidal, psychotic or with a primary diagnosis of
substance abuse or dependence, as assessed by the MINI interview, patients who do not
have sufficient command of the Dutch language to fill in the questionnaires, patients
who are pregnant, patients with a legal involvement against their employer, e.g. due to





Sample size (randomised): Total participants 126, intervention 65, control 61
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Usual occupational physician (PCP),
occupational physician (CM), psychiatrist (MH specialist)
2) a structured management plan: Contains the following elements: contracting (pa-
tient choice of treatment), adherence enhancing techniques (psychoeducation), manual-
guided self-help (focuses on behavioural activation, negative thoughts, return to work,
and aspects of healthy lifestyle), problem solving therapy (PST), a workplace interven-
tion (CM acts as mediator between patient and employer), active monitoring and, de-
pending on patient preference, prescription of ADs according to a treatment algorithm.
Patient starts with PST and the manual guided self-help, and some patients will also im-
mediately start ADs. The workplace intervention will be fitted in during the first weeks
of the intervention. Non-response will result in adding an extra 6 sessions of PST, or
by adding ADs to the treatment plan or by increasing or changing the AD. Continued
non-response at 18 weeks will be referred to specialised mental health care and where
medication is prescribed this will be handed over to GP
3) scheduled patient follow-ups: 9 contacts in 18 weeks (fortnightly). PST = 6 sessions
(plus extra 6 when required)
4) enhanced inter-professional communication: The PCP and CM communicated with
each other with written informed consent of the patient. CM consulted MH specialist
if needed and received regular group supervision with other CMs
Control: Treatment as usual in occupational health
Outcomes Depression (PHQ-9): 3, 6, 9, 12 months
Medication use: 3, 6, 9, 12 months
Notes AD: antidepressant; CM: case manager; GP: general practitioner; MH: mental health;
PCP: primary care provider; PHQ-9: Patient Health Questionnaire; PST: problem solv-
ing therapy
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on
primary depression outcome (PHQ-9 re-
sponse 50% reduction) was: overall 28/
126 (22%), 15/65 (23%) intervention and
13/61 (21%) control. Reasons for loss
to follow-up not provided. Intention-to-
treat analysis reported, multiple imputa-
tion used to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Waitzkin 2011
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Diagnosis of depression on the Patient Health Questionnaire (PHQ)
Inclusion criteria: Not stated
Exclusion criteria: Suicidal or homicidal ideation (emergency care was provided to such
patients), acute bereavement, psychotic or bipolar depression, age under 18; and general
health status precluding the interview
Age: 18 years and over
Gender: 77% female
Ethnicity: Not stated, majority Hispanic
Country: United States
Sample size (randomised): Total participants 120, intervention unclear, control unclear
Interventions Intervention: Enhanced care plus the promotoras contextual intervention
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care practitioners (PCP), pro-
motoras/lay health educators (CM)
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2) a structured management plan: Same process as enhanced care initially as depression
was assessed using measurement tool and findings provided to PCPs who then confirmed
diagnosis and decided treatment plan (medication and/or counselling/therapy). The
PCP and CM discuss plan, decide follow-up and CM leaves contact form in chart. In
addition CM interviews patient on contextual sources of depression (unemployment or
under-employment, housing, food , trauma) using a protocol and then assists the patient
to deal with any issues
3) scheduled patient follow-ups: Every two months or dependent on need and decided
between CM and PCP
4) enhanced inter-professional communication: CMprovides PCP with depression score
and depression guideline who reviews and determines treatment plan (medication and/or
counselling/therapy). CM and PCP discuss plan and decide follow-up and communicate
orally at least monthly. CMs complete a form at each contact. MH specialist provided
consultation or saw patients where necessary
Control: Enhanced care as depression was assessed using measurement tool and findings
provided to PCPswho then confirmed diagnosis and decided treatment plan (medication
and/or counselling/therapy). The PCP and CM discuss plan, decide follow-up and CM
leaves contact form in chart
Outcomes Depression (PHQ16): 6, 12 months
Notes CM: case manager; MH: mental health; PCP: primary care provider; PHQ: Patient
Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Coin-toss (three out of five)
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (PHQ16 symp-
tom count) was unclear Reasons for loss to
follow-up not provided
Intention to treat not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias High risk Case managers collaborated with PCPs to
develop treatment plans for patients in the
control group
Implementation Integrity Unclear risk Insufficient information available to assess
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Wells 2000a
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression measured by the Composite International Diagnostic Interview
(CIDI) and items assessing depressed symptoms in the past month. Defined patients
as having probable disorder if they had 2 weeks or more of depressed mood or loss of
interest in pleasurable activities during the last year or persistent depression over the year,
plus having at least 1 week of depression in the last 30 days
Inclusion criteria: Patients who intended to use the clinic as a source of care for the next
12 months
Exclusion criteria: Younger than 18 years, had an acute medical emergency, did not speak
English or Spanish, or did not have either insurance or a public-pay arrangement that
covered care delivered by the mental health specialists in the interventions. In the pilot
month for the first site, patients screening positive for bipolar disorder or alcoholism
were excluded, but not for the main study




Sample size (randomised): 31 primary care clinics, intervention 15, control 16; Total
participants 867, intervention 424, control 443
Interventions Intervention: Quality Improvement medication (QI-meds)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinicians (PCP), nurse
(CM), psychiatrist (MH specialist)
2) a structured management plan: The programme included 1) institutional commit-
ment, 2) training local leaders to implement interventions 3) training of CMs (patient
education and activation based on a written manual and videotape) 4) patient identi-
fication. CMs assessed, educated, and activated) patients, sharing the information with
PCPs who formulated a treatment plan with the patient. QI-meds involved CMs pro-
viding follow-up assessments and supporting adherence and facilitating referral for local
psychotherapy where necessary
3) scheduled patient follow-ups: 8 sessions (2 and 4 weeks then monthly for 6 months)
half were also randomised to receive 3 further sessions in preceding 6 months
4) enhanced inter-professional communication: CMs provided assessment information
to PCP who formulated a treatment plan with the patient. PCPs reviewed CM written
reports and met with patients when necessary. MH specialists reviewed CM reports and
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met with patients with poor treatment response at 6-8 weeks
Control: Treatment as usual enhanced as treatment guidelines, with quick reference
guides for clinicians, were sent to medical directors. Patients were told they could inform
the PCP of allocation/diagnosis
Outcomes Depression (Probable depression): 6, 12, 24, 57 months
Medication use: 6, 12, 18, 24 months
Quality of Life (mental and physical health): 6, 12, 18, 24, 57 months, 9 years
Notes CIDI: Composite International Diagnostic Interview; CM: case manager; MH: mental
health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters were organised into blocks of
3, blocks were randomised using random
numbers table
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Probable de-
pression) was: overall 113/867 (13%), 56/
424 (13%) intervention and 57/443 (13%)
control. Reasons for loss to follow-up not
provided by group. Used intention-to-treat
analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
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Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression measured by the Composite International Diagnostic Interview
(CIDI) and items assessing depressed symptoms in the past month. Defined patients
as having probable disorder if they had 2 weeks or more of depressed mood or loss of
interest in pleasurable activities during the last year or persistent depression over the year,
plus having at least 1 week of depression in the last 30 days
Inclusion criteria: Patients who intended to use the clinic as a source of care for the next
12 months
Exclusion criteria: Younger than 18 years, had an acute medical emergency, did not speak
English or Spanish, or did not have either insurance or a public-pay arrangement that
covered care delivered by the mental health specialists in the interventions. In the pilot
month for the first site, patients screening positive for bipolar disorder or alcoholism
were excluded, but not for the main study




Sample size (randomised): 31 primary care clinics, intervention 15, control 16; Total
participants 932, intervention 489, control 443
Interventions Intervention: Quality improvement therapy (QI-therapy)
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care clinicians (PCP), psy-
chotherapist (CM), psychologist (MH specialist)
2) a structured management plan: The programme included 1) institutional commit-
ment, 2) training local leaders to implement interventions 3) training of CMs (patient
education and activation based on a written manual and videotape) 4) patient identifica-
tion. CMs assessed, educated, and activated) patients, sharing the information with PCPs
who formulated a treatment plan with the patient. QI-therapy involved psychothera-
pists providing manualised individual or group CBT which consisted of 3 modules of 4
sessions with a recommendation for repeating the first one. Patients were provided with
a manual for recording clinical progress and homework assignments
3) scheduled patient follow-ups: 12-16 individual or group sessions (4 sessions for those
with minor depression)
4) enhanced inter-professional communication: CM used feedback forms to communi-
cate with PCPs at beginning, at termination and at module breaks
Control: Treatment as usual enhanced as treatment guidelines, with quick reference
guides for clinicians, were sent to medical directors. Patients were told they could inform
the PCP of allocation/diagnosis
Outcomes Depression (Probable depression): 6, 12, 24, 57 months
Medication use: 6, 12, 18, 24 months
Quality of Life (mental and physical health): 6, 12, 18, 24, 57 months, 9 years
Notes CBT: cognitive behaviour therapy; CIDI: Composite International Diagnostic Inter-
view; CM: case manager; MH: mental health; PCP: primary care provider
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Clusters were organised into blocks of
3, blocks were randomised using random
numbers table
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Probable de-
pression) was: overall 144/932 (15%), 87/
489 (18%) intervention and 57/443 (13%)
control. Reasons for loss to follow-up not
provided by group. Used intention-to-treat
analysis
Selective reporting (reporting bias) Low risk Protocol available and all prespecified out-
comes reported
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Wilkinson 1993
Methods Study design: Pilot randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depressive disorder judged by the General Practitioner to require treatment
with antidepressant medication
Inclusion criteria: Males and females above the age of consent
Exclusion criteria: Use of tricyclic antidepressants was not permitted for the 28 days
preceding entry to the study




Sample size (randomised): Total participants 61, intervention 30, control 31
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Wilkinson 1993 (Continued)
Interventions Intervention: Dothiepin plus Practice Nurse supplement
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General practitioner (PCP), practice
nurse (CM),
2) a structured management plan: CM aimed to enhance treatment adherence to med-
ication by discussion and encouragement particularly by providing explanation and re-
assurance about pharmacological adverse events of medication
3) scheduled patient follow-ups: 5 face-to-face sessions (days 0, 7, 14, 28, 56)
4) enhanced inter-professional communication: CM care under the supervision of the
PCP
Control: Treatment as usual plus dothiepin
Outcomes Depression (Global clinical effectiveness): 2 months
Medication use: 2 months
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random allocation in blocks of 4
Allocation concealment (selection bias) Unclear risk Sealed pre-packed study protocols were se-
lected in turn
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Global clinical
effectiveness)was: overall 9/61 (15%), 5/30
(17%) intervention and 4/31 (13%) con-
trol. Reasons for loss to follow-upprovided,
with similar reasons across groups. Inten-
tion to treat not reported
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessor was potentially aware of treatment
allocation
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Methods Study design: Randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: Diagnosis of major orminor depression. Those endorsing either the depressed
mood or the anhedonia item or those with scores ≥ 5 on the PHQ-9 regardless of
items endorsed were administered the structured clinical interview for Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) to confirm diagnosis
Inclusion criteria: Adults 18 years and older with ischaemic stroke, no severe language
impairment, no severe cognitive impairment, able to speak and understand English, had
a telephone, and who had a life expectancy of at least 6 months
Exclusion criteria: Hemorrhagic stroke, active psychosis, suicidality, or substance abuse;
those currently taking a monoamine oxidase inhibitor; and women pregnant at the time
of stroke. Severe aphasia, pre-existing dementia or failed cognitive screening




Sample size (randomised): Total participants 188, intervention 94, control 94
Interventions Intervention: Care management (Activate-Initiate-Monitor)
Contains the four elements of collaborative care:
1) amulti-professional approach topatient care: Primary care provider/neurologist (PCP)
, nurse (CM), study physician (Specialist)
2) a structured management plan: CM intervention consisted of 3 steps: (1) Activating
stroke survivors and their families to understand and accept depression diagnosis and
treatment (a structured psychoeducation session), (2) Initiating ADs (CM recommends
PCP prescribe AD using algorithm, typically a Selective Serotonin Reuptake Inhibitor);
and (3) Monitoring treatment effectiveness (scripted bimonthly telephone calls to assess
depression symptoms, medication side effects, and adherence). Non-response after 4
weeks led to increase inADdose. CMs hadweeklymeetings with Specialist and treatment
recommendations were fed back to PCP by CM
3) scheduled patient follow-ups: 7 sessions in 12 weeks (One face-to-face and bimonthly
telephone calls)
4) enhanced inter-professional communication: CMs recommended AD to PCP and
met with Specialist weekly and fed back treatment recommendations to PCP
Control: Patients received an identical number of baseline and telephone sessions to
serve as a control for an attention effect. Instead of depression, these sessions focused on
recognition and monitoring of stroke symptoms and risks
Outcomes Depression (HAMD): 6, 12 months
Notes AD: antidepressant; CM: casemanager;MH:mental health; PCP: primary care provider;
PHQ-9: Patient Health Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
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Williams 2007 (Continued)
Random sequence generation (selection
bias)
Low risk Computer generated in blocks of 2 and 4
(randomly selected)
Allocation concealment (selection bias) Low risk Sealed opaque envelopes prepared by an
individual not involved in patient recruit-
ment and opened sequentially
Incomplete outcome data (attrition bias)
All outcomes
Low risk Short-term loss to follow-up based on pri-
mary depression outcome (HAMD) was:
overall 6/188 (3%), 5/94 (5%) interven-
tion and 1/94 (1%) control. Reasons for
loss to follow-up provided, with similar rea-
sons across groups. Used intention-to-treat
analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Yeung 2010
Methods Study design: Randomised controlled trial
Participants Setting: Primary care
Diagnosis: Depression measured by a score of 10 or above on the Chinese Bilingual
Patient Health Questionnaire-9 (CB-PHQ-9)
Inclusion criteria: Chinese American adults (18 years or older) who attended the primary
care clinic
Exclusion criteria: Patients with unstable medical conditions, a high risk of suicide,
psychotic disorders, dysthymic disorder, bipolar disorder, and substance use disorders
Age: Mean 49.5 years
Gender: 68% female
Ethnicity: 100% Chinese American
Country: United States
Sample size (randomised): Total participants 100, intervention 55, control 45
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Yeung 2010 (Continued)
Interventions Intervention: Care management
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), bilingual
care manager (CM), psychiatrist (MH specialist)
2) a structured management plan: CMs established rapport, explained the roles of the
CM, and provided culturally sensitive education on major depression. Follow-ups fo-
cused on monitoring of depressive symptoms, adherence to medication treatment, man-
agement of adverse events, and knowledge of self-management strategies
3) scheduled patient follow-ups: 8 sessions (one face-to-face and 7 telephone at weeks 2,
4, 8, 12, 16, 20, 24)
4) enhanced inter-professional communication: CMs served as a link between patients,
PCPs, and consulting MH specialist. CMs received weekly supervision from MH spe-
cialist who also had consultations with patients and their PCPs when required
Control: Treatment as usual enhanced as patients with major depressive disorder were
encouraged to seek treatment from their PCP, who would receive a letter about the
patient’s diagnosis and a recommended treatment plan
Outcomes Depression (HAMD17): Most recent
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary depression outcome (Response 50%
reduction HAMD 17) was: overall 25/
100 (25%), 14/55 (25%) intervention and
11/45 (24%) control. Reasons for loss to
follow-up not provided. Intention-to-treat
analysis not reported, no description of
methods to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
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Yeung 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Zatzick 2001
Methods Study design: Pilot randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: The Centre for Epidemiological Studies Depression Scale (CES-D), a 20-
item self-report instrument to measure levels of depressive symptoms was used. Levels
of PTSD symptoms were assessed using the civilian version of the Post-Traumatic Stress
Disorder Checklist (PCL-C)
Inclusion criteria: Hospitalised motor vehicle crash or assault survivors between the ages
of 14-65, who were English speaking
Exclusion criteria: Patients who sustained severe injuries (i.e. Maximum Abbreviated
Injury Scale (AIS) score ≥ 5), were excluded




Sample size (randomised): Total participants 34, intervention 16, control 18
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Surgical/primary care provider (PCP),
nurse specialist/psychiatrist (CM), multidisciplinary team (MH specialist)
2) a structured management plan: CMs were instructed to develop a therapeutic rela-
tionship and follow patients for 4 months through primary care outpatient appoint-
ments and community rehabilitation. CM involved collaborative problem definition and
shared patient-provider treatment planning (based on post-traumatic concerns). CMs
intervened in resolution of these concerns and also provided a psychotherapy module
specifically targeting post-traumatic distress and substance use. The psychoeducational
component began with a review of the traumatic event, followed by a discussion of
related emotions, cognitions, and possible future post-traumatic symptoms, and closed
with suggested coping strategies including algorithms for contacting the CM. The mo-
tivational enhancement techniques focused on the evaluation of readiness to change and
implementation of a motivational interview targeting post-traumatic alcohol and drug
use
3) scheduled patient follow-ups: Face-to-face whilst inpatient and then follow for 4
months (typically telephone)
4) enhanced inter-professional communication: After discharge CMs had regular contact
with PCPs via telephone especially in first month. CMs met with MH specialists weekly
to review CM written records
Control: Treatment as usual for post-traumatic care
Outcomes Anxiety (PTSD): 1, 4 months
Quality of Life (mental and physical health): 1, 4 months
202Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zatzick 2001 (Continued)
Notes CM: case manager; MH: mental health; PCP: primary care provider
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers table used to determine
which patients to approach.Once recruited
an individual not involved in patient re-
cruitment randomised patients in blocks of
6
Allocation concealment (selection bias) Low risk Allocation conducted by an individual not
involved in patient recruitment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary anxiety outcome (PTSD) was: over-
all 8/34 (24%), 4/16 (25%) intervention
and 4/18 (22%) control. Reasons for loss to
follow-up not provided. Intention-to-treat
analysis reported, no description of meth-
ods to manage missing data
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Low risk Attempts were made to assess implemen-
tation integrity (e.g. direct observation or
rating of tapes)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessor was not aware of treatment alloca-
tion
Zatzick 2004
Methods Study design: Randomised controlled trial
Participants Setting: Specialist, primary care
Diagnosis: PTSD Checklist Civilian Version (PCL) and the Centre for Epidemiological
Studies Depression Scale (CES-D) were used. Patients were included if they had a PCL
score, ≥45 and/or a CESD-D score, ≥ 16
Inclusion criteria: English-speaking survivors of intentional and unintentional injuries,
203Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zatzick 2004 (Continued)
18 years and older, who lived within 50 miles of the trauma centre
Exclusion criteria: Participants were required to have a Glasgow Coma Scale score
of 15 and a score of at least 7 on the 2 Mini- Mental State Examination items that
assess orientation to location and date. Patients with severe injuries that prevented
participation were excluded from the study. Patients who had self-inflicted injuries or
active psychosis, who were currently incarcerated, or who had recent histories of violence
were also excluded




Sample size (randomised): Total participants 121, intervention 60, control 61
Interventions Intervention: Collaborative care
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: Primary care provider (PCP), masters
level case manager (CM), psychologist/psychiatrist (MH specialist)
2) a structured management plan: The intervention combined case management and
psychopharmacological and psychotherapeutic treatments as a stepped-care procedure.
For the first 6 months after injury, all patients received continuous case management de-
livered by CM. CMs and other intervention team members developed a comprehensive
care plan that addressed medical and psychosocial complications and coordinated care
across surgical inpatient, primary care outpatient, specialty mental health, and commu-
nity service settings. Patients had 24 hour 7 day a week access to CM pager and CMs
developed a therapeutic alliance that facilitated the delivery of evidence-based interven-
tions for alcohol abuse and PTSD. The CM motivational intervention consisted of an
inpatient session followed by as-needed booster sessions (test results, pros and cons of al-
cohol, importance of change, specific goals for alcohol, and action plans). Three months
after the injury patients with PTSD were given preference of CBT, pharmacotherapy, or
combined treatment (delivered by expert psychotherapy and pharmacotherapy consul-
tants). The CBT intervention included psychoeducation, muscle relaxation, cognitive
restructuring, and graded exposure. The psychopharmacological intervention consisted
of an initial psychiatric evaluation and medication targeting PTSD. CMs provided ed-
ucation about the diagnosis and facilitated the entry of patients into evidence-based
treatments. During the evidence-based PTSD intervention, CMs performed brief as-
sessments of adherence to medication therapy and symptom relapse. The stepped-care
procedure included relapse prevention and community integration components. From 6
to 12 months after the injury, non-responsive patients received combination treatments
and CMs periodically reassessed symptoms, function, and rehabilitation
3) scheduled patient follow-ups: Continuous for 6 months and then periodic 6-12
months for those that remained symptomatic
4) enhanced inter-professional communication: CMs coordinated linkages and inter-
faced with PCPs and met with MH specialist weekly to review cases and protocol pro-
cedures
Control: Treatment as usual for post-traumatic care
Outcomes Anxiety (DSM-IV PTSD): 1, 3, 6, 12 months
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Zatzick 2004 (Continued)
Notes CM: case manager; DSM-IV: Diagnostic and Statistical Manual fourth edition; MH:
mental health; PCP: primary care provider; PTSD: post-traumatic stress disorder
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Insufficient information available to assess
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Short-term loss to follow-up based on pri-
mary anxiety outcome (DSM-IV PTSD
from PTSD checklist) was: overall 17/121
(14%), 8/60 (13%) intervention and 9/61
(15%) control. Reasons for loss to follow-
up not provided. Used intention-to-treat
analysis
Selective reporting (reporting bias) Unclear risk Insufficient information available to assess
Other bias Unclear risk Insufficient information available to assess
Implementation Integrity Unclear risk Insufficient information available to assess
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel could not be
blinded, outcome likely to be influenced by
lack of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information available to assess
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akerblad 2003 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (only
one health professional involved)
Al-Saffar 2005 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (no
primary care provider)
Bolton 2001 Types of intervention: Does not meet criteria for enhanced inter-professional communication
205Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Braamse 2010 Types of intervention: Does not meet criteria for a multi-professional approach to care (no primary
care provider)
Britian 1999 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Brook 2003 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (no
primary care provider)
Callahan 1994 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (only
one health professional involved)
Callahan 2006 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Cheok 2003 Types of intervention: Does not meet criteria for scheduled patient follow-ups
Coleman 1999 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Dobscha 2006 Types of intervention: Does not meet criteria for scheduled patient follow-ups
Dobscha 2008 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Dobscha 2009 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Dozeman 2007 Types of participants: Participants were recruited and/or treated in specialist mental health setting
Gellis 2010 Types of intervention: Does not meet criteria for enhanced inter-professional communication
Geron 2006 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Hees 2010 Types of participants: Participants were recruited and/or treated in specialist mental health setting
Katon 1992 Types of intervention: Does not meet criteria for scheduled patient follow-ups
Kroenke 2009 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (no
primary care provider)
Lyles 2003 Types of participants: Less than 50% of participants had depression and/or anxiety at baseline
Meglic 2010 Types of studies: Not a randomised controlled trial (systematic alternating order without blinding)
Mudge 2011 Types of intervention: Intervention not focused on depression or anxiety
Oslin 2004 Types of intervention: Does not meet criteria for a multi-professional approach to care (no primary
care provider)
Peveler 1999 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (no
primary care provider)
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Pols 2008 Types of intervention: Primary care provider delivered intervention not case manager
Raue 2009 Types of studies: Not a randomised controlled trial
Rickles 2005 Types of intervention: Does not meet criteria for a multi-professional approach to patient care (no
primary care provider)
Riegel 2006 Types of intervention: Intervention not focused on depression
Seekles 2009 Types of intervention: Stepped care - collaborative care intervention not available for all patients in
treatment arm
Simon 2006 Types of intervention: Does not meet criteria for a multi-professional approach to care (no primary
care provider)
Sirey 2010 Types of intervention: Does not meet criteria for enhanced inter-professional communication
Stevens 2009 Types of participants: Participants were recruited and/or treated in specialist mental health setting
van der Feltz-Cornelis 2006 Types of intervention: Does not meet criteria for scheduled patient follow-ups
van der Feltz-Cornelis 2010 Types of intervention: Does not meet criteria for scheduled patient follow-ups
Van’t Veer-Tazelaar 2009 Types of intervention: Stepped care - collaborative care intervention not available for all patients in
treatment arm
Wang 2007 Types of participants: Participants were recruited and/or treated in specialist mental health setting
Whooley 2000 Types of intervention: Does not meet criteria for enhanced inter-professional communication
Characteristics of studies awaiting assessment [ordered by study ID]
Aragones 2007
Methods Study design: Cluster-randomised controlled trial
Participants Setting: Primary care
Inclusion criteria: Patients who have suffered from an episode of major depression (DSM-IV) and who have been
advised to take a new course of antidepressants. Those assigned to the doctor, aged ≥ 18 years, able to be contacted
by telephone, who have been diagnosed with an episode of major depression (DSM-IV), have a score of > 14 on the
PHQ-9 (moderate-severe depression) or a score of 10 to 14 (mild depression) that has persisted for more than one
month, and who have not received antidepressant medication in the previous three months
Exclusion criteria: Those who suffer from physical, psychiatric or linguistic limitations or a concurrent illness that
impede comprehension/participation in the study evaluations, patients with psychotic or bipolar disorders, patients
with alcohol or drug dependence and patients who are pregnant or breastfeeding
Age: Aged ≥ 18 years
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Sample size: 20 primary care centres, 400 patients
Interventions Intervention: An enhanced programme for depression management. A multi-component programme with clinical,
educational and organisational procedures that includes training for the health care provider and evidence-based
clinical guidelines. It also includes primary care nurses working as care-managers who provide educational and
emotional support for the patients and who are responsible for active and systematic clinical monitoring. The
programme aims to improve the primary care/specialised level interface
Control: The doctors in the centres that continue with standard treatment use their own criteria to attend depressed
patients and are allowed to use any resources they consider appropriate, including referral to the specialised level.
The doctors in the control group are given a training session on diagnosing and detecting depression with the same
content as that of the doctors in the intervention group
Outcomes Response and remission rates and depression severity (PHQ-9)
Notes Study complete but publication of results too late for inclusion in review at this stage; DSM-IV: Diagnostic and
Statistical Manual fourth edition; PHQ-9: Patient Health Questionnaire
Joubert 2006
Methods Study design: Randomised controlled trial
Participants Setting: Hospital/primary care
Inclusion criteria: Patients aged 20 and older admitted with transient ischaemic attack or completed stroke, both
first or recurrent stroke who would return to their GPs for management after discharge and who were willing to be
contacted for repeat assessments over a 12 month period
Exclusion criteria: Patients discharged to nursing homes, with serious or life-threatening co-morbidities (such as
cancer), non-English speaking, refused to participate, died while in hospital, cognitively impaired to the extent that
they could not cooperate with follow up visits with their GP, significantly aphasic, and living more than two hours




Sample size: Total 97, intervention 46, control 51
Interventions Intervention: Integrated care programme. A shared care package was prepared for the GP. This contained goals and
the recommendations for risk factor management according to clinical practice and evidence-based guidelines and
recommendations for treatment of depression in stroke patients. 5 visits arranged with the GP during the 12 months
post-discharge
Control: Treatment as usual. GPs contacted at 12 months for collection of study specific data
Outcomes Changes in risk factors: blood pressure, cholesterol, physical activity and depression (PHQ-9)
Notes Awaiting author response to clarify if 50% or more depressed at baseline; GP: general practitioner; PHQ-9: Patient
Health Questionnaire-9
208Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Joubert 2008
Methods Study design: Randomised controlled trial
Participants Setting: Hospital/primary care
Inclusion criteria: Patients aged 20 and older admitted with transient ischaemic attack or completed stroke, as
confirmed by CT scan
Exclusion criteria: Patients not returning to their GPs for management, discharged to a nursing home, serious
comorbidities or cognitive impairment, non-English speaking, died while in hospital, notably aphasic, lived more
than two hours away by car, family declining to take part, involvement in another research programme, and not




Sample size: Total 186, intervention 91, control 95
Interventions Intervention: Integrated care. Patients in the integrated care group received a structured model of care that linked
specialist stroke services with ongoing general practice care. GPs of treatment patients were sent an explanatory
letter, as well as a comprehensive but succinct discharge summary detailing relevant investigations, risk factor profile,
and medication for each patient. They also received a flowchart with goals and recommendations for risk factor
management, developed from evidence-based guidelines. The study coordinator contacted each patient before and
after each GP visit
Control: Standard Care patients were discharged to usual care from their GP with the standard accompanying
handover information. The frequency of visits, the guidelines adopted, and the actions taken were all left up to the
discretion of the GP
Outcomes Depression (PHQ-9)
Notes Awaiting author response to clarify if 50% or more depressed at baseline; CT: computer tomography; GP: general
practitioner; PHQ-9: Patient Health Questionnaire-9
Mareev 2010
Methods Study design: Randomised controlled trial
Participants Setting: Hospital
Inclusion criteria: Heart failure
Exclusion criteria: Unclear
Age: Mean 62 years
Gender: 39% female
Country: Russia
Sample size: Total 10745 , intervention 5360 , control 5385
Interventions Intervention: Amultidisciplinary, non-pharmacological, intervention (including pre-discharge patient education and
active follow-up with regular bi-lateral telephone contact)
Control: Usual care
Outcomes Depression (HADS)
Notes Awaiting author response to access published or unpublished data; HADS: Hospital Anxiety and Depression Scale
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O’Connor 2001
Methods Study design: Randomised controlled trial
Participants Setting: Primary care





Sample size: Total unclear, intervention unclear , control unclear
Interventions Intervention: GP based psychiatrist clinic
Control: Unclear
Outcomes Depression (HADS)
Notes National Research Register record - unable to get any further data or contact author; GP: general practitioner; HADS:
Hospital Anxiety and Depression Scale
Walker 2009a
Methods Study design: Randomised controlled trial
Participants Setting: Speciality oncology clinic
Inclusion criteria: Diagnosis of cancer active within last 5 years, 18 or over, attending specialist oncology clinic,
predicted survival of 12 months or more, meet DSM-IV for MDD present for 4 weeks or more
Exclusion criteria:Unable to provide consent, chronic depression (continuously depressed for 2 years ormore), requires
urgent psychiatric care or currently receiving same, cognitive impairment or communication difficulties, cerebral
metastases, unable to attend regularly, intervention inappropriate due to medical condition,comorbid psychiatric
condition or other clinical reason
Age: 18 or over
Gender: Unclear
Country: United Kingdom (Scotland)
Sample size: Total 500 planned
Interventions Intervention: Depression Care for People with Cancer
Contains the four elements of collaborative care:
1) a multi-professional approach to patient care: General practitioner (PCP), nurse (CM), SMaRT psychiatry team
(MH specialist)
2) a structuredmanagement plan: Treatment phase includes a) coordination of care across professionals, b)monitoring
symptoms, c) brief psychological intervention including education and PST. Maintenance phase includes completion
of outcome measure and appropriate action taken via automated Interactive Voice Response or CM. MH specialist
sees urgent cases or those with non-response to treatment
3) scheduled patient follow-ups: Treatment phase: 10 (30-45 minute) face-to-face sessions in 16 weeks (expected
average per patient = 6-8), maintenance: telephone every 4 weeks until end of trial
4) enhanced inter-professional communication: CM receives weekly supervision from MH specialist
Control: Treatment as usual enhanced as PCPs and oncologists were informed of patients diagnosis
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Walker 2009a (Continued)
Outcomes Depression (HSCL-20): Treatment response at 24 weeks; remission at 12, 24, 36 and 48 weeks; severity at 12, 24,
36 and 48 weeks. Also severity of anxiety symptoms
QoL: 12, 24, 38 and 48 weeks
Costs: 12, 24, 38, 48 weeks
Satisfaction: 12, 24, 38, 48 weeks
Social: 12, 24, 38, 48 weeks
Notes Study complete awaiting publication of results; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; HSCL: Hopkins Symptom Checklist; MDD: major depressive disorder; MH: mental health; PCP:
primary care provider; PST: problem solving therapy
Walker 2009b
Methods Study design: Randomised controlled trial
Participants Setting: Lung cancer outpatient clinics
Inclusion criteria: Diagnosis of lung cancer, 18 or over, predicted survival of 3 months or more, meet DSM-IV for
MDD present for 4 weeks or more
Exclusion criteria:Unable to provide consent, chronic depression (continuously depressed for 2 years ormore), requires
urgent psychiatric care or currently receiving same, cognitive impairment or communication difficulties, cerebral
metastases, unable to attend regularly, intervention inappropriate due to medical condition,comorbid psychiatric
condition or other clinical reason
Age: 18 or over
Gender: Unclear
Country: United Kingdom (Scotland)
Sample size: Total 200 planned
Interventions Intervention: Depression Care for People with Lung Cancer
Contains the four elements of collaborative care:
1) amulti-professional approach to patient care: General practitioner (PCP), nurse (CM), psychiatrist (MH specialist)
2) a structuredmanagement plan: Treatment phase includes a) coordination of care across professionals, b)monitoring
symptoms, c) brief psychological intervention including education and PST. Maintenance phase includes completion
of outcome measure and appropriate action taken by CM.MH specialist sees urgent cases or those with non-response
to treatment
3) scheduled patient follow-ups: 10 (30-45 minute) sessions in 16 weeks (expected average per patient = 6-8),
maintenance: telephone every 4 weeks until end of trial
4) enhanced inter-professional communication: CMs received weekly supervision from MH specialist
Control: Treatment as usual enhanced as PCPs and oncologists were informed of diagnosis
Outcomes Depression (HSCL-20): severity at 4, 8, 12, 16, 20, 24, 28, 32 weeks. Also severity of anxiety symptoms
QoL: 4, 8, 12, 16, 20, 24, 28, 32 weeks
Costs: 4, 8, 12, 16, 20, 24, 28, 32 weeks
Satisfaction: 4, 8, 12, 16, 20, 24, 28, 32 weeks
Social: 4, 8, 12, 16, 20, 24, 28, 32 weeks
Notes Study complete awaiting publication of results; CM: case manager; DSM-IV: Diagnostic and Statistical Manual
fourth edition; HSCL: Hopkins Symptom Checklist; MDD: major depressive disorder; MH: mental health; PCP:
primary care provider; PST: problem solving therapy
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Wu 2010
Methods Study design: Randomised controlled trial
Participants Setting: Community psychiatry





Sample size: Total 120, intervention 60, control 60
Interventions Intervention: case management of chronic disease
Abstract written in English reports collaborative care provided by psychiatrists, PCP and case managers and included
health education, psychotherapy and antidepressants
Control: Treatment as usual
Outcomes Depression (HAMD)
Notes Awaiting completion of transcription to accurately assess whether to include in review; DSM-IV: Diagnostic and
Statistical Manual fourth edition; PCP: primary care provider
Characteristics of ongoing studies [ordered by study ID]
Chen 2011
Trial name or title Depression care management for late-life depression in China primary care: protocol for a randomised con-
trolled trial
Methods RCT
Participants Patients aged 60 and over, community-dwelling residences, capable of independent communication, Mini-
Mental State Examination (MMSE) score ≥ 18. Major depression (PHQ-9, The Mood Disorder Module of
the Structured Clinical Interview for DSM-IV and the Hamilton Rating Scale for Depression)
Interventions Intervention: Depression care management. Antidepressant treatment, Care managers monitor the progress
of treatment and side effects, educate patients/family, and facilitate communication between providers
Control: Care as usual. Current practice, when depression is detected by PCPs, involves suggesting to patients
(or family members) that they consult a mental health institution for diagnosis and treatment. There is no
direct referral/transfer mechanism between PCPs and mental health specialists
Outcomes Depression (Hamilton Rating Scale for Depression), suicidal ideation, cognitive function, anxiety, medical
health, quality of life, treatment stigma, satisfaction
Starting date August 2010, ends July 2014
Contact information Shulin Chen csl@zju.edu.cn
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Chen 2011 (Continued)
Notes DSM-IV: Diagnostic and Statistical Manual fourth edition; PCP: primary care provider; PHQ-9: Patient
Health Questionnaire-9
Chung 2010
Trial name or title Using a community partnered participatory research approach to implement a randomised controlled trial:
Planning community partners in care
Methods Randomised controlled trial
Participants Clients who screen as possibly having depression
Interventions Compared a low-impact intervention, Resources for Services (RS), with a Community Partnered Participatory
Research planning process, Community Engagement and Planning (CEP), as approaches to implement
depression care in agencies and programs
Outcomes The study assesses the impact of the different implementation approaches on community agency administrator,
provider and client outcomes for depression
Starting date 2010
Contact information Bowen Chung bchung@mednet.ucla.edu
Notes
Cooper 2010
Trial name or title A cluster randomised trial of standard quality improvement versus patient-centred interventions to enhance
depression care for African Americans in the primary care setting: Study protocol NCT00243425
Methods Cluster randomised trial
Participants Patients had to be between the ages of 18 and 75 years and report their race or ethnicity as African American;
they had to be positive on a screener for major depressive and dysthymic disorder from the CIDI. In addi-
tion, screen-positive patients had to meet criteria for one-year major depression on a subsequent structured
interview, defined as: meeting DSM-IV criteria for MDD in the past year and having symptoms present for
at least one week in the past month, to be considered eligible for the study
Interventions Standard versus patient-centred quality improvement interventions. Both involved extensive one-on-one fol-
low-up with a Depression Case Manager (DCM) to assess patients’ depression status and to encourage adher-
ence to recommended treatments and exposure to educational materials. The patient-centred intervention
supplements standard interventions for depression by tailoring them to individual patients’ stated concerns
and incorporating patient-centred communication skills and cultural sensitivity training for clinicians
Outcomes Primary outcome is change in depression symptom severity (CES-D)
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Cooper 2010 (Continued)
Starting date March 2004, ends March 2007
Contact information Lisa Cooper lisa.cooper@jhmi.edu
Notes CES-D: Centre for Epidemiological Studies Depression; CIDI: Composite International Diagnostic Inter-
view; DSM-IV: Diagnostic and Statistical Manual fourth edition; MDD: major depressive disorder
Freund 2011
Trial name or title Primary care practice-based care management for chronically ill patients (PraCMan): Study protocol for a
cluster-randomised controlled trial
Methods Cluster-randomised controlled trial
Participants Patients had to suffer from at least one of the following index conditions: type 2 diabetesmellitus undermedical
treatment and/or chronic obstructive pulmonary disease under medical treatment and/or chronic heart failure
with confirmed diagnosis by a cardiologist. Further inclusion criteria were: High risk for future hospitalisation
(i.e. predicted likelihood of hospitalisation within the upper quartile of the total patient population) and age
≥ 18 years
Interventions Intervention: PraCMan is a complex care management intervention. Based on the results of a series of
exploratory studies a multifaceted intervention was developed to reduce (avoidable) hospitalisations of high
risk patients. Consists of assessment, planning and monitoring
Control: Practice teams in the control group will continue to provide standard care in the context of the PC-
centred care contract
Outcomes Primary outcome: all-cause hospitalisations. Secondary outcomes: sociodemographic data, mortality, quality
of life, quality of care, depression (PHQ-9), adherence, physical activity, smoking status, self-management,
medication regimen, healthcare costs, activities of daily living, co-morbidity, home visits/practice visits, CHF
decompensation (CHF patients), COPD exacerbation (COPD patients), Hypoglycaemia (DM patients)
, BMI, blood pressure, fasting glucose, Hemoglobin-A1c, Dyspnoea (CHF and COPD patients), Forced
expiratory volume (COPD patients)
Starting date November 2009
Contact information Tobias Freund tobias.freund@med.uni-heidelberg.de
Notes CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; PHQ-9: Patient Health Ques-
tionnaire-9; DM: diabetes mellitus
Gitlin 2012
Trial name or title A community-integrated home based depression intervention for older African Americans: description of the
Beat the Blues randomised trial and intervention costs
Methods Randomised controlled trial
214Collaborative care for depression and anxiety problems (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gitlin 2012 (Continued)
Participants African American, 55 years of age or older, English speaking, cognitively intact, and a score of 5 or over on
the PHQ-9 on two sequential testing occasions
Interventions Intervention: Beat the Blues. Up to 10 one hour sessions over 4 months. Sessions integrate case management,
referral and linkage, depression education, stress reduction techniques and behavioural activation
Control: Waiting list. No study related contact following the baseline interview
Outcomes Depression severity (PHQ-9). Secondary aims quality of life indicators, anxiety, depression education and
behavioural activation levels
Starting date September 2008, ends June 2012
Contact information Laura Gitlin lgitlin1@jhu.edu
Notes PHQ-9: Patient Health Questionnaire-9
Graven 2011
Trial name or title From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention
to reduce depression and facilitate participation post-stroke
Methods Randomised controlled trial
Participants All patients admitted to the inpatient hospital rehabilitation unit with the primary diagnosis of acute cere-
brovascular accident (inclusive of cerebral infarction, intracranial haemorrhage, and subarachnoid haemor-
rhage)
Interventions Intervention: A multi-factorial, integrated approach which incorporates both standardised and responsive
components. Participants receive written material developed by the National Stroke Foundation relating to
recovery after the event of a stroke, written stroke information resources, including contact phone numbers
and websites, if available and a copy of the goals that were collaboratively devised by the participant and
the rehabilitation team during the final two weeks of the inpatient rehabilitation admission. Participants also
receive home visits and telephone contacts
Conrol: Participants in the control group will receive usual care as arranged by the treating team at the point
of discharge from the inpatient rehabilitation admission
Outcomes Primary outcome is depressed mood (GDS-15). Secondary outcomes are: participation (ACS and LHS);
HRQoL (AQoL), activity/functional status (FIM-motor); self-efficacy (SUPPH); and cognition (MMSE)
Starting date March 2008
Contact information Christine Graven Christine.GRAVEN@svhm.org.au; ACS: acute coronary syndrome
Notes HRQoL: health related quality of life; AQoL: Assessment of Quality of Life; LHS: London Handicap Scale;
ACS: Activity Card Sort
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Horn 2007
Trial name or title Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the
general hospital setting, a randomised controlled trial
Methods Randomised controlled trial
Participants All patients visiting the participating departments, who have been diagnosed with a specific chronic disease,
as specified in their files, will be selected. Specific diagnoses are: DM type II in the DM department, COPD
in the pulmonary department, and chronic heart failure or post-acute myocardial infarction in the cardio-
vascular department. Patients will be included in the study if they reach a cutoff score of 15 (moderate to
severe depressive disorder) on the PHQ-9. For patients who reach the cut-off score, the MINI-International
Neuropsychiatric Interview (MINI) will also be held by telephone to classify the symptoms
Interventions Intervention: Based on a collaborative care model including collaboration of the patient with the treatment,
stepped care and collaboration between various medical disciplines. Treatment choices include antidepressant
medication, problem solving and manual-guided self-help
Control: Care as usual. Patients assigned to the care as usual group will be told that they can consult their
general practitioner if they feel that they need treatment, and they will be monitored
Outcomes Depression severity (PHQ-9). Secondary outcome measures: cost-effectiveness, somatoform presentation,
associated symptoms of comorbid chronic illness, preference and adherence, life-events and social support,
personality traits, treatment in the care as usual group
Starting date 2007
Contact information Eva K Horn EHorn@trimbos.nl
Notes COPD: chronic obstructive pulmonary disease; PHQ-9: Patient Health Questionnaire-9; DM: diabetes
mellitus
Ijff 2007
Trial name or title Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the
treatment of major depressive disorder in primary care; a randomised clinical trial
Methods Randomised controlled trial
Participants Patients with a diagnosis of major depressive disorder and who have dysfunction due to this depressive disorder
(i.e. by the loss of role-functioning in daily life). Patients will be included if they reach the cut-off score of 15
on the PHQ-9
Interventions Intervention: Collaborative care. A treatment plan is jointly formulated by the care manager, the patient and
the GP together Treatment choices include PST and antidepressant medication
Control: Care as usual
Outcomes Severity of depression symptoms (PHQ-9). Secondary outcome measures: remission of depression symptoms,
cost-utility and physical comorbidity
Starting date 2007
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Ijff 2007 (Continued)
Contact information Marjoliek A IJff mijff@trimbos.nl
Notes GP: general practitioner; PHQ-9: Patient Health Questionnaire-9; PST: problem solving therapy
Mitchell 2011
Trial name or title A randomised evaluation of collaborative care and active-surveillance for screen-positive elders with sub-
threshold depression (CASPER): study protocol for a randomised controlled trial
Methods Randomised controlled trial
Participants People aged over 75 years with sub-threshold depression assessed using The major depressive episode module
of the Mini International Neuropsychiatric Interview (MINI)
Interventions Intervention: Collaborative care with behavioural activation plus usual GP care intervention: Low intensity
collaborative care which has been designed specifically for those aged 75 or over with subthreshold depression,
over 8-10 weekly sessions. The defining features of collaborative care include a case manager working with
the participant, with access to the GP and a mental health specialist
Control: Usual GP care
Outcomes Depression severity and symptomatology at four months (PHQ-9). Secondary outcomes: depression severity
and symptomatology (at 12 months), binary description of the PHQ-9 (at 4 and 12 months), quality of life
measures (at 4 and 12 months), psychological anxiety (at 4 and 12 months), medication (at 4 and 12 months)
, and mortality (at 4 and 12 months)
Starting date October 2009, end June 2013
Contact information Simon Gilbody simon.gilbody@york.ac.uk
Notes GP: general practitioner; PHQ-9: Patient Health Questionnaire-9
Morgan 2009
Trial name or title The TrueBlue study: Is practice nurse-led collaborative care effective in the management of depression for
patients with heart disease or diabetes?
Methods Cluster-randomised intervention trial
Participants Patients with a diagnosis of CHD or T2 DM, patients who are either under 18 years of age or in residential
care are excluded from the study. Presence of at least mild depression assessed by PHQ-9 of greater than 5
Interventions Intervention: Nurse-led collaborative care. Patients will be invited to attend a practice nurse consultation
every 3 months prior to seeing their usual general practitioner. The PN will assess psychological, physiological
and lifestyle parameters then work with the patient to set management goals. The outcome of this assessment
will form the basis of a GP Management Plan document
Control: Patients will continue to receive their usual care for the first six months of the study before the PNs
undergo the training and switch to the intervention protocol
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Contact information Mark Morgan mark.morgan@greaterhealth.org
Notes CHD: coronary heart disease; GP: general practitioner; PHQ-9: Patient Health Questionnaire-9; DM: dia-
betes mellitus
Muntingh 2009
Trial name or title Collaborative stepped care for anxiety disorders in primary care: aims and design of a randomised controlled
trial
Methods Randomised controlled trial
Participants Patients with a primary diagnosis of PD with or without agoraphobia and/or a primary diagnosis of GAD
according to the criteria of the DSM-IV will be included in the study. Patients who are suicidal, suffer from
dementia or other severe cognitive disorders, psychotic disorder, bipolar disorder, dependence on drugs or
alcohol, or with an unstable severe medical condition as diagnosed by their GP or as assessed in a diagnostic
interview will be excluded. Patients with insufficient knowledge of the Dutch language to fill out the ques-
tionnaires, patients who are already receiving intensive psychological treatment (> 2 contacts per month with
a psychologist or psychiatrist) and patients who are under 18 years of age will also be excluded from the study
Interventions Intervention: Collaborative stepped-care. Care is provided by a team of the GP, the care manager, the patient
and a consultant psychiatrist. The collaborative stepped care intervention is composed of four steps: guided
self-help, CBT, antidepressants, optimisation of medication in primary care or referral to secondary care
Control: Care as usual comprises every form of care the GP is used to offer to his patient (e.g. watchful
waiting, prescription of medication, referral to a mental health care professional or any other form of care the
GP offers to his patient)
Outcomes Anxiety severity (Beck anxiety inventory). Secondary outcome measure: remission. Other outcome measures:
anxiety severity and impairment, physical symptoms, quality of life
Starting date 2009
Contact information Anna DT Muntingh amuntingh@trimbos.nl
Notes CBT: cognitive behaviour therapy; DSM-IV: Diagnostic and Statistical Manual fourth edition; GAD: gen-
eralised anxiety disorder; GP: general practitioner; PD: panic disorder
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Musselman 2006
Trial name or title Depression-Diabetes Mechanisms: Urban African Americans
Methods Randomised controlled trial
Participants Subjects must be English-speaking, African American, have type 2 diabetes per AmericanDiabetes Association
criteria, patient’s receiving care at Grady Hospital
Interventions Intervention: Computer-based cognitive behavioral therapy (CBT) programme entitled ”Beating the Blues“
+ the SSRI antidepressant escitalopram
Control: computer-based cognitive behavioral therapy (CBT) programme entitled ”Beating the Blues“ +
placebo
Outcomes Primary outcomes: Glycemic control: assessed as levels of HbA1c, neurometabolic variables, adherence,
variability in follow-up
Starting date May 2004, end May 2008
Contact information Dominique L Musselman
Notes SSRI: selective serotonin reuptake inhibitor
Pommer 2012
Trial name or title Managing comorbid depression and anxiety in primary care patients with asthma and/or chronic obstructive
pulmonary disease: study protocol for a randomised controlled trial
Methods Randomised controlled trial
Participants Patients included in the AsCoZoB management programme for patients with asthma/COPD are eligible.
Exclusion criteria - aged below 18, currently receiving treatment for depression and/or anxiety, diagnosed
with a psychiatric disorder, suicidal ideation, not being able to read or speak Dutch sufficiently. Depression
and anxiety assessed using the Mini International Neuropsychiatric Interview (MINI)
Interventions Intervention: Disease management condition - stepped care programme consisting of three consecutive steps
and monitoring of results. Stepped care intervention includes psychoeducation, course on coping with de-
pression/anxiety and coaching complemented with antidepressant/anxiolytic medication
Control: Care as usual
Outcomes Primary outcome measures: Depression and anxiety (PHQ-9, GAD-7, MINI) and quality of life/health status
Starting date January 2011, end December 2013
Contact information Francois Pouwer F.Pouwer@uvt.nl
Notes COPD: chronic obstructive pulmonary disease; GAD: generalised anxiety disorder; PHQ-9: Patient Health
Questionnaire-9
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Rollman 2004
Trial name or title Telephone-based care management programme for individuals with anxiety disorders
Methods RCT
Participants 18-64 years, diagnosis of panic disorder or generalised anxiety disorder, score of 7 or higher on the Panic
Disorder Severity Scale OR a score of 14 or higher on the Structured Interview Guide for the Hamilton
Anxiety Scale, life expectancy greater than 1 year, has household telephone, able to read and write in English
Interventions Intervention: Telephone based collaborative care
Usual care: Treatment as usual
Outcomes Primary: Health-related quality of life (SF-36 MCS) at 12 months
Secondary: Clinical (anxiety and depression), alcohol use, health services utilisation, health care costs - all at
12 months
Starting date March 2004 ends December 2012
Contact information Bruce Rollman
Notes
Steel 2011
Trial name or title Randomised controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons
learned
Methods Randomised controlled trial
Participants Inclusion criteria: Biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma; age 18 years or
older; and fluency in English. Exclusion criteria included: current suicidal or homicidal ideation, or current
psychosis, or thought disorder
Interventions Intervention:Collaborative care intervention.Combination of both cognitive-behavioral andpharmacological
treatment. The delivery of the intervention included face-to-face visits whenever the patient came into the
outpatient clinic or hospital for cancer treatment, telephone follow-up with a minimum of two telephone
contacts (before and after the patients’ cancer treatment) between cancer treatments, and access to a website
that was designed specifically for this RCT, which includes educational information, a self-management area,
journaling, a chat room, an audiovisual library, peer support, and other resources
Control: Enhanced usual care
Outcomes Primary outcomes: Depression (CES-D), pain, fatigue, quality of life. Secondary outcomes: Anxiety, sleep
quality, sexual functioning, substance use, healthcare utilisation and satisfaction with healthcare
Starting date 2011
Contact information Jennifer L Steel steeljl@upmc.edu
Notes CES-D: Centre for Epidemiological Studies Depression Scale; RCT: randomised controlled trial
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Stoop 2011
Trial name or title Disease management for comorbid depression and anxiety in diabetes mellitus: design of a randomised
controlled trial in primary care
Methods Randomised controlled trial
Participants Type 2 diabetes mellitus patients, aged 18 or over and with elevated depressive (PHQ-9 score 7 or more)
and/or anxiety symptoms (GAD-7 score 8 or more). Patients are excluded if they currently receive psycho-
logical treatment for their symptoms of depression or anxiety, experience major psychiatric problems, such as
schizophrenia and suicidal ideation, are addicted to alcohol, drugs or gambling, are cognitively impaired, or
are unable to read or speak Dutch sufficiently
Interventions Intervention: DiMaCoDeA-DM2 (disease management intervention for comorbid depression and anxiety in
patients with DM2) - active screening, stepped care treatment and monitoring of depression/anxiety
Control: Care as usual
Outcomes Depression and anxiety (PHQ-9 and GAD-7). Secondary outcomes: Quality of life, health status, diabetes
specific distress, self-management, medication adherence and cost-effectiveness
Starting date January 2011, end December 2013
Contact information Francois Pouwer f.pouwer@uvt.nl
Notes GAD: generalised anxiety disorder; PHQ-9: Patient Health Questionnaire-9; DM: diabetes mellitus
Trinh 2011
Trial name or title A study of a culturally focused psychiatric consultation service for Asian American and Latino American
primary care patients with depression
Methods Randomised controlled trial
Participants Adults who are 18 years of age or older; are members of either targeted Asian American or Latino American
minority groups; screen positive for symptoms of depression; and are able to consent to study participation.
Patients will be excluded if they have active unstable, untreated psychiatric illness precluding participation in
the study (e.g., actively suicidal or homicidal or actively psychotic). Patients in the intervention arm will be
excluded if they have bipolar disorder
Interventions Intervention: Culturally focused psychiatric intervention (CFP). Patients receiving the intervention will un-
dergo aCFP consultation assessment andwill receive a culturally appropriate CFP consultation patient toolkit,
available in their language of preference (i.e. English, Spanish, Chinese, or Vietnamese), as well as training in
using the toolkit materials
Control: Usual care
Outcomes Primary outcomes will determine the feasibility and cost associated with implementation of the service, and
evaluate patient and provider satisfaction with the CFP service
Starting date December 2009, end August 2011
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Trinh 2011 (Continued)
Contact information Nhi-Ha T Trinh ntrinh@partners.org
Notes
Tylee 2011
Trial name or title Up-Beat UK: A programme of research into the relationship between coronary heart disease and depression
in primary care patients
Methods Study design: Pilot randomised controlled trial
Participants Patients aged 16 or older, scoring 3 or more on the PHQ-2, and with symptomatic CHDwill then be assessed
further using the Hospital Anxiety and Depression Scale (HADS). If they score > 9 on the depression scale
of HADS they will be eligible to participate in the study
Exclusion criteria: Temporary registrations, actively suicidal patients, psychotic depression as evidenced by
delusions and/or hallucinations, non-English speaking, participants currently in hospital for treatment of
their CHD
Interventions Intervention: The nature of the intervention will be determined by the results of two qualitative studies
Control: Treatment as usual by GP and any other relevant professionals
Outcomes Primary outcomedepression (Hospital Anxiety andDepression Scale). Secondary outcomes depression,CHD,
quality of life, adherence to medication, life events, social problems, health service utilisation, illness percep-
tions, well-being, and participants problem priorities
Starting date Protocol published 2011
Contact information a.tylee@iop.kcl.ac.uk
Notes CHD: coronary heart disease; HADS: Hospital Anxiety and Depression Scale
Yeung 2011
Trial name or title A study of the effectiveness of telepsychiatry-based culturally sensitive collaborative treatment of depressed
Chinese Americans
Methods Randomised controlled trial
Participants Patients will be included if they are monolingual Chinese Americans, meaning that they require or prefer to
be interviewed in Chinese (Cantonese or Mandarin), are 18 years of age or older, are competent to consent to
study participation,meet criteria forMDDas diagnosed by theMini InternationalNeuropsychiatric Interview
(MINI), receive a score of 10 or greater on the CB-PHQ-9, and are willing to participate in phone interviews
for symptom monitoring, as well as for care management if they are randomised to the treatment group
Interventions Intervention: Telepsychiatry-based Culturally Sensitive Collaborative Treatment (T-CSCT) from a multidis-
ciplinary team involving assessment and care management to
monitor patients’ psychiatric treatment as well as to consolidate and streamline the treatment efforts of the
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Yeung 2011 (Continued)
patient’s PCP and psychiatrist
Control: Usual care
Outcomes Outcome measures include depressive symptom severity (HAM-D) as well as patient and PCP satisfaction
with the telepsychiatry-based care management service
Starting date January 2009, end July 2014
Contact information Albert Yeung ayeung@partners.org
Notes HAM-D: Hamilton Depression Rating Scale; MDD: major depressive disorder; PCP: primary care provider
Zatzick 2011
Trial name or title Enhancing the population impact of collaborative care interventions: mixed method development and im-
plementation of stepped care targeting post-traumatic stress disorder and related comorbidities after acute
trauma
Methods Randomised controlled trial
Participants English-speaking women and men 18 years and older who presented to Harborview with injuries so severe
that they required inpatient surgical admissions. Patients who had suffered head, spinal cord or other severe
injuries that prevented participation in the inpatient ward interview were excluded from the study. Patients
who required immediate intervention (i.e. self-inflicted injury, active psychosis) were referred for evaluation to
the inpatient psychiatric consult service. Patients who were currently incarcerated or who had recent histories
of severe violence were also excluded. Patients living at great distances from the trauma centre (i.e. N50-
100 miles) were excluded as the investigative team anticipated difficulty in long distance care co-ordination
activities
Interventions Intervention: Stepped collaborative care intervention. The intervention included trauma-focused care man-
agement, and an initial choice of starting with either evidence-based pharmacotherapy or CBT targeting
PTSD and related comorbidities
Control: Usual care
Outcomes PTSD symptom reduction (PTSD checklist (PCL) and the Clinician-Administered PTSD Scale (CAPS)).
Secondary outcomes include ratings of substance use and functional outcomes
Starting date 2011
Contact information Douglas Ztzick dzatzick@u.washington.edu
Notes CBT: cognitive behaviour therapy; PTSD: post-traumatic stress disorder
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D A T A A N D A N A L Y S E S
Comparison 1. Collaborative care versus ’usual care’ (adults)




participants Statistical method Effect size
1 Improvement in depression
symptoms
33 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 0 to 6 months 30 5984 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.41, -0.27]
1.2 7 to 12 months 13 4092 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.41, -0.15]
1.3 13 to 24 months 1 1379 Std. Mean Difference (IV, Random, 95% CI) -0.35 [-0.46, -0.24]
1.4 0 to 6 months (cluster
ICC 0.00)
30 6786 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.39, -0.26]
1.5 0 to 6 months (cluster
ICC 0.05)
30 5946 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.41, -0.26]
1.6 0 to 6 months (sensitivity
analysis - cluster comparisons
removed)
21 4361 Std. Mean Difference (IV, Random, 95% CI) -0.37 [-0.46, -0.28]
1.7 0 to 6 months (sensitivity
analysis - comparisons
including patients with physical
comorbidity removed)
23 5082 Std. Mean Difference (IV, Random, 95% CI) -0.29 [-0.37, -0.21]
1.8 0 to 6 months (sensitivity
analysis - comparisons at risk
of bias due to allocation of
concealment removed)
14 3758 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.42, -0.26]
1.9 0 to 6 months (sensitivity
analysis - comparisons at risk
of bias due to loss to follow-up
removed)
27 5793 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.40, -0.26]
1.10 7 to 12 months
(sensitivity analysis -
comparisons with intervention
length > 6 months removed)
6 1300 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.30, -0.08]
2 Depression response 58 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 0 to 6 months 48 11250 Risk Ratio (M-H, Random, 95% CI) 1.32 [1.22, 1.43]
2.2 7 to 12 months 29 8001 Risk Ratio (M-H, Random, 95% CI) 1.31 [1.17, 1.48]
2.3 13 to 24 months 6 2983 Risk Ratio (M-H, Random, 95% CI) 1.29 [1.18, 1.41]
2.4 25+ months 5 943 Risk Ratio (M-H, Random, 95% CI) 1.12 [0.98, 1.27]
2.5 0 to 6 months (cluster
ICC 0.00)
48 13459 Risk Ratio (M-H, Random, 95% CI) 1.32 [1.22, 1.42]
2.6 0 to 6 months (cluster
ICC 0.05)
48 10346 Risk Ratio (M-H, Random, 95% CI) 1.34 [1.23, 1.45]
2.7 0 to 6 months (sensitivity
analysis - cluster comparisons
removed)
39 8500 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.22, 1.49]
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2.8 0 to 6 months (sensitivity
analysis - comparisons
including patients with physical
comorbidity removed)
37 8948 Risk Ratio (M-H, Random, 95% CI) 1.26 [1.16, 1.37]
2.9 0 to 6 months (sensitivity
analysis - comparisons at risk
of bias due to allocation of
concealment removed)
22 5349 Risk Ratio (M-H, Random, 95% CI) 1.37 [1.21, 1.57]
2.10 0 to 6 months (sensitivity
analysis - comparisons at risk
of bias due to loss to follow-up
removed)
35 9267 Risk Ratio (M-H, Random, 95% CI) 1.36 [1.24, 1.49]
2.11 7 to 12 months
(sensitivity analysis -
comparisons with intervention
length > 6 months removed)
11 2514 Risk Ratio (M-H, Random, 95% CI) 1.19 [1.06, 1.34]
3 Antidepressant medication use 55 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 0 to 6 months 44 10117 Risk Ratio (M-H, Random, 95% CI) 1.47 [1.33, 1.63]
3.2 7 to 12 months 26 6486 Risk Ratio (M-H, Random, 95% CI) 1.43 [1.26, 1.61]
3.3 13 to 24 months 6 2963 Risk Ratio (M-H, Random, 95% CI) 1.22 [1.03, 1.45]
3.4 25+ months 3 232 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.87, 1.21]
4 Improvement in anxiety
symptoms
1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 0 to 6 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 7 to 12 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.3 13 to 24 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Anxiety response 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 0 to 6 months 4 1248 Risk Ratio (M-H, Random, 95% CI) 1.50 [1.21, 1.87]
5.2 7 to 12 months 5 1374 Risk Ratio (M-H, Random, 95% CI) 1.41 [1.18, 1.69]
5.3 13 to 24 months 1 804 Risk Ratio (M-H, Random, 95% CI) 1.26 [1.11, 1.42]
6 Anxiety medication use 4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
6.1 0 to 6 months 3 1144 Risk Ratio (M-H, Random, 95% CI) 1.24 [0.93, 1.63]
6.2 7 to 12 months 4 1225 Risk Ratio (M-H, Random, 95% CI) 1.17 [1.03, 1.32]
6.3 13 to 24 months 1 804 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.92, 1.30]
7 Mental QoL 21 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
7.1 0 to 6 months 14 4954 Std. Mean Difference (IV, Random, 95% CI) 0.26 [0.13, 0.38]
7.2 7 to 12 months 11 3534 Std. Mean Difference (IV, Random, 95% CI) 0.20 [0.09, 0.31]
7.3 13 to 24 months 3 1278 Std. Mean Difference (IV, Random, 95% CI) 0.25 [0.08, 0.43]
7.4 25+ months 2 991 Std. Mean Difference (IV, Random, 95% CI) 0.10 [-0.03, 0.23]
8 Physical QoL 15 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 0 to 6 months 10 2957 Std. Mean Difference (IV, Random, 95% CI) 0.06 [-0.01, 0.13]
8.2 7 to 12 months 10 4552 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.04, 0.18]
8.3 13 to 24 months 4 2657 Std. Mean Difference (IV, Random, 95% CI) 0.10 [0.02, 0.17]
9 Patient satisfaction 10 3333 Std. Mean Difference (IV, Random, 95% CI) 0.31 [0.13, 0.49]
10 Patient satisfaction 24 5500 Risk Ratio (M-H, Random, 95% CI) 1.27 [1.18, 1.38]
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Comparison 2. Collaborative care versus ’usual care’ (adolescents)




participants Statistical method Effect size
1 Depression symptoms 2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 0 to 6 months 2 471 Std. Mean Difference (IV, Random, 95% CI) -0.17 [-0.35, 0.01]
1.2 7 to 12 months 1 114 Std. Mean Difference (IV, Random, 95% CI) -0.32 [-0.69, 0.05]
2 Depression 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 0 to 6 months 2 460 Risk Ratio (M-H, Random, 95% CI) 0.73 [0.56, 0.96]
2.2 7 to 12 months 2 441 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.54, 2.06]
2.3 13 to 24 months 1 322 Risk Ratio (M-H, Random, 95% CI) 0.75 [0.51, 1.11]
3 Antidepressant medication use 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
3.1 0 to 6 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.2 7 to 12 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.3 13 to 24 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4 Mental QoL 2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 0 to 6 months 2 471 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.03, 0.33]
4.2 7 to 12 months 2 441 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.24, 0.33]
4.3 13 to 24 months 1 322 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.13, 0.31]
5 Physical QoL 1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
5.1 0 to 6 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5.2 7 to 12 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6 Patient satisfaction 2 471 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.38, 0.57]
Comparison 3. Collaborative care versus feedback (adults)




participants Statistical method Effect size
1 Depression 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 4. Collaborative care versus consultation liaison (adults)




participants Statistical method Effect size
1 Depression 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 7 to 12 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 5. Collaborative care plus consultation liaison versus collaborative care (adults)




participants Statistical method Effect size
1 Depression 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 25+ months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 6. Collaborative care versus enhanced referral (adults)




participants Statistical method Effect size
1 Depression symptoms 1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 7. Collaborative care (psychotherapy) versus collaborative care (medication) (adults)




participants Statistical method Effect size
1 Depression 1 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 7 to 12 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 13 to 24 months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.4 25+ months 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 8. Collaborative care plus psychotherapy versus collaborative care (adults)




participants Statistical method Effect size
1 Depression symptoms 1 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
1.1 0 to 6 months 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2 Depression 3 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 0 to 6 months 2 488 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.97, 1.33]
2.2 7 to 12 months 1 41 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.79, 1.75]
2.3 25+ months 1 137 Risk Ratio (M-H, Random, 95% CI) 1.43 [0.90, 2.26]
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